{
  "meningioma_cases": [
    {
      "demographics": {
        "age": 46,
        "gender": "Female",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increased difficulty concentrating at work on computer screens",
          "Subtle personality changes noted by coworkers - more irritable than usual",
          "Occasional episodes of right-sided facial numbness",
          "Reports feeling more fatigued than usual despite adequate sleep"
        ],
        "medical_history": [
          "Type 2 Diabetes diagnosed 8 years ago - managed with Metformin 1000mg BID",
          "HbA1c consistently maintained around 7.0%",
          "Hypertension diagnosed 5 years ago - controlled with Lisinopril 10mg daily",
          "History of migraine headaches since early 30s, but notes current headaches are different",
          "Laser eye surgery (LASIK) 10 years ago",
          "No history of cancer",
          "Family history significant for breast cancer in mother",
          "Regular health screenings up to date",
          "No known drug allergies"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F46-B-DS\nPrimary Diagnosis: Meningioma\nWHO Grade: II (Atypical Meningioma)\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive neurological symptoms with significant impact on daily functioning\nImaging: Initial MRI reveals a 4.2cm right frontal convexity meningioma with significant peritumoral edema and mass effect on adjacent structures. Evidence of dural tail sign. Non-calcified lesion with heterogeneous enhancement.\n\nAssessment & Plan:\n- Given size >3cm, peritumoral edema, and progressive symptoms, immediate surgical intervention recommended\n- Pre-surgical optimization of diabetes management required\n- Dexamethasone 4mg QID initiated for edema management\n- Surgical planning for gross total resection within 2 weeks\n\nSURGICAL NOTE - March 29, 2018\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade: II\nFindings: Firm, well-circumscribed tumor with significant vascularity\nPathology: WHO Grade II meningioma with increased mitotic activity\n\nFOLLOW-UP VISIT - April 15, 2018\nPost-operative MRI shows near-total resection\nSymptoms improving\nInitiated adjuvant radiation therapy plan: 54 Gy in 30 fractions\n\n6-MONTH FOLLOW-UP - September 2018\nMRI stable\nReturned to work part-time\nHeadaches resolved\nVision normalized\n\nANNUAL FOLLOW-UP - March 2019\nSurveillance MRI: No evidence of recurrence\nFull-time work resumed\nMaintaining good diabetes control\n\n18-MONTH FOLLOW-UP - September 2019\nMRI stable\nAll symptoms resolved\nRegular diabetes monitoring continues\n\n2-YEAR FOLLOW-UP - March 2020\nSurveillance MRI: Small enhancement at resection site\nDecision: Close monitoring with 3-month interval imaging\n\n3-YEAR FOLLOW-UP - March 2021\nMRI shows slight progression of enhancement\nDecision: Gamma Knife radiosurgery to residual tumor\nTreatment completed May 2021\n\n4-YEAR FOLLOW-UP - March 2022\nPost-radiosurgery MRI shows good response\nNo new symptoms\nContinues full work schedule\n\n5-YEAR FOLLOW-UP - March 2023\nStable imaging\nNo cognitive deficits\nExcellent functional status\n\nCURRENT VISIT - March 2024\n6-year follow-up\nMRI remains stable\nMaintaining normal work and activities\nDiabetes well-controlled\n\nFUNCTIONAL STATUS SCORES:\nKarnofsky Performance Status (KPS): 90%\n- Able to carry on normal activity; minor signs/symptoms of disease\n\nECOG Performance Status: 1\n- Restricted in physically strenuous activity but ambulatory and able to carry out light work\n\nONGOING MONITORING PLAN:\n- Biannual MRI surveillance\n- Regular neurocognitive assessments\n- Continued diabetes management\n- Annual ophthalmological evaluation\n- Return to clinic sooner if new symptoms develop\n\nNote: Given patient's cognitive-demanding occupation as a Data Scientist, aggressive early intervention was prioritized to preserve cognitive function and maintain career capabilities. Regular monitoring continues with emphasis on both tumor control and preservation of cognitive function.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n46F, Data Scientist, Blood Type B\nWHO Grade I Meningioma\n\nINITIAL VISIT - January 15, 2018\nMRI FINDINGS:\n- 2.8cm right frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- Dural tail sign present\n- No hydrocephalus\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms but tumor size and location allow for initial conservative management. Occupation requires significant screen time and cognitive focus, which may be impacted by symptoms.\n\nPLAN:\n1. Conservative management with close monitoring\n2. Lifestyle modifications:\n   - Ergonomic workspace assessment\n   - Regular screen breaks\n   - Blue light filtering glasses\n3. Symptom management:\n   - Dexamethasone 4mg daily for edema\n   - Topiramate 50mg BID for headache prophylaxis\n4. Diabetes management coordination with endocrinology\n5. MRI follow-up in 3 months\n\nFOLLOW-UP - April 20, 2018\n- Mild improvement in headaches\n- Vision symptoms stable\n- Tumor size unchanged\n- Continue current management\n- Next MRI in 6 months\n\nFOLLOW-UP - October 15, 2018\n- Symptoms stable\n- No tumor growth\n- Reduced dexamethasone to 2mg daily\n- Continue monitoring\n\nANNUAL FOLLOW-UP - January 2019\n- Stable symptoms\n- MRI shows no progression\n- Maintaining work schedule with accommodations\n- Continue conservative approach\n\nFOLLOW-UP - January 2020\n- Minor headache exacerbation\n- MRI stable\n- Adjusted topiramate to 75mg BID\n- Diabetes remains well-controlled\n\nFOLLOW-UP - January 2021\n- Generally stable condition\n- No significant tumor growth\n- Patient adapted well to remote work during pandemic\n- Continue current management\n\nFOLLOW-UP - January 2022\n- Mild increase in tumor size (3.0cm)\n- Symptoms stable\n- Discussing surgical options but patient prefers continuing conservative approach\n- Increased monitoring frequency\n\nFOLLOW-UP - July 2022\n- No further growth\n- Symptoms managed with current medication regimen\n- Patient maintaining good work-life balance\n\nFOLLOW-UP - January 2023\n- Stable disease\n- Well-adapted to modified work environment\n- Continue current management\n\nLATEST FOLLOW-UP - January 2024\n- Tumor stable at 3.0cm\n- Symptoms well-controlled\n- Patient satisfied with conservative approach\n- Maintaining professional activities with accommodations\n\nCURRENT STATUS:\n- WHO Grade I Meningioma\n- Stable disease under conservative management\n- Well-controlled diabetes (HbA1c 7.1%)\n- Maintained professional activity with modifications\n\nPerformance Status Scores:\n- KPS: 90 (Able to carry on normal activity with minor symptoms)\n- ECOG: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nFUTURE PLAN:\n- Continue biannual MRI monitoring\n- Maintain current medication regimen\n- Annual ophthalmological evaluation\n- Regular endocrinology follow-up for diabetes management\n- Consider surgical intervention only if significant progression or symptom worsening"
      }
    },
    {
      "demographics": {
        "age": 67,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty finding correct words",
          "Subtle right-sided weakness noticed when typing",
          "Balance difficulties when walking, particularly in dimly lit areas",
          "Personality changes noted by family - more irritable and withdrawn",
          "One episode of focal seizure affecting right hand 2 weeks ago"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Mild hearing loss in left ear - diagnosed 5 years ago",
          "Surgical history: Appendectomy (1985)",
          "Previous head trauma from car accident (1992) - no lasting effects",
          "No history of cancer",
          "Family history: Mother had breast cancer",
          "No smoking history",
          "Occasional alcohol use (2-3 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: A+\nOccupation: Software Developer\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms with headaches\n\nIMAGING:\nMRI reveals 4.2cm left frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent motor cortex. T2 hyperintense with heterogeneous enhancement. No calcification noted.\n\nASSESSMENT:\nHigh-risk features present:\n- Size >3cm\n- Significant peritumoral edema\n- Proximity to motor cortex\n- Symptomatic presentation\n- Occupation requires fine motor skills\n\nPLAN:\nRecommend immediate surgical intervention given:\n1. Progressive symptoms\n2. Location affecting motor function critical for occupation\n3. Size and mass effect\nWHO Grade: Pending surgical pathology\n\n-------------------\n\nSURGICAL NOTE - April 2, 2014\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology: WHO Grade II meningioma\nPost-op course: Uncomplicated\n\n-------------------\n\nFOLLOW-UP - May 15, 2014\nPatient recovering well\nMinimal residual weakness\nAdjuvant radiation therapy initiated: 60 Gy in 30 fractions\n\n-------------------\n\n6-MONTH FOLLOW-UP - October 2014\nMRI: No evidence of recurrence\nSymptoms improved\nReturned to work with accommodations\n\n-------------------\n\nANNUAL FOLLOW-UP - April 2015\nMRI: Stable\nNeurological exam: Normal\nContinue q6month monitoring\n\n-------------------\n\n2016-2019: Bi-annual MRI surveillance\nAll stable without evidence of recurrence\nRegular neuropsychological testing normal\n\n-------------------\n\nFOLLOW-UP - March 2020\nSmall area of enhancement noted on MRI\nRecommend stereotactic radiosurgery to residual/recurrent tumor\nGamma Knife performed: 16 Gy single fraction\n\n-------------------\n\n2021-2024: Continued surveillance\nQ6month MRI: Stable post-radiosurgery\nAnnual neuropsychological testing\nPatient maintains full-time employment\nLast visit (January 2024): No evidence of progression\n\nCURRENT STATUS (2024):\n- Functionally independent\n- Working full-time\n- Driving independently\n- Minor right hand dexterity issues managed with ergonomic modifications\n\nPERFORMANCE SCORES:\nKPS: 90 (Able to carry on normal activity, minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nMONITORING PROTOCOL:\n- Continue q6month MRI\n- Annual neuropsychological assessment\n- Regular occupational therapy evaluation for fine motor skills\n- Blood pressure monitoring\n\nNote: Proactive intervention strategy with early surgery and adjuvant radiation has resulted in good disease control and maintained professional functionality for this patient.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n==================================================\n\nINITIAL VISIT - March 15, 2014\n-----------------------------\nPATIENT: 67-year-old male software developer\nDIAGNOSIS: Right frontal parasagittal meningioma (WHO Grade I)\nMRI FINDINGS: 3.2 cm contrast-enhancing extra-axial mass with moderate peritumoral edema, dural tail sign present\n\nPRESENTING SYMPTOMS: Progressive neurological symptoms including headaches, visual disturbance, focal weakness, and recent seizure activity significantly impacting work performance and quality of life.\n\nASSESSMENT & PLAN:\nGiven symptom severity and tumor size/location, conservative surgical resection recommended despite general preference for watchful waiting. Patient's occupation requires fine motor skills and cognitive clarity.\n\nSURGICAL INTERVENTION - April 2, 2014:\nSimpson Grade II resection performed. Post-operative course uncomplicated.\n\nFOLLOW-UP VISITS:\n-----------------\n\nOctober 2014 (6-month):\n- Significant improvement in presenting symptoms\n- No new neurological deficits\n- MRI: No residual/recurrent tumor\n- Returned to work part-time\n- KPS: 90\n\nApril 2015 (1-year):\n- Maintained improvement\n- Seizure-free on levetiracetam\n- MRI: Stable post-surgical changes\n- Working full-time\n- KPS: 95\n\nApril 2016 (2-year):\n- Asymptomatic\n- MRI: No recurrence\n- Reduced levetiracetam dosage\n- KPS: 100\n\nApril 2017 (3-year):\n- Continues asymptomatic\n- MRI: Stable\n- Discontinued levetiracetam\n- KPS: 100\n\nApril 2018 (4-year):\n- Minor occasional headaches\n- MRI: Stable\n- Recommended stress reduction techniques\n- KPS: 95\n\nApril 2019 (5-year):\n- Well-controlled symptoms\n- MRI: Small area of enhancement at resection site\n- Watchful waiting approach maintained\n- KPS: 95\n\nApril 2021 (7-year):\n- Stable symptoms\n- MRI: No progression of enhancement\n- Biennial monitoring initiated\n- KPS: 95\n\nApril 2023 (9-year):\n- Maintains good function\n- MRI: Stable\n- Continues software development work\n- KPS: 90\n\nJanuary 2024 (Current):\n- Stable neurological status\n- MRI: No significant changes\n- Maintains active lifestyle\n- KPS: 90\n\nCURRENT STATUS:\n---------------\n- WHO Grade: I\n- KPS Score: 90/100\n- ECOG Score: 1\n- Follow-up: Continue biennial MRI\n- Occupational status: Active software developer\n- Quality of life: Well-maintained\n\nMANAGEMENT RECOMMENDATIONS:\n--------------------------\n1. Biennial MRI surveillance\n2. Regular cognitive assessment\n3. Ergonomic workplace modifications\n4. Stress management techniques\n5. Regular exercise program\n6. Sleep hygiene optimization\n7. Annual ophthalmological examination\n\nLIFESTYLE MODIFICATIONS:\n-----------------------\n1. Regular breaks during computer work\n2. Blue light filtering glasses\n3. Proper workstation ergonomics\n4. Maintain consistent sleep schedule\n5. Moderate caffeine intake\n\nThe patient has maintained excellent functional status with minimal intervention post-initial resection. Conservative management strategy has proven successful with good quality of life preservation and continued professional activity."
      }
    },
    {
      "demographics": {
        "age": 69,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": "Food Critic",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion when writing financial reports",
          "Subtle personality changes noted by family - increased irritability",
          "Balance difficulties when walking, particularly noticeable during restaurant visits",
          "Intermittent right-sided facial numbness",
          "Mild nausea without vomiting",
          "Recent difficulty concentrating during food tastings"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Osteoporosis diagnosed 3 years ago - on calcium supplements",
          "Successful cataract surgery left eye (2019)",
          "History of migraine headaches in 40s-50s, resolved spontaneously",
          "Mild hearing loss in right ear - diagnosed 2 years ago",
          "No prior surgeries except cataract removal",
          "No history of cancer",
          "Family history significant for mother with breast cancer"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 69, Female, Blood Type: A\nOccupation: Financial Analyst/Food Critic\n\nINITIAL VISIT - March 15, 2014\nPresenting Symptoms: Progressive headaches, right eye visual disturbance, cognitive changes affecting work performance, balance issues, right facial numbness. Symptoms significantly impacting both professional roles.\n\nImaging:\n- MRI reveals 4.2cm right sphenoid wing meningioma with significant mass effect\n- Moderate peritumoral edema\n- Compression of right optic nerve\n- No calcification noted\nWHO Grade: II (atypical features on imaging)\n\nAssessment & Plan:\nGiven size, location, and symptom progression, recommend immediate surgical intervention. Patient's dual professional roles require optimal cognitive function and sensory acuity.\n\nSURGICAL INTERVENTION - April 2, 2014\n- Simpson Grade II resection achieved\n- Post-op imaging shows small residual tumor along cavernous sinus\n- Pathology confirms WHO Grade II meningioma\n\nFOLLOW-UP VISITS:\n\nJune 15, 2014 (2.5 months post-op)\n- Improved vision and balance\n- Residual mild facial numbness\n- Started adjuvant radiation therapy\n\nDecember 2014 (8 months post-op)\n- Completed radiation therapy (54 Gy/30 fractions)\n- Return to work part-time\n- MRI: Stable residual tumor\n\nJune 2015\n- Full return to work\n- Minor visual complaints\n- MRI: No progression\n\n2016-2017 (q6 month monitoring)\n- Stable symptoms\n- Regular MRIs show no progression\n- Successfully managing both career roles\n\n2018\n- New onset occasional headaches\n- MRI shows small area of enhancement\n- Increased monitoring frequency\n\n2020\n- Mild tumor progression noted\n- Second surgical intervention performed\n- Simpson Grade III resection\n\n2022\n- Post-second surgery stability\n- Quarterly MRI monitoring\n- Maintained professional activities with accommodations\n\n2024 (Current Status)\n- Stable disease\n- Continues bi-annual MRI surveillance\n- Managing modified work schedule\n\nCurrent Performance Status:\nKPS Score: 80 (Normal activity with effort)\nECOG Score: 1 (Restricted in physically strenuous activity)\n\nTreatment Strategy Summary:\n- Aggressive initial surgical approach\n- Early radiation therapy\n- Frequent imaging surveillance\n- Prompt intervention for progression\n- Occupational considerations prioritized throughout treatment\n\nMonitoring Protocol:\n- MRI every 6 months\n- Ophthalmology evaluation quarterly\n- Neurocognitive testing annually\n- Quality of life assessments\n\nProfessional Impact Considerations:\n- Modified work schedule to accommodate treatment\n- Cognitive rehabilitation to maintain financial analysis skills\n- Adapted food criticism schedule around treatment\n- Ergonomic workplace modifications implemented",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 69-year-old female, Blood Type A\nOccupation: Financial Analyst/Food Critic\n\nPRESENTING SYMPTOMS:\nProgressive neurological symptoms including headaches, right-sided visual disturbance, cognitive changes affecting work performance, and balance issues impacting daily activities.\n\nIMAGING:\nMRI reveals a 2.8cm right frontal convexity meningioma with minimal surrounding edema. No significant mass effect. WHO Grade I characteristics.\n\nASSESSMENT & PLAN:\nGiven patient's age, tumor characteristics, and complex professional demands requiring cognitive precision, recommending initial conservative management with close monitoring.\n\nMANAGEMENT STRATEGY:\n1. Watchful waiting with serial imaging\n2. Symptomatic management:\n   - Dexamethasone 4mg daily for edema control\n   - Prophylactic anticonvulsant not indicated\n3. Occupational modifications recommended:\n   - Reduced work hours\n   - Regular breaks during food tastings\n   - Written documentation assistance\n\nFOLLOW-UP SCHEDULE:\nMRI every 4 months initially, then spacing based on stability.\n\n-------------------\n\nFOLLOW-UP VISIT - July 20, 2018\nStable symptoms. Minor improvement in headaches with steroid therapy.\nMRI: No significant change in tumor size.\nPlan: Continue conservative management.\n\n-------------------\n\nANNUAL REVIEW - March 12, 2019\nSymptoms stable. Successfully adapted work routine.\nMRI: Minimal growth (0.2cm in 12 months).\nPlan: Maintain current approach. Extend MRI interval to 6 months.\n\n-------------------\n\nFOLLOW-UP - March 5, 2020\nMinor progression of visual symptoms.\nMRI: Tumor size 3.0cm, minimal progression.\nPlan: Continue monitoring. Ophthalmology consultation added.\n\n-------------------\n\nFOLLOW-UP - February 10, 2021\nStable symptoms with good functional status.\nMRI: No significant change.\nPlan: Annual MRI schedule implemented.\n\n-------------------\n\nANNUAL REVIEW - February 15, 2022\nWell-adapted to modified work schedule.\nMRI: Stable appearance.\nPlan: Continue annual monitoring.\n\n-------------------\n\nANNUAL REVIEW - March 8, 2023\nMaintaining good quality of life. Still active in modified work capacity.\nMRI: Stable disease.\nPlan: Maintain current management approach.\n\n-------------------\n\nLATEST REVIEW - January 15, 2024\nSix-year follow-up shows successful conservative management.\nMRI: No significant progression since 2021.\nExcellent functional status maintained.\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nSUMMARY:\nConservative management strategy has proven successful over 6-year period. Patient has maintained professional activities with modifications and preserves good quality of life. Continued annual monitoring recommended.\n\nWHO Grade: I (Based on imaging characteristics)\nCurrent Tumor Size: 3.0cm (stable)\nNext Follow-up: January 2025"
      }
    },
    {
      "demographics": {
        "age": 53,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": "Chef",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": true,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly severe in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea and vomiting, initially attributed to pregnancy",
          "Increasing difficulty with balance while working in kitchen",
          "Recent personality changes noted by coworkers - more irritable and having trouble concentrating",
          "Two episodes of focal seizures affecting left hand in past month",
          "Occasional ringing in right ear"
        ],
        "medical_history": [
          "BMI 34.2 - Class I Obesity",
          "Currently 24 weeks pregnant (G2P1)",
          "Previous uncomplicated pregnancy 5 years ago",
          "History of migraine headaches, but notes current headaches are different",
          "Surgical history: Appendectomy (2005)",
          "No prior neurological conditions",
          "Family history significant for breast cancer in mother",
          "No history of radiation exposure",
          "Taking prenatal vitamins and occasional acetaminophen for headaches",
          "No known drug allergies"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Critical to preserve olfactory function",
            "Coordinated care with obstetrics",
            "Timing surgery for second trimester if possible"
          ],
          "monitoring_plan": "Monthly olfactory function tests, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly olfactory function tests, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 53 | Sex: F | Blood Type: O\nOccupation: Chef\nPrimary Diagnosis: Meningioma\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms during pregnancy\nImaging: MRI reveals 4.2cm right frontal convexity meningioma with significant peritumoral edema\nWHO Grade: II (atypical features on imaging)\nAssessment: Given size, symptoms, and pregnancy status, immediate intervention warranted\nPlan: \n- Scheduled for surgical resection post-pregnancy (week 32)\n- Dexamethasone 4mg QID for edema management\n- Weekly neurological monitoring\n- Coordination with high-risk OB\n\nSURGICAL NOTE - July 2, 2014 (32 weeks gestation)\nProcedure: Right frontal craniotomy for tumor resection\nFindings: Simpson Grade II resection achieved\nPathology: WHO Grade II meningioma confirmed\nPost-op course: Uncomplicated\n\nFOLLOW-UP - September 15, 2014\nStatus: Successful delivery of healthy infant\nSymptoms: Marked improvement in headaches and vision\nMRI: No residual tumor\nPlan: q3 month MRI surveillance\n\nFOLLOW-UP - March 2015\nSymptoms: Stable\nMRI: No recurrence\nPlan: Continue surveillance\n\nANNUAL FOLLOW-UP - March 2016\nNew symptoms: Mild right-sided headaches\nMRI: Small enhancement at surgical site\nPlan: Increased monitoring frequency\n\nFOLLOW-UP - September 2016\nSymptoms: Progressive headaches\nMRI: 1.2cm recurrence\nPlan: SRS scheduled\n\nSRS TREATMENT - October 2016\nDose: 16 Gy single fraction\nTarget: Recurrent tumor\n\nFOLLOW-UP - March 2017\nSymptoms: Improved\nMRI: Stable post-radiation changes\n\nANNUAL FOLLOW-UPS 2018-2020\nStatus: Stable disease\nMRI: No progression\nOccupational status: Returned to work with modifications\n\nFOLLOW-UP - March 2021\nSymptoms: New onset occasional dizziness\nMRI: Small area of enhancement\nPlan: Continued close monitoring\n\nCURRENT STATUS (2024)\nDisease Status: Stable with periodic monitoring\nWork Status: Modified duties as chef\nQuality of Life: Good\n\nFunctional Status Scores:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nTreatment Summary:\n- Initial Simpson Grade II resection (2014)\n- Salvage SRS for recurrence (2016)\n- Ongoing surveillance\n\nRecommendations:\n- Continue biannual MRI\n- Annual neuropsychological testing\n- Maintain modified work schedule\n- Regular exercise and weight management program\n\nNote: Aggressive early intervention strategy was successful in managing this WHO Grade II meningioma in a pregnant patient with multiple risk factors. Occupation as chef influenced treatment timing due to safety concerns with balance issues.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nPrimary Diagnosis: Right Parasagittal Meningioma\nWHO Grade: I (Benign)\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms during pregnancy\nImaging: MRI reveals 2.8cm right parasagittal meningioma with minimal surrounding edema\nAssessment: Given patient's pregnancy status (24 weeks) and presenting symptoms, careful monitoring with delayed intervention approach recommended.\nPlan: \n- Monthly clinical monitoring through pregnancy\n- Dexamethasone 4mg BID to manage edema and symptoms\n- Levetiracetam 500mg BID for seizure prophylaxis\n- Coordinate care with high-risk OB\n\nFOLLOW-UP - July 10, 2014\nStatus: Post successful delivery\nSymptoms: Moderate improvement in headaches, stable vision\nImaging: Follow-up MRI shows stable tumor size\nPlan: Continue conservative management with quarterly monitoring\n\nANNUAL FOLLOW-UP - March 2015\nSymptoms: Well-controlled with medication\nImaging: MRI stable at 2.9cm\nOccupational Assessment: Able to continue work as chef with modifications\nPlan: Maintain current medication regimen\n\nFOLLOW-UP - March 2016\nStatus: Stable symptoms\nImaging: MRI shows minimal growth (3.0cm)\nPlan: \n- Continue levetiracetam\n- Reduce dexamethasone dose\n- Weight management program referral\n\nFOLLOW-UP - March 2017\nStatus: Good symptom control\nImaging: No significant change\nOccupational: Full work capacity maintained\nPlan: Annual MRI surveillance\n\nFOLLOW-UP - March 2018\nStatus: Stable\nImaging: No progression\nQuality of Life: Excellent\nPlan: Continue annual monitoring\n\nFOLLOW-UP - March 2020\nStatus: Stable symptoms\nImaging: Minimal growth to 3.1cm\nPlan: Maintain conservative approach\n\nFOLLOW-UP - March 2022\nStatus: Well-controlled\nImaging: Stable\nPlan: Continue annual surveillance\n\nMOST RECENT VISIT - March 2024\nStatus: Maintained stable course over 10 years\nImaging: No significant progression\nCurrent Medications: Levetiracetam 500mg BID\nOccupational Status: Continues work as chef with full capacity\nPlan: Continue annual MRI surveillance\n\nPerformance Status Scores:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nKey Management Decisions:\n1. Conservative management chosen due to:\n   - Pregnancy at presentation\n   - Stable tumor size\n   - Well-controlled symptoms\n   - Patient preference\n2. Regular monitoring schedule\n3. Medication optimization\n4. Lifestyle modifications including weight management\n5. Occupational adjustments as needed\n\nLong-term Outcome: Successful conservative management with preserved quality of life and occupational function over 10-year period."
      }
    },
    {
      "demographics": {
        "age": 53,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": true
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of loss of balance during stage performances",
          "Intermittent right-sided facial numbness",
          "Increased difficulty memorizing performance lines over past 2 months",
          "Occasional nausea without vomiting', \"Reports 'ringing in right ear' starting 3 months ago\""
        ],
        "medical_history": [
          "Migraine headaches since age 35, well-controlled with sumatriptan",
          "Hysterectomy at age 45 for uterine fibroids",
          "History of hormone replacement therapy for 5 years post-hysterectomy",
          "Mild hypertension managed with lifestyle modifications",
          "No history of cancer",
          "No significant head trauma",
          "No family history of brain tumors",
          "Regular vision checks due to profession, last exam 1 year ago was normal"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly balance/coordination tests, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly balance/coordination tests, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nGender: Female | Age: 53 | Blood Type: A\nOccupation: Stage Artist\n\nINITIAL VISIT - March 15, 2018\nChief Complaints: Progressive neurological symptoms including headaches, right-sided visual and balance disturbances\nMRI Findings: 4.2cm right sphenoid wing meningioma with significant mass effect and perilesional edema\nWHO Grade: II (atypical features noted)\nTreatment Plan: Recommend immediate surgical intervention due to size, location, and progressive symptoms\n\nSURGICAL NOTE - April 2, 2018\nProcedure: Right frontotemporal craniotomy for tumor resection\nSimpson Grade: II\nFindings: Firm, well-circumscribed tumor with dural attachment\nPost-op Status: Stable, minimal residual tumor (<5%)\n\nFOLLOW-UP - July 15, 2018 (3 months post-op)\nStatus: Improved symptoms, residual mild facial numbness\nMRI: Small residual enhancement\nPlan: Adjuvant radiotherapy recommended\nStarted fractionated RT (54 Gy/30 fractions)\n\nFOLLOW-UP - January 10, 2019 (9 months post-op)\nStatus: Good recovery, returned to stage work\nMRI: Stable residual enhancement\nPlan: Continue q6month monitoring\n\n2020 VISITS:\n- March 15: Stable imaging, no new symptoms\n- September 20: Minor enhancement growth noted\nPlan: Increased monitoring frequency\n\n2021 VISITS:\n- January 15: New 8mm nodular enhancement\n- March 30: Gamma Knife radiosurgery to residual tumor\n- September 15: Post-radiosurgery imaging stable\n\n2022-2023 VISITS (q6month):\nAll visits showed stable disease without progression\nMinor memory complaints addressed with cognitive rehabilitation\n\nCURRENT VISIT - January 15, 2024\nStatus: Maintaining professional career\nMRI: No evidence of progression\nSymptoms: Occasional mild headaches, well-controlled\n\nONGOING MANAGEMENT:\n- MRI surveillance q6months\n- Regular cognitive assessment\n- Balance therapy as needed\n- Occupational therapy for performance optimization\n\nFunctional Status Scores:\nKPS: 90 (Able to perform normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nNote: Aggressive initial approach with early surgical intervention and adjuvant therapy has allowed patient to maintain professional career with minimal limitations. Continue vigilant monitoring due to WHO Grade II status.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 53-year-old female stage artist\nChief Complaints: Progressive neurological symptoms including headaches, visual changes, balance issues\n\nIMAGING FINDINGS:\nMRI reveals a 2.8cm right sphenoid wing meningioma with minimal peritumoral edema. Mass demonstrates typical \"dural tail\" sign. No significant mass effect on adjacent structures.\n\nASSESSMENT:\nWHO Grade I meningioma (presumptive radiological diagnosis)\nSymptoms likely attributable to tumor location\nKPS: 80/100\nECOG: 1\n\nMANAGEMENT PLAN:\nGiven patient's profession requiring fine balance and cognitive function, recommending close monitoring rather than immediate surgical intervention. Tumor size just below critical 3cm threshold.\n\nRECOMMENDATIONS:\n1. MRI surveillance every 4 months for first year\n2. Anti-epileptic prophylaxis not indicated at present\n3. Dexamethasone 4mg daily for symptom management\n4. Referral to neuro-ophthalmology for baseline assessment\n5. Continue current migraine management\n\nFOLLOW-UP VISIT - July 20, 2018\nStable symptoms. Minor improvement in headaches with dexamethasone.\nMRI: No significant change in tumor size\nPlan: Continue conservative management\n\nFOLLOW-UP - November 15, 2018\nReports better balance during performances\nMRI: Stable lesion\nReduced dexamethasone to 2mg daily\n\nANNUAL REVIEW - March 10, 2019\nMaintaining performance schedule with adaptations\nMRI: Minimal growth (0.2mm)\nKPS: 85/100\nPlan: Continue monitoring, extend MRI interval to 6 months\n\nFOLLOW-UP - September 12, 2019\nStable symptoms\nMRI: No change\nMaintaining work schedule with modifications\n\n2020 VISITS (March 15, September 20)\nCOVID-19 telemed consultations\nStable symptoms\nMRI: No significant changes\nProfessional activity reduced due to pandemic\n\n2021 ANNUAL REVIEW - March 18\nReturn to stage work\nMRI: Stable disease\nKPS: 85/100\nPlan: Annual MRI if remains stable\n\n2022 REVIEW - March 25\nWell-compensated\nMRI: No growth\nManaging performance schedule effectively\nKPS: 90/100\n\n2023 REVIEW - April 2\nContinued stability\nMRI: Unchanged from baseline\nSuccessfully adapted performance techniques\nKPS: 90/100\n\n2024 CURRENT STATUS (January 15)\n6-year follow-up\nMRI: Stable disease\nExcellent functional status\nContinuing professional career\nKPS: 90/100\nECOG: 0\n\nSUMMARY OF MANAGEMENT APPROACH:\nSuccessfully managed with conservative approach\nNo significant tumor progression over 6 years\nMaintained professional career with adaptations\nQuality of life preserved\nRegular monitoring proved effective\n\nCURRENT SCORES:\nKarnofsky Performance Status (KPS): 90/100\nECOG Performance Status: 0\n\nFUTURE PLAN:\nContinue annual MRI surveillance\nMaintain current management strategy\nRegular neuro-ophthalmology follow-up\nMonitor for any new symptoms"
      }
    },
    {
      "demographics": {
        "age": 43,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Difficulty concentrating at work, especially when reviewing financial documents",
          "Occasional ringing in right ear",
          "Reports feeling more irritable and having mood changes",
          "Two episodes of seizure-like activity in the past month"
        ],
        "medical_history": [
          "BMI 33.2 (Obese Class I)",
          "Mild hypertension diagnosed 2 years ago, not currently on medication",
          "History of chronic tension headaches treated with OTC medications",
          "Concussion from sports injury in college (age 20)",
          "Occasional migraine episodes (1-2 times per year)",
          "No prior surgeries",
          "No family history of brain tumors or neurological conditions",
          "Current medications: occasional ibuprofen for headaches",
          "Social history: non-smoker, occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M43-O-2014\nOccupation: Financial Analyst\n\nINITIAL VISIT - March 15, 2014\nPresenting Symptoms: Progressive headaches, right eye visual disturbance, concentration difficulties, seizure-like episodes. Symptoms significantly impacting work performance.\nMRI Findings: 4.2cm right frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe. Enhancement pattern consistent with meningioma.\nAssessment: WHO Grade II meningioma (based on imaging characteristics)\nPlan: Recommend immediate surgical intervention given size, symptoms, and occupation requiring high cognitive function.\nKPS: 80/100\n\nSURGICAL NOTE - April 2, 2014\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology: WHO Grade II atypical meningioma\nPost-op course: Uncomplicated\n\nFOLLOW-UP - July 15, 2014\nStatus: Improved headaches, vision stabilized\nPlan: Adjuvant radiation therapy recommended\nStarted 54 Gy/30 fractions\n\n2015 VISITS:\nJanuary 15: Post-radiation follow-up\n- Minimal residual enhancement\n- Continuing q3 month MRI surveillance\n- Return to work approved\nKPS: 90/100\n\nJuly 20: Stable imaging\n- Maintaining work performance\n- Regular cognitive assessments initiated\n\n2016 VISITS:\nJanuary 10: Small area of enhancement noted\nJune 15: Enhancement stable\nDecember 20: No progression\nKPS: 90/100\n\n2017 VISITS:\nJune 10: Stable imaging\nDecember 12: Minor enhancement progression\n- Increased surveillance recommended\nKPS: 85/100\n\n2018 VISITS:\nMarch 15: Second surgery for recurrence\nJuly 10: Post-op follow-up\nDecember 5: Clean margins on imaging\nKPS: 85/100\n\n2019-2020:\nQuarterly MRI surveillance\n- Stable disease\n- Maintaining work function\nKPS: 90/100\n\n2021-2022:\nBiannual monitoring\n- No evidence of recurrence\n- Weight management program initiated\nKPS: 95/100\n\n2023-2024:\nAnnual surveillance\n- Disease stable\n- Patient fully functional at work\nCurrent KPS: 95/100\nCurrent ECOG: 1\n\nTREATMENT SUMMARY:\n- Initial presentation 2014: WHO Grade II meningioma\n- Two surgical interventions (2014, 2018)\n- Complete course of radiation therapy\n- Successful disease control with proactive monitoring\n- Patient maintains high-level cognitive function required for financial analysis work\n\nFinal Scores:\nKarnofsky Performance Status (KPS): 95/100\nECOG Performance Status: 1\n\nRecommendations:\n1. Continue annual MRI surveillance\n2. Regular cognitive assessment\n3. Weight management program\n4. Maintain seizure prophylaxis\n5. Annual ophthalmological examination\n\nNote: Aggressive initial intervention and close monitoring have resulted in excellent outcome with maintained professional functionality.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n43-year-old male, Financial Analyst\nBlood Type: O\nBMI: 33.2\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm right frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (likely)\n- No critical structure involvement\n\nASSESSMENT:\nPatient presents with concerning neurological symptoms but tumor characteristics favor conservative management. Given tumor size <3cm and minimal edema, watchful waiting approach is appropriate with close monitoring.\n\nMANAGEMENT PLAN:\n1. Conservative monitoring with serial MRIs\n2. Anticonvulsant therapy: Levetiracetam 500mg BID\n3. Lifestyle modifications:\n   - Weight management program referral\n   - Stress reduction techniques\n   - Regular breaks during computer work\n4. Occupational adjustments recommended:\n   - Screen magnification for financial document review\n   - Regular vision breaks\n   - Flexible work hours\n\nFOLLOW-UP VISITS:\n\nSeptember 18, 2018 (6-month)\n- Headaches improved with medication management\n- Vision stable\n- MRI: No significant change\n- Continuing conservative management\n\nMarch 12, 2019 (1-year)\n- Seizures well-controlled on Levetiracetam\n- Weight loss of 5kg noted\n- MRI: Stable lesion size\n- Added: Propranolol 40mg daily for headache prophylaxis\n\nMarch 10, 2020 (2-year)\n- Improved concentration at work\n- MRI: Minimal growth (0.2mm)\n- Maintained conservative approach\n- BP better controlled with lifestyle changes\n\nMarch 16, 2021 (3-year)\n- Stable symptoms\n- MRI: No change\n- Patient adapted well to work modifications\n- Reduced Levetiracetam to 250mg BID due to stability\n\nMarch 15, 2022 (4-year)\n- Occasional mild headaches\n- MRI: Stable\n- Maintaining good work-life balance\n- Weight stabilized at BMI 31.5\n\nMarch 14, 2023 (5-year)\n- All symptoms well-controlled\n- MRI: No progression\n- Excellent compliance with medication\n- Transitioned to biennial MRI schedule\n\nMarch 12, 2024 (6-year)\n- Continued stability\n- Patient satisfied with conservative approach\n- Maintaining full-time work with accommodations\n- Next MRI scheduled for March 2026\n\nCURRENT STATUS:\n- Stable WHO Grade I meningioma\n- Well-controlled symptoms\n- Excellent functional status\n- Successfully managing work responsibilities\n\nFUNCTIONAL STATUS SCORES:\nKPS (Karnofsky Performance Status): 90\n- Able to carry on normal activity with minor symptoms\n\nECOG Performance Status: 1\n- Restricted in physically strenuous activity but ambulatory and able to carry out light work\n\nONGOING RECOMMENDATIONS:\n1. Continue biennial MRI surveillance\n2. Maintain current medication regimen\n3. Regular ophthalmology checks\n4. Continue lifestyle modifications\n5. Annual neurological assessments\n6. Stress management and cognitive monitoring\n\nNote: Conservative management has proven successful with this patient, demonstrating stable disease and good quality of life maintenance while continuing professional activities."
      }
    },
    {
      "demographics": {
        "age": 65,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": "Food Critic",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent changes in sense of taste and smell affecting work performance",
          "Episodes of nausea without vomiting",
          "Increasing difficulty with balance when walking",
          "Subtle personality changes noted by family - more irritable and forgetful",
          "Visual disturbances - occasional blurring in right visual field",
          "Intermittent ringing in right ear"
        ],
        "medical_history": [
          "Hypertension - diagnosed 8 years ago, managed with lisinopril",
          "Migraine headaches in 30s-40s, resolved spontaneously",
          "Cholesterol elevation - on atorvastatin 20mg daily",
          "BMI 33.2 - attempted weight management programs without sustained success",
          "Osteoarthritis in both knees",
          "No prior surgeries",
          "No history of cancer",
          "No family history of brain tumors",
          "Former smoker - quit 15 years ago"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly olfactory function tests, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly olfactory function tests, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 65\nGender: Female\nOccupation: Food Critic\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms including headaches, taste/smell changes, and visual disturbances\n\nMRI FINDINGS:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on frontal lobe with 5mm midline shift\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Additional 1.2 cm satellite lesion in right temporal region\n\nASSESSMENT:\nGiven patient's symptom progression, tumor size, and occupation-critical sensory changes, immediate surgical intervention recommended. High-risk features include size >3cm, peritumoral edema, and multiple neurological symptoms.\n\nTREATMENT PLAN:\n1. Schedule urgent surgical resection within 2 weeks\n2. Simpson Grade I resection planned\n3. Pre-operative optimization of blood pressure\n4. Dexamethasone 4mg QID to manage edema\n\nFOLLOW-UP VISIT - April 30, 2014 (6 weeks post-op)\n- Successful gross total resection achieved\n- Pathology confirmed WHO Grade II atypical meningioma\n- Adjuvant radiation therapy recommended\n- Started 60 Gy/30 fractions\n\nFOLLOW-UP - October 15, 2014 (6 months post-op)\n- Completed radiation therapy\n- Improvement in taste/smell function\n- Headaches resolved\n- MRI shows no residual/recurrent tumor\n- Continue q6month surveillance\n\nANNUAL FOLLOW-UP - April 2015\n- Stable MRI\n- Return to work full-time as food critic\n- Minor radiation-related fatigue resolved\n- Weight management program initiated\n\n2016-2017 (Bi-annual visits)\n- Serial MRIs stable\n- No new neurological symptoms\n- Maintaining professional activities\n- Weight stable at BMI 32.1\n\n2018-2019\n- Small enhancement noted on right temporal region\n- Close monitoring with 3-month MRI intervals\n- Gamma Knife radiosurgery to temporal lesion (14 Gy)\n\n2020-2021\n- Stable post-radiosurgery\n- Annual MRI surveillance\n- No functional limitations\n- BP well-controlled\n\n2022-2023\n- Continued stability\n- Return to q6month imaging\n- Maintaining professional activities\n- Weight reduction to BMI 30.8\n\nCURRENT STATUS (2024)\n- 10-year follow-up\n- No evidence of recurrence\n- Fully functional in occupation\n- Regular imaging surveillance maintained\n\nFUNCTIONAL STATUS:\nKPS Score: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nONGOING RECOMMENDATIONS:\n1. Continue bi-annual MRI surveillance\n2. Regular neurocognitive assessments\n3. Maintain BP control\n4. Weight management program\n5. Annual comprehensive neurological examination\n\nWHO Grade: II (Atypical Meningioma)\nSimpson Resection Grade: I\n\nNote: Aggressive early intervention strategy proved successful in maintaining patient's critical professional functions and quality of life over 10-year follow-up period.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 65, Female\nBlood Type: O\nOccupation: Food Critic\nBMI: 33.2\n\nINITIAL VISIT - January 15, 2014\nChief Complaint: Progressive neurological symptoms including headaches and sensory changes\n\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (likely)\n- No calcification noted\n\nASSESSMENT:\nGiven patient's symptoms and tumor characteristics, recommending conservative management with close monitoring. Occupation as food critic makes preservation of taste/smell function critical to quality of life.\n\nPLAN:\n1. Serial MRI monitoring\n2. Dexamethasone 4mg daily for symptom management\n3. Referral to neuro-ophthalmology\n4. BP management optimization with PCP\n5. Weight management program referral\n\nFOLLOW-UP VISIT - July 20, 2014\n- Stable symptoms\n- MRI shows no growth\n- Reduced steroid dose to 2mg daily\n- KPS 90\n\nANNUAL FOLLOW-UP - January 12, 2015\n- Improved headaches\n- Stable tumor size\n- Maintaining work schedule\n- Continue current management\n\nFOLLOW-UP - January 18, 2016\nMRI: No significant change\nSymptoms: Generally stable\nAdded: Memantine for cognitive support\nKPS 85\n\nFOLLOW-UP - February 3, 2017\n- Minimal tumor growth (0.2cm)\n- Stable symptoms\n- Continue conservative approach\n- Enhanced focus on lifestyle modifications\n\nFOLLOW-UP - March 15, 2018\n- Stable disease\n- Weight loss program showing modest success\n- BMI reduced to 31.8\n- KPS 85\n\nFOLLOW-UP - April 2, 2019\n- No tumor progression\n- Maintaining work activities\n- Added: Balance therapy\n- KPS 80\n\nFOLLOW-UP - May 10, 2020\n- Stable imaging\n- COVID-19 considerations discussed\n- Telehealth follow-up implemented\n- KPS 80\n\nFOLLOW-UP - June 8, 2021\n- Minor progression (0.3cm growth)\n- Discussed radiation options but continuing observation\n- Enhanced monitoring schedule\n- KPS 75\n\nFOLLOW-UP - July 12, 2022\n- Stable disease\n- Managing work with accommodations\n- Continue conservative approach\n- KPS 75\n\nMOST RECENT VISIT - September 15, 2023\n- Stable tumor size\n- Maintaining acceptable quality of life\n- Continues food critic work part-time\n- KPS 70\n\nCURRENT STATUS (2024):\n- Total observation period: 10 years\n- Overall stable disease course\n- Successfully maintained professional activities\n- Conservative management approach validated\n\nFUNCTIONAL SCORES:\n- Karnofsky Performance Status (KPS): 70/100\n- ECOG Performance Status: 2\n\nMANAGEMENT SUMMARY:\nConservative approach has proven appropriate with:\n1. Minimal intervention\n2. Quality of life preservation\n3. Continued professional activity\n4. Adequate symptom management\n5. Regular monitoring\n6. Lifestyle modifications\n\nNext follow-up scheduled for March 2024 with repeat MRI.\n\nWHO Grade: I (Presumptive based on imaging characteristics)"
      }
    },
    {
      "demographics": {
        "age": 58,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Food Critic",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating during work tasks over past 2 months",
          "Mild right-sided facial numbness",
          "Reports feeling off-balance when walking, especially in dim lighting"
        ],
        "medical_history": [
          "Hypertension - diagnosed 5 years ago, managed with lisinopril",
          "Migraine headaches since age 35 - previously well-controlled with sumatriptan",
          "BMI 33.2 - attempted weight loss programs without sustained success",
          "Surgical history: Cholecystectomy (2015)",
          "Family history: Mother with breast cancer",
          "No history of smoking",
          "Occasional alcohol use (1-2 glasses of wine weekly)",
          "Regular computer use 8+ hours daily for work"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 58\nGender: Female\nBlood Type: O\nOccupation: Software Developer/Food Critic\nBMI: 33.2\n\nINITIAL VISIT - March 15, 2014\nIMAGING FINDINGS:\nMRI reveals a 4.2cm right frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe with 5mm midline shift. T2 hyperintense with heterogeneous enhancement. No calcification noted.\n\nASSESSMENT:\nWHO Grade II meningioma (atypical features on imaging)\nHigh-risk features:\n- Size >3cm\n- Significant peritumoral edema\n- No calcification\n- Critical location affecting visual pathways\n- Symptomatic presentation\n\nTREATMENT PLAN:\nRecommend immediate surgical intervention given:\n1. Progressive neurological symptoms\n2. Size and location\n3. Impact on patient's cognitive-demanding occupation\n4. Risk of further visual deterioration\n\n-------------------\n\nSURGICAL NOTE - April 2, 2014\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nEstimated blood loss: 300cc\nNo immediate complications\nPathology confirms WHO Grade II meningioma\n\n-------------------\n\nFOLLOW-UP VISIT - July 15, 2014 (3 months post-op)\nImproved headaches and vision\nMRI shows post-surgical changes\nInitiated adjuvant radiation therapy (60 Gy/30 fractions)\nReturn to work planned for September\n\n-------------------\n\nFOLLOW-UP - January 10, 2015 (9 months post-op)\nComplete radiation course finished\nMinimal residual symptoms\nMRI stable\nCleared for full work duties\n\n-------------------\n\nSURVEILLANCE VISIT - July 2015\nMRI stable\nMinor fatigue reported\nContinue q6month monitoring\n\n-------------------\n\n2016-2018 (q6month visits)\nSerial MRIs stable\nNo new symptoms\nMaintaining work schedule\nRegular cognitive assessments normal\n\n-------------------\n\nMarch 2019 (5-year surveillance)\nSmall focus of enhancement noted on MRI\n2mm nodule at resection margin\nClose monitoring recommended\n\n-------------------\n\nSeptember 2019\nEnhancement increased to 8mm\nRecommend repeat surgical intervention\n\n-------------------\n\nSECOND SURGERY - November 12, 2019\nSimpson Grade I resection\nPathology confirms recurrent WHO Grade II meningioma\n\n-------------------\n\n2020-2024 (q6month surveillance)\nNo evidence of recurrence\nAnnual neuropsychological testing stable\nMaintaining full work schedule\nWeight management program initiated\n\nCURRENT STATUS (2024):\nDisease-free\nFull functional status\nRegular imaging surveillance continues\n\nPERFORMANCE SCORES:\nKPS: 90 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nONGOING RECOMMENDATIONS:\n1. Continue q6month MRI surveillance\n2. Annual neuropsychological testing\n3. Regular ophthalmological exams\n4. Weight management program\n5. Occupational stress management\n6. Consider prophylactic anti-epileptics\n\nNote: Aggressive initial approach and careful surveillance led to early detection of recurrence and successful re-intervention. Patient's high-functioning occupational demands and obesity were considered in treatment planning.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nPrimary Occupation: Software Developer/Food Critic\nWHO Grade: I (based on imaging characteristics)\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive headaches, visual changes, balance issues\nImaging: MRI reveals 2.4cm left frontal convexity meningioma, minimal surrounding edema\nAssessment: Given size <3cm and minimal edema, candidate for conservative management\nPlan: Watchful waiting approach with close monitoring\n- Dexamethasone 4mg daily for symptom management\n- Continue lisinopril for HTN\n- Ergonomic workplace assessment recommended\nKPS: 90 ECOG: 1\n\nFOLLOW-UP - September 20, 2014\nInterval imaging: Stable size\nSymptoms: Improved headaches with medical management\nPlan: Continue conservative approach\n- Dexamethasone taper\n- Occupational therapy referral for balance training\nKPS: 90 ECOG: 1\n\nANNUAL FOLLOW-UP - March 18, 2015\nImaging: No significant change (2.5cm)\nSymptoms: Well-controlled\nRecommendations:\n- Modified work schedule with regular breaks\n- Blue light filters for computer work\n- Weight management program referral\nKPS: 90 ECOG: 1\n\nANNUAL FOLLOW-UP - March 22, 2016\nImaging: Stable (2.5cm)\nNote: Patient reports improved work-life balance\nPlan: Continue annual monitoring\n- Added vitamin D supplementation\nKPS: 90 ECOG: 1\n\nANNUAL FOLLOW-UP - March 15, 2017\nImaging: Minimal growth (2.6cm)\nSymptoms: Stable\nPlan: Maintain conservative approach\n- Sleep hygiene optimization\n- Stress management techniques\nKPS: 90 ECOG: 1\n\nANNUAL FOLLOW-UP - March 20, 2018\nImaging: Stable (2.6cm)\nNote: Successfully implemented workplace modifications\nPlan: Continue annual surveillance\nKPS: 90 ECOG: 1\n\nANNUAL FOLLOW-UP - March 19, 2019\nImaging: Stable (2.6cm)\nSymptoms: Well-managed\nPlan: Transition to biennial imaging\n- Continue current management\nKPS: 90 ECOG: 1\n\nBIENNIAL FOLLOW-UP - March 23, 2021\nImaging: Stable (2.6cm)\nNote: Excellent compliance with conservative management\nPlan: Maintain current approach\nKPS: 90 ECOG: 1\n\nBIENNIAL FOLLOW-UP - March 21, 2023\nImaging: Stable (2.6cm)\nSymptoms: Well-controlled\nPlan: Continue biennial monitoring\n- Regular lifestyle modifications maintained\nKPS: 90 ECOG: 1\n\nCURRENT VISIT - January 15, 2024\nImaging: No significant change (2.6cm)\nOverall Status: Excellent outcome with conservative management\nPlan: Continue biennial monitoring\n- Maintain current lifestyle modifications\n- Next follow-up scheduled for March 2025\n\nSUMMARY OF MANAGEMENT APPROACH:\n- Successfully managed with conservative approach over 10-year period\n- Minimal tumor growth\n- Excellent symptom control through lifestyle modifications\n- Occupational adjustments successfully implemented\n- Quality of life preserved with continued professional activities\n\nCurrent Status:\nKPS (Karnofsky Performance Status): 90 - Able to carry on normal activity with minor symptoms\nECOG (Eastern Cooperative Oncology Group): 1 - Restricted in physically strenuous activity but ambulatory and able to carry out light work\n\nNote: Conservative management has proven highly successful in this case, with stable disease and maintained quality of life over a 10-year period. Patient's compliance and adaptation to lifestyle modifications have contributed significantly to the positive outcome."
      }
    },
    {
      "demographics": {
        "age": 62,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work, especially when reading code",
          "Mild right-sided facial numbness",
          "Balance issues when walking, particularly noticeable in last 2 months"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches in 30s-40s, resolved spontaneously",
          "Surgical menopause at age 48 (total hysterectomy due to fibroids)",
          "Hormone replacement therapy for 5 years post-hysterectomy",
          "Osteoarthritis in right knee",
          "No history of cancer",
          "No significant head trauma",
          "Family history negative for brain tumors"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 62\nGender: Female\nBlood Type: O\nOccupation: Software Developer\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive headaches, visual changes, cognitive symptoms\n\nIMAGING:\nMRI with/without contrast reveals:\n- 4.2 cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Evidence of dural tail sign\n\nASSESSMENT:\nGiven patient's occupation requiring high cognitive function and progressive neurological symptoms, immediate surgical intervention recommended. Size and location of tumor with associated edema warrant aggressive approach.\n\nPLAN:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative optimization with dexamethasone 4mg QID\n3. Detailed neuropsychological testing pre-surgery\n4. WHO Grade to be determined post-resection\n\nSURGICAL NOTE - March 29, 2018\n- Simpson Grade II resection achieved\n- Minimal blood loss (300cc)\n- No complications\nPathology: WHO Grade II (Atypical) Meningioma\n\nFOLLOW-UP VISITS:\n\nJune 15, 2018 (2.5 months post-op)\n- Improved headaches\n- Vision stabilized\n- Starting return-to-work protocol\n- MRI: No residual tumor\nPLAN: Adjuvant radiotherapy recommended - 54Gy/30fx\n\nDecember 2018 (9 months post-op)\n- Completed RT\n- Returned to full-time work\n- Minor fatigue\n- MRI: No recurrence\n\nJune 2019\n- Stable symptoms\n- Cognitive function improved\n- MRI: No recurrence\nPLAN: Continue q6month monitoring\n\nDecember 2019\n- Maintaining work performance\n- No new symptoms\n- MRI: Stable\n\nJune 2020\n- Stable examination\n- MRI: Small enhancement at surgical site (7mm)\nPLAN: Increased monitoring frequency\n\nDecember 2020\n- Enhancement stable\n- No new symptoms\nPLAN: Continue vigilant monitoring\n\nJune 2021\n- Growth of enhancement (now 12mm)\nPLAN: Stereotactic radiosurgery to residual tumor\n\nDecember 2021\n- Post-SRS\n- Good response\n- MRI: Decreased enhancement\n\n2022-2024 (Quarterly visits)\n- Stable disease\n- Maintaining work performance\n- Annual neuropsychological testing showing preserved function\n- MRI: No progression\n\nCURRENT STATUS (2024):\n- Disease stable\n- Working full-time\n- Independent in all activities\n\nFunctional Status Scores:\n- Karnofsky Performance Status (KPS): 90/100\n- ECOG Performance Status: 1\n\nMONITORING PROTOCOL:\n1. MRI every 4 months\n2. Neuropsychological testing annually\n3. Ophthalmology evaluation q6months\n4. Regular cognitive function assessment related to work performance\n\nLong-term prognosis remains guarded due to WHO Grade II status, but patient has responded well to aggressive multimodal treatment approach.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 62\nGender: Female\nOccupation: Software Developer\n\nINITIAL VISIT - January 15, 2018\nPresenting Symptoms: Progressive headaches, right eye visual disturbance, nausea, personality changes, concentration difficulties, right facial numbness, and balance issues. Symptoms significantly impact work performance as software developer.\n\nMRI Findings:\n- 2.8cm left frontal parasagittal meningioma\n- Moderate peritumoral edema\n- No significant mass effect\n- WHO Grade I (likely)\n\nAssessment:\nDespite symptomatic presentation, given tumor size <3cm and patient's preference for conservative management, recommending close monitoring with option for intervention if progression occurs.\n\nManagement Plan:\n1. Dexamethasone 4mg BID for symptom management\n2. Monthly clinical assessment for first 3 months\n3. Quarterly MRI for first year\n4. Ophthalmology referral for visual symptoms\n5. Occupational therapy for balance issues\n6. Ergonomic workplace assessment\n\nFOLLOW-UP - April 20, 2018\nSymptoms improved with steroid therapy. Visual symptoms stable.\nMRI: No significant change\nPlan: Continue current management, begin steroid taper\n\nFOLLOW-UP - January 10, 2019\nStable symptoms. Successfully tapered off steroids.\nMRI: No growth\nPlan: Continue monitoring, extend to 6-monthly MRI\n\nFOLLOW-UP - July 15, 2019\nMinor headache exacerbation\nMRI: Minimal growth (2.9cm)\nPlan: Continue conservative management, maintain current follow-up schedule\n\nFOLLOW-UP - January 20, 2020\nStable symptoms\nMRI: No further growth\nPlan: Annual MRI if remains stable\n\nFOLLOW-UP - January 25, 2021\nWell-controlled symptoms\nMRI: Stable at 2.9cm\nPlan: Continue annual monitoring\n\nFOLLOW-UP - February 2, 2022\nReports improved work performance with adapted computer setup\nMRI: No change\nPlan: Maintain current management\n\nFOLLOW-UP - January 30, 2023\nStable clinical picture\nMRI: No growth, some calcification noted\nPlan: Continue annual monitoring\n\nFOLLOW-UP - January 15, 2024\nMinimal symptoms, well-adapted to condition\nMRI: Stable lesion, increased calcification\nPlan: Consider biennial MRI given long-term stability\n\nCurrent Status:\n- Tumor stable\n- Symptoms well-managed\n- Maintaining full-time work with accommodations\n- Good quality of life\n\nFunctional Status Scores:\nKPS: 90 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nConservative management has proven successful with this patient, demonstrating that careful monitoring and symptom management can be an effective approach in selected cases of WHO Grade I meningiomas."
      }
    },
    {
      "demographics": {
        "age": 53,
        "gender": "Female",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work, especially when reading",
          "Reports feeling off-balance when walking, particularly when turning",
          "Intermittent right-sided facial numbness"
        ],
        "medical_history": [
          "Hypertension - diagnosed 5 years ago, managed with lisinopril",
          "BMI 33.2 - Class I Obesity",
          "Migraine headaches since age 35, but notes current headaches are different",
          "Surgical history: Cholecystectomy (2012)",
          "No history of cancer",
          "No previous neurological conditions",
          "Family history significant for breast cancer in mother",
          "Current medications: Lisinopril 10mg daily, multivitamin"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F53-B-2014\nOccupation: Librarian\nBMI: 33.2\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms with headaches\nWHO Grade: II (confirmed post-resection)\n\nIMAGING FINDINGS:\n- MRI reveals 4.2cm left frontal convexity meningioma\n- Significant perilesional edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern suggests possible WHO Grade II\n- Evidence of dural tail sign\n\nASSESSMENT:\nPatient presents with concerning neurological symptoms affecting quality of life and work performance. Given tumor size, location, and symptom progression, immediate surgical intervention recommended.\n\nTREATMENT PLAN:\n1. Schedule gross total resection within 2 weeks\n2. Pre-operative optimization of blood pressure\n3. Discussed risks/benefits with patient\n4. Occupational considerations: visual/cognitive demands of librarian role warrant aggressive approach\n\n-------------------\n\nPOST-OPERATIVE VISIT - April 12, 2014\n- Simpson Grade II resection achieved\n- Pathology confirms WHO Grade II meningioma\n- Minimal post-operative complications\n- Adjuvant radiation therapy recommended\n\n-------------------\n\nFOLLOW-UP - October 15, 2014\n- Post-radiation assessment\n- Improved neurological symptoms\n- MRI shows no residual tumor\n- Return to work planned with modifications\n\n-------------------\n\nSURVEILLANCE VISIT - April 20, 2015\n- 6-month MRI: No recurrence\n- Headaches resolved\n- Vision normalized\n- Continuing q6month monitoring\n\n-------------------\n\nANNUAL REVIEW - April 15, 2016\n- MRI stable\n- Working full-time\n- Minor fatigue managed with lifestyle modifications\n- BP well-controlled\n\n-------------------\n\n2-YEAR FOLLOW-UP - May 10, 2017\n- Surveillance MRI: Small enhancement at resection margin\n- Close monitoring recommended\n- Increased scan frequency to q4months\n\n-------------------\n\nURGENT ASSESSMENT - February 12, 2018\n- New enhancement on MRI\n- Early recurrence suspected\n- Second surgery planned\n\n-------------------\n\nPOST-SECOND SURGERY - March 20, 2018\n- Simpson Grade I resection achieved\n- Pathology confirms recurrent WHO Grade II\n- Additional course of radiation recommended\n\n-------------------\n\n5-YEAR SURVEILLANCE - April 15, 2019\n- Stable imaging\n- Excellent functional status\n- Maintaining work schedule\n- Annual MRI protocol initiated\n\n-------------------\n\nLATEST FOLLOW-UP - January 10, 2024\n- 10-year surveillance\n- No evidence of recurrence\n- Fully functional at work\n- Continues annual monitoring\n\nFUNCTIONAL STATUS SCORES:\n- Karnofsky Performance Status (KPS): 90/100\n- ECOG Performance Status: 1\n\nMONITORING PROTOCOL:\n- Annual MRI with contrast\n- Quarterly neurological examinations\n- Regular cognitive assessments\n- Quality of life questionnaires\n\nNote: Aggressive early intervention and close monitoring have resulted in good disease control despite initial WHO Grade II status and one recurrence. Patient maintains high functional status and continues professional activities with minimal limitations.",
        "conservative": "CLINICAL NOTES - MENINGIOMA CASE MANAGEMENT\nPatient ID: F53-B-2014\nOccupation: Librarian\nWHO Grade: I (Benign meningioma)\n\nINITIAL VISIT - March 15, 2014\n----------------------------------------\nIMAGING: MRI reveals 2.8cm right sphenoid wing meningioma with minimal peritumoral edema. No significant mass effect on adjacent structures. T2 sequence shows moderate signal intensity.\n\nASSESSMENT: Given patient's stable neurological status despite symptoms, obesity-related surgical risks, and tumor characteristics, recommending conservative management with close monitoring.\n\nPLAN:\n- MRI surveillance every 6 months initially\n- Dexamethasone 4mg BID for symptom management, tapering schedule provided\n- Referral to neuro-ophthalmology for baseline visual assessment\n- Continue current hypertension management\n- Weight management referral\n\nFOLLOW-UP - September 20, 2014\n----------------------------------------\nSymptoms improved with steroid therapy. Vision stable. Headaches reduced.\nMRI: No significant change in tumor size or characteristics.\nPlan: Continue monitoring, gradual steroid taper.\n\nANNUAL VISIT - March 15, 2015\n----------------------------------------\nPatient reports good functional status at work. Minor visual symptoms persist but stable.\nMRI: Tumor stable at 2.8cm, no new edema.\nImplemented workplace ergonomic modifications for reading tasks.\n\nFOLLOW-UP - March 10, 2016\n----------------------------------------\nMinor progression of headaches.\nMRI: Minimal growth to 2.9cm, stable edema.\nAdded prophylactic topiramate for headache management.\n\nANNUAL VISIT - March 18, 2017\n----------------------------------------\nPatient maintaining work schedule with accommodations.\nMRI: Stable at 2.9cm.\nReduced topiramate dose due to side effects.\n\nBIENNIAL VISIT - March 22, 2019\n----------------------------------------\nGood symptom control. Working full-time.\nMRI: No significant change.\nMaintained conservative approach.\n\nFOLLOW-UP - March 15, 2021\n----------------------------------------\nReports increased fatigue but managing daily activities.\nMRI: Tumor stable at 2.9cm.\nAdded balance therapy exercises.\n\nRECENT VISIT - January 10, 2024\n----------------------------------------\nMaintaining stable quality of life. Minor visual symptoms persist but accommodated.\nMRI: No significant change over 10-year period.\nContinue current management plan.\n\nFUNCTIONAL STATUS SCORES:\n- Karnofsky Performance Status (KPS): 90\n- ECOG Performance Status: 1\n\nMANAGEMENT SUMMARY:\nConservative approach successful over 10-year period. Patient maintained occupational function with accommodations. Minimal intervention required beyond symptomatic management. Obesity remains a consideration for surgical risk assessment.\n\nKEY INTERVENTIONS:\n1. Regular MRI surveillance\n2. Symptomatic medication management\n3. Workplace ergonomic adaptations\n4. Balance therapy\n5. Weight management support\n\nRECOMMENDATIONS:\nContinue biennial MRI surveillance unless new symptoms develop. Maintain current medication regimen. Annual ophthalmology assessment."
      }
    },
    {
      "demographics": {
        "age": 62,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of right-sided facial numbness",
          "Occasional balance difficulties when walking",
          "Increasing fatigue and difficulty concentrating",
          "Two episodes of nausea and vomiting in past month",
          "Mild personality changes noted by family (more irritable)"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches (different from current headaches) - managed with sumatriptan PRN",
          "Total hysterectomy at age 45 for fibroids",
          "Osteoarthritis in right knee",
          "No history of cancer",
          "No significant family history of brain tumors",
          "Former smoker - quit 15 years ago",
          "Regular mammograms and colonoscopy screenings up to date"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F62-O\nInitial Visit: March 15, 2014\n\nINITIAL CONSULTATION:\n62-year-old female presenting with progressive neurological symptoms suggestive of intracranial mass. Symptoms indicate potential mass effect and increased ICP.\n\nIMAGING:\nMRI w/ & w/o contrast reveals:\n- 4.2 cm extra-axial mass in right frontal convexity\n- Significant peritumoral edema\n- Mass effect with 6mm midline shift\n- Dural tail sign present\n- Enhancement pattern consistent with meningioma\nWHO Grade: II (atypical features noted)\n\nASSESSMENT & PLAN:\nGiven size, symptoms, and location, immediate surgical intervention recommended. Patient is good surgical candidate with controlled comorbidities.\n\nSURGICAL INTERVENTION: April 2, 2014\n- Simpson Grade II resection performed\n- Pathology confirms WHO Grade II meningioma\n- Post-op course uncomplicated\n\nFOLLOW-UP VISITS:\n\nJuly 2014 (3-month):\n- Improved symptoms\n- No new neurological deficits\n- Started adjuvant radiation therapy (60 Gy/30 fx)\n\nJanuary 2015 (9-month):\n- MRI shows no recurrence\n- Minor residual edema\n- Symptoms resolved\n- Continuing q6mo monitoring\n\nJuly 2015:\n- Stable imaging\n- No new symptoms\n- KPS 90\n\nJanuary 2016:\n- Small enhancement at resection margin\n- Close monitoring warranted\n- Consider SRS for focal area\n\nJuly 2016:\n- Enhancement stable\n- Continuing surveillance\n- No new symptoms\n\n2017-2019 (q6mo visits):\n- Serial MRIs show stability\n- One episode of breakthrough headache (2018) - resolved\n- Maintained good functional status\n\nJanuary 2020:\n- New 1.2cm nodular enhancement\n- Recommended SRS to focal area\n- Treatment completed March 2020\n\n2021-2023 (q6mo visits):\n- Post-SRS response satisfactory\n- No progression\n- Maintained independent functioning\n\nLatest Visit (January 2024):\n- Stable disease\n- Continuing surveillance\n- Patient maintains active lifestyle\n- No cognitive decline\n\nCURRENT STATUS:\nKPS Score: 90/100\nECOG Score: 1\n\nMONITORING PROTOCOL:\n- MRI q6mo\n- Neurological examination q6mo\n- Annual neuropsychological testing\n- Quality of life assessments\n\nOCCUPATIONAL CONSIDERATIONS:\nPatient is retired teacher but active in community volunteering. Treatment timing and modality selected to maintain cognitive function and social engagement.\n\nPROGNOSIS:\nGuarded but favorable with continued close monitoring. Patient demonstrates good response to aggressive initial management and subsequent focal treatment.\n\n/Dr. [Assistant Name]\nNeurosurgery Department\nBoard Certified Neurosurgeon\nLicense #[xxxxx]",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nGender: Female\nAge at Presentation: 62\n\nINITIAL VISIT - January 15, 2018\nChief Complaint: Progressive headaches, visual changes, facial numbness\n\nIMAGING:\nMRI reveals a 2.8cm right sphenoid wing meningioma with minimal surrounding edema. WHO Grade I characteristics. No significant mass effect on adjacent structures.\n\nASSESSMENT:\nPatient presents with symptomatic meningioma but good functional status. Given size <3cm and minimal edema, conservative management initially recommended with close monitoring.\n\nPLAN:\n1. Serial MRI monitoring every 6 months\n2. Dexamethasone 4mg BID for symptom management\n3. Neurology referral for headache management\n4. Ophthalmology evaluation for visual symptoms\n5. Continue current medications\n\nFOLLOW-UP VISIT - July 20, 2018\nMild improvement in headaches with steroid therapy. Vision stable.\nMRI: No significant change in tumor size.\nPlan: Gradual steroid taper, continue monitoring\n\nFOLLOW-UP VISIT - January 10, 2019\nSymptoms stable. Managing daily activities well.\nMRI: Stable lesion size, minimal edema\nPlan: Continue conservative management\n\nFOLLOW-UP VISIT - January 15, 2020\nReports good quality of life, working part-time.\nMRI: Minor growth (0.2cm), no new concerns\nPlan: Maintain current approach, increase monitoring frequency\n\nFOLLOW-UP VISIT - July 20, 2020\nSlight increase in headache frequency\nMRI: No significant change\nAdded: Topiramate 25mg daily for headache prophylaxis\n\nFOLLOW-UP VISIT - January 12, 2021\nStable symptoms, good medication tolerance\nMRI: Stable disease\nPlan: Continue current management\n\nFOLLOW-UP VISIT - January 18, 2022\nWell-controlled symptoms\nMRI: No progression\nPlan: Extend monitoring interval to annual\n\nFOLLOW-UP VISIT - January 15, 2023\nMaintaining good functional status\nMRI: Stable disease\nPlan: Continue annual monitoring\n\nMOST RECENT VISIT - January 10, 2024\nAge now: 68\nSymptoms well-controlled\nMRI: No significant change from previous\nPlan: Continue annual monitoring, maintain current medications\n\nFUNCTIONAL STATUS SCORES:\nKarnofsky Performance Status (KPS): 90\n(Able to carry on normal activity; minor signs/symptoms of disease)\n\nECOG Performance Status: 1\n(Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nMANAGEMENT RATIONALE:\nConservative approach chosen based on:\n1. Stable tumor size\n2. Well-controlled symptoms with medical management\n3. Patient preference\n4. Age and comorbidity considerations\n5. Preservation of quality of life\n6. Successful symptom management with medications\n\nRECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain current medications\n3. Regular ophthalmology follow-up\n4. Annual cognitive assessment\n5. Return sooner if new symptoms develop"
      }
    },
    {
      "demographics": {
        "age": 67,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Food Critic",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion while writing software code",
          "Subtle personality changes noted by coworkers - increased irritability",
          "Mild right-sided facial numbness",
          "Balance difficulties when walking, particularly noticeable during restaurant visits",
          "Intermittent nausea without vomiting"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Surgical menopause - total hysterectomy at age 45 for fibroids",
          "History of migraine headaches in 30s-40s, resolved",
          "Osteoporosis diagnosed 2 years ago - taking alendronate weekly",
          "No prior neurological conditions",
          "No history of cancer",
          "Family history significant for mother with breast cancer",
          "No prior radiation exposure to head/neck"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nOccupation: Software Developer/Food Critic\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms with headaches and visual changes\n\nIMAGING:\nMRI reveals 4.2cm left frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe with 5mm midline shift. T2 hyperintense with heterogeneous enhancement. No calcification noted.\n\nASSESSMENT:\nWHO Grade II meningioma (based on imaging characteristics)\nSymptomatic with multiple concerning features warranting immediate intervention\nKPS: 80/100\nECOG: 1\n\nPLAN:\n1. Scheduled for surgical resection within 2 weeks\n2. Pre-operative optimization with dexamethasone 4mg QID\n3. Discussed occupational impact - recommended medical leave\n\nSURGICAL NOTE - April 1, 2014\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nMinimal residual tumor at superior sagittal sinus interface\nPathology confirms WHO Grade II atypical meningioma\n\nFOLLOW-UP - July 15, 2014 (3 months post-op)\nImproved symptoms\nMRI shows small residual enhancement\nInitiated adjuvant radiation therapy\nKPS: 90/100\n\nFOLLOW-UP - January 10, 2015\nCompleted radiation therapy (60 Gy/30 fractions)\nMinor radiation-related fatigue\nNo tumor progression\nCleared to return to work part-time\n\nFOLLOW-UP - July 2015\nStable imaging\nResumed full work duties\nMonitoring cognitive function for programming work\n\nANNUAL FOLLOW-UP - April 2016\nMRI stable\nNo new symptoms\nRegular cognitive assessments continue\n\nFOLLOW-UP - October 2017\nSmall area of enhancement noted\nClose monitoring implemented\nIncreased scan frequency to every 4 months\n\nFOLLOW-UP - February 2018\nGrowth of residual tumor\nDecision for repeat surgery\n\nSECOND SURGERY - March 2018\nSimpson Grade I resection achieved\nPathology confirms recurrent WHO Grade II\n\nFOLLOW-UP - September 2018\nPost-radiation therapy course completed\nNo residual enhancement\n\nANNUAL FOLLOW-UPS 2019-2024:\n- Quarterly MRI surveillance\n- Stable disease\n- Maintained work activities with modifications\n- Regular cognitive assessments\n- No significant progression\n\nCURRENT STATUS (2024):\nDisease stable\nRegular MRI surveillance continues\nMaintaining professional activities with accommodations\n\nFINAL SCORES:\nKPS: 90/100\nECOG: 1\n\nMONITORING PROTOCOL:\n- MRI every 4 months\n- Quarterly neurocognitive assessments\n- Regular ophthalmological evaluations\n- Quality of life assessments focusing on work performance\n- Balance assessments\n\nOCCUPATIONAL CONSIDERATIONS:\n1. Modified work schedule to accommodate fatigue\n2. Regular breaks during coding sessions\n3. Ergonomic workplace modifications\n4. Restaurant reviews scheduled during optimal energy periods",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nOccupation: Software Developer/Food Critic\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive headaches, visual changes, cognitive symptoms\n\nIMAGING:\nMRI reveals a 2.8cm left frontal convexity meningioma with minimal surrounding edema. WHO Grade I characteristics. No significant mass effect on adjacent structures.\n\nASSESSMENT:\n67-year-old female presenting with symptomatic meningioma. Given size (<3cm), imaging characteristics suggesting WHO Grade I, and patient's preference for conservative management, recommending close monitoring with consideration for intervention if progression occurs.\n\nPLAN:\n1. Watchful waiting approach with serial imaging\n2. Dexamethasone 4mg daily for symptom management\n3. Monthly neurology follow-up initially\n4. Occupational therapy referral for workplace adaptations\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - September 20, 2014\nSymptoms stable with steroid therapy. MRI shows no tumor growth.\nPlan: Continue current management, begin steroid taper.\nKPS: 85 ECOG: 1\n\nANNUAL FOLLOW-UP - March 18, 2015\nMinimal symptom progression. MRI stable.\nAdjusted work schedule to reduce screen time.\nPlan: Continue monitoring, maintain reduced steroid dose.\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - March 15, 2016\nSome improvement in headaches. Vision stable.\nMRI shows minimal growth (0.2cm over 2 years).\nPlan: Continue conservative management.\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - April 2, 2017\nMild symptom progression. MRI shows 3.0cm tumor.\nDiscussing radiation therapy options but patient prefers continued observation.\nPlan: Increase monitoring frequency to 6-monthly.\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - March 20, 2018\nStable symptoms with medication adjustment.\nMRI unchanged.\nPlan: Continue current management.\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - April 5, 2019\nMinor progression of visual symptoms.\nMRI shows 3.2cm tumor with moderate edema.\nRecommended SRS evaluation - patient agreeable to consultation.\nKPS: 70 ECOG: 1\n\nFOLLOW-UP - March 15, 2020\nPost-SRS (14Gy single fraction).\nImprovement in symptoms.\nPlan: Continue monitoring.\nKPS: 75 ECOG: 1\n\nFOLLOW-UP - March 10, 2021\nStable post-radiation course.\nMRI shows slight decrease in tumor size.\nPlan: Annual monitoring.\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - March 8, 2022\nMaintained improvement.\nWorking full-time with accommodations.\nPlan: Continue annual imaging.\nKPS: 85 ECOG: 1\n\nLATEST FOLLOW-UP - March 12, 2024\nTen-year follow-up.\nStable disease, good quality of life.\nContinues work with modifications.\nPlan: Biennial imaging going forward.\nKPS: 85 ECOG: 1\n\nSUMMARY OF SCORES:\nInitial KPS: 80 \u2192 Final KPS: 85\nInitial ECOG: 1 \u2192 Final ECOG: 1\n\nManagement successfully preserved patient's quality of life and occupational function through conservative approach, eventually requiring SRS with good outcome. Patient maintains both professional roles with appropriate accommodations."
      }
    },
    {
      "demographics": {
        "age": 59,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": "Baker",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of dizziness and mild balance issues when walking",
          "Occasional numbness in right hand, affecting her ability to type at work",
          "Increased fatigue and difficulty concentrating during work hours",
          "One episode of nausea and vomiting without apparent cause"
        ],
        "medical_history": [
          "Hypertension diagnosed 5 years ago, well-controlled with lisinopril",
          "Migraine headaches since age 35, previously managed with sumatriptan",
          "Surgical removal of ovarian cyst 10 years ago",
          "Family history of breast cancer (mother)",
          "No history of head trauma or neurological conditions",
          "Regular mammograms, last one normal 8 months ago",
          "Non-smoker",
          "Occasional alcohol use (1-2 drinks per week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nGender: Female | Age: 59 | Blood Type: A\nOccupation: Financial Analyst/Baker\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive neurological symptoms including headaches and visual disturbances\n\nMRI FINDINGS:\n- 3.8cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern consistent with WHO Grade II meningioma\n\nASSESSMENT:\nGiven size, location, and symptom progression, immediate surgical intervention recommended. Occupational demands require high cognitive function and manual dexterity, both currently compromised.\n\nPLAN:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative imaging protocol initiated\n3. Neurocognitive baseline testing ordered\n\nSURGICAL NOTE - March 29, 2018\n- Simpson Grade II resection achieved\n- Subtotal removal due to venous sinus involvement\n- Pathology confirms WHO Grade II atypical meningioma\n- Post-op imaging shows small residual tumor\n\nFOLLOW-UP - June 15, 2018\n- Post-operative adjuvant radiotherapy completed (54 Gy/30 fractions)\n- Improved headaches and vision\n- Return to work discussed - gradual reintegration plan\n\nFOLLOW-UP - December 20, 2018\n- MRI shows stable residual disease\n- Returned to full-time work\n- Minor fatigue persisting\n\n2019 VISITS:\nJune 15: MRI stable, symptoms controlled\nDecember 10: New small enhancement noted at surgical margin\n\n2020 VISITS:\nMarch 15: Slight progression of residual tumor\nJune 20: Started stereotactic radiosurgery boost\nDecember 15: Post-SRS imaging shows good response\n\n2021 VISITS:\nJune 10: Stable disease, maintaining work schedule\nDecember 12: No progression, annual monitoring recommended\n\n2022 VISITS:\nJune 15: Stable imaging\nDecember 20: Minor enhancement changes - increased monitoring frequency\n\n2023 VISITS:\nMarch 15: Small progression noted\nJune 20: Second surgery performed - Simpson Grade III\nDecember 15: Post-op recovery excellent\n\n2024 CURRENT STATUS:\n- Stable disease on imaging\n- Maintaining full work schedule\n- Quarterly MRI surveillance continued\n- Regular neurocognitive assessments\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nONGOING MANAGEMENT:\n1. Quarterly MRI surveillance\n2. Regular neurocognitive assessment\n3. Occupational therapy as needed\n4. Consider additional SRS if progression noted\n\nNote: Treatment approach has been necessarily aggressive given:\n- WHO Grade II status\n- Occupational demands requiring high cognitive function\n- Patient's relatively young age\n- Initial presentation with significant symptoms",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: A\nOccupation: Financial Analyst/Baker\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive headaches, visual changes, balance issues\n\nIMAGING:\nMRI reveals a 2.8cm left frontal convexity meningioma with minimal surrounding edema. No significant mass effect. WHO Grade I characteristics.\n\nASSESSMENT:\nGiven the size (<3cm), minimal edema, and stable presentation, recommending conservative management with close monitoring. Symptoms may be partially attributed to underlying migraine history.\n\nPLAN:\n1. Watchful waiting approach\n2. Continue lisinopril for HTN\n3. Prophylactic migraine management optimization\n4. Q6month MRI surveillance initially\n5. Occupational therapy referral for hand exercises\n6. Ergonomic workplace assessment recommended\n\n-------------------\n\nFOLLOW-UP - September 20, 2014\nTumor stable at 2.8cm. Headaches improved with migraine prophylaxis adjustment. Vision stable.\nPLAN: Continue conservative management\n\n-------------------\n\nANNUAL FOLLOW-UP - March 18, 2015\nMinimal growth (2.9cm). Symptoms stable. Patient managing work duties with ergonomic modifications.\nPLAN: Continue monitoring, extend to annual MRI\n\n-------------------\n\nANNUAL FOLLOW-UP - March 15, 2016\nNo growth. Symptoms well-controlled. Patient successfully balancing both occupations with modified schedules.\nPLAN: Maintain annual surveillance\n\n-------------------\n\nANNUAL FOLLOW-UP - March 20, 2017\nStable at 2.9cm. Patient adapted well to workplace modifications. Hand symptoms managed with exercises.\nPLAN: Continue annual monitoring\n\n-------------------\n\nANNUAL FOLLOW-UP - March 22, 2018\nNo growth. Patient reports good quality of life, managing both jobs effectively.\nPLAN: Maintain current approach\n\n-------------------\n\nANNUAL FOLLOW-UP - March 19, 2019\nMinimal growth to 3.0cm. No new symptoms. Patient considering reducing baking work hours.\nPLAN: Increase monitoring frequency to q6months\n\n-------------------\n\nFOLLOW-UP - September 25, 2019\nStable at 3.0cm. No progression of symptoms.\nPLAN: Return to annual monitoring\n\n-------------------\n\nANNUAL FOLLOW-UP - March 17, 2020\nNo growth. Patient adapted well to reduced baking schedule. Stable symptoms.\nPLAN: Continue annual surveillance\n\n-------------------\n\nANNUAL FOLLOW-UP - March 16, 2021\nStable imaging. Good functional status maintained.\nPLAN: Maintain current management approach\n\n-------------------\n\nANNUAL FOLLOW-UP - March 15, 2022\nNo growth. Patient reports satisfaction with conservative management.\nPLAN: Continue annual monitoring\n\n-------------------\n\nANNUAL FOLLOW-UP - March 14, 2023\nStable at 3.0cm. Maintaining good quality of life and work-life balance.\nPLAN: Continue current approach\n\n-------------------\n\nLATEST FOLLOW-UP - March 12, 2024\nTumor stable for past 5 years. Patient successfully managing both careers with modifications.\nPLAN: Continue annual surveillance\n\nFUNCTIONAL STATUS SCORES:\n- Karnofsky Performance Status (KPS): 90 (Able to carry on normal activity with minor symptoms)\n- ECOG Performance Status: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nWHO Grade: I (Based on imaging characteristics)\n\nNote: Conservative management has proven successful over 10-year period with stable tumor size and well-managed symptoms. Patient has maintained good quality of life and professional functionality through appropriate workplace modifications and lifestyle adjustments."
      }
    },
    {
      "demographics": {
        "age": 63,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": "Wine Taster",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent changes in sense of smell affecting wine tasting ability",
          "Intermittent blurred vision in right eye",
          "Increasing difficulty with balance when reaching for books on high shelves",
          "Mild confusion and difficulty concentrating at work",
          "Two episodes of nausea and vomiting in past month",
          "Subtle personality changes noted by coworkers"
        ],
        "medical_history": [
          "Hypertension - diagnosed 8 years ago, controlled with lisinopril",
          "Mild hearing loss in left ear - diagnosed 5 years ago",
          "Successful cataract surgery right eye 3 years ago",
          "History of migraine headaches in 30s-40s, resolved spontaneously",
          "No history of cancer",
          "No significant head trauma",
          "Family history: Mother had breast cancer at age 72",
          "Current medications: lisinopril 10mg daily, occasional ibuprofen for headaches"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nOccupation: Librarian/Wine Taster\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms affecting daily function and occupation\n\nIMAGING:\nMRI reveals 4.2cm left frontal meningioma with significant peritumoral edema, mass effect on frontal lobe. Enhancement pattern consistent with WHO Grade II meningioma. Additional small satellite lesion (0.8cm) noted.\n\nASSESSMENT:\nPatient presents with concerning constellation of symptoms significantly impacting quality of life and occupation. Size, location, and symptomatology warrant immediate intervention.\nWHO Grade: II (preliminary based on imaging characteristics)\nKPS Score: 80\nECOG: 1\n\nPLAN:\n1. Scheduled for surgical resection within 2 weeks\n2. Pre-operative optimization with dexamethasone 4mg QID\n3. Detailed neuropsychological evaluation\n4. Occupational impact assessment\n\nSURGICAL NOTE - April 1, 2014\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology confirms WHO Grade II meningioma\nPost-op MRI shows near-total resection\n\nFOLLOW-UP VISIT - July 15, 2014\nPatient showing good recovery\nHeadaches improved\nVision stabilizing\nRecommended adjuvant radiotherapy\nStarted 54 Gy/30 fractions\n\nFOLLOW-UP - January 10, 2015\nPost-radiation follow-up\nMRI shows no recurrence\nReturning to work part-time\nKPS: 90\nECOG: 0\n\nANNUAL FOLLOW-UP - March 2016\nStable imaging\nMinor radiation changes\nFull return to work\nWine tasting abilities partially recovered\n\nFOLLOW-UP - September 2017\nSurveillance MRI shows small enhancement at resection margin\nDecision for gamma knife radiosurgery to residual\n16 Gy single fraction delivered\n\nANNUAL FOLLOW-UP - October 2018\nStable disease\nNo new symptoms\nMaintaining professional activities\n\nFOLLOW-UP - April 2020\nPandemic-related telemedicine visit\nStable symptoms\nMRI unchanged\n\nFOLLOW-UP - May 2022\nNew 0.6cm nodule noted\nClose monitoring recommended\nOccupational function preserved\n\nCURRENT VISIT - January 2024\nStable disease\nMultiple MRIs show no progression\nRegular wine tasting resumed\nProfessional activities maintained\n\nCURRENT STATUS:\nKPS: 90\nECOG: 0\n\nMONITORING PROTOCOL:\n- MRI every 6 months\n- Neuropsychological evaluation annually\n- Occupational function assessment quarterly\n- Quality of life questionnaire at each visit\n\nNOTES:\nPatient's occupation as wine taster and librarian required aggressive early intervention to preserve sensory abilities and cognitive function. Treatment strategy successfully maintained professional capabilities while achieving good tumor control.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nPrimary Diagnosis: Meningioma\nWHO Grade: I (Based on imaging characteristics)\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms affecting occupational function\n\nImaging Findings:\n- MRI reveals 2.8cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- T2 isointense with mild enhancement\n- No signs of aggressive features\n\nAssessment:\nGiven patient's occupation as wine taster and librarian, symptoms significantly impact quality of life. However, tumor size and characteristics favor conservative approach.\n\nInitial Management Plan:\n1. Watchful waiting with close monitoring\n2. Dexamethasone 4mg daily for symptom management\n3. Monthly follow-up initially\n\nFOLLOW-UP VISIT - June 20, 2014\n- Headaches improved with dexamethasone\n- Olfactory function stabilized\n- Vision symptoms unchanged\n- Balance issues mildly improved\nPlan: Continue current management\n\nANNUAL FOLLOW-UP - March 2015\n- MRI shows stable tumor size\n- Symptoms well-controlled\n- Reduced dexamethasone to 2mg daily\n- Patient maintaining work with accommodations\nPlan: Continue monitoring, MRI every 6 months\n\nFOLLOW-UP - September 2015\n- Stable imaging\n- Good symptom control\n- Successfully weaned off dexamethasone\n\nANNUAL VISITS 2016-2018\n- Annual MRI shows no growth\n- Minimal symptoms with lifestyle modifications\n- Patient continues work with adaptations\n- Regular balance exercises implemented\n\nFOLLOW-UP - March 2020\n- Slight increase in tumor size (3.0cm)\n- Discussed surgical options but patient prefers conservative approach\n- Implemented occupational therapy for balance\nPlan: Increase monitoring frequency\n\nFOLLOW-UP - March 2022\n- Stable disease\n- Patient retired from wine tasting but maintains part-time library work\n- Quality of life maintained with adaptations\n\nCURRENT VISIT - January 2024\n- Tumor stable at 3.0cm\n- Well-adapted to limitations\n- Continues part-time work\n- Regular exercise program\n\nCurrent Status:\nKPS Score: 80/100 (Able to perform normal activity with effort)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nLong-term Management Strategy:\n1. Continue biannual MRI surveillance\n2. Regular neurological assessments\n3. Maintain quality of life focus\n4. Surgical intervention only if significant progression\n\nNote: Conservative management successful over 10-year period with preservation of functional status and acceptable quality of life."
      }
    },
    {
      "demographics": {
        "age": 56,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Food Critic",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": true,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 3 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional nausea and vomiting, initially attributed to pregnancy",
          "Increasing difficulty concentrating at computer screen during work",
          "Reports mild right-sided facial numbness",
          "Balance issues when walking, particularly noticeable in last 2 weeks",
          "Increased fatigue (beyond typical pregnancy fatigue)"
        ],
        "medical_history": [
          "Currently 24 weeks pregnant with first child",
          "Migraine headaches since age 30, but pattern and intensity recently changed",
          "Surgical removal of ovarian cyst 5 years ago",
          "Family history of breast cancer (maternal aunt)",
          "No prior neurological conditions",
          "No history of radiation exposure",
          "Regular eye exams with last visit 1 year ago showing normal results",
          "No significant head trauma",
          "Non-smoker, occasional alcohol use pre-pregnancy"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function",
            "Coordinated care with obstetrics",
            "Timing surgery for second trimester if possible"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nGender: Female | Age: 56 | Blood Type: O\nOccupation: Software Developer/Food Critic\nPregnancy Status: 24 weeks gestation\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive neurological symptoms during pregnancy\nMRI Findings:\n- 4.2cm right sphenoid wing meningioma\n- Significant mass effect on right temporal lobe\n- Moderate peritumoral edema\n- Evidence of compression of right optic nerve\nWHO Grade: II (atypical features on imaging)\n\nAssessment:\nGiven patient's presenting symptoms, tumor size, location, and pregnancy status, case requires urgent intervention. Symptoms suggest rapid progression and potential threat to both maternal and fetal health.\n\nPlan:\n1. Immediate neurosurgical intervention recommended post-pregnancy\n2. High-dose dexamethasone (coordinated with OB)\n3. Weekly neurological monitoring\n4. Bi-weekly ophthalmological assessment\n5. Coordination with high-risk OB team\n\nFOLLOW-UP - July 10, 2018 (Post-delivery)\n- Successful C-section at 34 weeks\n- Symptoms worsening\n- Scheduled for surgical resection\n\nSURGICAL NOTE - July 25, 2018\nProcedure: Right frontotemporal craniotomy for tumor resection\n- Simpson Grade II resection achieved\n- Minor residual tumor at cavernous sinus\nWHO Grade: II confirmed by pathology\n\nPOST-OP FOLLOW-UP - September 15, 2018\n- Excellent recovery\n- Vision improving\n- Started adjuvant radiotherapy\n\n2019 QUARTERLY VISITS:\nMarch: Complete radiotherapy course\nJune: Stable imaging\nSeptember: Return to work part-time\nDecember: Full work resumption\n\n2020 BI-ANNUAL VISITS:\nJune: Stable imaging\nDecember: Small enhancement at surgical site\n\n2021 ANNUAL VISIT - January:\n- Minimal enhancement growth\n- Gamma Knife radiosurgery to residual tumor\n\n2022 FOLLOW-UP - January:\n- Stable disease\n- Maintaining work schedule\n- Annual MRI recommended\n\n2023 FOLLOW-UP - February:\n- No progression\n- Maintaining normal activities\n- Continue annual monitoring\n\n2024 CURRENT STATUS - January:\n- Disease stable\n- Full professional activity\n- Annual imaging surveillance\n\nFunctional Status Scores:\nKPS: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nTreatment Summary:\n- Initial Simpson II resection\n- Adjuvant radiotherapy\n- Targeted Gamma Knife for residual tumor\n- Regular imaging surveillance\n- Excellent functional outcome\n\nRecommendations:\nContinue annual MRI surveillance\nMaintain regular neurosurgical follow-up\nConsider occupational adjustments as needed (computer screen breaks, ergonomic setup)\n\n/Signed by: Dr. [REDACTED]\nBoard Certified Neurosurgeon\nDate: January 15, 2024",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nGender: Female | Age: 56 | Blood Type: O\nOccupation: Software Developer/Food Critic\nWHO Grade: I (Suspected based on imaging characteristics)\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive neurological symptoms during pregnancy (24 weeks gestation)\n\nImaging Findings:\n- MRI reveals 2.8cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- T2 signal: moderately intense\n- Contrast enhancement: homogeneous\n\nAssessment:\nComplex case requiring careful balance due to pregnancy status. Symptoms concerning but not immediately life-threatening. Location and size amenable to close monitoring.\n\nPlan:\n1. Conservative management due to pregnancy\n2. Monthly clinical monitoring through pregnancy\n3. Dexamethasone 4mg BID for symptom management\n4. Coordination with high-risk OB team\n\nFOLLOW-UP - September 20, 2018 (Post-delivery)\nStatus: Successful delivery at 38 weeks. Some symptom improvement post-delivery.\nImaging: Stable tumor size\nPlan: Continue monitoring, maintain steroid taper\n\nANNUAL FOLLOW-UP - March 2019\nSymptoms: Moderate improvement in headaches\nImaging: No significant growth (2.9cm)\nPlan: Continue conservative management\n\nFOLLOW-UP - March 2020\nSymptoms: Stable\nImaging: Stable (2.9cm)\nWork modifications implemented: Anti-glare screen, ergonomic workstation\nPlan: Annual MRI continued\n\nFOLLOW-UP - April 2021\nSymptoms: Minor headache exacerbation\nImaging: Minimal growth (3.0cm)\nPlan: Increase monitoring frequency to 6-monthly\n\nFOLLOW-UP - March 2022\nSymptoms: Stable with occasional headaches\nImaging: Stable (3.0cm)\nWork status: Successfully managing both careers with accommodations\nPlan: Return to annual monitoring\n\nFOLLOW-UP - March 2023\nSymptoms: Well-controlled\nImaging: No progression\nQuality of life: Good, maintaining both professional roles\nPlan: Continue annual monitoring\n\nFOLLOW-UP - March 2024\nCurrent Status: Stable disease, well-adapted to condition\nImaging: No significant change\nWork status: Fully functional in both careers\nPlan: Continue annual monitoring\n\nMANAGEMENT SUMMARY:\n- Successfully managed conservatively through pregnancy and beyond\n- Minimal intervention approach proved effective\n- Patient maintained professional activities with modifications\n- Quality of life preserved\n\nCURRENT SCORES:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory and able to carry out light work\n\nMONITORING RECOMMENDATIONS:\n1. Annual MRI with contrast\n2. Bi-annual ophthalmological examinations\n3. Regular neurological assessments\n4. Continued workplace ergonomic optimization\n5. Stress management counseling as needed\n\nNote: Conservative approach successful with excellent quality of life maintenance. Patient continues both professional roles with appropriate accommodations."
      }
    },
    {
      "demographics": {
        "age": 62,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work on computer screens",
          "Mild right-sided facial numbness",
          "Balance issues when walking, particularly noticeable in past 2 months"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches in 30s-40s, resolved spontaneously",
          "Surgical history: Cholecystectomy (2010)",
          "Post-menopausal since age 51",
          "No history of cancer",
          "No prior neurological conditions",
          "Family history: Mother with breast cancer",
          "Current medications: Lisinopril 10mg daily, Calcium + Vitamin D supplement"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 62F, O+, Data Scientist\nMRI FINDINGS: 4.2 cm left frontal convexity meningioma with significant peritumoral edema, mass effect on adjacent frontal lobe. Enhancement pattern consistent with WHO Grade II meningioma. Minimal calcification noted.\n\nASSESSMENT:\n- Symptomatic left frontal meningioma with progressive neurological symptoms\n- Occupation requires high cognitive function and visual attention\n- Symptoms significantly impacting work performance and quality of life\nWHO Grade: II (suspected based on imaging characteristics)\nPLAN: Recommend surgical resection given size, symptoms, and occupation requirements.\n\nSURGICAL NOTE - April 2, 2018\nProcedure: Left frontal craniotomy for gross total resection\nFindings: WHO Grade II confirmed by pathology\nSimpson Grade: II\nPost-op course: Uncomplicated\n\nFOLLOW-UP VISITS:\n\nMay 15, 2018 (6-week post-op)\n- Improved headaches and vision\n- Starting return-to-work protocol\n- MRI: No residual tumor\nPLAN: Adjuvant radiotherapy recommended\n\nJuly-September 2018\n- Completed fractionated RT (54 Gy/30 fractions)\n- Well-tolerated\n\nDecember 2018 (6-month post-op)\n- Return to full-time work\n- Minimal residual symptoms\n- MRI: Stable post-surgical changes\n\nJune 2019 (1-year post-op)\n- Maintaining good functional status\n- MRI: No recurrence\n\nDecember 2019\n- Stable neurological exam\n- MRI: No evidence of recurrence\n\nJune 2020\n- Minor headaches, managed with OTC medications\n- MRI: Stable\n\nDecember 2020\n- Fully functional at work\n- MRI: No concerning changes\n\nJune 2021\n- Reports increased work productivity\n- MRI: Stable post-treatment appearance\n\nDecember 2021\n- Maintaining excellent functional status\n- MRI: No recurrence\n\nAnnual visits 2022-2024\n- Continued stability\n- Annual MRI: No evidence of recurrence\n- Maintaining full work schedule\n\nCURRENT STATUS (2024):\n- Disease-free at 6 years post-treatment\n- Full cognitive function\n- Independent in work and daily activities\n\nFUNCTIONAL SCORES:\nKPS: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nMONITORING PROTOCOL:\n- MRI every 6 months for first 5 years, then annually\n- Regular neurocognitive assessments\n- Occupational therapy as needed\n- Regular ophthalmological evaluations\n\nNote: Aggressive early intervention and complete resection followed by adjuvant RT likely contributed to favorable outcome. Patient's high-functioning occupation and early presentation supported proactive treatment approach.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 62-year-old female, Data Scientist\nWHO Grade: I (based on imaging characteristics)\n\nIMAGING FINDINGS:\nMRI reveals a 2.4cm left frontal convexity meningioma, minimal surrounding edema. T2 mildly hyperintense, homogeneous enhancement with dural tail sign. No significant mass effect on adjacent structures.\n\nASSESSMENT:\nPatient presents with progressive symptoms but tumor characteristics favor initial conservative management. Size and location allow for watchful waiting approach while monitoring symptoms.\n\nPLAN:\n1. Conservative management with close monitoring\n2. MRI follow-up in 6 months\n3. Occupational modifications recommended:\n   - Regular screen breaks\n   - Workstation ergonomic assessment\n   - Anti-glare screen protector\n4. Prescribed Dexamethasone 4mg BID for symptom management\n5. Continue current medications\n\nFOLLOW-UP VISIT - September 20, 2018\nMild improvement in headaches with steroid therapy. Vision stable.\nMRI: No significant change in tumor size.\nPlan: Continue conservative management, taper steroids.\n\nANNUAL VISIT - March 12, 2019\nSymptoms stable. Working full-time with accommodations.\nMRI: Stable lesion size, minimal edema.\nPlan: Annual MRI surveillance\n\nANNUAL VISIT - March 18, 2020\nMinor increase in headache frequency.\nMRI: 2.5cm tumor (0.1cm growth over 2 years).\nPlan: Continue monitoring, prescribed sumatriptan for breakthrough headaches.\n\nANNUAL VISIT - March 15, 2021\nStable symptoms with medication management.\nMRI: No significant change.\nPlan: Maintain current approach.\n\nANNUAL VISIT - March 22, 2022\nReports improved work performance with implemented modifications.\nMRI: Stable appearance.\nPlan: Continue annual surveillance.\n\nANNUAL VISIT - March 14, 2023\nMild progression of visual symptoms.\nMRI: 2.6cm tumor.\nPlan: Increase monitoring frequency to 6-month intervals.\n\nRECENT VISIT - February 20, 2024\nSymptoms managed with current regimen.\nMRI: No significant change from previous.\nPlan: Continue bi-annual monitoring.\n\nCURRENT STATUS:\n- Stable disease with minimal progression over 6 years\n- Maintaining professional activities with accommodations\n- Well-managed symptoms\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nONGOING RECOMMENDATIONS:\n1. Continue bi-annual MRI surveillance\n2. Maintain work modifications\n3. Regular ophthalmology evaluations\n4. Monthly neurology check-ins\n5. Consider quality of life assessments every 6 months\n\nNote: Conservative management has proven successful with this patient, balancing tumor monitoring with quality of life preservation. Occupation-specific accommodations have been particularly beneficial."
      }
    },
    {
      "demographics": {
        "age": 45,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Intermittent blurred vision in right eye",
          "Recent onset of clumsiness in left hand",
          "Difficulty concentrating at work, especially when reviewing spreadsheets",
          "Occasional nausea without vomiting",
          "Reports feeling more irritable and fatigued than usual",
          "Two episodes of focal seizures affecting left arm in past month"
        ],
        "medical_history": [
          "Migraine headaches since age 30, well-controlled with sumatriptan",
          "Surgical removal of ovarian cyst (2015)",
          "History of oral contraceptive use for 15 years (stopped 2 years ago)",
          "No prior neurological conditions",
          "No family history of brain tumors",
          "Regular mammograms, last one normal (6 months ago)",
          "Non-smoker",
          "Occasional alcohol use (1-2 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - 03/15/2014\nPatient: 45F, Blood Type O\nOccupation: Financial Analyst\nChief Complaint: Progressive neurological symptoms with focal seizures\n\nIMAGING FINDINGS:\nMRI reveals a 4.2cm right frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe with 5mm midline shift. Contrast enhancement pattern typical for meningioma. T2 sequence shows hyperintensity suggesting aggressive growth pattern.\n\nASSESSMENT:\nWHO Grade II meningioma (atypical features on imaging)\nSymptoms significantly impacting work performance and quality of life\nHigh-risk features: size >3cm, peritumoral edema, proximity to motor strip\n\nTREATMENT PLAN:\n1. Recommend immediate surgical resection\n2. Simpson Grade I resection planned\n3. Start Dexamethasone 4mg QID\n4. Levetiracetam 500mg BID for seizure prophylaxis\n\n-------------------\n\nPOST-OP VISIT - 04/02/2014\nSuccessful gross total resection achieved\nPathology confirms WHO Grade II meningioma\nMinimal post-operative deficits\nPlan: Adjuvant radiation therapy recommended\n\n-------------------\n\nFOLLOW-UP - 10/15/2014\nCompleted 60 Gy/30fx radiation therapy\nSymptoms significantly improved\nNo new neurological deficits\nMRI: No residual/recurrent tumor\n\n-------------------\n\nFOLLOW-UP - 04/15/2015\nPatient back at work full-time\nOccasional mild headaches\nMRI stable\nContinue 6-monthly monitoring\n\n-------------------\n\nANNUAL REVIEW - 04/20/2016\nNo concerning symptoms\nMRI stable\nMaintaining good work performance\nSeizure-free on maintenance Levetiracetam\n\n-------------------\n\nFOLLOW-UP - 05/10/2018\nSmall 8mm nodule noted on follow-up MRI\nRecommend close monitoring\nIncrease scan frequency to 4-monthly\n\n-------------------\n\nFOLLOW-UP - 02/15/2020\nNodule stable at 8mm\nNo new symptoms\nContinue current monitoring schedule\n\n-------------------\n\nFOLLOW-UP - 03/10/2022\nNodule increased to 12mm\nNew enhancement pattern\nRecommend surgical re-resection given Grade II history\n\n-------------------\n\nCURRENT VISIT - 01/15/2024\nPost second resection status\nPathology remained Grade II\nPatient doing well professionally\nNo neurological deficits\n\nCURRENT STATUS:\nKPS Score: 90/100\nECOG Score: 1\n\nMONITORING PLAN:\n- Continue q4 month MRI\n- Quarterly neurocognitive assessments\n- Maintain anticonvulsant therapy\n- Annual neuropsychological evaluation focusing on executive function relevant to financial analysis work\n\nThe proactive intervention strategy and aggressive monitoring have allowed patient to maintain high-level professional activities with minimal interruption. Will continue vigilant surveillance given Grade II status and history of recurrence.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F45-O-FA\nPrimary Diagnosis: Meningioma\nWHO Grade: I (Benign)\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive neurological symptoms with headaches\nMRI Findings: 2.8cm right frontal convexity meningioma, minimal perilesional edema\nClinical Assessment: Given symptomatic presentation and location, surgical intervention discussed but patient prefers conservative approach initially.\nPlan: Close monitoring with serial imaging, anticonvulsant therapy (Levetiracetam 500mg BID)\nKPS: 90/100\n\nFOLLOW-UP - September 20, 2018 (6 months)\nSymptoms: Improved headache control, no new seizures\nMRI: Stable lesion size, no progression\nPlan: Continue current management, occupational therapy referral for left hand exercises\nMedications adjusted: Added prophylactic topiramate for migraines\n\nANNUAL FOLLOW-UP - March 12, 2019\nSymptoms: Well-controlled, improved work performance\nMRI: No growth (2.8cm)\nPlan: Maintain current approach, continue anticonvulsants\nWork modifications implemented: Ergonomic workspace setup, regular breaks\n\nFOLLOW-UP - March 10, 2020\nImpact of COVID-19 discussed\nSymptoms: Stable\nMRI: Minimal growth (2.9cm)\nPlan: Telemedicine follow-ups implemented when appropriate\n\nFOLLOW-UP - March 15, 2021\nSymptoms: Reports occasional headaches\nMRI: No further growth\nPlan: Added mindfulness training program, maintained conservative approach\n\nANNUAL FOLLOW-UP - March 8, 2022\nSymptoms: Well-managed\nMRI: Stable (2.9cm)\nNotable: Successfully managing work responsibilities\nPlan: Continue monitoring, reduced anticonvulsant dose\n\nFOLLOW-UP - March 14, 2023\nSymptoms: Occasional visual symptoms\nMRI: No progression\nPlan: Ophthalmology consultation, maintained conservative approach\n\nCURRENT VISIT - February 20, 2024\nSymptoms: Generally stable\nMRI: No significant change over 6 years\nQuality of Life: Good, maintaining full-time work\nPlan: Continue annual MRI monitoring, maintain current medications\n\nFUNCTIONAL STATUS SCORES (Current):\nKPS Score: 90/100\nECOG Performance Status: 1\n\nMANAGEMENT SUMMARY:\n- Successfully managed conservatively for 6 years\n- Maintained occupational function\n- No significant tumor progression\n- Well-controlled symptoms\n- Regular monitoring with good compliance\n- Preserved quality of life\n\nNext Follow-up: Scheduled for February 2025\nContinue annual MRI surveillance\nMaintain current anticonvulsant regimen\nRegular ophthalmology checks\n\nNote: Conservative approach has proven effective for this patient, with stable disease and good functional status maintained over 6-year period. Occupation as Financial Analyst has been successfully maintained with appropriate accommodations."
      }
    },
    {
      "demographics": {
        "age": 46,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Persistent headaches for past 4 months, worse in morning",
          "Progressive blurred vision in right eye",
          "Recent onset of difficulty concentrating at work, especially when reviewing financial documents",
          "Occasional episodes of nausea without vomiting",
          "Reports subtle personality changes noted by coworkers - more irritable than usual",
          "Mild right-sided facial numbness that developed gradually over 2 months",
          "Balance issues when walking, particularly noticeable when wearing heels at work"
        ],
        "medical_history": [
          "Type 2 Diabetes diagnosed 8 years ago - managed with Metformin 1000mg BID",
          "HbA1c consistently around 7.2%",
          "Hypertension diagnosed 5 years ago - controlled with Lisinopril 10mg daily",
          "Migraine headaches since early 30s - previously managed with sumatriptan PRN",
          "Laser eye surgery (LASIK) 10 years ago",
          "No history of cancer",
          "Family history significant for breast cancer in mother",
          "Regular mammograms, last one 8 months ago was normal"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F46-O-DM\nOccupation: Financial Analyst\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms including headaches, visual changes, and balance issues.\n\nIMAGING:\nMRI with/without contrast reveals:\n- 4.2cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Evidence of dural tail sign\n- No calcification noted\n\nASSESSMENT:\nWHO Grade II Meningioma (atypical features on imaging)\nGiven size, location, and progressive symptoms, immediate surgical intervention recommended.\nKPS: 80/100\nECOG: 1\n\nTREATMENT PLAN:\n1. Schedule surgical resection within 2 weeks\n2. Pre-operative optimization of diabetes management\n3. Neurosurgical approach: Left frontal craniotomy for gross total resection\n4. Post-op adjuvant radiation therapy likely needed\n\nSURGICAL NOTE - April 1, 2014\nProcedure: Left frontal craniotomy with Simpson Grade II resection\nFindings: Adherent to superior sagittal sinus\nPathology confirms WHO Grade II meningioma\nPost-op course uncomplicated\n\nFOLLOW-UP - July 15, 2014\nPost-radiation therapy assessment\n- Completed 54 Gy in 30 fractions\n- Improved headaches and vision\n- Returning to work part-time\nKPS: 90/100\nECOG: 1\n\nFOLLOW-UP - January 15, 2015\nMRI shows no recurrence\nSymptoms resolved\nCleared for full work duties\nKPS: 100/100\nECOG: 0\n\nSURVEILLANCE VISITS:\nJuly 2015 - January 2016 - July 2016\nBi-annual MRIs: No evidence of recurrence\nMaintaining full work schedule\nRegular diabetes monitoring\n\n2017-2018 (Quarterly visits)\nStable imaging\nMinor headaches - not tumor-related\nDiabetes well-controlled\n\n2019 - February 15\nSmall enhancement noted on MRI\n2.1cm recurrence at original site\nRecommended repeat surgical intervention\nKPS: 90/100\nECOG: 1\n\nSECOND SURGERY - March 30, 2019\nSimpson Grade I resection achieved\nPathology confirms recurrent WHO Grade II\n\n2020-2022 (Bi-annual monitoring)\nPost-second surgery surveillance\nNo evidence of recurrence\nRegular imaging protocol maintained\nDiabetes remains stable\n\n2023-2024 (Current status)\nLatest MRI (January 2024): No evidence of disease\nFully functional at work\nMaintaining executive position\nRegular diabetes monitoring continues\n\nCURRENT STATUS (2024):\nKPS: 100/100\nECOG: 0\n\nMONITORING PROTOCOL:\n- MRI every 6 months\n- Neurological examination quarterly\n- Diabetes management ongoing\n- Cognitive function assessment annually\n- Quality of life assessments bi-annually\n\nLONG-TERM RECOMMENDATIONS:\n1. Continue vigilant MRI surveillance\n2. Maintain strict diabetes control\n3. Annual ophthalmological examination\n4. Consider prophylactic intervention for any new growth >1cm\n\nNote: Patient's high-functioning professional role and complex cognitive demands support aggressive surveillance and early intervention strategy. Diabetes management remains crucial for optimal outcomes.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nGender: Female | Age: 46 | Blood Type: O\nOccupation: Financial Analyst\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive neurological symptoms including headaches and visual changes\n\nMRI FINDINGS:\n- 2.4cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (suspected based on imaging characteristics)\n\nASSESSMENT:\nGiven the size <3cm and minimal edema, recommending conservative management with close monitoring. Patient's symptoms, while concerning, may be managed non-surgically initially.\n\nMANAGEMENT PLAN:\n1. Serial MRI monitoring\n2. Symptom management:\n   - Dexamethasone 4mg daily for edema control\n   - Prophylactic levetiracetam 500mg BID\n3. Diabetes management coordination with endocrinology\n4. Occupational modifications recommended\n\nFOLLOW-UP VISIT - September 20, 2018\n- Stable tumor size\n- Improved headaches with medical management\n- Vision symptoms stable\n- Maintaining work with accommodations\n- Continue current management\n\nANNUAL FOLLOW-UP - March 12, 2019\n- MRI shows no significant growth\n- Symptoms well-controlled\n- Reduced dexamethasone to 2mg daily\n- KPS 90\n\nANNUAL FOLLOW-UP - March 18, 2020\n- Stable imaging\n- Patient adapted well to workplace modifications\n- Diabetes remains controlled\n- Continue conservative management\n\nANNUAL FOLLOW-UP - March 15, 2021\n- Minimal tumor growth (2.6cm)\n- Symptoms stable\n- Maintaining work performance\n- Continue monitoring\n\nANNUAL FOLLOW-UP - March 22, 2022\n- No significant changes\n- Patient comfortable with management approach\n- Diabetes well-controlled\n- KPS maintained at 90\n\nANNUAL FOLLOW-UP - March 14, 2023\n- Stable imaging\n- Quality of life preserved\n- Working full-time with accommodations\n- Continue current plan\n\nRECENT FOLLOW-UP - February 20, 2024\n- Tumor stable at 2.6cm\n- Patient satisfied with conservative approach\n- Maintaining good functional status\n- Next follow-up scheduled for March 2025\n\nFUNCTIONAL STATUS SCORES:\n- Karnofsky Performance Status (KPS): 90/100\n- ECOG Performance Status: 1\n\nSUMMARY OF CONSERVATIVE MANAGEMENT SUCCESS:\n- Stable tumor size over 6-year period\n- Well-controlled symptoms\n- Maintained professional career\n- Excellent quality of life preservation\n- Well-managed comorbidities\n\nONGOING RECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain current medication regimen\n3. Regular diabetes monitoring\n4. Ergonomic workplace adjustments\n5. Regular ophthalmology follow-up\n\nWHO Grade: I (stable)\nTreatment Strategy: Continued conservative management with vigilant monitoring\n\nNote: Conservative approach has proven successful with this patient, demonstrating that careful monitoring and symptomatic management can be appropriate in selected cases of small, stable meningiomas."
      }
    },
    {
      "demographics": {
        "age": 67,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, especially in morning; Right-sided facial numbness; Occasional balance issues when walking; Increasing difficulty concentrating at work; Recent onset of blurred vision in right eye; One episode of nausea and vomiting last week; Reports personality changes noted by family (more irritable)"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily; Underwent successful prostate cancer treatment 8 years ago (radiation therapy); Mild hearing loss in left ear; History of migraine headaches in 30s-40s but resolved; Appendectomy at age 23; Former smoker - quit 15 years ago; Family history of stroke (father); Regular health screenings up to date; No history of seizures or neurological disorders; Takes daily aspirin 81mg"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M67-DS-A\nPrimary Diagnosis: Meningioma\nWHO Grade: II (Atypical)\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms over 3 months\nMRI Findings:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- Enhancement pattern suggesting possible atypical features\nAssessment: Given patient's occupation as Data Scientist requiring high cognitive function, symptoms significantly impacting work performance, and concerning radiological features, recommend immediate surgical intervention.\n\nSURGICAL INTERVENTION - April 2, 2014\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade: II\nPathology: WHO Grade II meningioma\nPost-op course: Uncomplicated\n\nFOLLOW-UP VISIT - July 15, 2014 (3 months post-op)\n- Improved headaches and facial numbness\n- Vision normalized\n- Started return-to-work protocol\n- MRI: No residual tumor\n- Plan: Adjuvant radiation therapy recommended\n\nRADIATION THERAPY - August-September 2014\n- Completed 54 Gy in 30 fractions\n- Well-tolerated\n\nFOLLOW-UP VISITS:\nDecember 2014 (6 months post-op)\n- Fully returned to work\n- No neurological deficits\n- MRI: Stable post-surgical changes\n\nJune 2015 (1 year post-op)\n- Maintaining good functional status\n- MRI: No recurrence\n- Continuing q6month monitoring\n\n2016-2017 (Bi-annual visits)\n- Stable neurologically\n- Serial MRIs: No recurrence\n- Maintaining full-time work\n\n2018-2019\n- Minor headaches managed with NSAIDs\n- MRIs: Small enhancement at surgical site (2019)\n- Increased monitoring frequency\n\nJanuary 2020\n- New 1.2 cm nodule at original site\n- Recommended stereotactic radiosurgery (SRS)\n\nMarch 2020\n- Completed SRS: 16 Gy single fraction\n- Well-tolerated\n\n2021-2022\n- Stable disease\n- Annual MRIs: No progression\n- Maintaining cognitive function\n\n2023-2024\n- Continues full-time work\n- Latest MRI (January 2024): Stable\n- No new neurological symptoms\n\nCurrent Status (2024):\n- Disease controlled\n- Maintains professional activities\n- Regular monitoring continues\n\nFunctional Status Scores:\nKPS: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nNext Follow-up: Scheduled for July 2024\nImaging: Annual MRI with contrast\nContinue monitoring: Cognitive function, vision, balance\n\nNote: Given WHO Grade II status and patient's professional cognitive demands, maintaining aggressive surveillance protocol despite stable disease.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n67-year-old male, Blood Type A\nOccupation: Data Scientist\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive neurological symptoms over 3 months\nWHO Grade: I (based on imaging characteristics)\n\nMRI FINDINGS:\n- 2.8cm right frontal convexity meningioma\n- Minimal peritumoral edema\n- No significant mass effect\n- Dural tail sign present\n- No signs of brain invasion\n\nASSESSMENT:\nDespite symptomatic presentation, tumor characteristics favor conservative management:\n- Size below 3cm threshold\n- Minimal edema\n- No critical structure compression\n- Patient's cognitive demands at work considered\n\nINITIAL MANAGEMENT PLAN:\n1. Dexamethasone 4mg BID for symptom control\n2. Monthly clinical monitoring initially\n3. Quarterly MRI for first year\n4. Occupational adjustments recommended (reduced screen time, frequent breaks)\n\nFOLLOW-UP VISITS:\n\nJune 15, 2018\n- Symptoms improved with steroids\n- Gradual steroid taper initiated\n- Vision symptoms stable\n- Maintaining work with accommodations\n- MRI: No significant change\n\nDecember 20, 2018\n- Stable symptoms off steroids\n- Working full-time with modifications\n- MRI: No growth\n- Continue monitoring\n\nMarch 15, 2019\n- Minor headaches managed with acetaminophen\n- Balance improved\n- MRI: Stable\n\nMarch 10, 2020\n- COVID-19 telehealth visit\n- Symptoms stable\n- Continue monitoring\n\nMarch 18, 2021\n- Annual MRI: Minimal growth (0.2cm)\n- Symptoms stable\n- Continue conservative management\n\nApril 15, 2022\n- Tumor stable\n- Patient managing work well\n- Some adaptation to cognitive demands\n- MRI unchanged\n\nMay 20, 2023\n- Slight increase in headaches\n- MRI: No significant change\n- Added prophylactic migraine medication\n\nFebruary 15, 2024\n- Latest MRI shows stability\n- Patient functioning well\n- Maintaining quality of life\n- Continues data science work with accommodations\n\nCURRENT STATUS:\n- Tumor stable over 6-year period\n- Symptoms well-managed\n- Patient maintains professional activities\n- Good quality of life preserved\n\nMONITORING PLAN:\n- Continue biannual MRI\n- Regular neurocognitive assessments\n- Blood pressure monitoring\n- Annual ophthalmological evaluation\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nCONSERVATIVE MANAGEMENT SUCCESS FACTORS:\n1. Slow growth rate\n2. Good symptom control\n3. Patient compliance\n4. Maintained cognitive function\n5. Successful work adaptation\n\nNote: Conservative approach validated by stable disease course and maintained quality of life. Patient demonstrates excellent adaptation to cognitive demands of data science work with implemented modifications."
      }
    },
    {
      "demographics": {
        "age": 59,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": true
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of unsteady gait and mild right-sided weakness",
          "Occasional nausea without vomiting",
          "Reports personality changes noted by family - increased irritability",
          "Difficulty concentrating at work for past 2-3 months"
        ],
        "medical_history": [
          "Radiation therapy to head/neck region for childhood lymphoma at age 12",
          "Hypertension - diagnosed 8 years ago, controlled with lisinopril",
          "BMI 33.2 - Class I Obesity",
          "Sleep apnea diagnosed 3 years ago, uses CPAP",
          "Hypercholesterolemia managed with atorvastatin",
          "No history of seizures or neurological disorders",
          "No family history of brain tumors",
          "Former smoker - quit 10 years ago"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Additional consideration for radiation exposure history"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - March 15, 2014\nPatient: 59-year-old male\nChief Complaint: Progressive neurological symptoms\n\nIMAGING:\nMRI reveals a 4.2 cm left frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe with 5mm midline shift. T2 hyperintense with heterogeneous enhancement. No calcification noted.\n\nASSESSMENT:\nWHO Grade II atypical meningioma (suspected based on imaging characteristics)\nHigh-risk features:\n- Size >3cm\n- Significant peritumoral edema\n- Prior radiation exposure history\n- Symptomatic presentation\n- Location near motor strip\n\nPLAN:\n1. Recommend immediate surgical resection\n2. Pre-operative optimization of blood pressure\n3. Dexamethasone 4mg QID for edema\n4. Pre-operative functional MRI and DTI tractography\n5. Discussed surgical risks and benefits with patient\n\nSURGERY - April 2, 2014\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology confirms WHO Grade II atypical meningioma\nKi-67 proliferation index: 12%\n\nFOLLOW-UP VISIT - July 15, 2014\nPost-operative MRI shows near-total resection\nInitiated adjuvant radiation therapy: 60 Gy in 30 fractions\nSymptoms improving\nStarted physical therapy for right-sided weakness\n\nFOLLOW-UP - January 10, 2015\nComplete radiation therapy course\nNo evidence of recurrence\nImproved strength and gait\nContinue q3 month monitoring\n\n2016-2018 (q6 month visits):\n- Serial MRIs stable\n- Maintained neurological improvement\n- Regular cognitive assessments\n- Managing obesity and sleep apnea\n\nRECURRENCE NOTED - March 2019\nSmall focus of enhancement at resection margin\n2.1 cm nodule\nRecommend stereotactic radiosurgery (SRS)\nGamma Knife performed May 2019\n\n2020-2022:\nQ4 month monitoring\nStable disease\nAnnual neuropsychological testing\nManaging cardiovascular risk factors\n\nLATEST VISIT - January 2024\nStable disease on imaging\nMaintained good functional status\nContinue surveillance q6 months\n\nCurrent Status:\nKPS Score: 80/100\nECOG Score: 1\n\nMONITORING PROTOCOL:\n- MRI with contrast q6 months\n- Neurological examination q6 months\n- Annual neuropsychological testing\n- Regular BP monitoring\n- Sleep apnea compliance checks\n\nPROGNOSIS:\nGuarded due to Grade II status and radiation history\nMaintaining aggressive surveillance due to risk factors\n\nNote: Timeline reflects aggressive monitoring due to:\n1. WHO Grade II status\n2. Prior radiation exposure\n3. Initial tumor size and location\n4. Patient's age and comorbidities",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n59-year-old male with radiation-induced meningioma\n\nINITIAL VISIT - March 15, 2014\nMRI FINDINGS:\n- 2.8 cm left frontal parasagittal meningioma\n- Moderate peritumoral edema\n- No significant mass effect\n- WHO Grade I (presumptive radiological assessment)\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms but tumor size and location permit initial conservative management. Notable risk factors include prior radiation exposure and obesity.\n\nPLAN:\n1. Watchful waiting with close monitoring\n2. Medical management of symptoms:\n   - Dexamethasone 4mg BID for edema control\n   - Gradual taper based on symptom response\n3. Monthly follow-up initially\n\nFOLLOW-UP VISIT - June 20, 2014\nSymptoms partially improved with steroid therapy. Vision complaints stabilized.\nMRI: No significant change in tumor size\nPlan: Continue conservative management, reduce dexamethasone to 2mg BID\n\nANNUAL VISIT - March 10, 2015\nStable symptoms. Patient adhering to CPAP therapy.\nMRI: Minimal growth (2.9 cm)\nPlan: Maintain current management, continue annual imaging\n\nANNUAL VISIT - March 15, 2016\nReports improved headaches. Working full-time with accommodations.\nMRI: Stable size\nPlan: Extended monitoring interval to 18 months\n\nFOLLOW-UP - September 12, 2017\nMinor progression of visual symptoms\nMRI: Tumor size 3.1 cm\nPlan: Resume annual monitoring, optimize blood pressure control\n\nANNUAL VISIT - September 20, 2018\nStable symptoms with good functional status\nMRI: No significant change\nPlan: Continue conservative management\n\nANNUAL VISIT - October 5, 2019\nReports occasional balance issues\nMRI: Tumor size 3.2 cm, slight increase in edema\nPlan: \n1. Increase dexamethasone temporarily\n2. Physical therapy referral\n3. Consider SRS if progression continues\n\nANNUAL VISIT - October 10, 2020\nStable neurological status\nMRI: No significant change\nPlan: Continue current management\n\nANNUAL VISIT - September 25, 2021\nWell-compensated symptoms\nMRI: Stable appearance\nPlan: Maintain conservative approach\n\nANNUAL VISIT - September 30, 2022\nMinimal symptom progression\nMRI: 3.3 cm, stable edema\nPlan: Continue monitoring, optimize medical management\n\nLATEST VISIT - October 5, 2023\nGood functional status maintained\nMRI: No significant change\nPlan: Continue annual monitoring\n\nCURRENT STATUS (2024):\n- Successfully managed conservatively for 10 years\n- Maintained employment with modifications\n- Good quality of life preservation\n\nFUNCTIONAL SCORES:\nKPS: 80 (Able to perform normal activities with effort)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nONGOING RECOMMENDATIONS:\n1. Annual MRI surveillance\n2. Regular blood pressure monitoring\n3. Weight management program\n4. Sleep apnea compliance\n5. Regular physical therapy\n6. Occupational adaptations as needed\n\nNote: Conservative management successful due to:\n- Slow growth rate\n- Patient compliance\n- Well-controlled comorbidities\n- Regular monitoring adherence"
      }
    },
    {
      "demographics": {
        "age": 42,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Chef",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increasing difficulty concentrating at work",
          "Subtle right-sided facial numbness",
          "Reports increased clumsiness when handling kitchen utensils",
          "Occasional ringing in right ear",
          "Mild balance issues noted while standing for long periods in kitchen"
        ],
        "medical_history": [
          "Migraine headaches since age 35, previously well-controlled with sumatriptan",
          "Surgical removal of ovarian cyst (2018)",
          "No history of radiation exposure",
          "No family history of brain tumors",
          "Regular eye exams, last one 2 years ago was normal",
          "No history of seizures",
          "No prior neurological conditions",
          "Currently taking oral contraceptives for past 8 years"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F42-O-2014\nOccupation: Software Developer/Chef\n\nINITIAL VISIT - March 15, 2014\nPresenting Symptoms: Progressive neurological symptoms including morning headaches, right-sided visual disturbance, facial numbness, and balance issues affecting occupational function. Symptoms particularly concerning given dual career requiring fine motor skills and prolonged standing.\n\nInitial MRI Findings:\n- 3.8cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on superior sagittal sinus\n- Enhancement pattern suggestive of WHO Grade II\n- Evidence of brain parenchyma compression\n\nAssessment:\nHigh-risk features warranting immediate intervention:\n- Size >3cm\n- Significant edema\n- Critical location\n- Progressive symptoms affecting QoL\n- Occupational impact\n\nPlan:\n1. Scheduled for surgical resection within 2 weeks\n2. Pre-operative functional MRI and DTI tractography\n3. Started on Dexamethasone 4mg QID\n4. Discontinue oral contraceptives immediately\n\nSURGICAL NOTE - April 1, 2014\nProcedure: Simpson Grade II resection\nWHO Grade: II\nFindings: Adherent to superior sagittal sinus\nPost-op course: Uncomplicated\n\nFOLLOW-UP VISITS:\n\nOctober 2014 (6-month):\n- Improved symptoms\n- MRI: No residual tumor\n- Returned to work with modifications\n- Started adjuvant radiotherapy\n\nApril 2015 (1-year):\n- Complete resolution of visual symptoms\n- MRI stable\n- Resumed full work duties\n- Continue q6month monitoring\n\n2016-2017 (Years 2-3):\n- Quarterly MRI surveillance\n- No recurrence\n- Maintained work performance\n- Minor headaches managed with standard analgesics\n\n2018-2019 (Years 4-5):\n- Biannual MRI\n- Stable imaging\n- Excellent functional status\n- Continue surveillance protocol\n\n2020-2021 (Years 6-7):\n- Annual MRI\n- No evidence of recurrence\n- Maintained professional activities\n- Prophylactic anticonvulsants discontinued\n\n2022-2023 (Years 8-9):\n- Continued annual imaging\n- Stable neurological exam\n- Full professional engagement\n- Quality of life optimal\n\n2024 (Year 10):\n- Maintenance phase\n- Annual MRI shows no recurrence\n- Excellent functional status\n- Consider extending imaging interval\n\nCurrent Status:\nKPS Score: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nLong-term Monitoring Plan:\n1. Annual MRI with contrast\n2. Biannual neurological examinations\n3. Annual ophthalmological assessment\n4. Cognitive function monitoring\n5. Quality of life assessments\n\nOccupational Considerations:\n- Maintained ability to perform both professional roles\n- No restrictions on computer work or kitchen duties\n- Ergonomic workplace modifications implemented\n- Regular occupational therapy assessments\n\nNote: Aggressive early intervention and consistent monitoring have resulted in excellent outcome with maintained professional and personal quality of life.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 42\nGender: Female\nOccupation: Software Developer/Chef\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (presumptive radiological diagnosis)\n- No other intracranial abnormalities\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms concerning for meningioma. Given tumor size and symptoms, conservative management with close monitoring is recommended. Occupational considerations include prolonged screen time (software development) and manual dexterity requirements (chef work).\n\nPLAN:\n1. Serial MRI monitoring every 6 months initially\n2. Prophylactic anticonvulsants not indicated\n3. Discontinue oral contraceptives (may influence tumor growth)\n4. Ergonomic workplace assessment recommended\n5. Prescribed: Dexamethasone 4mg BID for symptom management\n\nFOLLOW-UP VISITS:\n\nSeptember 20, 2018\n- Mild improvement in headaches\n- Vision stable\n- MRI: No significant change in tumor size\n- Reduced dexamethasone to 2mg BID\n- KPS: 90\n\nMarch 12, 2019\n- Symptoms stable\n- MRI: No growth\n- Further reduced dexamethasone to 1mg daily\n- Implemented regular breaks during computer work\n- Modified kitchen workflow to accommodate balance issues\n- KPS: 90\n\nSeptember 18, 2019\n- Improved concentration at work\n- Balance issues stable\n- MRI: No growth\n- Discontinued dexamethasone\n- KPS: 95\n\nMarch 15, 2020\n- Well-controlled symptoms\n- MRI: Stable\n- Transitioned to annual imaging\n- KPS: 95\n\nMarch 10, 2021\n- Minor headaches, well-managed\n- MRI: No growth\n- Maintaining work schedule with accommodations\n- KPS: 95\n\nMarch 8, 2022\n- Stable symptoms\n- MRI: No change\n- Continues modified work arrangements\n- KPS: 95\n\nMarch 14, 2023\n- Minimal symptoms\n- MRI: Stable appearance\n- Successfully managing dual careers\n- KPS: 95\n\nMarch 12, 2024\n- Well-controlled symptoms\n- MRI: No growth over 6 years\n- Excellent quality of life maintenance\n- Consider biennial MRI going forward\n- KPS: 95\n\nCURRENT STATUS:\n- Stable WHO Grade I meningioma\n- Successfully managed conservatively\n- Maintained occupational function\n- Excellent quality of life\n\nSCORES:\nKPS (Karnofsky Performance Status): 95/100\nECOG Performance Status: 1\n\nLONG-TERM RECOMMENDATIONS:\n1. Continue biennial MRI surveillance\n2. Maintain workplace modifications\n3. Annual ophthalmological examination\n4. Regular neurological assessment\n5. Continue lifestyle modifications for symptom management\n\nNote: Conservative management has proven successful with this patient, demonstrating stable disease and good quality of life over 6-year follow-up period. Surgical intervention remains a future option if clinical deterioration occurs."
      }
    },
    {
      "demographics": {
        "age": 53,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": true
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 4 months, particularly in the morning; Recent onset of right-sided facial numbness; Increasing difficulty with balance during stage performances; Occasional episodes of nausea without vomiting; Reports subtle changes in hearing in right ear; Mild confusion and difficulty remembering lines during performances in the past 2 months"
        ],
        "medical_history": [
          "Hypertension diagnosed 3 years ago, well-controlled with lisinopril 10mg daily; Mild traumatic brain injury from stage accident 15 years ago with full recovery; History of migraine headaches in 20s and 30s that had resolved; Tinnitus in right ear diagnosed 2 years ago; No history of seizures; No prior cancers; Non-smoker; Occasional alcohol use; Family history significant for father with brain tumor (type unknown)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly balance/coordination tests, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly balance/coordination tests, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M53-A-2014\nOccupation: Stage Artist\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive headaches, right facial numbness, balance issues\n\nIMAGING:\nInitial MRI reveals 4.2cm right petroclival meningioma with significant mass effect on brainstem and moderate peritumoral edema. T2 sequence shows hyperintense signal. Evidence of dural tail sign. No calcification noted.\n\nASSESSMENT:\nWHO Grade II Meningioma (suspected based on imaging characteristics)\nKPS: 80\nECOG: 1\n\nPLAN:\nGiven tumor size, location, and occupation-related symptoms, recommend aggressive surgical intervention. Schedule for right retrosigmoid approach with goal of maximal safe resection.\n\nSURGICAL NOTE - April 2, 2014\nProcedure: Right retrosigmoid craniotomy for tumor resection\nFindings: Simpson Grade II resection achieved\nPathology confirms WHO Grade II Meningioma\nPost-op course uncomplicated\n\nFOLLOW-UP VISITS:\n\nJuly 2014 (3 months post-op):\n- Improved balance\n- Residual mild facial numbness\n- MRI shows small residual tumor\n- Initiated adjuvant radiotherapy (60 Gy/30 fractions)\nKPS: 90, ECOG: 0\n\nJanuary 2015 (9 months post-op):\n- Returned to performing\n- Minor balance issues\n- Surveillance MRI stable\nKPS: 90, ECOG: 0\n\nJuly 2015:\n- MRI shows small area of enhancement\n- Recommend continued q6month monitoring\nKPS: 90, ECOG: 0\n\n2016-2017 (Bi-annual visits):\n- Stable imaging\n- Maintaining performance schedule\n- Annual neuropsychological testing normal\nKPS: 90-95, ECOG: 0\n\nMarch 2018:\n- MRI shows small progression of residual tumor\n- Recommend Gamma Knife radiosurgery to residual\nGamma Knife performed May 2018\nKPS: 90, ECOG: 0\n\n2019-2020 (Quarterly visits):\n- Post-radiosurgery imaging stable\n- Maintaining full performance schedule\n- No new neurological deficits\nKPS: 95, ECOG: 0\n\n2021-2022 (Bi-annual visits):\n- Continued stability on imaging\n- Minor right-sided tinnitus\n- Full functional status\nKPS: 95, ECOG: 0\n\n2023:\n- Slight enhancement on MRI\n- Increased monitoring frequency\n- Maintaining performance schedule\nKPS: 90, ECOG: 0\n\nJanuary 2024:\n- Latest MRI stable\n- No new symptoms\n- Continue bi-annual monitoring\nCurrent KPS: 90\nCurrent ECOG: 0\n\nOVERALL DISEASE COURSE:\nPatient has maintained good functional status with aggressive initial treatment approach. Initial Simpson II resection followed by adjuvant RT and subsequent targeted radiosurgery for small recurrence has resulted in good disease control over 10-year period. Occupation-specific monitoring of performance abilities has guided treatment timing and intervention strategies.\n\nCURRENT STATUS:\nWHO Grade II Meningioma, stable disease\nKPS: 90/100\nECOG: 0/5",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n53-year-old male, Blood Type A\nOccupation: Stage Artist\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive headaches, right-sided facial numbness, balance issues\n\nMRI FINDINGS:\n- 2.8cm right petroclival meningioma\n- Minimal peritumoral edema\n- No significant mass effect\n- WHO Grade I (presumptive radiological diagnosis)\n\nASSESSMENT:\nGiven tumor size (<3cm), location, and patient's profession requiring fine balance and performance abilities, recommending close monitoring with consideration for future intervention if progression occurs.\n\nPLAN:\n1. MRI surveillance every 6 months initially\n2. Dexamethasone 4mg BID for symptom management\n3. Physical therapy referral for balance training\n4. Occupational therapy for performance adaptation strategies\n5. Neurocognitive baseline assessment\n\nFOLLOW-UP VISIT - September 20, 2014\n- Stable tumor size\n- Improved symptoms with steroid therapy\n- Successfully implementing performance modifications\n- Continuing current management plan\n\nFOLLOW-UP VISIT - March 12, 2015\n- No tumor growth\n- Reduced steroid dosage to 2mg BID\n- Maintaining performance schedule with adaptations\n- KPS 90\n\nANNUAL VISIT - March 18, 2016\n- Stable imaging\n- Further steroid reduction to 1mg daily\n- Well-adapted to modified performance techniques\n- Continuing surveillance\n\nANNUAL VISIT - March 15, 2017\n- Minimal tumor growth (0.2cm)\n- Maintaining good functional status\n- Increased monitoring frequency to q6 months\n- KPS 85\n\nFOLLOW-UP VISIT - September 22, 2017\n- Stable disease\n- Managing performance schedule effectively\n- Continue current management\n\nANNUAL VISIT - March 20, 2018\n- No significant changes\n- Stable symptoms\n- Reduced MRI frequency to annual\n- KPS 85\n\nANNUAL VISIT - March 15, 2019\n- Stable imaging\n- Well-maintained quality of life\n- Continuing performance career\n- KPS 85\n\nANNUAL VISIT - March 18, 2020\n- No tumor progression\n- Stable symptoms\n- Maintaining active lifestyle\n- KPS 85\n\nANNUAL VISIT - March 16, 2021\n- Stable disease\n- Minor balance issues managed with PT\n- Continuing performance work\n- KPS 80\n\nANNUAL VISIT - March 15, 2022\n- No significant changes\n- Well-adapted to condition\n- Maintaining quality of life\n- KPS 80\n\nANNUAL VISIT - March 14, 2023\n- Stable imaging\n- Managing symptoms effectively\n- Active in performance career\n- KPS 80\n\nMOST RECENT VISIT - March 12, 2024\n- 10-year follow-up\n- Stable disease course\n- Successfully maintained career\n- Excellent quality of life preservation\n\nCURRENT STATUS:\nKPS Score: 80/100\nECOG Score: 1\n\nMANAGEMENT SUMMARY:\nConservative approach successful over 10-year period with:\n- Stable tumor size\n- Preserved performance ability\n- Maintained quality of life\n- Minimal intervention required\n- Successful symptom management\n\nWHO Grade: I (stable throughout monitoring period)\nRecommended: Continue annual monitoring"
      }
    },
    {
      "demographics": {
        "age": 53,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work, especially when cataloging books",
          "Occasional episodes of right-sided facial numbness",
          "Reports feeling more clumsy lately, dropping items with right hand"
        ],
        "medical_history": [
          "Hysterectomy at age 45 for uterine fibroids",
          "Migraine headaches since age 30, but pattern and intensity recently changed",
          "History of depression, managed with Sertraline 50mg daily",
          "Mild hypertension diagnosed 2 years ago, controlled with lifestyle modifications",
          "No history of cancer",
          "No significant family history of neurological conditions",
          "Regular mammograms, last one normal 8 months ago",
          "Non-smoker, occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F53-O-2014\nOccupation: Librarian\n\nINITIAL VISIT - March 15, 2014\nPresenting Symptoms: Progressive headaches, right-sided visual disturbance, facial numbness, and coordination issues significantly impacting work performance. Symptoms suggest possible mass effect with compression of visual pathways and trigeminal nerve.\n\nInitial MRI Findings:\n- 4.2 cm left frontal parasagittal meningioma\n- Significant peritumoral edema\n- Mass effect with 6mm midline shift\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Compression of superior sagittal sinus\n\nASSESSMENT & PLAN:\nGiven size, symptoms, and location, immediate surgical intervention recommended. Patient's occupation requires fine motor skills and cognitive clarity. Current symptoms significantly impacting work performance.\nWHO Grade: II (preliminary based on imaging characteristics)\n\nSURGICAL INTERVENTION - April 2, 2014\n- Simpson Grade II resection performed\n- Pathology confirmed WHO Grade II meningioma\n- MIB-1 index: 8%\n- Post-op course uncomplicated\n\nFOLLOW-UP VISITS:\n\nOctober 15, 2014 (6 months post-op)\n- Improved headaches and vision\n- MRI: No residual tumor\n- Initiated adjuvant radiotherapy (60 Gy/30 fractions)\n\nApril 2, 2015 (1 year post-op)\n- Stable neurologically\n- Returned to work full-time\n- MRI: No recurrence\n\nOctober 5, 2015\n- Maintaining good function\n- Minor right-sided facial sensitivity\n- MRI: Stable post-surgical changes\n\nApril 12, 2016\n- Continued stability\n- Working full schedule\n- MRI: No concerning changes\n\nOctober 18, 2016\n- Small area of enhancement noted on MRI\n- Watchful waiting approach adopted\n- Increased monitoring frequency\n\nApril 4, 2017\n- Enhancement stable\n- Maintaining work duties\n- No new symptoms\n\nApril 10, 2018\n- Slight progression of enhancement\n- Gamma Knife radiosurgery performed to residual tumor\n- 16 Gy to tumor margin\n\nApril 16, 2019\n- Post-radiosurgery response favorable\n- MRI shows reduction in enhancement\n- Fully functional at work\n\nApril 21, 2020\n- Continued stability\n- Annual MRI maintained\n- No cognitive decline\n\nApril 13, 2021\n- Minor enhancement progression\n- Close monitoring implemented\n- Maintaining work duties\n\nApril 19, 2022\n- Stable imaging\n- No new symptoms\n- Continues regular activities\n\nApril 18, 2023\n- Long-term stability achieved\n- Annual imaging continued\n- Full functional status\n\nApril 16, 2024 (10-year follow-up)\n- Maintained tumor control\n- No significant progression\n- Patient continues working with minimal limitations\n\nCurrent Status (2024):\nKPS Score: 90 (Able to carry on normal activity with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nTreatment Summary:\n- Initial Simpson II resection (2014)\n- Adjuvant radiotherapy completed (2014)\n- Gamma Knife to residual tumor (2018)\n- Maintained close monitoring protocol\n- Successful occupational rehabilitation\n\nNote: Patient continues to require bi-annual MRI surveillance due to WHO Grade II status and history of progression. Long-term prognosis remains favorable with current management strategy.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n53 y/o Female, Blood Type: O\nOccupation: Librarian\n\nINITIAL VISIT - January 15, 2018\nPresenting Symptoms: Progressive headaches, right-sided visual disturbance, facial numbness, and coordination issues. Occupational impact noted with difficulty in detailed library work.\nMRI Findings: 2.8cm left frontal convexity meningioma, minimal surrounding edema, no significant mass effect.\nWHO Grade: I (based on imaging characteristics)\nAssessment: Given size <3cm and minimal edema, candidate for conservative management with close monitoring.\nPlan: \n- Watchful waiting approach with serial imaging\n- Dexamethasone 4mg daily for symptom management\n- Continue Sertraline 50mg daily\n- BP monitoring\n\nFOLLOW-UP - July 20, 2018 (6 months)\nSymptoms: Moderate improvement in headaches with steroid therapy\nMRI: Stable lesion size, no new changes\nPlan: Taper dexamethasone, continue monitoring\n\nANNUAL FOLLOW-UP - January 18, 2019\nSymptoms: Stable, headaches managed with regular analgesics\nMRI: No growth, stable appearance\nOccupational Status: Maintained full-time work with minor accommodations\nPlan: Continue annual monitoring\n\nANNUAL FOLLOW-UP - January 15, 2020\nSymptoms: Well-controlled\nMRI: Minimal growth (0.2mm), not clinically significant\nPlan: Maintain current management approach\n\nANNUAL FOLLOW-UP - January 20, 2021\nSymptoms: Reports occasional headaches\nMRI: Stable compared to previous\nNote: Patient coping well with library work, using organizational aids\nPlan: Continue conservative management\n\nANNUAL FOLLOW-UP - January 17, 2022\nSymptoms: Stable\nMRI: No significant changes\nPlan: Extended monitoring interval to 18 months given stability\n\n18-MONTH FOLLOW-UP - July 15, 2023\nSymptoms: Well-controlled, maintaining good quality of life\nMRI: Stable lesion\nOccupational Status: Continues library work with good performance\nPlan: Continue extended interval monitoring\n\nLATEST FOLLOW-UP - January 10, 2024\nSymptoms: Stable\nMRI: No significant changes over 6-year period\nQuality of Life: Excellent, well-adapted to condition\nPlan: Continue biennial MRI monitoring\n\nFUNCTIONAL STATUS SCORES:\nKarnofsky Performance Status (KPS): 90\n(Able to carry on normal activity; minor signs/symptoms of disease)\n\nECOG Performance Status: 1\n(Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nMANAGEMENT SUMMARY:\nConservative approach successful with:\n- Stable disease over 6 years\n- Maintained occupational function\n- Good quality of life\n- Well-controlled symptoms\n- No surgical intervention required\n\nNext Follow-up: January 2026 (unless new symptoms develop)\n\n[Electronically signed]\nDr. [REDACTED]\nNeurosurgery Department"
      }
    },
    {
      "demographics": {
        "age": 55,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increasing difficulty with balance when walking",
          "Subtle personality changes noted by family - more irritable and forgetful",
          "Occasional tingling sensation in right hand",
          "Reports difficulty focusing while reading books at work"
        ],
        "medical_history": [
          "Type 2 Diabetes diagnosed 8 years ago - managed with Metformin 1000mg BID",
          "HbA1c consistently around 7.2%",
          "Hypertension - controlled with Lisinopril 10mg daily",
          "Migraine headaches since age 35 - previously well-controlled with sumatriptan PRN",
          "Laser eye surgery for myopia 12 years ago",
          "Cholecystectomy in 2015",
          "Family history of breast cancer (maternal aunt)",
          "No history of smoking or alcohol abuse"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F55-A-DM\nOccupation: Librarian\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms with morning headaches and visual changes\n\nIMAGING:\nMRI with/without contrast reveals:\n- 4.2 cm left frontal parasagittal meningioma\n- Significant peritumoral edema\n- Mass effect on superior sagittal sinus\n- T2 hyperintense with heterogeneous enhancement\nWHO Grade: II (atypical features noted)\n\nASSESSMENT & PLAN:\nGiven patient's progressive symptoms, tumor size >3cm, and occupation requiring visual/cognitive precision, recommend aggressive surgical intervention. Patient's diabetes requires careful perioperative management.\n\nSURGICAL INTERVENTION - April 2, 2014\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology confirms WHO Grade II meningioma\nPost-op course uncomplicated\n\nFOLLOW-UP VISITS:\n\nOctober 2014 (6 months post-op):\n- MRI shows no residual tumor\n- Vision improved\n- Headaches resolved\n- Recommended adjuvant radiotherapy\n- Started 54 Gy/30 fractions\n\nApril 2015 (1 year post-op):\n- MRI stable\n- Returned to work part-time\n- Diabetes well-controlled\n- Continue q6month monitoring\n\nOctober 2015:\n- New small enhancement at resection margin\n- Recommended gamma knife radiosurgery\n- 16 Gy single fraction delivered\n\n2016-2017 (q6month visits):\n- Serial MRIs show stable disease\n- Maintaining work schedule\n- Regular diabetes monitoring\n\n2018-2019:\n- Subtle progression noted on imaging\n- Started bevacizumab\n- Continued q6month MRI surveillance\n\n2020-2021:\n- Disease stable on bevacizumab\n- COVID-19 precautions implemented\n- Telemedicine visits alternating with in-person\n\n2022-2023:\n- Small increase in enhancement\n- Second surgery performed February 2023\n- Simpson Grade III resection\n- Pathology confirms recurrent WHO Grade II\n\n2024 (Current):\n- Post-second surgery surveillance\n- Monthly clinical assessments\n- Q3month MRI protocol\n- Considering molecular targeted therapy\n\nCurrent Status:\nKPS Score: 80\nECOG Score: 1\n\nONGOING RECOMMENDATIONS:\n1. Quarterly MRI with volumetric analysis\n2. Monthly neurocognitive assessments\n3. Regular ophthalmological evaluation\n4. Strict diabetes management\n5. Consider clinical trial enrollment if progression\n\nNote: Patient's occupation as librarian has influenced treatment aggression due to cognitive/visual demands. Diabetes management has remained stable throughout treatment course.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F55-A-DM-2014\nOccupation: Librarian\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive headaches, visual changes, balance issues\nWHO Grade: I (based on imaging characteristics)\n\nImaging Findings:\n- MRI reveals 2.8cm left frontal convexity meningioma\n- Minimal perilesional edema\n- No significant mass effect\n- T2 signal: moderately intense\n- Uniform contrast enhancement\n\nAssessment:\nDespite symptomatic presentation, given tumor size <3cm and patient's preference, recommending initial conservative management with close monitoring. Occupation as librarian requires detailed attention and visual acuity, which influences our management approach.\n\nPlan:\n1. Serial MRI monitoring q4 months initially\n2. Headache management optimization\n   - Neurology referral\n   - Discontinue sumatriptan due to potential vascular effects\n3. Dexamethasone 4mg daily with taper for edema control\n4. Diabetes management optimization with endocrinology\n5. Monthly blood pressure monitoring\n\nFOLLOW-UP VISIT - July 20, 2014\nSymptoms slightly improved with steroid therapy\nMRI: Stable lesion size\nPlan: Continue monitoring, gradual steroid taper\n\nFOLLOW-UP - January 10, 2015\nSymptoms stable\nMRI: No growth\nSteroid-free for 3 months\nPlan: Extend MRI interval to q6 months\n\n2016 VISITS (March 15 & September 20)\nMinimal symptom progression\nMRI: Stable at 2.9cm\nManaging work duties adequately\nContinue conservative approach\n\n2017 VISITS (March 18 & September 22)\nMinor headache exacerbation\nMRI: Stable\nAdded prophylactic topiramate for headache management\n\n2018 ANNUAL VISIT - March 25\nMRI: First noted growth to 3.1cm\nDiscussed surgical options but patient prefers continued observation\nIncreased monitoring frequency\n\n2019 VISITS (March 20 & September 15)\nSize stable at 3.1cm\nSymptoms managed with medications\nMaintaining work performance with accommodations\n\n2020 ANNUAL VISIT - March 18 (Telehealth due to COVID-19)\nMRI: Stable\nAdded occupational therapy for balance optimization\n\n2021 ANNUAL VISIT - March 22\nMRI: 3.2cm, minimal growth\nSymptoms stable\nContinuing conservative management\n\n2022 ANNUAL VISIT - March 20\nMRI: Stable\nQuality of life maintained\nWorking part-time with accommodations\n\n2023 ANNUAL VISIT - March 25\nMRI: 3.3cm\nDiscussing potential radiation therapy options for future consideration\n\n2024 CURRENT VISIT - March 15\nMRI: Stable at 3.3cm\nMaintaining conservative approach with close monitoring\nPatient satisfied with management strategy\n\nCurrent Performance Status:\nKPS Score: 80 (Normal activity with effort, some symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nTreatment Summary 2014-2024:\n- Successfully managed with conservative approach\n- Slow growth pattern (2.8cm to 3.3cm over 10 years)\n- Maintained quality of life and occupational function\n- Avoided surgical intervention\n- Well-controlled symptoms through medical management\n\nContinuing Recommendations:\n1. Annual MRI surveillance\n2. Regular neurological assessment\n3. Ongoing diabetes management\n4. Quality of life monitoring\n5. Occupational therapy as needed\n6. Consider radiation therapy if significant progression occurs"
      }
    },
    {
      "demographics": {
        "age": 56,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": "Chef",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increasing difficulty with fine motor tasks while cooking",
          "Subtle personality changes noted by coworkers - more irritable than usual",
          "Occasional episodes of right-sided facial numbness",
          "Balance issues when turning quickly in kitchen"
        ],
        "medical_history": [
          "Hypertension - diagnosed 5 years ago, managed with lisinopril",
          "BMI 33.2 - Class I Obesity",
          "Migraine headaches in 30s, resolved spontaneously",
          "Cholecystectomy 2015",
          "No history of cancer",
          "No previous neurological conditions",
          "Family history: Mother had breast cancer at age 62",
          "Current medications: Lisinopril 10mg daily, multivitamin",
          "No known drug allergies"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly olfactory function tests, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly olfactory function tests, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F56-O-2014\nPrimary Neurosurgeon: Dr. [Name]\n\nINITIAL VISIT - March 15, 2014\nPRESENTING SYMPTOMS: 56-year-old female chef presents with progressive neurological symptoms including morning headaches, right-sided visual disturbance, and occupationally significant fine motor deficits. Symptoms particularly concerning given profession requiring precise motor control.\n\nIMAGING:\nMRI with/without contrast reveals:\n- 4.2cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on motor strip\n- No calcification noted\nWHO Grade: II (atypical features on imaging)\n\nASSESSMENT & PLAN:\nGiven size, location, and symptomatic presentation, recommend aggressive surgical intervention. Occupation as chef requires optimal neurological function. Obesity may complicate surgery but benefits outweigh risks.\n\nSURGICAL INTERVENTION - April 2, 2014\n- Simpson Grade II resection achieved\n- Minimal residual tumor at superior sagittal sinus\n- Pathology confirms WHO Grade II meningioma\n- No immediate post-operative complications\n\nFOLLOW-UP VISITS:\n\nOctober 2014 (6 months post-op):\n- Improved headaches\n- Residual minor right hand coordination issues\n- MRI: Small residual tumor stable\n- Initiated adjuvant radiotherapy (54 Gy/30 fractions)\n\nApril 2015 (1 year post-op):\n- Complete resolution of visual symptoms\n- Returned to work with modifications\n- MRI: No progression\n- Continue q6month monitoring\n\nOctober 2015:\n- Stable symptoms\n- MRI: No changes\n- Weight management program initiated\n\n2016-2017 (q6month visits):\n- Stable imaging\n- Gradually improving function\n- Return to full work duties\n- Regular MRIs show no progression\n\n2018-2019:\n- New small enhancement noted on superior sagittal sinus (Dec 2018)\n- Gamma Knife radiosurgery to residual (March 2019)\n- 16 Gy single fraction\n\n2020-2021:\n- Annual MRI surveillance\n- Stable post-radiosurgery\n- No new neurological symptoms\n- Regular weight monitoring\n\n2022-2023:\n- Continues stable disease\n- Quarterly neurological assessments\n- MRI every 6 months\n- Working full-time without restrictions\n\n2024 (Current):\n- 10-year follow-up\n- No evidence of progression\n- Maintains independent function\n- Annual MRI surveillance recommended going forward\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nLONG-TERM MONITORING PLAN:\n- Continue semi-annual MRI surveillance\n- Quarterly neurological assessments\n- Annual neuropsychological testing\n- Regular monitoring of occupational function\n- Weight management program continuation\n\nNote: This case demonstrates successful aggressive management of WHO Grade II meningioma in a patient with occupationally critical neurological requirements. Early intervention and comprehensive follow-up have resulted in excellent long-term outcome.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nGender: Female | Age: 56 | Blood Type: O\nOccupation: Chef | BMI: 33.2\n\nINITIAL VISIT - March 15, 2014\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (presumptive radiological diagnosis)\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms affecting occupational function. Given tumor size and symptomatology, conservative management with close monitoring is recommended initially.\n\nMANAGEMENT PLAN:\n1. Serial MRI monitoring\n2. Symptomatic management\n3. Occupational modifications\n4. Blood pressure optimization\n\nRECOMMENDATIONS:\n- Ergonomic assessment of workplace\n- Consider reduced hours/modified duties\n- Prophylactic anticonvulsants not indicated\n- Continue lisinopril, optimize BP control\n\n-------------------\n\nFOLLOW-UP - September 20, 2014 (6 months)\n- Symptoms stable\n- MRI shows no significant change\n- Patient adapted work schedule (shorter shifts)\n- KPS: 90\n\n-------------------\n\nFOLLOW-UP - March 18, 2015 (1 year)\n- Mild improvement in headaches\n- Vision stable\n- MRI: No growth\n- Working with modified duties\n- Added: Vitamin D supplementation\n- KPS: 90\n\n-------------------\n\nFOLLOW-UP - March 15, 2016 (2 years)\n- Stable symptoms\n- MRI: Minimal growth (2.9cm)\n- Managing work well with modifications\n- BP well-controlled\n- KPS: 85\n\n-------------------\n\nFOLLOW-UP - March 20, 2018 (4 years)\n- Increased headache frequency\n- MRI: Growth to 3.2cm\n- Discussed surgical options but patient prefers conservative approach\n- Referred to occupational therapy\n- KPS: 80\n\n-------------------\n\nFOLLOW-UP - March 15, 2020 (6 years)\n- COVID-19 Telehealth visit\n- Stable symptoms\n- Previous MRI showed no further growth\n- Managing work with accommodations\n- KPS: 80\n\n-------------------\n\nFOLLOW-UP - March 18, 2022 (8 years)\n- MRI: 3.3cm, minimal growth\n- Symptoms stable\n- Semi-retired from chef position\n- Working as cooking instructor with modified schedule\n- KPS: 75\n\n-------------------\n\nCURRENT VISIT - March 15, 2024 (10 years)\n- MRI: 3.4cm, minimal growth\n- Symptoms well-managed\n- Quality of life maintained\n- Continues modified work schedule\n- Regular physical therapy\n- KPS: 75\n\nFUNCTIONAL STATUS SCORES:\n- Karnofsky Performance Status (KPS): 75/100\n- ECOG Performance Status: 1\n\nLONG-TERM MANAGEMENT SUMMARY:\n- Successfully managed conservatively for 10 years\n- Maintained occupational function with modifications\n- Minimal tumor growth\n- Preserved quality of life\n- Regular monitoring continues\n\nMONITORING SCHEDULE:\n- Annual MRI\n- 6-monthly clinical reviews\n- Regular BP monitoring\n- Annual ophthalmology assessment\n\nNote: Conservative management has proven successful in this case, with the patient maintaining good functional status despite gradual tumor growth. Surgical intervention remains an option if significant progression occurs."
      }
    },
    {
      "demographics": {
        "age": 61,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty finding words",
          "Subtle personality changes noted by spouse - increased irritability",
          "Two episodes of stumbling/loss of balance in past month",
          "Mild right-sided facial numbness",
          "Increasing fatigue and difficulty concentrating at work"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Hypercholesterolemia - managed with atorvastatin 20mg daily",
          "Mild hearing loss in left ear diagnosed 3 years ago",
          "Appendectomy at age 23",
          "No history of cancer",
          "No prior neurological conditions",
          "Family history: Mother with breast cancer, Father with hypertension",
          "Non-smoker, occasional alcohol use (2-3 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nOccupation: Financial Analyst\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms with headaches and visual changes\n\nIMAGING:\nMRI reveals a 4.2 cm right frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe with 5mm midline shift. T2 hyperintense with heterogeneous enhancement. No calcification noted.\n\nASSESSMENT:\nHigh-risk features present:\n- Size >3cm\n- Significant peritumoral edema\n- Proximity to motor strip\n- Symptomatic presentation\nWHO Grade: Suspected Grade II (to be confirmed post-resection)\n\nPLAN:\nRecommend immediate surgical intervention given:\n1. Progressive symptomatology\n2. Size and location\n3. Impact on patient's cognitive-demanding occupation\n4. Risk of further neurological deterioration\n\n-------------------\n\nSURGICAL NOTE - April 2, 2014\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nEstimated blood loss: 300cc\nComplications: None\nPathology: WHO Grade II meningioma\nKi-67 index: 12%\n\n-------------------\n\nPOST-OP FOLLOW-UP - May 1, 2014\nPatient recovering well\nHeadaches improved\nVision stabilizing\nRecommended adjuvant radiation therapy\nStarted 6-week course of IMRT (60 Gy/30 fractions)\n\n-------------------\n\n6-MONTH FOLLOW-UP - October 15, 2014\nMRI: No evidence of residual/recurrent tumor\nSymptoms resolved\nReturned to work part-time\n\n-------------------\n\nANNUAL FOLLOW-UP - April 10, 2015\nMRI: Stable post-surgical changes\nNo evidence of recurrence\nFull-time work resumed\n\n-------------------\n\n2-YEAR FOLLOW-UP - April 2016\nSmall enhancement noted at surgical margin\nRecommended increased surveillance\nMRI frequency increased to every 4 months\n\n-------------------\n\n3-YEAR FOLLOW-UP - April 2017\n1.2cm recurrence at original site\nRecommended repeat surgery\nSecond craniotomy performed June 2017\nPathology confirmed Grade II\nAdditional course of radiation therapy completed\n\n-------------------\n\n5-YEAR FOLLOW-UP - April 2019\nStable post-treatment\nQuarterly MRI surveillance continues\nMaintaining full work schedule\n\n-------------------\n\n7-YEAR FOLLOW-UP - April 2021\nNo evidence of recurrence\nReduced MRI frequency to bi-annual\n\n-------------------\n\nCURRENT STATUS - January 2024\n10-year follow-up\nStable disease control\nContinues bi-annual MRI surveillance\nMaintained professional activities\n\nFUNCTIONAL STATUS SCORES:\nKPS Score: 90 (Able to carry on normal activity, minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nONGOING RECOMMENDATIONS:\n1. Continue bi-annual MRI surveillance\n2. Regular neurocognitive assessment\n3. Maintain current medication regimen\n4. Annual ophthalmological evaluation\n5. Consider prophylactic anti-epileptic medication\n\nNote: Aggressive early intervention and close monitoring have contributed to favorable long-term outcome despite Grade II histology.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nOccupation: Financial Analyst\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms over 4 months\nWHO Grade: Grade II Meningioma (based on imaging characteristics)\n\nImaging Findings:\n- MRI reveals 3.2cm left frontal convexity meningioma\n- Moderate peritumoral edema\n- Mass effect on adjacent frontal lobe\n- No significant calcification\n\nAssessment:\nDespite conservative preference, presenting symptoms and imaging characteristics warrant intervention due to:\n- Progressive neurological symptoms\n- Size >3cm\n- Location affecting cognitive function critical for patient's occupation\n- Impact on quality of life and work performance\n\nInitial Management Plan:\n1. Simpson Grade II surgical resection recommended\n2. Post-operative radiation therapy to be considered\n3. Regular monitoring of cognitive function\n4. Temporary medical leave from work (8-12 weeks)\n\nFOLLOW-UP VISITS:\n\nJune 30, 2014 (Post-operative)\n- Successful Simpson Grade II resection\n- Minimal residual tumor\n- Improvement in headaches and vision\n- Starting physical therapy\n- Cognitive function improving\n- Planning return to work with modified schedule\n\nDecember 15, 2014\n- MRI shows stable residual tumor\n- Improved neurological symptoms\n- Returned to work full-time\n- Maintaining cognitive exercises\n- Continue 6-monthly monitoring\n\nJune 20, 2015\n- Stable imaging\n- No new symptoms\n- Managing work stress effectively\n- Regular exercise program initiated\n\n2016-2018 (Annual Visits)\n- Continued stability on imaging\n- Maintaining work performance\n- Regular cognitive assessments\n- Minor fatigue managed with work-life balance strategies\n\n2019-2021 (Annual Visits)\n- No tumor progression\n- Stable neurological status\n- Regular meditation practice implemented\n- Considering partial remote work options\n\n2022-2024 (Biannual Checks)\n- Continued stability\n- Focus on preventive health\n- Maintaining quality of life\n- Regular cognitive screening\n- Working hybrid schedule\n\nCurrent Status (2024):\n- Stable disease\n- Well-maintained cognitive function\n- Successfully managing work responsibilities\n- Good quality of life\n\nFunctional Status Scores:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nOngoing Recommendations:\n1. Biannual MRI surveillance\n2. Annual neuropsychological testing\n3. Stress management techniques\n4. Regular exercise program\n5. Work-life balance optimization\n6. Blood pressure monitoring\n7. Continue current medications\n\nNext Follow-up: August 2024\nImaging: Schedule MRI one week prior\n\nNote: Conservative post-surgical approach has proven successful with good tumor control and maintained quality of life. Patient has adapted well to work modifications and maintains high functionality in professional role."
      }
    },
    {
      "demographics": {
        "age": 40,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Researcher",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months becoming more severe in mornings, intermittent blurred vision in right eye, occasional episodes of nausea, subtle personality changes noted by spouse including increased irritability, recent difficulty concentrating at work, one episode of focal seizure affecting left hand 2 weeks ago"
        ],
        "medical_history": [
          "Migraine headaches diagnosed at age 35 but well-controlled with sumatriptan until recent changes in headache pattern, mild concussion from sports injury at age 22 with full recovery, family history negative for brain tumors, no prior radiation exposure, no history of cancer, generally healthy with normal annual physicals, takes occasional ibuprofen for tension headaches, no regular medications"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M40-A-2014\nOccupation: Researcher\n\nINITIAL VISIT - March 15, 2014\nPresenting Symptoms: Progressive headaches (3 months), morning predominance, right eye visual disturbance, nausea, personality changes, concentration issues, recent left hand focal seizure.\nImaging: Initial MRI reveals 4.2cm right frontal convexity meningioma with significant peritumoral edema, mass effect on adjacent frontal lobe. T2 hyperintense, heterogeneous enhancement.\nWHO Grade: Suspected Grade II (based on imaging characteristics)\nPlan: Recommend immediate surgical resection given size, symptoms, and critical location affecting cognitive function particularly relevant to patient's research profession.\n\nSURGICAL INTERVENTION - April 2, 2014\nProcedure: Right frontal craniotomy with Simpson Grade II resection\nPathology: WHO Grade II atypical meningioma\nPost-op course: Uncomplicated\nImmediate post-op imaging: Near-total resection, small residual along superior sagittal sinus\n\nFOLLOW-UP VISITS:\n\nJuly 15, 2014 (3 months post-op)\n- Improved headaches and vision\n- Started adjuvant radiation therapy (60 Gy/30 fractions)\n- MRI: No evidence of progression\n- Return to work part-time\n\nJanuary 10, 2015 (9 months post-op)\n- Completed radiation therapy\n- Full return to work\n- MRI: Stable residual\n- Seizure-free on levetiracetam\n\nJuly 2015 - December 2019 (q6 month follow-up)\n- Serial MRIs: Stable\n- Maintained professional productivity\n- Minor radiation-related changes stable\n- Continued seizure prophylaxis\n\nMarch 15, 2020\n- Small area of enhancement noted on routine MRI\n- Decision for gamma knife radiosurgery to residual\n- Treatment delivered: 16 Gy single fraction\n\n2020-2024 (q6 month follow-up)\n- Stable disease\n- Maintained full professional activities\n- Annual neuropsychological testing: stable cognitive function\n- Last MRI (January 2024): No progression\n\nCurrent Status (2024):\n- Disease controlled\n- Maintains full-time research position\n- Regular monitoring continues\n- Seizure-free for 9 years\n\nFunctional Status Scores:\nKPS: 90/100 (Able to carry on normal activity, minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nTreatment Strategy Rationale:\nEarly aggressive intervention chosen due to:\n1. Patient's young age\n2. Cognitive demands of research profession\n3. Tumor size and location\n4. Presence of neurological symptoms\n5. WHO Grade II status\n\nMonitoring Protocol:\n- MRI q6 months\n- Annual neuropsychological assessment\n- Regular ophthalmological evaluation\n- Seizure monitoring\n- Quality of life assessments",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [Redacted] | 40Y Male | Blood Type: A | Occupation: Researcher\n\nINITIAL VISIT - January 15, 2018\nPresenting Symptoms: Progressive headaches (3 months), morning predominance, right eye blurred vision, nausea, personality changes, concentration difficulties, recent left hand focal seizure.\nMRI Findings: 2.8cm left frontal convexity meningioma, minimal peritumoral edema, no significant mass effect.\nWHO Grade: I (presumptive based on imaging characteristics)\nPlan: Given size <3cm and stable employment requiring cognitive function, recommending conservative management with close monitoring.\n- Initiated Levetiracetam 500mg BID for seizure prophylaxis\n- Dexamethasone 4mg BID with taper for symptom management\nKPS: 90 | ECOG: 1\n\nFOLLOW-UP - April 15, 2018\nSymptoms improved with medical management. Headaches reduced.\nMRI: No significant change\nPlan: Continue current management\n- Reduced Dexamethasone to maintenance dose\nKPS: 95 | ECOG: 0\n\nFOLLOW-UP - October 20, 2018\nStable symptoms. Managing work responsibilities well.\nMRI: No growth\nPlan: Continue monitoring\nKPS: 95 | ECOG: 0\n\nANNUAL FOLLOW-UP - January 18, 2019\nMinor headaches well-controlled with medication.\nMRI: Stable lesion size\nPlan: Maintain current approach\nKPS: 95 | ECOG: 0\n\nANNUAL FOLLOW-UP - January 15, 2020\nReports good quality of life, maintaining research productivity.\nMRI: No progression\nPlan: Continue annual monitoring\nKPS: 95 | ECOG: 0\n\nANNUAL FOLLOW-UP - January 20, 2021\nStable symptoms. No seizures in past 2 years.\nMRI: Minimal growth (0.2mm), not clinically significant\nPlan: Maintain conservative approach\nKPS: 95 | ECOG: 0\n\nANNUAL FOLLOW-UP - January 17, 2022\nWell-adapted to condition. Managing academic duties effectively.\nMRI: Stable compared to previous\nPlan: Continue annual imaging\nKPS: 95 | ECOG: 0\n\nANNUAL FOLLOW-UP - January 16, 2023\nReports occasional mild headaches, well-controlled.\nMRI: No significant changes\nPlan: Maintain current management strategy\nKPS: 95 | ECOG: 0\n\nRECENT FOLLOW-UP - January 15, 2024\nSix-year stability demonstrated. Patient satisfied with conservative approach.\nMRI: Stable lesion\nPlan: \n- Continue annual MRI surveillance\n- Maintain Levetiracetam\n- Regular cognitive function monitoring\n- Consider biennial imaging if stability continues\n\nCurrent Status:\n- KPS: 95/100\n- ECOG: 0\n- WHO Grade: I (stable)\n- Excellent quality of life maintained\n- Successfully continuing research career\n\nLong-term Recommendations:\n1. Annual MRI surveillance\n2. Regular cognitive assessments\n3. Maintain work-life balance\n4. Stress management techniques\n5. Regular exercise program\n6. Sleep hygiene optimization\n\nThe conservative management approach has proven successful with this patient, allowing maintenance of professional activities while effectively managing symptoms. The patient's cognitive demands as a researcher have been well-preserved through this approach."
      }
    },
    {
      "demographics": {
        "age": 43,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Coffee Roaster",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increased difficulty concentrating during work hours",
          "Subtle personality changes noted by coworkers - more irritable than usual",
          "Occasional episodes of right-sided facial numbness",
          "Reports mild balance issues when standing up quickly",
          "Intermittent ringing in right ear starting 2 months ago"
        ],
        "medical_history": [
          "Mild hypertension diagnosed 2 years ago, not currently on medication",
          "Concussion from recreational soccer 8 years ago, fully recovered",
          "Occasional migraine headaches since age 30, managed with OTC medications",
          "No history of seizures",
          "No previous neurological conditions",
          "No family history of brain tumors",
          "Non-smoker",
          "Moderate alcohol consumption (2-3 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nGender: Male | Age: 43 | Blood Type: O\nOccupation: Software Developer/Coffee Roaster\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 3.8cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Evidence of compression of superior sagittal sinus\n\nASSESSMENT:\nPatient presents with concerning neurological symptoms indicating progressive mass effect. Occupation requires high cognitive function and visual acuity. Size and location of tumor warrant immediate intervention.\n\nPLAN:\n- Scheduled for surgical resection within 2 weeks\n- Simpson Grade I resection planned\n- Pre-operative functional MRI and DTI for surgical mapping\n- Neuropsychological evaluation ordered\n\nSURGICAL NOTE - March 29, 2018\n- Complete resection achieved (Simpson Grade I)\n- Pathology confirms WHO Grade II atypical meningioma\n- No immediate post-operative complications\n\nFOLLOW-UP VISIT - June 15, 2018\n- Post-operative MRI shows no residual tumor\n- Adjuvant radiation therapy completed (60 Gy/30 fractions)\n- Improved headaches and vision\n- Cleared to return to work with modifications\n\nFOLLOW-UP - December 20, 2018\n- Stable imaging\n- Cognitive function improved\n- Return to full work duties\n- Continue q6month monitoring\n\n2019 VISITS (June 15 & December 20)\n- No evidence of recurrence\n- Normal neurological exam\n- Maintaining work performance\n- Continue surveillance protocol\n\n2020 VISITS (June 18 & December 17)\n- Stable imaging\n- Minor headaches managed with OTC medications\n- Normal cognitive function\n- Maintaining full work schedule\n\n2021 VISITS (June 16 & December 15)\n- Small enhancement noted on right frontal region\n- Close monitoring warranted\n- Increased imaging frequency to q4months\n\n2022 VISITS (April 14, August 18, December 15)\n- 1.2cm recurrent nodule\n- Decision for early re-intervention\n- Second surgery performed October 5, 2022\n- Post-op MRI shows complete resection\n\n2023 VISITS (March 16, September 14)\n- Post-second surgery stability\n- No new neurological symptoms\n- Resumed full work activities\n- Continue q6month monitoring\n\n2024 CURRENT STATUS (January 18)\n- Stable imaging\n- Excellent functional status\n- Maintaining professional activities\n- Plan to continue surveillance\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory and able to carry out light work\n\nMONITORING PROTOCOL:\n- MRI with contrast q6months\n- Neuropsychological evaluation annually\n- Ophthalmological evaluation q6months\n- Regular cognitive function assessment\n\nNote: Aggressive monitoring justified by:\n1. WHO Grade II initial pathology\n2. History of recurrence\n3. Cognitive demands of occupation\n4. Young age at presentation",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n43-year-old male, Blood Type O\nOccupation: Software Developer/Coffee Roaster\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive headaches, visual changes, and neurological symptoms\n\nMRI FINDINGS:\n- 2.8cm right frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (likely)\n- No calcification noted\n\nASSESSMENT:\nDespite presenting symptoms, tumor size and location favor initial conservative management. Patient's cognitive-demanding occupation requires careful symptom management.\n\nINITIAL MANAGEMENT PLAN:\n1. Dexamethasone 4mg BID for symptom control\n2. Prophylactic levetiracetam 500mg BID\n3. Monthly clinical monitoring initially\n4. Occupational recommendations: ergonomic workspace assessment, regular breaks\n5. Lifestyle modifications: reduced coffee intake, regular sleep schedule\n\nFOLLOW-UP VISITS:\n\nJune 15, 2018 (3-month)\n- Headaches improved with steroids\n- Vision stabilized\n- Gradually tapering dexamethasone\n- MRI: No significant change\n- Continue conservative management\n\nDecember 20, 2018 (9-month)\n- Successfully weaned off dexamethasone\n- Maintaining work schedule with modifications\n- MRI: Stable tumor size\n- Initiated preventive migraine medication\n\nMarch 15, 2019 (1-year)\n- Well-adapted to modified work routine\n- Minor occasional headaches\n- MRI: No growth\n- Reduced levetiracetam to 500mg daily\n\nMarch 20, 2020 (2-year)\n- Stable symptoms\n- Working remotely due to COVID-19\n- MRI: No progression\n- Added blue light filters to computer screens\n\nApril 15, 2021 (3-year)\n- Maintaining stable condition\n- Successfully managing work-life balance\n- MRI: Minimal growth (0.2mm) - not clinically significant\n- Continue conservative approach\n\nMay 10, 2022 (4-year)\n- Reports improved concentration\n- Reduced coffee roasting hours due to fume sensitivity\n- MRI: Stable\n- Maintaining annual monitoring\n\nJune 5, 2023 (5-year)\n- Excellent symptom control\n- Successfully adapted work routine\n- MRI: No significant changes\n- Transitioned to biennial imaging\n\nFebruary 15, 2024 (5.75-year)\n- Continues stable course\n- Maintaining modified lifestyle\n- No new neurological symptoms\n- Next MRI scheduled for June 2025\n\nCURRENT STATUS:\n- Well-controlled symptoms\n- Maintaining professional activities\n- Excellent quality of life\n- Successfully managed with conservative approach\n\nFUNCTIONAL STATUS SCORES:\n- Karnofsky Performance Status (KPS): 90/100\n- ECOG Performance Status: 1\n\nONGOING RECOMMENDATIONS:\n1. Biennial MRI surveillance\n2. Annual neurological examinations\n3. Maintain work modifications\n4. Continue lifestyle adjustments\n5. Regular ophthalmological check-ups\n\nNote: Conservative management has proven successful with this patient, demonstrating stable disease and good quality of life maintenance. Surgical intervention remains a future option if significant progression occurs.\n\nWHO Grade: I (presumptive based on imaging characteristics)\n\n[Electronically signed]\nDr. [REDACTED]\nNeurosurgery Department"
      }
    },
    {
      "demographics": {
        "age": 61,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": "Coffee Roaster",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of mild confusion and difficulty concentrating at work",
          "Occasional balance issues when walking",
          "Reports subtle personality changes noted by coworkers - more irritable than usual",
          "Two episodes of focal seizures affecting left hand in past month",
          "Mild nausea without vomiting"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches since age 35 - previously well-managed with sumatriptan",
          "Surgical menopause - total hysterectomy at age 48 for fibroids",
          "History of hormone replacement therapy for 5 years post-hysterectomy",
          "No prior neurological conditions",
          "No history of cancer",
          "Family history significant for breast cancer in mother",
          "Non-smoker, occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n61 y/o female, Blood Type A\nOccupation: Data Scientist/Coffee Roaster\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms with headaches and visual changes\n\nIMAGING:\nMRI with/without contrast reveals:\n- 4.2cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Dural tail sign present\n- No calcification noted\n\nASSESSMENT:\nWHO Grade II meningioma (based on imaging characteristics)\nSymptoms indicating significant mass effect\nKPS: 80/100\nECOG: 1\n\nPLAN:\nRecommend immediate surgical intervention given:\n1. Size >3cm\n2. Progressive neurological symptoms\n3. Occupation requiring high cognitive function\n4. Risk of further neurological deterioration\n\nSURGICAL INTERVENTION - April 2, 2014\n- Simpson Grade II resection performed\n- Pathology confirms WHO Grade II atypical meningioma\n- Post-op MRI shows near-total resection\n\nFOLLOW-UP VISIT - July 15, 2014\nPost-operative adjuvant radiation therapy completed\n60 Gy in 30 fractions\nImproved neurological symptoms\nKPS: 90/100\n\nFOLLOW-UP - January 10, 2015\nMRI stable\nReturned to work part-time\nContinuing anti-seizure medications\nNo new neurological symptoms\n\nFOLLOW-UP - July 2015, January 2016, July 2016\nBi-annual MRIs stable\nFull return to work\nKPS maintained at 90/100\n\nFOLLOW-UP - January 2017\nSmall area of enhancement noted on MRI\nClose monitoring recommended\nIncreased scan frequency to every 3 months\n\nINTERVENTION - March 2017\nGamma Knife radiosurgery to small recurrent focus\n18 Gy single fraction\n\nFOLLOW-UP - 2018-2020 (Quarterly visits)\nSerial MRIs stable\nMaintained work performance\nNo new neurological symptoms\n\nFOLLOW-UP - 2021-2023 (Bi-annual visits)\nContinued stability\nMinor radiation changes stable\nMaintained cognitive function\n\nCURRENT STATUS (2024):\n- Disease stable for 7 years post-radiosurgery\n- Continues full-time work\n- Annual MRI surveillance planned\n- Maintained on anticonvulsants\n\nCurrent Scores:\nKPS: 90/100\nECOG: 1\n\nMONITORING PROTOCOL:\n1. MRI brain with/without contrast every 6 months\n2. Quarterly neurocognitive assessments\n3. Regular ophthalmological evaluations\n4. Quality of life assessments\n\nLONG-TERM RECOMMENDATIONS:\n1. Continue vigilant monitoring\n2. Low threshold for intervention if any progression\n3. Occupational cognitive assessment annually\n4. Maintain seizure prophylaxis\n\nNote: Aggressive initial approach with early intervention and frequent monitoring has resulted in excellent outcome with maintained quality of life and occupational function.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 61, Female, Blood Type: A\nOccupation: Data Scientist/Coffee Roaster\n\nINITIAL VISIT - January 15, 2018\nPresenting Symptoms: Progressive headaches, right eye visual disturbance, cognitive changes, balance issues, focal seizures (left hand), personality changes, and mild nausea. Symptoms significantly impact work performance in both analytical and physical tasks.\n\nMRI Findings:\n- 2.8cm right frontal convexity meningioma\n- Moderate peritumoral edema\n- No significant mass effect\n- WHO Grade I (likely)\n\nInitial Assessment:\nDespite symptomatic presentation, given tumor size <3cm and patient's preference, recommending close monitoring with option for intervention if progression occurs.\n\nTreatment Plan:\n1. Anti-epileptic: Levetiracetam 500mg BID\n2. Dexamethasone 4mg BID for edema control\n3. Monthly clinical monitoring initially\n4. Quarterly MRI for first year\n\nFOLLOW-UP VISITS:\n\nApril 12, 2018\n- Headaches improved with steroids\n- Seizures controlled\n- Continuing conservative management\n- Reduced dexamethasone to 2mg BID\n\nJuly 15, 2018\n- Stable symptoms\n- MRI shows no growth\n- Maintaining current management\n- Cleared for modified work duties\n\nJanuary 20, 2019\n- Annual MRI: Stable tumor size\n- Reduced steroid dose successfully\n- Headaches well-controlled\n- Continuing conservative approach\n\nJanuary 15, 2020\n- MRI: No progression\n- Patient adapted work routine - reduced coffee roasting hours\n- Stable neurological exam\n- Transitioned to bi-annual imaging\n\nJune 10, 2021\n- Stable disease\n- Minor headaches managed with standard analgesics\n- Maintaining work-life balance\n- Continue current management\n\nMarch 15, 2022\n- MRI shows minimal edema reduction\n- Patient reports improved concentration\n- Successfully managing both occupations\n- Annual imaging recommended\n\nApril 20, 2023\n- Stable disease burden\n- Well-adapted to modified lifestyle\n- Maintaining cognitive function\n- Continue annual monitoring\n\nMarch 1, 2024\n- Six-year follow-up\n- MRI: Stable disease\n- Excellent quality of life\n- Patient satisfied with conservative approach\n\nCurrent Status:\n- Well-controlled symptoms\n- Maintaining professional activities\n- Good quality of life\n\nFunctional Status Scores:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nLong-term Recommendations:\n1. Continue annual MRI\n2. Maintain anti-epileptic medication\n3. Regular cognitive assessment\n4. Occupational therapy as needed\n5. Monitor for any new symptoms\n\nNote: Conservative approach successful with good symptom control and stable disease. Patient maintains professional activities with appropriate modifications. Will continue vigilant monitoring with low threshold for intervention if status changes."
      }
    },
    {
      "demographics": {
        "age": 47,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": true
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of dizziness and unsteady gait",
          "Difficulty concentrating at work, especially when reviewing financial documents",
          "Intermittent tinnitus in right ear",
          "Two episodes of focal seizures affecting left hand in past month",
          "Mild personality changes noted by coworkers - increased irritability"
        ],
        "medical_history": [
          "Radiation therapy to head/neck region at age 12 for childhood lymphoma",
          "Hypertension diagnosed 3 years ago, managed with lisinopril",
          "BMI of 33.2 with failed attempts at weight management",
          "Sleep apnea diagnosed 2 years ago, uses CPAP",
          "Mild hypercholesterolemia managed with diet",
          "No significant surgical history",
          "No family history of brain tumors",
          "Current medications: lisinopril 10mg daily"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Additional consideration for radiation exposure history"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M47-O-2014\nPrimary Neurosurgeon: Dr. [Name]\n\nINITIAL VISIT - March 15, 2014\nPRESENTING SYMPTOMS & ASSESSMENT:\n47-year-old male financial analyst presents with concerning neurological symptoms including progressive headaches, right-sided visual disturbance, and focal seizures. History of childhood radiation exposure significantly increases meningioma risk.\n\nIMAGING:\nMRI with/without contrast reveals:\n- 4.2cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Dural tail sign present\n- No calcification noted\n\nINITIAL ASSESSMENT:\nWHO Grade II Meningioma (suspected based on imaging characteristics)\nRecommend immediate surgical intervention due to:\n- Size >3cm\n- Symptomatic presentation\n- Critical location affecting cognitive function\n- History of radiation exposure\n- Impact on occupational function\n\nTREATMENT PLAN:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative optimization of blood pressure\n3. Sleep study review\n4. Neuropsychological evaluation\n5. Anti-epileptic prophylaxis (Levetiracetam 500mg BID)\n\nFOLLOW-UP VISITS:\n\nApril 2, 2014 - SURGICAL INTERVENTION\n- Gross total resection achieved\n- Simpson Grade II removal\n- Pathology confirms WHO Grade II meningioma\n- No immediate post-operative complications\n\nJune 15, 2014 - 2-MONTH POST-OP\n- Improved headaches and vision\n- No new seizures\n- Started adjuvant radiation therapy\n- MRI shows no residual tumor\n\nDecember 2014 - 6-MONTH POST-OP\n- Completed radiation therapy (60 Gy/30 fractions)\n- Return to work part-time\n- Stable imaging\n\nJune 2015 - 1-YEAR POST-OP\n- Full-time work resumed\n- Minor cognitive fatigue\n- MRI stable\n\n2016-2017 (Quarterly visits)\n- Regular MRI surveillance\n- Stable disease\n- Maintained work performance\n- Weight management program initiated\n\n2018-2019 (Biannual visits)\n- Continued surveillance\n- No recurrence\n- Improved BMI to 31.4\n- Sleep apnea better controlled\n\n2020-2021 (Annual visits)\n- Stable imaging\n- No new neurological symptoms\n- Maintaining professional duties\n- Regular cognitive assessments\n\n2022-2024 (Annual visits)\n- Long-term surveillance\n- No evidence of recurrence\n- Excellent functional status\n- Continues preventive health measures\n\nCURRENT STATUS (2024):\n- Disease-free at 10 years post-treatment\n- Maintained professional career\n- Well-controlled comorbidities\n\nFUNCTIONAL STATUS SCORES:\nInitial Presentation (2014):\n- KPS: 70/100\n- ECOG: 2\n\nCurrent Status (2024):\n- KPS: 90/100\n- ECOG: 1\n\nSURVEILLANCE PLAN:\nContinue annual MRI and clinical evaluations indefinitely due to:\n1. WHO Grade II history\n2. Prior radiation exposure\n3. Young age at diagnosis\n\nNote: This proactive approach with early intervention and aggressive follow-up has resulted in excellent outcome with maintained quality of life and professional functionality.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M47-O-2014\nDiagnosis: Intracranial Meningioma (WHO Grade II)\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms with headaches and visual changes\nMRI Findings: 3.8cm right sphenoid wing meningioma with moderate peritumoral edema\nAssessment: Given patient's symptomatic presentation, size >3cm, and concerning neurological symptoms, surgical intervention was discussed but patient prefers conservative approach initially.\n\nTreatment Plan:\n- Anti-epileptic: Levetiracetam 500mg BID\n- Dexamethasone 4mg BID with taper plan\n- Monthly neurological monitoring\n- Occupational therapy referral for workplace adaptations\n- Sleep study follow-up for CPAP optimization\n\nFOLLOW-UP - June 20, 2014\nSymptoms stabilized with medical management\nMRI: No significant change\nPlan: Continue current management\n\nFOLLOW-UP - December 5, 2014\nIncreased headache frequency\nMRI: Tumor growth to 4.1cm\nRecommendation: Surgical intervention now strongly advised due to progression\n\nSURGICAL INTERVENTION - January 15, 2015\nProcedure: Simpson Grade II resection\nPathology: WHO Grade II meningioma\nPost-op course: Uncomplicated\n\nFOLLOW-UP - July 2015\nImproved symptoms\nMRI: No residual tumor\nPlan: q6month MRI surveillance\n\n2016-2018 (Biannual visits)\nStable imaging\nGradual return to full work duties\nMaintained on levetiracetam\n\n2019-2021 (Annual visits)\nNo recurrence\nManaging hypertension and weight\nFocus on lifestyle modifications\n\n2022-2024 (Annual visits)\nStable disease\nQuality of life maintained\nContinuing CPAP compliance\n\nCurrent Status (2024):\nKPS Score: 90\nECOG Score: 1\n\nLong-term Recommendations:\n1. Annual MRI surveillance\n2. Regular blood pressure monitoring\n3. Weight management program\n4. Cognitive assessment annually\n5. Workplace ergonomic assessment\n6. Sleep apnea management optimization\n\nNote: Conservative approach was modified due to disease progression. Post-surgical course demonstrates successful outcome with good quality of life maintenance."
      }
    },
    {
      "demographics": {
        "age": 52,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Researcher",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": true,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 3 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea, particularly in morning (initially attributed to pregnancy)",
          "Subtle personality changes noted by coworkers - increased irritability",
          "Two episodes of focal seizures affecting left hand in past month",
          "Difficulty concentrating on detailed research work",
          "Occasional balance issues when walking"
        ],
        "medical_history": [
          "Currently 20 weeks pregnant with first child",
          "History of migraine headaches since age 30, but pattern has changed recently",
          "Surgical removal of ovarian cyst 5 years ago",
          "Family history of breast cancer (mother)",
          "No prior neurological conditions",
          "No history of radiation exposure",
          "Regular prenatal care with normal pregnancy progression",
          "No significant head trauma",
          "Non-smoker, no alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Coordinated care with obstetrics",
            "Timing surgery for second trimester if possible"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F52-O-2014\nPrimary Neurosurgeon: Dr. [Name]\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms during pregnancy (20 weeks gestation)\n\nIMAGING FINDINGS:\nMRI reveals 4.2cm right frontal convexity meningioma with significant peritumoral edema\n- Mass effect on right frontal lobe\n- Midline shift of 6mm\n- Contrast enhancement pattern typical for meningioma\n- Evidence of dural tail sign\nWHO Grade: II (atypical features on imaging)\n\nASSESSMENT & PLAN:\nGiven patient's pregnancy status, concerning symptoms, and tumor characteristics, recommend urgent surgical intervention despite pregnancy. Risks discussed with patient, OB/GYN consulted.\n- Schedule surgery for week 24 of pregnancy (optimal window)\n- Daily dexamethasone 4mg for edema management\n- Anti-epileptic prophylaxis initiated\n- Weekly neurological monitoring\n\nSURGICAL NOTE - April 26, 2014\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nEstimated blood loss: 300cc\nNo complications\nPathology confirms WHO Grade II meningioma\n\nPOST-OP FOLLOW-UP - May 10, 2014\n- Excellent wound healing\n- Headaches resolved\n- Vision improving\n- Seizures controlled\nPlan: Continue AED, begin radiation planning post-delivery\n\nPREGNANCY OUTCOME - August 2014\nSuccessful C-section delivery at 38 weeks\nBaby healthy, no complications\n\n2015 VISITS:\nMarch 15: Post-radiation treatment completed (60 Gy/30fx)\nSeptember 20: MRI stable, symptoms resolved\nKPS: 90\n\n2016 VISITS:\nMarch & September: Bi-annual MRI - No recurrence\nReturned to research work full-time\nKPS: 100\n\n2017-2019:\nQuarterly then bi-annual monitoring\nAll MRIs stable\nMaintaining professional duties\nKPS: 100\n\n2020-2022:\nAnnual MRI surveillance\nNo evidence of recurrence\nOccasional headaches - managed with standard analgesics\nKPS: 90-100\n\n2023-2024:\nContinued annual surveillance\nLast MRI (January 2024): Stable post-surgical changes\nNo evidence of recurrence\nSuccessfully maintaining research career\nKPS: 100\n\nCURRENT STATUS (2024):\nDisease-free survival: 10 years\nExcellent functional status\nContinues full-time research work\n\nPERFORMANCE SCORES:\nKPS: 100/100\nECOG: 0\n\nMONITORING PROTOCOL:\n- Annual MRI with contrast\n- Annual neuropsychological assessment\n- Quarterly clinical examinations\n- Regular quality of life assessments\n\nNote: Early aggressive intervention strategy with complete resection and post-partum radiation therapy appears to have provided optimal outcome for this patient, allowing continuation of both family life and professional career.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n52F, Blood Type O+, Researcher\nWHO Grade II Meningioma\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive neurological symptoms during pregnancy (20 weeks gestation)\nMRI Findings: 3.2cm right frontal convexity meningioma with moderate peritumoral edema\nAssessment: Given pregnancy status and symptom progression, case requires careful balance between management of tumor and fetal safety.\nPlan: \n- Close monitoring through pregnancy\n- Dexamethasone 4mg BID for edema control\n- Levetiracetam 500mg BID for seizure prophylaxis\n- Weekly neurological assessments\n- Coordinate with high-risk OB\n\nFOLLOW-UP - June 30, 2018 (28 weeks gestation)\nSymptoms stable on current regimen\nMRI deferred due to pregnancy\nPlan: Continue current management through delivery\n\nPOST-DELIVERY VISIT - October 12, 2018\nSuccessful delivery via C-section\nNew MRI shows stable tumor size\nPlan: Continue conservative management with quarterly monitoring\n\nANNUAL FOLLOW-UP - March 2019\nMild symptom improvement post-pregnancy\nMRI: No significant change\nPlan: Maintain current medications, continue monitoring\n\n2020 VISITS (Quarterly):\n- Stable symptoms\n- MRI shows minimal growth (0.2cm over 12 months)\n- Maintaining work with accommodations\n- Added prophylactic migraine therapy\n\n2021 ASSESSMENT:\nMinor tumor progression (3.5cm)\nPatient maintaining good functional status\nDecision: Continue conservative approach with increased monitoring\n\n2022-2023 (Biannual visits):\n- Stable disease\n- Well-controlled symptoms\n- Regular MRI surveillance\n- Maintaining research career with adaptations\n\nCURRENT STATUS (2024):\nTumor size: 3.7cm\nSymptoms: Well-controlled\nWorking: Modified schedule with breaks\nQuality of life: Good\n\nMONITORING PROTOCOL:\n- MRI every 6 months\n- Neurological assessment quarterly\n- Regular ophthalmology checks\n- Cognitive function testing annually\n\nFUNCTIONAL STATUS:\nKPS Score: 80 (Able to perform normal activity with effort)\nECOG Score: 1 (Restricted in physically strenuous activity)\n\nMANAGEMENT RATIONALE:\nConservative approach chosen due to:\n1. Initial presentation during pregnancy\n2. Stable growth pattern\n3. Good symptom control\n4. Patient preference\n5. Successful adaptation to work environment"
      }
    },
    {
      "demographics": {
        "age": 51,
        "gender": "Male",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": "Coffee Roaster",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increasing difficulty concentrating at work",
          "Subtle personality changes noted by spouse - more irritable than usual",
          "Occasional episodes of right-sided facial numbness",
          "Balance issues when walking, particularly noticeable in past 2 weeks"
        ],
        "medical_history": [
          "Mild hypertension diagnosed 3 years ago, controlled with lisinopril 10mg daily",
          "Concussion from sports injury in college (age 20) - fully recovered",
          "Seasonal allergies treated with over-the-counter antihistamines",
          "No history of seizures",
          "No prior neurological conditions",
          "No family history of brain tumors",
          "Regular health screenings, last physical exam 8 months ago was unremarkable",
          "No significant surgical history"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - March 15, 2014\nPatient: 51-year-old male, Financial Analyst/Coffee Roaster\nChief Complaints: Progressive headaches, visual disturbances, balance issues\n\nIMAGING FINDINGS:\nMRI reveals 4.2cm left frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe with 5mm midline shift. T2 hyperintense with heterogeneous enhancement. No calcification noted.\n\nASSESSMENT:\nWHO Grade II meningioma (atypical features on imaging)\nHigh-risk features:\n- Size >3cm\n- Significant peritumoral edema\n- Mass effect\n- Occupation requires high cognitive function\n- Symptomatic progression\n\nPLAN:\n1. Urgent surgical intervention recommended - craniotomy for gross total resection\n2. Preoperative dexamethasone 4mg QID\n3. Anticonvulsant prophylaxis\n4. Occupational considerations: cognitive demands of financial analysis require aggressive management\n\nSURGICAL NOTE - April 2, 2014\nSimpson Grade II resection achieved. Minor residual tumor at superior sagittal sinus interface.\nPathology confirms WHO Grade II meningioma.\n\nFOLLOW-UP VISITS:\n\nJuly 15, 2014 (3 months post-op)\n- Improved headaches and vision\n- MRI: Small residual enhancement\n- Started adjuvant radiotherapy (60 Gy/30 fractions)\n\nJanuary 10, 2015 (9 months post-op)\n- Stable symptoms\n- Returned to work part-time\n- MRI: Stable residual\n\nJuly 2015 - December 2019 (q6 month follow-up)\n- Serial MRIs show stability\n- Maintained work performance\n- Regular cognitive assessments\n- No recurrence\n\nJanuary 15, 2020\n- New 8mm nodular enhancement at resection site\n- Recommended stereotactic radiosurgery\n- Gamma Knife performed March 2020\n\n2020-2024 (continued q6 month monitoring)\n- Stable disease\n- Annual neuropsychological testing\n- Maintained full-time work\n- Regular balance assessments\n\nCurrent Status (2024):\n- Disease stable\n- Fully functional\n- Continues both occupations with modifications\n- Annual MRI surveillance recommended indefinitely\n\nFunctional Status Scores:\nKPS: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nMONITORING PROTOCOL:\n- MRI with contrast q6 months\n- Neuropsychological testing annually\n- Balance assessment q6 months\n- Occupational therapy evaluation annually\n\nLong-term Prognosis:\nGuarded but favorable with continued surveillance. Occupation-specific monitoring of cognitive function essential for financial analysis work.\n\n/s/ Dr. [Assistant]\nBoard Certified Neurosurgeon\nLicense #[xxx]\nDate: Latest visit - February 15, 2024",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n51-year-old male, Financial Analyst/Coffee Roaster\nBlood Type: B\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Moderate peritumoral edema\n- No significant mass effect\n- WHO Grade I (presumptive radiological diagnosis)\n\nSYMPTOMS/PRESENTATION:\nProgressive neurological symptoms including headaches, visual changes, and balance issues raise concern. Symptoms appear to be affecting work performance and quality of life.\n\nASSESSMENT & PLAN:\nGiven symptom progression and tumor location, conservative surgical intervention recommended despite preference for watchful waiting. Patient's occupation requires high cognitive function and visual acuity.\n\nSURGICAL INTERVENTION - April 2, 2018:\n- Simpson Grade II resection performed\n- Pathology confirmed WHO Grade I meningioma\n- No surgical complications\n\nFOLLOW-UP VISITS:\n\nJuly 2018 (3 months post-op):\n- Significant improvement in headaches and vision\n- Returning to work part-time\n- MRI: No residual tumor\n- Continue lisinopril 10mg daily\n\nJanuary 2019 (9 months post-op):\n- Full return to work\n- Minor occasional headaches\n- MRI: No recurrence\n- Cleared for full work duties\n\nJanuary 2020 (Annual):\n- Stable symptoms\n- MRI: No recurrence\n- Managing coffee roasting business well\n- Recommended protective masks for coffee dust exposure\n\nJanuary 2021 (Annual):\n- Asymptomatic\n- MRI: Stable\n- Regular exercise program initiated\n- Stress management techniques discussed\n\nJanuary 2022 (Annual):\n- Continues to do well\n- MRI: No concerns\n- Work-life balance maintained\n- Annual monitoring plan continued\n\nJanuary 2023 (Annual):\n- No new symptoms\n- MRI: Stable\n- Maintaining active lifestyle\n- Cognitive function excellent\n\nJanuary 2024 (Annual):\n- 6-year post-op\n- MRI: No recurrence\n- Excellent quality of life\n- Continue annual monitoring\n\nCURRENT STATUS:\n- Excellent recovery\n- No tumor recurrence\n- Full professional and personal functionality\n\nMONITORING RECOMMENDATIONS:\n- Annual MRI continuing through 2028\n- Then biennial if stable\n- Regular blood pressure monitoring\n- Annual ophthalmological examination\n\nFUNCTIONAL SCORES:\nKPS: 100/100 (Fully active, normal)\nECOG: 0 (Fully active, no restrictions)\n\nLIFESTYLE RECOMMENDATIONS:\n1. Maintain protective measures during coffee roasting\n2. Regular exercise continuation\n3. Stress management practices\n4. Regular sleep schedule\n5. Monitor cognitive function through work performance\n\nNext scheduled follow-up: January 2025\nContinue annual MRI surveillance\n\n/Dr. [REDACTED]\nBoard Certified Neurosurgeon\n[Hospital Name]\n[Contact Information]"
      }
    },
    {
      "demographics": {
        "age": 46,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": "Food Critic",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Persistent headaches increasing in frequency over past 4 months",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Subtle changes in sense of taste noted over past 6 months (relevant to occupation)",
          "Occasional balance issues when walking",
          "Reports feeling of pressure behind right eye",
          "Morning headaches that improve throughout the day",
          "Recent difficulty concentrating during food reviews"
        ],
        "medical_history": [
          "BMI 33.2 - Class I Obesity",
          "Migraine headaches since age 35, but notes pattern has changed",
          "Hypertension diagnosed 2 years ago, managed with lisinopril",
          "No history of cancer",
          "No previous neurological conditions",
          "Tonsillectomy at age 12",
          "No relevant family history of brain tumors",
          "Regular vision checks due to occupation - last exam showed slight right-sided visual field deficit"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly olfactory function tests, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly olfactory function tests, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F46-O-2014\nOccupation: Food Critic\nWHO Grade: II (confirmed post-resection)\n\nINITIAL VISIT - March 15, 2014\nPresenting Complaint: Progressive neurological symptoms with occupational impact\nMRI Findings: 3.8cm right sphenoid wing meningioma with significant peritumoral edema, mass effect on optic nerve\nAssessment: Given tumor size, location, and progressive symptoms affecting vision and occupation, immediate surgical intervention recommended.\nPlan: Scheduled for aggressive microsurgical resection\n\nSURGICAL NOTE - April 2, 2014\nProcedure: Right frontotemporal craniotomy for meningioma resection\nFindings: Simpson Grade II resection achieved\nPathology: WHO Grade II meningioma\nPost-op course: Uncomplicated\n\nFOLLOW-UP - July 15, 2014 (3 months post-op)\nStatus: Improved vision, headaches resolved\nMRI: Post-surgical changes, no residual tumor\nPlan: Adjuvant radiotherapy recommended given WHO Grade II\n\nRADIATION ONCOLOGY - August-September 2014\nTreatment: Completed 54 Gy in 30 fractions\nTolerance: Good, minimal side effects\n\nFOLLOW-UP - January 2015 (6 months post-radiation)\nStatus: Return to work part-time\nMRI: Stable post-treatment changes\nPlan: Continue q4 month monitoring\n\n2015-2016 (q4 month visits)\nStatus: Full return to work\nSerial MRIs: Stable\n\n2017-2018 (q6 month visits)\nNotable: Small enhancement at surgical site (December 2017)\nAction: Increased monitoring frequency\nGamma Knife radiosurgery to focal recurrence (March 2018)\n\n2019-2021 (q6 month visits)\nStatus: Maintained professional activities\nMRIs: Stable post-radiosurgery\n\n2022-2024 (annual visits)\nStatus: Sustained remission\nLast MRI (January 2024): No evidence of recurrence\nOccupational Impact: Successfully maintained career with adaptations\n\nCurrent Status (2024):\n- Disease controlled\n- Maintains modified work schedule\n- Annual MRI surveillance\n- Regular ophthalmology monitoring\n\nFunctional Status Scores:\nKPS: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nTreatment Summary:\n1. Primary Surgery (2014)\n2. Adjuvant Radiation (2014)\n3. Focal Radiosurgery for recurrence (2018)\n4. Ongoing surveillance\n\nNote: Aggressive initial approach with multimodal therapy justified by:\n- WHO Grade II histology\n- Occupation requiring intact sensory function\n- Young age\n- Progressive symptoms at presentation",
        "conservative": "CLINICAL NOTES - MENINGIOMA CASE MANAGEMENT\nPatient ID: [Redacted]\nGender: Female | Age: 46 | Blood Type: O\nOccupation: Food Critic | BMI: 33.2\n\nINITIAL VISIT - March 15, 2014\n----------------------------------------\nPRESENTING SYMPTOMS:\n- Progressive headaches (4-month duration)\n- Right eye blurred vision\n- Occupationally significant taste alterations\n- Balance disturbances\n- Right orbital pressure\n- Morning headaches\n- Cognitive concerns affecting work\n\nIMAGING:\nMRI reveals 2.4cm right sphenoid wing meningioma\nWHO Grade I (based on imaging characteristics)\nMinimal peritumoral edema\nNo significant mass effect\n\nMANAGEMENT PLAN:\nGiven patient's occupation and symptoms affecting quality of life, recommending conservative management with close monitoring.\n- Monthly headache diary\n- Quarterly ophthalmological evaluations\n- Consider prophylactic migraine medication\n\nFOLLOW-UP - September 20, 2014 (6 months)\n----------------------------------------\nStable symptoms\nMRI: No significant growth\nVisual field testing: Stable\nInitiated topiramate 50mg daily for headache management\nWeight management program discussed\n\nANNUAL FOLLOW-UP - March 18, 2015\n----------------------------------------\nImproved headache control\nMRI: Stable lesion size\nVision stable\nBMI reduced to 32.1\nContinuing conservative management\n\nFOLLOW-UP - March 15, 2016\n----------------------------------------\nMinor symptom progression\nMRI: 2.6cm tumor (minimal growth)\nAdjusted topiramate to 75mg daily\nAdded memantine for cognitive support\n\nFOLLOW-UP - March 20, 2017\n----------------------------------------\nStable clinical picture\nMRI: No additional growth\nPatient maintaining work schedule\nBMI: 31.8\n\nFOLLOW-UP - March 15, 2018\n----------------------------------------\nStable symptoms\nMRI: 2.7cm tumor\nDiscussed surgical options but patient prefers continuation of conservative management\nAdded CoQ10 supplement for migraine prophylaxis\n\nFOLLOW-UP - March 22, 2019\n----------------------------------------\nWell-controlled symptoms\nMRI: Stable\nPatient successfully adapted work routine\nRegular exercise program initiated\n\nFOLLOW-UP - March 17, 2020\n----------------------------------------\nStable condition\nMRI: No progression\nMaintaining good quality of life\nVirtual consultations implemented due to COVID-19\n\nFOLLOW-UP - March 15, 2021\n----------------------------------------\nMinor headache increase\nMRI: 2.8cm tumor\nAdjusted medications\nAdded stress management techniques\n\nFOLLOW-UP - March 20, 2022\n----------------------------------------\nStable symptoms\nMRI: No significant changes\nPatient maintaining work performance\nBMI: 30.9\n\nFOLLOW-UP - March 18, 2023\n----------------------------------------\nWell-controlled condition\nMRI: Stable lesion\nPatient adapted well to conservative management\n\nRECENT FOLLOW-UP - March 15, 2024\n----------------------------------------\n10-year follow-up milestone\nMRI: 2.8cm tumor (stable since 2021)\nExcellent quality of life maintenance\nContinuing conservative management\n\nFUNCTIONAL STATUS SCORES:\n- Karnofsky Performance Status (KPS): 90\n- ECOG Performance Status: 1\n\nCURRENT MANAGEMENT:\n- Biannual MRI surveillance\n- Quarterly ophthalmological evaluations\n- Medication regimen:\n  * Topiramate 75mg daily\n  * Memantine 10mg daily\n  * Lisinopril 10mg daily\n  * CoQ10 supplement\n\nConservative management has proven successful over 10-year period with minimal tumor growth and maintained quality of life. Patient has successfully adapted work routine and lifestyle modifications."
      }
    },
    {
      "demographics": {
        "age": 69,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Coffee Roaster",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": true
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, worse in the morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty finding words",
          "Subtle personality changes noted by family members",
          "Mild right-sided weakness when typing at work",
          "Reports of intermittent tinnitus in right ear",
          "Balance difficulties when walking, particularly in dim light"
        ],
        "medical_history": [
          "Radiation therapy to scalp for tinea capitis treatment in childhood (1960)",
          "Hypertension - controlled with lisinopril 10mg daily",
          "Mild hearing loss diagnosed 5 years ago",
          "Cataract surgery left eye (2019)",
          "History of migraine headaches, but notes current headaches are different",
          "No history of seizures or neurological disorders",
          "No family history of brain tumors",
          "Former smoker - quit 15 years ago"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function",
            "Additional consideration for radiation exposure history"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n69-year-old male, Software Developer\nBlood Type: O\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive neurological symptoms with morning headaches and right-sided visual/motor deficits\n\nIMAGING:\nInitial MRI reveals a 4.2cm right frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe with 5mm midline shift. T2 hyperintense with heterogeneous enhancement. No calcification noted.\n\nASSESSMENT:\nWHO Grade II meningioma (atypical features on imaging)\nHigh-risk features:\n- Size >3cm\n- Significant peritumoral edema\n- Occupational impact (affecting typing ability)\n- History of radiation exposure\n- Progressive neurological symptoms\n\nPLAN:\n1. Surgical resection recommended urgently\n2. Pre-operative optimization with dexamethasone 4mg QID\n3. Scheduled for craniotomy within 2 weeks\n\nSURGICAL NOTE - March 29, 2018\nSimpson Grade II resection achieved. Minor residual tumor along superior sagittal sinus.\nPathology confirms WHO Grade II meningioma.\n\nFOLLOW-UP - June 15, 2018\nPost-operative MRI shows minimal residual disease\nInitiated adjuvant radiation therapy: 60 Gy in 30 fractions\n\nFOLLOW-UP - December 20, 2018\nCompleted radiation therapy\nImproved right-sided weakness\nReturned to work part-time\n\n2019 VISITS (Every 6 months):\n- June: Stable MRI, improving symptoms\n- December: No evidence of progression\n\n2020 VISITS:\n- June: Small enhancement at surgical site, close monitoring\n- December: Enhancement stable, continued surveillance\n\n2021 VISITS:\n- June: New 1cm nodule adjacent to resection cavity\n- December: Nodule increased to 1.5cm, recommended re-resection\n\nSECOND SURGERY - February 15, 2022\nSimpson Grade I resection of recurrence\nPathology: Maintained WHO Grade II status\n\n2022-2024 FOLLOW-UP VISITS (Every 4 months):\n- All subsequent MRIs stable\n- Patient maintained full-time work\n- Annual neuropsychological testing\n- Regular ophthalmology monitoring\n\nCURRENT STATUS (2024):\n- Disease stable\n- Maintained independent work status\n- Annual MRI surveillance recommended\n- Continue regular neurocognitive assessment\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nMONITORING PROTOCOL:\n1. MRI with contrast every 4 months\n2. Neuropsychological testing annually\n3. Visual field testing every 6 months\n4. Regular blood pressure monitoring\n5. Occupational therapy assessment as needed\n\nOCCUPATIONAL CONSIDERATIONS:\n- Ergonomic workplace modifications implemented\n- Regular breaks during computer work\n- Reduced screen time when symptomatic\n- Modified work schedule as needed\n\nThis case demonstrates the importance of aggressive early intervention in WHO Grade II meningiomas, particularly in patients with prior radiation exposure and occupational impact. The patient's positive outcome validates our proactive surgical approach and intensive monitoring protocol.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nOccupation: Software Developer/Coffee Roaster\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms including headaches and visual changes\n\nIMAGING FINDINGS:\nMRI reveals a 2.8cm right frontal convexity meningioma with moderate peritumoral edema. No significant mass effect on adjacent structures. WHO Grade I characteristics on imaging.\n\nASSESSMENT:\nGiven patient's age, occupation requiring fine motor skills, and history of prior radiation exposure, recommending close monitoring with conservative management initially. Symptoms warrant attention but may be manageable with medical therapy.\n\nPLAN:\n1. Start Dexamethasone 4mg BID for edema management\n2. Levetiracetam 500mg BID prophylactically\n3. Monthly clinical monitoring initially\n4. Occupational therapy evaluation for typing difficulties\n5. Quarterly MRI for first year\n\nFOLLOW-UP VISIT - September 20, 2014\nSymptoms stable with steroid therapy. Vision complaints improved. Continuing conservative management.\nMRI: No significant change in tumor size.\nPlan: Taper dexamethasone, continue levetiracetam\n\nANNUAL VISIT - March 12, 2015\nMild symptom progression but patient maintaining work activities.\nMRI: Minimal growth (0.2cm), stable edema\nPlan: Continue current management, ergonomic workplace modifications recommended\n\nFOLLOW-UP - April 5, 2016\nPatient reports good functional status. Occasional headaches managed with standard analgesics.\nMRI: Stable disease\nPlan: Extend monitoring interval to 6 months\n\nFOLLOW-UP - March 18, 2018\nMinor progression of visual symptoms.\nMRI: Tumor size 3.0cm, increased edema\nPlan: Increase dexamethasone temporarily, consider radiation therapy if progression continues\n\nFOLLOW-UP - February 22, 2020\nCOVID-19 telehealth visit\nStable symptoms. Managing work remotely.\nMRI: No significant change\nPlan: Continue conservative management\n\nFOLLOW-UP - March 15, 2022\nSome increase in balance difficulties.\nMRI: Tumor size 3.2cm\nPlan: Referral to balance therapy, discuss radiation therapy options as backup\n\nCURRENT VISIT - January 10, 2024\nMaintaining stable functional status with some adaptations.\nMRI: Stable disease compared to 2022\nPlan: Continue conservative management with biannual monitoring\n\nFUNCTIONAL STATUS SCORES:\nKarnofsky Performance Status (KPS): 80\n- Able to perform normal activity with effort\nECOG Performance Status: 1\n- Restricted in physically strenuous activity but ambulatory\n\nMANAGEMENT RATIONALE:\nConservative approach chosen due to:\n1. Patient's age and comorbidities\n2. Prior radiation exposure history\n3. Stable tumor growth pattern\n4. Maintained functional status\n5. Patient preference for non-surgical management\n\nOCCUPATIONAL CONSIDERATIONS:\n- Modified work station for visual/typing challenges\n- Reduced exposure to coffee roasting heat/fumes\n- Flexible scheduling to manage fatigue\n- Regular occupational therapy input"
      }
    },
    {
      "demographics": {
        "age": 49,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Intermittent blurred vision in right eye for past 6 weeks",
          "Recent onset of difficulty concentrating at work, especially when reviewing financial documents",
          "Occasional episodes of nausea without vomiting",
          "Reports subtle personality changes noted by spouse - increased irritability",
          "Mild right-sided facial numbness that began 2 months ago",
          "Two episodes of brief loss of balance while walking in the past month"
        ],
        "medical_history": [
          "Migraine headaches since age 30, well-controlled with sumatriptan until recent changes in headache pattern",
          "Surgical removal of ovarian cyst (2015)",
          "History of oral contraceptive use for 15 years (stopped 2 years ago)",
          "Treated for depression with sertraline 50mg daily (2018-2020)",
          "No history of head trauma or neurological disorders",
          "No family history of brain tumors or neurological conditions",
          "Annual eye exams normal until most recent visit showing slight papilledema",
          "No history of radiation exposure"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F49-O-FA\nPrimary Neurosurgeon: Dr. [Name]\n\nINITIAL VISIT - September 15, 2018\nPRESENTING SYMPTOMS: Progressive neurological symptoms including morning headaches, right-sided visual disturbance, cognitive changes, and balance issues suggesting possible mass effect.\n\nIMAGING:\nMRI with/without contrast reveals:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe with 6mm midline shift\n- Enhancement pattern typical for meningioma\n- No calcification noted\n\nASSESSMENT:\nWHO Grade II meningioma (suspected based on imaging characteristics)\nGiven patient's young age, occupation requiring cognitive precision, and progressive symptoms, immediate surgical intervention recommended.\n\nTREATMENT PLAN:\n1. Schedule craniotomy for gross total resection within 2 weeks\n2. Preoperative steroid therapy (Dexamethasone 4mg QID)\n3. Anticonvulsant prophylaxis (Levetiracetam 500mg BID)\n\nSURGICAL NOTE - October 1, 2018\n- Right frontal craniotomy performed\n- Simpson Grade II resection achieved\n- Minimal blood loss (300cc)\n- No complications\n- Pathology confirms WHO Grade II meningioma\n\nFOLLOW-UP VISITS:\n\nDecember 15, 2018 (2.5 months post-op)\n- Excellent wound healing\n- Headaches resolved\n- Vision improving\n- MRI shows no residual tumor\n- Continue anticonvulsants for 3 months\n\nJune 1, 2019 (8 months post-op)\n- Return to work full-time\n- Cognitive function normalized\n- MRI stable\n- Plan q4 month imaging\n\nFebruary 15, 2020\n- Small enhancement noted at surgical site\n- Recommend proactive SRS to prevent progression\n- Gamma Knife performed March 2020\n\n2021 (Quarterly visits)\n- Stable imaging\n- No new symptoms\n- Maintaining full work schedule\n- Annual neuropsychological testing normal\n\n2022-2023 (Biannual visits)\n- Continued stability\n- No evidence of recurrence\n- Regular MRI surveillance\n- Maintaining excellent functional status\n\nJanuary 2024 (Most recent)\n- 5-year post-treatment milestone\n- No evidence of disease\n- Full cognitive function\n- Continue biannual MRI surveillance\n\nCURRENT STATUS:\nKPS Score: 100/100\nECOG Score: 0\n\nLONG-TERM MONITORING PLAN:\n1. Biannual MRI with contrast\n2. Annual neuropsychological assessment\n3. Quarterly clinical evaluations\n4. Immediate imaging for any new symptoms\n\nNote: Aggressive early intervention and proactive SRS for minimal enhancement likely contributed to excellent outcome. Patient's high-functioning occupation and young age justified aggressive approach.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nOccupation: Financial Analyst\nAge: 49\nGender: Female\n\nINITIAL VISIT - September 15, 2018\nMRI FINDINGS:\n- 2.4 cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (presumptive radiological diagnosis)\n- No other intracranial abnormalities\n\nASSESSMENT:\nGiven the size (<3cm), minimal edema, and stable neurological status, recommending conservative management with close monitoring. Patient's symptoms warrant attention but don't necessitate immediate surgical intervention.\n\nMANAGEMENT PLAN:\n1. Watchful waiting approach with serial imaging\n2. Symptomatic management:\n   - Dexamethasone 4mg daily for 2 weeks, then taper\n   - Continue sumatriptan for breakthrough headaches\n   - Ophthalmology follow-up for papilledema monitoring\n3. Work modifications:\n   - Recommended frequent breaks during detailed financial analysis\n   - Screen adjustments and ergonomic workspace evaluation\n\nFOLLOW-UP SCHEDULE:\n- MRI every 6 months for first year\n- Neurological evaluation quarterly\n\n-------------------\n\nFOLLOW-UP VISIT - March 20, 2019\n- Tumor stable at 2.4 cm\n- Improved headaches after steroid course\n- Vision symptoms stabilized\n- Maintaining full work schedule with modifications\nPLAN: Continue conservative management\n\n-------------------\n\nFOLLOW-UP VISIT - September 18, 2019\n- No tumor growth\n- Further improvement in symptoms\n- Discontinued steroids successfully\nPLAN: Extend MRI interval to annual\n\n-------------------\n\nANNUAL VISIT - September 15, 2020\n- Tumor stable at 2.5 cm (minimal growth not clinically significant)\n- Well-adapted to work modifications\n- Headaches managed with occasional sumatriptan\nPLAN: Continue annual monitoring\n\n-------------------\n\nANNUAL VISIT - September 20, 2021\n- Stable imaging findings\n- Maintaining good quality of life\n- No new neurological symptoms\nPLAN: Continue current management\n\n-------------------\n\nANNUAL VISIT - September 15, 2022\n- Tumor stable at 2.5 cm\n- Patient maintaining independent lifestyle\n- Excellent work performance\nPLAN: Continue annual monitoring\n\n-------------------\n\nANNUAL VISIT - September 19, 2023\n- No significant changes in tumor size or characteristics\n- Patient well-adjusted to management strategy\n- Maintaining full professional activities\nPLAN: Continue annual monitoring\n\n-------------------\n\nMOST RECENT VISIT - March 15, 2024\n- Tumor remains stable at 2.5 cm\n- Patient satisfied with conservative approach\n- Quality of life well-maintained\n- Successfully managing work responsibilities\nPLAN: \n1. Continue annual MRI surveillance\n2. Maintain current symptom management strategy\n3. Next follow-up scheduled for March 2025\n\n-------------------\n\nFUNCTIONAL STATUS SCORES:\nKarnofsky Performance Status (KPS): 90\n(Able to carry on normal activity; minor signs/symptoms of disease)\n\nECOG Performance Status: 1\n(Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nNOTES:\nConservative management has proven successful over 5+ years with:\n- Stable tumor size\n- Well-controlled symptoms\n- Maintained professional functionality\n- Preserved quality of life\n- No need for surgical intervention"
      }
    },
    {
      "demographics": {
        "age": 41,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Right-sided blurred vision developing over last 6 weeks",
          "Occasional episodes of nausea without vomiting",
          "Recent onset of right-sided facial numbness",
          "Increased fatigue and difficulty concentrating at work",
          "One episode of focal seizure affecting right hand 2 weeks ago"
        ],
        "medical_history": [
          "Migraine headaches since age 25, well-controlled with sumatriptan",
          "Surgical removal of ovarian cyst (2018)",
          "Family history of breast cancer (maternal aunt)",
          "No history of radiation exposure",
          "Current medications: oral contraceptive pills, multivitamin",
          "No known drug allergies",
          "Regular menstrual cycles",
          "Never smoker, occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nSex: Female | Age: 41 | Blood Type: A\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive neurological symptoms with right-sided predominance\n\nIMAGING FINDINGS:\nMRI reveals a 4.2 cm right sphenoid wing meningioma with significant mass effect and perilesional edema. T2 sequence shows hyperintensity. Enhancement pattern suggests WHO Grade II characteristics.\n\nASSESSMENT:\nGiven size >3cm, critical location, and progressive symptomatology, immediate surgical intervention recommended. WHO Grade II suspected based on imaging characteristics.\n\nTREATMENT PLAN:\n1. Schedule craniotomy for gross total resection within 2 weeks\n2. Preoperative optimization with dexamethasone 4mg QID\n3. Anticonvulsant prophylaxis with levetiracetam 500mg BID\n\nSURGICAL NOTE - March 29, 2018\n- Simpson Grade II resection achieved\n- Minimal residual tumor at cavernous sinus interface\n- Pathology confirms WHO Grade II atypical meningioma\n- MIB-1 index: 8%\n\nFOLLOW-UP VISITS:\n\nJune 2018 (3 months post-op):\n- Improved vision and headaches\n- Post-op MRI shows small residual enhancement\n- Initiated adjuvant radiotherapy (60 Gy/30 fractions)\n\nDecember 2018 (9 months post-op):\n- Stable neurological exam\n- MRI shows no progression\n- Continue q4 month monitoring\n\n2019 (Quarterly visits):\n- Serial MRIs stable\n- Maintaining work schedule with accommodations\n- Minor right facial paresthesias persist\n\n2020 (Biannual visits):\n- February: Stable imaging\n- August: Small area of enhancement noted\n- Decision for SRS boost to residual tumor (16 Gy single fraction)\n\n2021-2022 (Quarterly monitoring):\n- Post-SRS response favorable\n- No new neurological deficits\n- Maintaining good functional status\n\n2023:\n- February: Stable disease\n- August: Minimal progression noted\n- Decision for close observation with q3 month imaging\n\n2024 (Current):\n- Latest MRI shows stable disease\n- Patient maintains full-time employment\n- Annual mammography negative\n- Continue surveillance protocol\n\nCURRENT STATUS:\nKPS Score: 90/100\nECOG Score: 1\n\nONGOING RECOMMENDATIONS:\n1. MRI brain with contrast q3 months\n2. Neurosurgery follow-up q4 months\n3. Annual mammography screening\n4. Continue anticonvulsant prophylaxis\n5. Regular cognitive assessment\n6. Occupational therapy as needed\n\nPROGNOSIS:\nGuarded but favorable with current stability. Requires ongoing vigilance due to WHO Grade II status and initial presentation characteristics.\n\nNote: This proactive approach with early intervention and aggressive monitoring has likely contributed to patient's maintained functional status despite Grade II pathology.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 41F, Blood Type A\nWHO Grade: I (confirmed via imaging characteristics)\n\nPRESENTING SYMPTOMS:\n- Progressive headaches (4-month duration)\n- Right-sided visual disturbance (6 weeks)\n- Right facial paresthesia\n- Cognitive complaints\n- Single focal seizure event (right hand)\n\nIMAGING FINDINGS:\nMRI reveals a 2.8cm right sphenoid wing meningioma with minimal perilesional edema. No significant mass effect on adjacent structures. T2 sequence shows moderate signal intensity.\n\nASSESSMENT & PLAN:\nGiven the patient's relatively young age and symptomatic presentation, close monitoring is warranted. However, considering tumor size <3cm and minimal edema, we can initiate conservative management with careful surveillance.\n\nRECOMMENDATIONS:\n1. Anti-epileptic medication (Levetiracetam 500mg BID)\n2. Dexamethasone 4mg daily for symptom management\n3. MRI surveillance every 4 months initially\n4. Neurology referral for headache management\n5. Neuro-ophthalmology evaluation\n\nFOLLOW-UP VISIT - July 20, 2018\nSymptoms stable. Visual symptoms improved with steroid therapy. Continuing conservative approach.\n\nANNUAL FOLLOW-UP - March 2019\nMinimal tumor growth (0.2mm). Symptoms well-controlled. Maintaining conservative management.\n\nFOLLOW-UP - March 2020\nNo significant growth. Patient adapted well to modified work schedule (reduced screen time). Headaches improved with lifestyle modifications.\n\nFOLLOW-UP - March 2021\nStable imaging. Patient managing well with current regimen. Reduced steroid dosage successfully.\n\nFOLLOW-UP - March 2022\nMinor growth noted (0.3mm). Symptoms stable. Continuing watchful waiting approach.\n\nFOLLOW-UP - March 2023\nTumor stable. Patient maintaining good quality of life. Working full-time with accommodations.\n\nLATEST FOLLOW-UP - January 2024\nImaging shows stability. Patient well-adjusted to management strategy. Maintaining regular activities.\n\nCURRENT MANAGEMENT:\n- MRI surveillance annually\n- Maintained on reduced steroid dose\n- Regular neuro-ophthalmology follow-up\n- Lifestyle modifications (stress management, sleep hygiene)\n- Occupational adjustments implemented\n\nFUNCTIONAL STATUS:\nKPS Score: 90 (Able to carry on normal activity with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nLONG-TERM CONSIDERATIONS:\n- Monitor for any changes in vision\n- Regular cognitive assessments\n- Quality of life maintenance\n- Occupational therapy as needed\n- Regular review of hormone replacement needs\n\nThe conservative approach has proven successful with this patient, maintaining good quality of life while avoiding surgical intervention. Will continue current management strategy unless significant changes occur."
      }
    },
    {
      "demographics": {
        "age": 40,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Persistent headaches increasing in frequency over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of dizziness and mild balance issues when standing quickly",
          "Occasional tingling sensation in right hand",
          "Reports increased fatigue and difficulty concentrating at work",
          "Two episodes of nausea and vomiting in past month, unrelated to food or illness",
          "Noticed mild personality changes - more irritable than usual according to family"
        ],
        "medical_history": [
          "BMI 33.2 - Class I Obesity",
          "Migraine headaches since age 35, but notes pattern and severity have changed",
          "Hypertension diagnosed 2 years ago, managed with lisinopril 10mg daily",
          "Surgical history: Appendectomy at age 12",
          "No history of cancer in immediate family",
          "Currently taking: lisinopril, multivitamin, occasional OTC pain relievers",
          "No known drug allergies",
          "Regular eye exams, last one 18 months ago was normal"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F40-O-FA\nPrimary Diagnosis: Meningioma\nWHO Grade: II (Atypical Meningioma)\n\nINITIAL VISIT - March 15, 2014\nMRI FINDINGS:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect with 5mm midline shift\n- Enhancement pattern suggesting possible atypical features\n- Compression of adjacent frontal lobe\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms indicating significant mass effect. Occupation as Financial Analyst requires high cognitive function, currently compromised. Symptoms and imaging findings warrant immediate intervention.\n\nTREATMENT PLAN:\n1. Scheduled for surgical resection within 2 weeks\n2. Simpson Grade I resection planned\n3. Pre-operative optimization of blood pressure\n4. Dexamethasone 4mg QID to manage edema\n\nFOLLOW-UP VISIT - April 30, 2014 (Post-operative)\n- Successful gross total resection achieved\n- Pathology confirms WHO Grade II meningioma\n- Minimal post-operative complications\n- Initiated adjuvant radiation therapy plan: 60 Gy in 30 fractions\n\nFOLLOW-UP - October 15, 2014 (6 months post-op)\n- Completed radiation therapy\n- Improved neurological symptoms\n- MRI shows no residual/recurrent tumor\n- Returned to work part-time\n\nANNUAL FOLLOW-UP - April 2015\n- MRI stable\n- No new neurological symptoms\n- Full return to work\n- Weight management program initiated\n\nFOLLOW-UP - October 2015\n- Surveillance MRI stable\n- Improved cognitive function\n- BP well-controlled\n\nANNUAL FOLLOW-UP - April 2016\n- Continued stability on imaging\n- Managing obesity through diet/exercise\n- No recurrent symptoms\n\nBIANNUAL FOLLOW-UP - October 2016\n- Small enhancement noted on MRI (7mm)\n- Close monitoring recommended\n- Increased scan frequency\n\nFOLLOW-UP - January 2017\n- Enhancement stable\n- Prophylactic SRS considered but deferred\n\n[Similar detailed follow-ups continue through 2020 with stable findings]\n\nSIGNIFICANT NOTE - March 2021\n- New 1.2cm nodule adjacent to resection cavity\n- Decision for repeat surgery vs. SRS discussed\n\nFOLLOW-UP - June 2021\n- Underwent SRS to new nodule\n- 16 Gy single fraction\n\nCURRENT STATUS (2024):\n- Stable disease\n- Maintained cognitive function\n- Regular MRI surveillance continues\n- Weight management ongoing\n- Full-time work continuation\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90 - Able to carry on normal activity, minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nMONITORING PROTOCOL:\n- MRI every 6 months\n- Neurological assessment quarterly\n- Annual neuropsychological testing\n- Regular ophthalmological evaluation\n\nNote: Treatment approach prioritized early intervention due to:\n1. Patient's young age\n2. Cognitive demands of occupation\n3. Progressive neurological symptoms\n4. Tumor size and location\n5. Evidence of mass effect",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nFemale, 40 years old, Blood Type O\nOccupation: Financial Analyst\n\nINITIAL VISIT - September 15, 2018\nChief Complaint: Progressive headaches, visual changes, balance issues\n\nIMAGING FINDINGS:\nMRI reveals a 2.4cm right frontal convexity meningioma with minimal surrounding edema. No significant mass effect. WHO Grade I characteristics on imaging.\n\nASSESSMENT:\nGiven the patient's age, symptom progression, and imaging findings, recommending conservative management with close monitoring. Symptoms appear related to meningioma but remain mild-moderate.\n\nMANAGEMENT PLAN:\n1. Watchful waiting approach with serial imaging\n2. Optimization of current medications\n3. Lifestyle modifications\n- Weight management program referral\n- Ergonomic workplace assessment\n- Stress reduction techniques\n4. Prophylactic anti-seizure medication not indicated at this time\n\nFOLLOW-UP VISIT - March 20, 2019 (6 months)\nSymptoms stable. No new neurological deficits.\nMRI: No significant change in tumor size or characteristics.\nInitiated workplace modifications and standing desk implementation.\nContinue current management plan.\n\nFOLLOW-UP - September 18, 2019 (1 year)\nReports improved headache control with lifestyle modifications.\nVision stable per ophthalmology evaluation.\nMRI: Stable lesion size and characteristics.\nBMI improved to 32.1\n\nFOLLOW-UP - September 15, 2020 (2 years)\nMinor symptom fluctuation but overall stable.\nMRI: No growth. Minimal edema unchanged.\nAdded meditation practice to daily routine.\nWorking remotely due to COVID-19 - monitoring screen time and ergonomics.\n\nFOLLOW-UP - September 20, 2021 (3 years)\nSymptoms well-controlled.\nMRI: Stable appearance.\nBMI: 31.8\nMaintaining work-life balance with hybrid work schedule.\n\nFOLLOW-UP - September 19, 2022 (4 years)\nOccasional headaches but manageable.\nMRI: No progression.\nAdded regular physical therapy for balance optimization.\n\nFOLLOW-UP - September 18, 2023 (5 years)\nStable neurological exam.\nMRI: No significant changes over 5-year period.\nPatient maintaining good quality of life and career performance.\n\nFOLLOW-UP - March 15, 2024 (5.5 years)\nContinues to do well with conservative management.\nMRI: Stable findings.\nPlan: Continue annual imaging and semi-annual clinical evaluations.\n\nFUNCTIONAL STATUS SCORES:\nKarnofsky Performance Status (KPS): 90 - Able to carry on normal activity; minor signs/symptoms of disease\nECOG Performance Status: 1 - Restricted in physically strenuous activity but ambulatory and able to carry out light/sedentary work\n\nONGOING RECOMMENDATIONS:\n1. Annual MRI surveillance\n2. Semi-annual clinical evaluations\n3. Regular ophthalmology follow-up\n4. Continue lifestyle modifications\n5. Maintain workplace ergonomic adjustments\n6. Monitor blood pressure\n7. Weight management program continuation\n\nConservative management has proven successful with this patient, demonstrating stable disease and good quality of life maintenance while continuing professional activities. Will continue current approach unless significant changes occur."
      }
    },
    {
      "demographics": {
        "age": 49,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Intermittent blurred vision in right eye",
          "Recent onset of difficulty concentrating at work, especially when reviewing financial documents",
          "Occasional episodes of nausea without vomiting",
          "Reports subtle personality changes noted by spouse - increased irritability",
          "Mild right-sided facial numbness that began 6 weeks ago",
          "Two episodes of loss of balance while walking in the past month"
        ],
        "medical_history": [
          "Migraine headaches since age 35, previously well-controlled with sumatriptan",
          "Surgical removal of ovarian cyst (2015)",
          "History of oral contraceptive use for 15 years (ages 25-40)",
          "Treated for depression with sertraline 50mg daily (2018-2020)",
          "No history of head trauma or radiation exposure",
          "No family history of brain tumors or neurological conditions",
          "Regular mammograms, last one normal (6 months ago)",
          "Non-smoker, occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - 03/15/2014\nPatient: 49F, Blood Type A\nOccupation: Financial Analyst\nWHO Grade: II (confirmed post-surgical pathology)\n\nPRESENTING SYMPTOMS:\n- Progressive headaches (4 months)\n- Right eye visual disturbance\n- Cognitive difficulties affecting work performance\n- Balance issues\n- Right facial numbness\n- Personality changes\n- Nausea\n\nIMAGING:\nMRI reveals 4.2cm left frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe with 5mm midline shift. T2 hyperintense with heterogeneous enhancement. Evidence of dural tail sign.\n\nTREATMENT PLAN:\nGiven size >3cm, symptoms affecting work performance, and presence of multiple neurological symptoms, recommend immediate surgical intervention. Schedule for craniotomy within 2 weeks.\n\n-------------------\n\nSURGICAL NOTE - 03/29/2014\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nMinimal blood loss: 300cc\nNo immediate complications\n\n-------------------\n\nFOLLOW-UP VISIT - 05/15/2014\nPost-operative MRI shows near-total resection\nResidual enhancement along superior sagittal sinus\nRecommend adjuvant radiation therapy\nStarted on dexamethasone taper\n\n-------------------\n\nFOLLOW-UP - 11/20/2014\nCompleted fractionated RT (54 Gy/30 fractions)\nImproved headaches\nReturn to work part-time\n\n-------------------\n\nANNUAL FOLLOW-UP - 03/15/2015\nMRI stable\nFull return to work\nMinimal residual symptoms\n\n-------------------\n\nFOLLOW-UP - 09/20/2015\nSurveillance MRI: No progression\nNeurologically stable\n\n-------------------\n\nANNUAL FOLLOW-UP - 03/18/2016\nMRI: Small enhancement at surgical site\nClinically asymptomatic\n\n[Similar stable follow-ups 2017-2019]\n\n-------------------\n\nFOLLOW-UP - 04/10/2020\nMRI shows 1.2cm recurrence at original site\nRecommend SRS to recurrent tumor\nGamma Knife performed 05/15/2020\n\n-------------------\n\nFOLLOW-UP - 10/15/2020\nPost-SRS MRI stable\nContinues full-time work\n\n[Regular stable follow-ups 2021-2023]\n\n-------------------\n\nLATEST FOLLOW-UP - 01/15/2024\n10-year follow-up\nMRI shows stable post-treatment changes\nNo evidence of recurrence\nMaintains full professional activities\n\nCURRENT STATUS:\n- No neurological deficits\n- Maintains executive function\n- Annual MRI surveillance recommended\n- Regular cognitive assessments\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nMONITORING PROTOCOL:\n- MRI every 6 months\n- Neuropsychological testing annually\n- Regular ophthalmological exams\n- Continue current work schedule with modifications as needed\n\nNote: Aggressive initial approach with early surgical intervention and adjuvant radiation therapy has resulted in good long-term control. Patient's high-functioning professional role and cognitive demands supported early intervention strategy.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nGender: Female | Age: 49 | Blood Type: A\nOccupation: Financial Analyst\n\nINITIAL VISIT - March 15, 2018\nPresenting Symptoms: Progressive headaches, right eye visual disturbance, concentration difficulties, nausea, personality changes, right facial numbness, and balance issues.\n\nMRI FINDINGS:\n- 2.4cm right frontal convexity meningioma\n- Minimal peritumoral edema\n- No mass effect on critical structures\n- WHO Grade I (likely)\n- No calcification noted\n\nASSESSMENT:\nDespite symptomatic presentation, tumor characteristics favor conservative management:\n- Size <3cm\n- Minimal edema\n- No critical structure compression\n- Patient's high-functioning professional status\n\nMANAGEMENT PLAN:\n1. Watchful waiting with regular MRI surveillance\n2. Symptomatic management:\n   - Topiramate 25mg daily, titrating to 50mg bid for headache prophylaxis\n   - Discontinue previous sumatriptan due to potential vascular effects\n3. Occupational modifications:\n   - Regular screen breaks\n   - Ergonomic workspace assessment\n   - Reduced overtime hours\n\nFOLLOW-UP SCHEDULE:\n- MRI every 4 months for first year\n- Neurological assessment quarterly\n\n=================\n\nFOLLOW-UP VISIT - July 20, 2018\nSymptoms stable. Headaches improved with topiramate.\nMRI: No significant change in tumor size.\nContinue current management.\n\n=================\n\nFOLLOW-UP VISIT - March 12, 2019\nImproved concentration at work.\nMRI: Stable tumor size.\nAdjusted to 6-monthly MRI schedule.\n\n=================\n\nFOLLOW-UP VISIT - March 5, 2020\nMinor headache increase during COVID-19 work-from-home transition.\nMRI: Stable appearance.\nAdded: Ergonomic home office recommendations\n\n=================\n\nFOLLOW-UP VISIT - April 10, 2021\nAll symptoms stable.\nMRI: Minimal growth (0.2mm), not clinically significant.\nMaintained conservative approach.\n\n=================\n\nFOLLOW-UP VISIT - May 15, 2022\nReports improved work performance.\nMRI: Stable disease.\nTransitioned to annual MRI schedule.\n\n=================\n\nFOLLOW-UP VISIT - June 1, 2023\nContinued stability.\nMRI: No progression.\nMaintaining excellent quality of life.\n\n=================\n\nCURRENT VISIT - February 20, 2024\nSix-year follow-up shows successful conservative management.\nMRI: Stable disease since 2021.\nPatient maintains full-time work with accommodations.\n\nFUNCTIONAL STATUS SCORES:\n- Karnofsky Performance Status (KPS): 90/100\n- ECOG Performance Status: 1\n\nSUMMARY OF CONSERVATIVE APPROACH SUCCESS:\n- Maintained professional career\n- Controlled symptoms\n- No tumor progression requiring intervention\n- Excellent quality of life preservation\n- Patient satisfaction with management strategy\n\nCONTINUING RECOMMENDATIONS:\n1. Annual MRI surveillance\n2. Maintain current medication regimen\n3. Regular ophthalmological checks\n4. Stress management techniques\n5. Continued workplace accommodations\n\nNext scheduled follow-up: February 2025\n\n[END OF NOTES]"
      }
    },
    {
      "demographics": {
        "age": 49,
        "gender": "Female",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Intermittent blurred vision in right eye",
          "Recent onset of clumsiness in right hand, dropping objects occasionally",
          "Mild personality changes noted by family - increased irritability",
          "Episodes of nausea without vomiting",
          "Subtle hearing loss in right ear reported in last 2 months"
        ],
        "medical_history": [
          "Migraine headaches since age 35, well-controlled with sumatriptan",
          "Hysterectomy at age 45 for uterine fibroids",
          "History of hormone replacement therapy for 2 years post-hysterectomy",
          "No history of cancer",
          "No significant family history of brain tumors",
          "Well-controlled hypertension (diagnosed 3 years ago) on lisinopril 10mg daily",
          "No prior neurological conditions",
          "No history of head trauma or radiation exposure"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F49-B-2014\nOccupation: Librarian\n\nINITIAL VISIT - March 15, 2014\nPresenting Symptoms: Progressive neurological symptoms including right-sided visual/auditory deficits, morning headaches, and motor coordination issues. Personality changes noted.\n\nInitial MRI Findings:\n- 4.2cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Evidence of dural tail sign\n- No calcification noted\n\nAssessment:\nWHO Grade II meningioma (confirmed post-surgery)\nHigh-risk features: size >3cm, peritumoral edema, proximity to motor strip\n\nTreatment Plan:\nRecommend immediate surgical intervention due to:\n1. Progressive neurological symptoms\n2. Size and location\n3. Impact on daily function as librarian requiring fine motor skills\n4. Evidence of mass effect\n\nSURGICAL NOTE - April 2, 2014\n- Simpson Grade II resection performed\n- Subtotal resection due to adherence to superior sagittal sinus\n- Post-op imaging shows small residual tumor (0.8cm)\n\nFOLLOW-UP VISITS:\n\nOctober 15, 2014 (6-month)\n- Adjuvant radiation therapy completed (54 Gy/30 fractions)\n- Improvement in headaches and visual symptoms\n- MRI: Stable residual disease\n- Returned to work part-time\n\nApril 10, 2015 (1-year)\n- Continued improvement\n- MRI: No progression\n- Working full-time\n- Minor right hand coordination issues persist\n\nOctober 2015 - April 2018 (Bi-annual visits)\n- Serial MRIs show stability\n- Maintained neurological status\n- Regular occupational therapy for fine motor skills\n\nMay 15, 2019 (5-year mark)\n- MRI shows small area of enhancement (1.2cm)\n- Decision for stereotactic radiosurgery to residual tumor\n- SRS completed June 2019\n\n2020-2022 (Annual visits)\n- Stable disease\n- Regular monitoring continues\n- Maintained work performance\n- No new neurological deficits\n\nJanuary 2024 (Most recent)\n- MRI shows no progression\n- Patient maintains good functional status\n- Continues full-time work\n- Annual monitoring plan continues\n\nCurrent Status:\nKPS Score: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nLong-term Monitoring Plan:\n- Annual MRI with contrast\n- Bi-annual neurological examinations\n- Regular cognitive function assessment\n- Quality of life monitoring\n- Occupational therapy as needed\n\nNote: Proactive intervention strategy with early surgery and adjuvant radiation has resulted in good disease control and maintained quality of life, allowing patient to continue in her profession with minimal limitations.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 49, Female, Blood Type: B\nOccupation: Librarian\n\nINITIAL VISIT - March 15, 2018\nPresenting Symptoms: Progressive headaches, right-sided visual/hearing symptoms, motor coordination issues, personality changes. Symptoms suggest right-sided intracranial mass effect.\n\nMRI Findings:\n- 2.8cm right petroclival meningioma\n- Minimal perilesional edema\n- No significant mass effect on brainstem\n- WHO Grade I features (based on imaging characteristics)\n\nAssessment & Plan:\nGiven tumor size <3cm and patient's stable neurological status, recommending conservative management with close monitoring. Occupation as librarian allows for flexible scheduling of follow-ups. \n\nInitial Management:\n1. Dexamethasone 4mg BID for symptom control\n2. Continue lisinopril 10mg daily\n3. Neurology referral for headache management\n4. Monthly neurological assessments for first 3 months\n\nFOLLOW-UP VISIT - June 20, 2018\nSymptoms improved with steroid therapy. Headaches better controlled.\nMRI: No significant change in tumor size\nPlan: Gradual steroid taper, continue monitoring\n\nANNUAL FOLLOW-UP - March 12, 2019\nStable symptoms. Minor right hand coordination issues persist but manageable.\nMRI: No growth (2.8cm)\nPlan: Continue annual monitoring\n\nANNUAL FOLLOW-UP - March 18, 2020\nStable condition. Patient adapted well to minor deficits.\nMRI: Minimal growth (2.9cm)\nPlan: Maintain conservative approach, increase monitoring frequency to 6-monthly\n\nFOLLOW-UP - September 15, 2020\nNo new symptoms. Working full-time with accommodations.\nMRI: Stable at 2.9cm\nPlan: Continue 6-monthly monitoring\n\nANNUAL FOLLOW-UP - March 22, 2021\nWell-compensated. Using assistive technology at work for vision challenges.\nMRI: No significant change\nPlan: Maintain current management\n\nANNUAL FOLLOW-UP - March 14, 2022\nStable symptoms. Good quality of life maintained.\nMRI: Stable lesion\nPlan: Return to annual monitoring\n\nANNUAL FOLLOW-UP - March 20, 2023\nMinor progression of right-sided hearing loss.\nMRI: Slight growth to 3.0cm\nPlan: Discuss surgical options but continue observation given patient preference\n\nCURRENT VISIT - February 15, 2024\nMaintaining good functional status despite mild symptoms.\nMRI: Stable at 3.0cm\nPlan: Continue annual monitoring. Surgery reserved for significant progression.\n\nCurrent Status:\n- Karnofsky Performance Status (KPS): 90\n- ECOG Performance Status: 1\n\nLong-term Management Strategy:\n1. Annual MRI surveillance\n2. Regular neurological assessments\n3. Quality of life focus\n4. Occupational therapy as needed\n5. Regular hearing assessments\n6. Conservative management unless significant progression\n\nNotes on Conservative Approach Success:\nPatient has maintained employment and good quality of life through careful monitoring and symptomatic management. Conservative approach has been appropriate given stable tumor size and well-controlled symptoms.\n\nNext Follow-up: February 2025\nContinue annual MRI unless new symptoms develop.\n\n[Electronically signed]\nDr. [REDACTED]\nNeurosurgery Department"
      }
    },
    {
      "demographics": {
        "age": 62,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Gradually worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of mild confusion and difficulty finding correct words while speaking",
          "Occasional balance issues when walking, particularly when turning corners",
          "Increasing fatigue and difficulty concentrating at work",
          "One episode of focal seizure affecting left hand 2 weeks ago"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches since age 35 - previously managed with sumatriptan PRN",
          "Total hysterectomy at age 45 for fibroids",
          "History of anxiety - managed with sertraline 50mg daily",
          "No prior neurological conditions",
          "No history of cancer",
          "Family history significant for breast cancer in mother",
          "No prior radiation exposure",
          "Regular mammograms, last one normal 8 months ago"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F62-O-2014\nOccupation: Librarian\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms with headaches and visual changes\n\nMRI FINDINGS:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Compression of superior sagittal sinus\n\nASSESSMENT:\nGiven size >3cm, peritumoral edema, and progressive neurological symptoms, immediate surgical intervention recommended. Occupation requires cognitive clarity and visual acuity, making aggressive treatment crucial.\n\nPLAN:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative optimization with dexamethasone 4mg QID\n3. Neurology consult for seizure management\n4. WHO Grade to be determined post-resection\n\nSURGICAL NOTE - April 1, 2014\n- Simpson Grade II resection achieved\n- Pathology confirms WHO Grade II atypical meningioma\n- Minor residual along superior sagittal sinus\n- Post-op imaging shows >95% resection\n\nFOLLOW-UP - July 15, 2014\n- Completed 6-week course of adjuvant radiation (60 Gy/30fx)\n- Improved headaches and vision\n- Return to work planned with modified duties\n- MRI shows post-surgical changes, no residual enhancement\n\nFOLLOW-UP - January 10, 2015\n- Stable neurological exam\n- Working full-time\n- MRI stable\n\nANNUAL FOLLOW-UP NOTES:\n\n2016:\n- Two surveillance MRIs: stable\n- Maintained work schedule\n- Minor fatigue managed with work modifications\n\n2018:\n- Small area of enhancement noted at surgical site\n- Gamma Knife radiosurgery to residual (16 Gy)\n- Continuing work with accommodations\n\n2020:\n- Stable disease post-radiosurgery\n- COVID-19 considerations: telehealth follow-up\n- Maintaining cognitive function\n\n2022:\n- MRI shows stable disease\n- Retired from library work\n- No new neurological symptoms\n\n2024 (Current):\n- 10-year follow-up\n- Disease remains stable\n- Quality of life maintained\n- Continues bi-annual MRI surveillance\n\nFUNCTIONAL STATUS SCORES:\n- Karnofsky Performance Status (KPS): 90/100 \n(Able to carry on normal activity with minor symptoms)\n\n- ECOG Performance Status: 1 \n(Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nCURRENT MANAGEMENT:\n- Continued bi-annual MRI surveillance\n- Annual neuropsychological assessment\n- Anti-epileptic medication maintenance\n- Regular cognitive function monitoring",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 62-year-old female librarian\nWHO Grade: I (based on imaging characteristics)\nMRI Findings: 2.8cm right frontal convexity meningioma with minimal surrounding edema, no significant mass effect on adjacent structures.\n\nAssessment:\n- Symptomatic meningioma with concerning progression of neurological symptoms\n- Multiple symptoms affecting quality of life and work performance\n- Location and size amenable to either surgical or radiation approaches\n- Good functional status and controlled comorbidities\n\nInitial Management Plan:\nGiven patient's stable neurological status and preference for conservative management:\n1. Start Dexamethasone 4mg BID with slow taper to manage edema\n2. Prophylactic Levetiracetam 500mg BID given seizure history\n3. Close monitoring with serial imaging\n4. Occupational modifications discussed - reduced hours and ergonomic workspace adjustments\n\nFOLLOW-UP VISIT - September 20, 2018 (6 months)\n- Improvement in headaches and vision symptoms with steroid therapy\n- Successfully weaned off dexamethasone\n- MRI shows stable tumor size\n- Continuing anticonvulsant therapy\n- No new neurological deficits\n\nFOLLOW-UP VISIT - March 12, 2019 (1 year)\n- Stable symptoms\n- MRI shows no growth\n- Maintaining work schedule with accommodations\n- Added memantine 10mg daily for cognitive support\n\nFOLLOW-UP VISIT - March 15, 2020 (2 years)\n- Minor progression of fatigue\n- MRI shows 2mm growth\n- Continuing conservative management\n- Added CoQ10 supplementation\n\nFOLLOW-UP VISIT - March 18, 2021 (3 years)\n- Stable symptoms\n- MRI unchanged\n- Maintaining good quality of life\n- Working part-time with accommodations\n\nFOLLOW-UP VISIT - March 20, 2022 (4 years)\n- Well-controlled symptoms\n- MRI stable\n- Retired from library work\n- Focus on cognitive exercises and balance training\n\nFOLLOW-UP VISIT - March 16, 2023 (5 years)\n- Minimal symptom progression\n- MRI shows 3mm growth over 5 years\n- Maintaining independence\n- Continuing conservative management\n\nFOLLOW-UP VISIT - March 14, 2024 (6 years)\n- Stable clinical status\n- MRI shows no new growth\n- Good quality of life maintained\n- Plan to continue annual monitoring\n\nCurrent Status:\n- Well-controlled symptoms\n- Maintaining independence\n- Good cognitive function\n- Active lifestyle within limitations\n\nFunctional Status Scores:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nFuture Recommendations:\n1. Continue annual MRI surveillance\n2. Maintain current medication regimen\n3. Regular cognitive assessments\n4. Balance exercises\n5. Consider radiation therapy only if significant progression\n\nThe conservative management approach has been successful in maintaining quality of life while managing symptoms effectively. Patient has adapted well to lifestyle modifications and maintains good functional status."
      }
    },
    {
      "demographics": {
        "age": 48,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Increasing difficulty concentrating at work on computer screens",
          "Subtle right-sided facial numbness noticed in past 2 months",
          "Reports feeling more fatigued than usual",
          "Mild balance issues when walking, especially in dimly lit areas"
        ],
        "medical_history": [
          "Migraine headaches since age 30, well-controlled with sumatriptan",
          "Surgical removal of ovarian cyst (2015)",
          "History of oral contraceptive use for 15 years (stopped 2 years ago)",
          "No prior neurological conditions",
          "No history of cancer",
          "No significant family history of brain tumors",
          "Regular eye exams, last one 1 year ago was normal",
          "Non-smoker",
          "Occasional alcohol use (1-2 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 48F, Blood Type O\nOccupation: Software Developer\nChief Complaint: Progressive neurological symptoms\n\nIMAGING FINDINGS:\nMRI reveals a 3.8cm left frontotemporal meningioma with significant peritumoral edema. Mass effect on adjacent structures with 4mm midline shift. Contrast enhancement pattern typical for meningioma. T2 sequence shows hyperintensity suggesting aggressive growth pattern.\n\nASSESSMENT:\nWHO Grade II meningioma (atypical) suspected based on imaging characteristics\nSymptoms significantly impacting quality of life and occupational function\nHigh-risk features: size >3cm, significant edema, proximity to critical structures\n\nTREATMENT PLAN:\n1. Surgical resection recommended within 2 weeks\n2. Simpson Grade I resection targeted\n3. Started on Dexamethasone 4mg QID\n4. Pre-operative optimization and surgical planning with neuronavigation\n\nFOLLOW-UP VISIT - April 30, 2018 (Post-operative)\nSurgical intervention: Complete resection achieved (Simpson Grade I)\nPathology confirmed WHO Grade II meningioma\nPost-op MRI shows complete resection\nInitiated adjuvant radiation therapy (60 Gy/30 fractions)\n\n6-MONTH FOLLOW-UP - October 15, 2018\nSymptoms significantly improved\nMRI: No evidence of recurrence\nContinuing rehabilitation program\nCleared to return to work with modifications\n\nANNUAL FOLLOW-UP - April 2019\nMRI stable\nMinimal residual symptoms\nFull return to work achieved\nMaintaining q6month imaging protocol\n\n2020 VISITS (April and October)\nBoth MRIs stable\nNo new symptoms\nMaintaining cognitive function\nVisual symptoms resolved\n\n2021 VISITS (April and October)\nContinued stability on imaging\nRegular cognitive assessments normal\nWorking full-time without restrictions\n\n2022 VISITS (April and October)\nSlight enhancement noted on April MRI\nClose monitoring initiated\nOctober MRI stable - no progression\n\n2023 VISITS (April and October)\nImaging remains stable\nAnnual neuropsychological testing normal\nMaintaining regular follow-up schedule\n\n2024 VISIT (January)\n10-year surveillance milestone\nNo evidence of recurrence\nExcellent functional status\n\nCURRENT STATUS:\nKPS Score: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nMONITORING PROTOCOL:\n- Bi-annual MRI with volumetric analysis\n- Annual neuropsychological assessment\n- Regular ophthalmological evaluation\n- Continued surveillance planned for minimum 15 years\n\nNote: Early aggressive intervention with complete resection and adjuvant radiation therapy has resulted in excellent outcome. Patient's occupation as software developer influenced the urgency of treatment due to visual and cognitive demands. Regular monitoring continues due to WHO Grade II status.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n48 y/o Female, Blood Type O\nOccupation: Software Developer\n\nINITIAL VISIT - January 15, 2018\nPresenting Symptoms: Progressive headaches, right eye visual disturbance, facial numbness, balance issues\nMRI Findings: 2.8cm left frontal convexity meningioma, minimal surrounding edema\nWHO Grade: I (based on imaging characteristics)\nAssessment: Given size <3cm and minimal edema, candidate for watchful waiting with close monitoring\nPlan: Conservative management with 6-month MRI follow-up\nRecommendations: \n- Ergonomic workplace assessment\n- Blue light filtering glasses for computer work\n- Physical therapy referral for balance training\n- Continue sumatriptan for migraine management\n\nFOLLOW-UP - July 20, 2018\nTumor stable at 2.8cm\nSymptoms: Mild improvement in headaches with ergonomic adjustments\nPlan: Continue monitoring, extend to annual MRI\n\nANNUAL FOLLOW-UP - July 15, 2019\nMRI: No significant growth (2.9cm)\nSymptoms stable\nVisual acuity test: 20/25 right eye, 20/20 left eye\nPlan: Continue annual monitoring\n\nANNUAL FOLLOW-UP - August 3, 2020\nMRI: Minimal growth to 3.0cm\nPatient managing work with accommodations\nBalance improved with PT exercises\nPlan: Continue conservative management, maintain annual imaging\n\nANNUAL FOLLOW-UP - July 28, 2021\nMRI: Stable at 3.0cm\nSymptoms well-controlled\nAdded occupational therapy for workplace strategies\nPlan: Maintain current approach\n\nANNUAL FOLLOW-UP - August 10, 2022\nMRI: No progression (3.0cm)\nPatient adapted well to modified work environment\nVision stable\nPlan: Continue annual monitoring\n\nANNUAL FOLLOW-UP - July 25, 2023\nMRI: Stable disease\nQuality of life maintained\nWorking full-time with accommodations\nPlan: Continue conservative management\n\nMOST RECENT FOLLOW-UP - January 15, 2024\nMRI: No significant changes\nPatient satisfied with conservative approach\nMaintaining good work-life balance\nPlan: Continue annual imaging\n\nCurrent Status:\nKPS Score: 90 (Able to carry on normal activity with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nNote: Conservative management has proven successful with this patient, demonstrating stable disease over 6 years. Patient has maintained high functional status and successful career with appropriate accommodations. Will continue watchful waiting approach unless significant progression occurs."
      }
    },
    {
      "demographics": {
        "age": 60,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": true
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty concentrating at work",
          "Mild right-sided facial numbness",
          "Balance difficulties when walking, particularly in dim lighting",
          "Increased irritability and personality changes noted by family",
          "Intermittent ringing in right ear"
        ],
        "medical_history": [
          "Radiation therapy to head/neck region for childhood lymphoma at age 12",
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches - previously well-controlled with sumatriptan PRN",
          "Mild hearing loss in right ear diagnosed 2 years ago",
          "No history of seizures",
          "No prior brain surgeries",
          "Family history negative for brain tumors",
          "Annual eye exams normal until recent changes",
          "No significant head trauma"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Additional consideration for radiation exposure history"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M60-DS-O\nPrimary Neurosurgeon: Dr. [Assistant]\n\nINITIAL VISIT - March 15, 2018\nPRESENTING SYMPTOMS: Multiple concerning neurological symptoms including progressive headaches, right-sided visual/facial symptoms, and cognitive changes suggesting possible mass effect.\n\nIMAGING:\nInitial MRI reveals a 4.2cm right sphenoid wing meningioma with significant mass effect on temporal lobe and moderate peritumoral edema. Enhancement pattern typical for meningioma. No calcification noted.\n\nASSESSMENT:\nWHO Grade II meningioma (confirmed post-surgery)\nHigh-risk features:\n- Size >3cm\n- Critical location near cavernous sinus\n- Peritumoral edema\n- History of radiation exposure\n- Symptomatic presentation\n\nTREATMENT PLAN:\nRecommend immediate surgical intervention given:\n1. Size and location\n2. Progressive symptoms\n3. Occupation requiring high cognitive function\n4. Prior radiation exposure increasing tumor aggression risk\n\n-------------------\n\nPOST-OP FOLLOW-UP - April 30, 2018\nSimpson Grade II resection achieved. Minor residual tumor along cavernous sinus.\nPathology confirms WHO Grade II meningioma.\nInitiated adjuvant radiation therapy (54 Gy/30 fractions).\n\n-------------------\n\n6-MONTH FOLLOW-UP - October 2018\nImproved symptoms. MRI shows no progression.\nContinuing cognitive rehabilitation.\nReturned to work part-time.\n\n-------------------\n\n1-YEAR FOLLOW-UP - April 2019\nMRI stable. Full-time work resumed.\nOccasional headaches managed with medication.\nVision improved to baseline.\n\n-------------------\n\n2-YEAR FOLLOW-UP - May 2020\nSmall area of enhancement noted at surgical margin.\nIncreased surveillance recommended.\n\n-------------------\n\n3-YEAR FOLLOW-UP - June 2021\nGrowth of residual tumor (1.2cm increase).\nSecond surgery performed with adjuvant radiotherapy.\n\n-------------------\n\n4-YEAR FOLLOW-UP - July 2022\nStable post second surgery.\nQuarterly MRI surveillance continued.\n\n-------------------\n\n5-YEAR FOLLOW-UP - August 2023\nNo evidence of progression.\nMaintaining work performance.\n\n-------------------\n\nCURRENT STATUS - January 2024\nStable disease. Continuing surveillance.\nMRI every 4 months.\n\nFUNCTIONAL STATUS:\nKPS Score: 90 (Able to perform normal activities with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nMONITORING PROTOCOL:\n- MRI with contrast every 4 months\n- Quarterly neurocognitive assessments\n- Visual field testing every 6 months\n- Annual neuropsychological evaluation\n\nOCCUPATIONAL CONSIDERATIONS:\nMaintaining close monitoring due to cognitive demands of data science work. Patient uses computer screens extensively - regular ophthalmological assessments included in follow-up protocol.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nOccupation: Data Scientist\n\nINITIAL VISIT - January 15, 2018\nChief Complaint: Progressive neurological symptoms with headaches\n\nMRI FINDINGS:\n- 2.8cm right sphenoid wing meningioma\n- Moderate peritumoral edema\n- Mass effect on right temporal lobe\n- WHO Grade I (radiological features)\n\nASSESSMENT:\nDespite symptomatic presentation, considering patient's history of prior radiation exposure and preference for conservative management. KPS 80, ECOG 1.\n\nPLAN:\n1. Close monitoring with serial imaging\n2. Medical management of symptoms:\n   - Dexamethasone 4mg BID for edema\n   - Gradual taper based on symptoms\n   - Continue lisinopril 10mg daily\n3. Occupational modifications recommended:\n   - Regular screen breaks\n   - Ergonomic workspace assessment\n   - Reduced screen time when possible\n\nFOLLOW-UP: 3 months\n\n-------------------\n\nFOLLOW-UP VISIT - April 20, 2018\nImproved symptoms with steroid therapy\nMRI: Stable tumor size\nPlan: Continue conservative management\nSteroid taper initiated\n\n-------------------\n\nFOLLOW-UP VISIT - October 12, 2018\nSymptoms stable\nMRI: No progression\nSteroids successfully tapered\nKPS 85, ECOG 1\n\n-------------------\n\nANNUAL FOLLOW-UP - January 15, 2019\nMinor headache complaints\nMRI: Stable disease\nMaintained conservative approach\nAdded prophylactic topiramate 50mg daily\n\n-------------------\n\nANNUAL FOLLOW-UP - January 20, 2020\nWell-controlled symptoms\nMRI: Minimal growth (2.9cm)\nContinue conservative management\nKPS 80, ECOG 1\n\n-------------------\n\nANNUAL FOLLOW-UP - February 2, 2021\nIncreased headache frequency\nMRI: Tumor stable at 2.9cm\nAdjusted medications\nAdded meditation/stress management program\n\n-------------------\n\nANNUAL FOLLOW-UP - January 25, 2022\nStable symptoms\nMRI: No significant changes\nMaintaining work schedule with accommodations\nKPS 80, ECOG 1\n\n-------------------\n\nANNUAL FOLLOW-UP - January 30, 2023\nMinor visual symptoms progression\nMRI: Tumor 3.0cm, slight increase in edema\nIncreased topiramate to 75mg daily\nConsider radiation options if progression continues\n\n-------------------\n\nRECENT FOLLOW-UP - January 15, 2024\nSymptoms stable with medication\nMRI: No significant change from 2023\nContinue conservative management\nRegular ophthalmology follow-up added\n\nCURRENT STATUS:\nKPS Score: 80\nECOG Score: 1\n\nLONG-TERM MANAGEMENT STRATEGY:\n1. Continue annual MRI surveillance\n2. Maintain medical management\n3. Monitor vision changes\n4. Regular cognitive assessments\n5. Quality of life focus\n6. Occupational therapy involvement\n\nNote: Conservative approach successful over 6-year period with acceptable symptom control and stable disease. Patient maintains professional activities with modifications. Will consider more aggressive intervention only if significant progression occurs."
      }
    },
    {
      "demographics": {
        "age": 50,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, worse in morning; Right-sided facial numbness; Occasional blurred vision in right eye; Balance difficulties when walking; Memory lapses and difficulty concentrating at work; One episode of seizure-like activity 2 weeks ago lasting approximately 2 minutes"
        ],
        "medical_history": [
          "Hypertension diagnosed 5 years ago, controlled with lisinopril 10mg daily; Migraine headaches since age 30, previously managed with sumatriptan PRN but current headaches differ in character; Mild traumatic brain injury from car accident 15 years ago with full recovery; No history of cancer; Family history significant for father with brain tumor (type unknown); Current medications: lisinopril 10mg daily, occasional ibuprofen for headaches; No known drug allergies; Social history: Former smoker (quit 10 years ago), occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - March 15, 2014\nPatient: 50Y Male, Blood Type O\nChief Complaint: Progressive neurological symptoms with right-sided predominance\n\nIMAGING FINDINGS:\nMRI reveals 4.2cm right frontal convexity meningioma with significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- T2 hyperintense with heterogeneous enhancement\n- Dural tail sign present\n- Evidence of mass effect on superior sagittal sinus\n\nASSESSMENT:\nWHO Grade II Meningioma (suspected based on imaging characteristics)\nHigh-risk features:\n- Size >3cm\n- Significant peritumoral edema\n- Proximity to critical venous structures\n- Progressive neurological symptoms\n\nPLAN:\n1. Urgent surgical intervention recommended within 2-3 weeks\n2. Pre-operative optimization of blood pressure\n3. Started on Dexamethasone 4mg QID\n4. Anti-epileptic prophylaxis with Levetiracetam 500mg BID\n5. Neurosurgical admission scheduled for April 1, 2014\n\nSURGICAL NOTE - April 1, 2014\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nEstimated blood loss: 400cc\nNo immediate complications\n\nPOST-OPERATIVE FOLLOW-UP - April 15, 2014\nPathology confirms WHO Grade II Meningioma\nWound healing appropriate\nNeurological symptoms improving\nPlan: Adjuvant radiation therapy recommended\n\nRADIATION ONCOLOGY - May-June 2014\nCompleted fractionated RT: 60 Gy in 30 fractions\n\nFOLLOW-UP VISITS:\n\n2014 (Q3-Q4):\n- Monthly MRI surveillance\n- Gradual improvement in symptoms\n- KPS 80\n\n2015:\nQ1-Q2: Bi-monthly MRI - No recurrence\nQ3-Q4: Quarterly MRI - Stable\n- Return to work with modifications\n- KPS 90\n\n2016:\n- Quarterly MRI surveillance\n- Complete resolution of initial symptoms\n- Maintained on Levetiracetam\n- KPS 90\n\n2017:\n- Bi-annual MRI\n- No evidence of recurrence\n- Discontinued Levetiracetam\n- KPS 100\n\n2018-2019:\n- Annual MRI\n- Stable imaging\n- No new symptoms\n- KPS 100\n\n2020:\n- Small enhancement noted on routine MRI\n- Close monitoring initiated\n- Remains asymptomatic\n- KPS 90\n\n2021:\n- Growth of enhancement\n- New surgical planning initiated\n- Second resection performed in November\n- Pathology confirms recurrent WHO Grade II\n- KPS 80\n\n2022-2023:\n- Quarterly then bi-annual MRI\n- No evidence of further recurrence\n- Maintained on prophylactic AEDs\n- KPS 90\n\n2024 (Current):\n- Stable disease\n- Annual MRI surveillance continues\n- Fully functional at work\n- KPS 90\n\nCURRENT STATUS:\nKPS Score: 90/100\nECOG Score: 1\n\nONGOING RECOMMENDATIONS:\n1. Annual MRI surveillance\n2. BP monitoring\n3. Neuropsychological assessment annually\n4. Continue regular follow-up\n5. Low threshold for additional imaging if new symptoms develop\n\nNote: Throughout treatment course, emphasis placed on proactive monitoring and early intervention for any changes, considering patient's professional responsibilities and quality of life impact.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n==================================================\n\nINITIAL VISIT - March 15, 2014\n-----------------------------\nPATIENT: 50-year-old male, Blood Type O\nDIAGNOSIS: Right frontal parasagittal meningioma (4.2 x 3.8 x 3.5 cm)\nWHO GRADE: Grade I (presumptive based on imaging characteristics)\n\nIMAGING FINDINGS:\n- MRI reveals well-circumscribed, dural-based mass\n- Moderate peritumoral edema\n- Mass effect on superior sagittal sinus\n- Homogeneous contrast enhancement\n\nPRESENTING SYMPTOMS:\nConcerning constellation of symptoms including progressive headaches, right-sided facial numbness, visual disturbances, and recent seizure activity warrant careful consideration of management options.\n\nMANAGEMENT PLAN:\nGiven tumor size and symptomatology, surgical intervention would typically be indicated. However, considering patient preference for conservative management:\n\n1. Anti-epileptic medication: Levetiracetam 500mg BID\n2. Dexamethasone 4mg BID with taper over 2 weeks for edema\n3. Monthly clinical monitoring initially\n4. MRI follow-up in 3 months\n5. Neurocognitive assessment baseline\n\nFOLLOW-UP - June 20, 2014\n-------------------------\nSymptoms improved with medical management:\n- Headaches reduced\n- No further seizures\n- Facial numbness stable\nMRI: No significant change in tumor size\nPlan: Continue current management, reduce monitoring to quarterly\n\nANNUAL FOLLOW-UP - March 2015\n----------------------------\nStable symptoms\nMRI: Minimal growth (< 2mm in maximum diameter)\nPlan: Continue conservative management\nAdded: Memantine 10mg daily for cognitive support\n\n2016-2018 ANNUAL REVIEWS\n-----------------------\nTumor stability maintained\nOccasional headache exacerbations managed with medication adjustments\nAnnual MRI shows no significant progression\nKPS maintained at 90\n\nSIGNIFICANT UPDATE - September 2020\n---------------------------------\nNew onset of more frequent headaches\nMRI: 5mm growth over 6 months\nDECISION POINT: Discussed surgical options but patient preferred continued conservative management\nAdded: Increased dexamethasone dosing temporarily\n\n2021-2024 FOLLOW-UP SUMMARY\n--------------------------\n- Bi-annual MRI showing slow growth (total 8mm over 4 years)\n- Maintained conservative management with medication adjustments\n- Quality of life preserved with minor adaptations to work schedule\n- Regular cognitive assessments showing stable function\n\nCURRENT STATUS (2024):\n---------------------\n- Tumor size: 4.8 x 4.2 x 3.9 cm\n- Stable symptoms with medical management\n- Patient continues full-time work with accommodations\n- Regular monitoring continues\n\nFUNCTIONAL STATUS SCORES:\n------------------------\nKarnofsky Performance Status (KPS): 80\nECOG Performance Status: 1\n\nONGOING RECOMMENDATIONS:\n-----------------------\n1. Continue bi-annual MRI monitoring\n2. Monthly neurology reviews\n3. Cognitive assessment every 6 months\n4. Maintain current medication regimen\n5. Consider surgical intervention if significant progression occurs\n\nNote: Conservative management has been successful in maintaining patient's quality of life while monitoring tumor progression. Surgical intervention remains an option if clinical deterioration occurs."
      }
    },
    {
      "demographics": {
        "age": 66,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": "Baker",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": true,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Data generation failed"
        ],
        "medical_history": [
          "Data generation failed"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function",
            "Coordinated care with obstetrics",
            "Timing surgery for second trimester if possible"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - MENINGIOMA CASE STUDY (2014-2024)\n\nPATIENT DEMOGRAPHICS:\n66-year-old female, Blood Type O\nOccupation: Financial Analyst/Baker\nComorbidities: Diabetes\nNotable: Currently pregnant (High-risk pregnancy given age)\n\nINITIAL VISIT - September 15, 2014\nMRI revealed an incidental finding of right frontal convexity meningioma (2.8cm)\nWHO Grade I (presumptive based on imaging characteristics)\nNo significant mass effect\nMinimal peritumoral edema\nKPS: 90/100\nECOG: 1\n\nFOLLOW-UP - March 20, 2015\nTumor size increased to 3.2cm\nDecision for surgical intervention due to:\n- Growth rate\n- Pregnancy status (concerns about hormonal influence)\n- Occupational demands requiring cognitive clarity\nPre-surgical planning initiated\n\nSURGICAL INTERVENTION - May 15, 2015\nSimpson Grade II resection performed\nPathology confirmed WHO Grade I meningioma\nPost-op course uncomplicated\nKPS: 80/100 (immediate post-op)\nECOG: 1\n\nFOLLOW-UP - December 10, 2015\nPost-surgical MRI shows no residual tumor\nReturned to work (modified duties)\nDiabetes well-controlled\nKPS: 90/100\nECOG: 0\n\nANNUAL FOLLOW-UP - 2016-2019\nRegular MRI surveillance\nNo evidence of recurrence\nContinued occupational activities\nRegular diabetes monitoring\nKPS maintained at 90-95/100\nECOG: 0\n\nFOLLOW-UP - March 2020\nSmall area of enhancement noted on MRI (0.8cm)\nClose monitoring recommended\nKPS: 90/100\nECOG: 0\n\nFOLLOW-UP - September 2021\nEnhancement stable\nContinued surveillance\nKPS: 90/100\nECOG: 0\n\nCURRENT STATUS (2024)\nNo evidence of recurrence\nAnnual MRI surveillance recommended\nDiabetes well-controlled\nFully functional in both occupations\nKPS: 95/100\nECOG: 0\n\nTREATMENT RATIONALE:\nEarly surgical intervention chosen due to:\n1. Tumor growth during pregnancy\n2. Cognitive demands of financial analysis work\n3. Physical demands of baking profession\n4. Potential complications with diabetes management\n\nMONITORING PROTOCOL:\n- MRI with contrast every 6 months for first 2 years\n- Annual MRI thereafter\n- Regular diabetes management\n- Occupational assessment every 6 months\n\nFINAL SCORES:\nCurrent KPS: 95/100\nCurrent ECOG: 0\n\nRECOMMENDATIONS:\nContinue annual MRI surveillance\nMaintain diabetes management\nNo current restrictions on work activities",
        "conservative": "CLINICAL NOTES - CONSERVATIVE MANAGEMENT OF MENINGIOMA\n\nInitial Visit - March 15, 2018\nPatient: 66F, Blood Type O\nOccupation: Financial Analyst/Baker\nRelevant History: Type 2 Diabetes, Currently Pregnant (High-risk pregnancy given advanced maternal age)\n\nIMAGING:\nIncidental finding on MRI: Right frontal convexity meningioma, 1.8cm, no significant mass effect or edema\nWHO Grade: I (presumptive based on imaging characteristics)\n\nASSESSMENT:\n- Small, asymptomatic meningioma\n- Multiple comorbidities warranting conservative approach\n- Pregnancy status necessitates avoiding radiation exposure\n\nPLAN:\n- Watchful waiting approach\n- Defer any intervention during pregnancy\n- Follow-up MRI post-delivery\n\nFollow-up Visit - December 10, 2018\nPost-delivery status\nMRI: Stable lesion size and characteristics\nRecommendations: Continue observation\n\nAnnual Follow-up - January 15, 2019\nMRI: No growth (1.8cm)\nPatient maintaining full work activities\nBlood glucose well-controlled\nPlan: Annual MRI surveillance\n\nJanuary 20, 2020\nMRI: Minimal growth (1.9cm)\nNo neurological symptoms\nContinues working both jobs\nPlan: Maintain current observation schedule\n\nFebruary 12, 2021\nMRI: Stable (1.9cm)\nPatient reports mild occasional headaches\nRecommendations:\n- Ergonomic workplace assessment\n- Stress management given dual occupation\n- Continue diabetes management\n\nMarch 5, 2022\nMRI: Stable\nQuality of life assessment: Excellent\nWorking full-time with modifications\nPlan: Continue annual monitoring\n\nApril 18, 2023\nMRI: Stable\nNo new symptoms\nSuccessfully managing work-life balance\nPlan: Consider biennial MRI schedule\n\nFebruary 20, 2024\nMRI: Stable (1.9cm)\n6-year stability demonstrated\nPatient now semi-retired from banking\nContinues part-time baking\n\nCURRENT STATUS:\nKarnofsky Performance Status (KPS): 90%\nECOG Performance Status: 1\n\nLONG-TERM RECOMMENDATIONS:\n1. Continue biennial MRI\n2. Regular diabetes monitoring\n3. Ergonomic assessment for baking activities\n4. Annual neurological examinations\n5. Quality of life assessments\n6. Stress management strategies\n\nConservative management has proven successful with stable disease and maintained quality of life over 6-year period."
      }
    },
    {
      "demographics": {
        "age": 45,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of right-sided facial numbness",
          "Occasional nausea without vomiting",
          "Increasing difficulty concentrating at work",
          "Reports mild balance issues when walking",
          "Two episodes of right-sided tinnitus in past month"
        ],
        "medical_history": [
          "Migraine headaches since age 30, managed with sumatriptan PRN",
          "Surgical removal of ovarian cyst (2015)",
          "History of oral contraceptive use for 15 years (stopped 2018)",
          "No prior neurological conditions",
          "No history of cancer",
          "No radiation exposure",
          "Family history negative for brain tumors",
          "Regular mammograms, last one normal (6 months ago)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nGender: Female | Age: 45 | Blood Type: O\n\nINITIAL VISIT - September 15, 2018\nChief Complaint: Progressive headaches, visual disturbances, facial numbness\n\nIMAGING:\nMRI reveals 3.8cm right sphenoid wing meningioma with significant peritumoral edema\n- Mass effect on right optic nerve\n- T2 hyperintense with heterogeneous enhancement\n- Evidence of dural tail sign\n- Moderate mass effect on adjacent temporal lobe\n\nASSESSMENT:\nWHO Grade II meningioma (suspected based on imaging characteristics)\nKPS Score: 80\nECOG: 1\n\nPLAN:\nRecommend immediate surgical intervention due to:\n1. Tumor size >3cm\n2. Progressive neurological symptoms\n3. Critical location affecting vision\n4. Patient's young age and professional status\n\n-------------------\n\nSURGICAL NOTE - October 3, 2018\nProcedure: Right frontotemporal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology confirms WHO Grade II atypical meningioma\nPost-op course uncomplicated\n\n-------------------\n\nFOLLOW-UP - December 15, 2018\nPatient recovering well\nHeadaches improved\nVision stabilizing\nRecommended adjuvant radiation therapy\nStarted 60 Gy/30 fractions\n\n-------------------\n\n6-MONTH FOLLOW-UP - April 3, 2019\nMRI shows no residual/recurrent tumor\nSymptoms resolved\nKPS: 90\nECOG: 0\n\n-------------------\n\n1-YEAR FOLLOW-UP - October 2019\nStable imaging\nMaintaining regular work schedule\nContinue q6month MRI protocol\n\n-------------------\n\n2-YEAR FOLLOW-UP - October 2020\nSmall enhancement noted at surgical site\nRecommended stereotactic radiosurgery boost\nKPS: 90\nECOG: 0\n\n-------------------\n\n3-YEAR FOLLOW-UP - October 2021\nPost-SRS imaging stable\nNo new symptoms\nMaintaining work schedule\nContinue q6month monitoring\n\n-------------------\n\n4-YEAR FOLLOW-UP - October 2022\nStable imaging\nNo neurological deficits\nKPS: 90\nECOG: 0\n\n-------------------\n\n5-YEAR FOLLOW-UP - October 2023\nComplete imaging stability\nTransition to annual MRI\nNo evidence of recurrence\nPatient fully functional\n\n-------------------\n\nCURRENT STATUS (2024):\nDisease-free interval: 5.5 years\nCurrent KPS: 100\nCurrent ECOG: 0\n\nMONITORING PROTOCOL:\n- Annual MRI with contrast\n- Biannual neurosurgical evaluation\n- Annual ophthalmological assessment\n- Regular cognitive function testing\n\nLONG-TERM PROGNOSIS:\nFavorable given:\n- Complete initial resection\n- Successful adjuvant therapy\n- Sustained period of stability\n- Excellent functional status\n\nFinal Scores:\nKPS: 100/100\nECOG: 0/5\n\nNote: Early aggressive intervention with complete surgical resection and adjuvant radiation therapy appears to have provided optimal outcome for this WHO Grade II meningioma case.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nGender: Female | Age: 45 | Blood Type: O\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive headaches, visual changes, facial numbness\n\nIMAGING:\nMRI reveals a 2.1cm right sphenoid wing meningioma with minimal peritumoral edema.\nWHO Grade: I (presumptive based on imaging characteristics)\nLocation: Right sphenoid wing, minimal mass effect on adjacent structures\n\nASSESSMENT:\nPatient presents with symptomatic meningioma but favorable imaging characteristics. Given size <3cm and minimal edema, conservative management initially recommended with close monitoring.\n\nPLAN:\n1. MRI surveillance every 6 months initially\n2. Neurology referral for headache management\n3. Ophthalmology evaluation for visual symptoms\n4. Discontinue any hormonal medications\n5. Consider prophylactic anti-seizure medication\n\n-------------------\n\nFOLLOW-UP - September 20, 2018\nTumor stable at 2.1cm\nVisual symptoms improved with prescribed glasses\nHeadaches better managed with adjusted migraine medication\nKPS: 90\n\n-------------------\n\nFOLLOW-UP - March 12, 2019\nMinimal growth (2.2cm)\nPatient reports improved concentration at work\nBalance issues resolved\nContinue conservative management\nKPS: 90\n\n-------------------\n\nFOLLOW-UP - March 10, 2020\nTumor stable at 2.2cm\nAll symptoms well-controlled\nPatient adapted work schedule to reduce screen time\nKPS: 95\n\n-------------------\n\nFOLLOW-UP - March 15, 2021\nSlight growth to 2.3cm\nMinimal symptoms\nDiscussed surgical options but patient prefers continued observation\nKPS: 90\n\n-------------------\n\nFOLLOW-UP - March 8, 2022\nTumor stable at 2.3cm\nNo new symptoms\nAnnual MRI recommended\nKPS: 95\n\n-------------------\n\nFOLLOW-UP - March 14, 2023\nNo growth\nPatient maintaining good quality of life\nContinues full-time work with accommodations\nKPS: 95\n\n-------------------\n\nFOLLOW-UP - February 20, 2024\nTumor stable at 2.3cm\nAll symptoms well-controlled\nContinue annual MRI surveillance\nKPS: 95\n\nCURRENT STATUS:\n- Successful conservative management over 6-year period\n- Stable tumor size\n- Well-controlled symptoms\n- Maintained professional activity\n- Excellent quality of life\n\nSCORES:\nKarnofsky Performance Status (KPS): 95/100\nECOG Performance Status: 1\n\nRECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain regular neurology follow-up\n3. Annual ophthalmology evaluations\n4. Continue current lifestyle modifications\n5. Patient to report any new or worsening symptoms immediately\n\nNote: Conservative management has proven successful in this case, with stable disease and good symptom control. Patient has adapted well to lifestyle modifications and maintains high functional status. Surgical intervention remains an option if significant progression occurs."
      }
    },
    {
      "demographics": {
        "age": 59,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Increasing difficulty concentrating at work, especially when looking at computer screens",
          "Subtle personality changes noted by family - more irritable than usual",
          "Mild right-sided facial numbness that began 2 months ago",
          "Reports feeling more fatigued than usual despite adequate sleep"
        ],
        "medical_history": [
          "Type 2 Diabetes diagnosed 8 years ago - managed with Metformin 1000mg BID",
          "Hypertension - controlled with Lisinopril 10mg daily",
          "Migraine headaches since age 35 - previously well-controlled with sumatriptan PRN",
          "Total hysterectomy at age 45 for fibroids",
          "Family history of breast cancer (maternal aunt)",
          "HbA1c consistently maintained between 6.5-7.0%",
          "No history of smoking or alcohol abuse",
          "Regular eye exams due to diabetes - last exam 1 year ago was normal"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F59-DS-A\nPrimary Diagnosis: Meningioma\nWHO Grade: II (Atypical Meningioma)\n\nINITIAL VISIT - March 15, 2014\nChief Complaints: Progressive headaches, right-sided visual disturbance, cognitive changes\nImaging: Initial MRI reveals a 4.2cm right sphenoid wing meningioma with significant peritumoral edema and mass effect on the optic nerve. Enhancement pattern suggests possible atypical features.\nAssessment: High-risk presentation given size, location, and symptom progression\nPlan: Recommend urgent surgical intervention due to:\n- Critical location affecting vision\n- Cognitive symptoms impacting work performance\n- Size >3cm with significant edema\nPre-surgical clearance initiated with endocrinology consult for diabetes management.\n\nSURGICAL INTERVENTION - April 2, 2014\nProcedure: Right frontotemporal craniotomy with Simpson Grade II resection\nFindings: Firm, well-vascularized tumor with some adherence to dura\nPathology: WHO Grade II meningioma with increased mitotic activity\n\nPOST-OP FOLLOW-UP - May 15, 2014\nStatus: Good recovery, improvement in headaches and vision\nPlan: Initiate adjuvant radiation therapy\n- Prescribed: 60 Gy in 30 fractions\nDiabetes remains well-controlled\n\nRADIATION COMPLETION - July 30, 2014\nTreatment completed as planned\nMinor fatigue, well-tolerated\n\nFOLLOW-UP VISITS:\n\nDecember 15, 2014\nMRI: No evidence of recurrence\nSymptoms: Significant improvement in all presenting symptoms\nPlan: Continue q4 month monitoring\n\nApril 15, 2015\nStatus: Maintaining improvement\nWork: Returned to full-time data science work with accommodations\nPlan: Continue monitoring\n\n2016-2018 (Quarterly visits)\nSerial MRIs: Stable without evidence of recurrence\nRegular ophthalmology checks: Vision stable\nDiabetes: Well-controlled\n\n2019-2021 (Biannual visits)\nContinued stability on imaging\nMinor radiation-related changes stable\nRegular cognitive assessments given occupation: Performing well\n\n2022-2024 (Annual visits)\nLast visit: January 15, 2024\nMRI: No evidence of recurrence\nCognitive function: Excellent\nWork status: Continues full-time employment\nDiabetes: Well-controlled on adjusted regimen\n\nCurrent Status (2024):\n- Disease-free at 10 years post-treatment\n- Maintained cognitive function crucial for career\n- Regular monitoring continues\n\nFunctional Status Scores:\nKPS: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nTreatment Success Factors:\n1. Early aggressive intervention\n2. Complete adjuvant therapy\n3. Strict follow-up compliance\n4. Excellent diabetes management\n5. Strong support system\n6. High functional baseline\n\nRecommendations:\nContinue annual MRI surveillance\nMaintain regular diabetes monitoring\nAnnual neurocognitive assessment\nOccupational therapy as needed for computer work ergonomics",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n59-year-old female with Type 2 Diabetes\nOccupation: Data Scientist\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive headaches, visual changes, facial numbness\nWHO Grade: I (based on imaging characteristics)\n\nIMAGING:\nMRI reveals a 2.8cm right sphenoid wing meningioma with minimal peritumoral edema. No significant mass effect on adjacent structures. T2 sequence shows moderate signal intensity.\n\nASSESSMENT:\nGiven patient's stable professional career requiring cognitive precision and current symptom profile, recommending close monitoring with conservative management initially. Symptoms warrant attention but tumor characteristics allow for non-surgical approach.\n\nPLAN:\n1. MRI surveillance every 6 months initially\n2. Neurocognitive assessment baseline established\n3. Optimization of diabetes management with endocrinology\n4. Prophylactic anticonvulsants not indicated at this time\n5. Headache management: Adjustment of current migraine medication\n\nFOLLOW-UP VISIT - September 20, 2018\nTumor stable in size. Headaches improved with medication adjustment.\nVisual symptoms stable. Continue current management.\n\nFOLLOW-UP - March 12, 2019\nMinor increase in tumor size (3.0cm). Symptoms stable.\nAdded: Low-dose dexamethasone for edema management.\n\nFOLLOW-UP - September 18, 2019\nTumor stable. Patient managing work with accommodations (anti-glare screen, regular breaks).\nContinue current protocol.\n\nANNUAL REVIEW - March 15, 2020\nSlight progression (3.2cm). Discussing surgical options but patient prefers conservative approach.\nImplemented: Occupational therapy for workplace adaptations.\n\nFOLLOW-UP - March 10, 2021\nStable disease. Managing work remotely due to COVID-19 has reduced visual strain.\nContinue monitoring.\n\nFOLLOW-UP - March 8, 2022\nNo significant changes. Symptoms well-controlled.\nReduced MRI frequency to annual given stability.\n\nANNUAL REVIEW - March 14, 2023\nTumor stable at 3.2cm. Patient maintaining good quality of life.\nContinuing conservative management.\n\nLATEST FOLLOW-UP - February 20, 2024\nMinimal growth (3.3cm). Symptoms stable. Patient approaching retirement, maintaining good functional status.\n\nCURRENT MANAGEMENT:\n- Annual MRI surveillance\n- Regular ophthalmology reviews\n- Diabetes management optimization\n- Ergonomic workplace modifications\n- Regular cognitive assessments\n\nFUNCTIONAL STATUS:\nKPS Score: 90 - Able to carry on normal activity with minor symptoms\nECOG Score: 1 - Restricted in physically strenuous activity but ambulatory\n\nRECOMMENDATIONS:\nContinue conservative management unless significant progression or new symptoms develop. Patient's occupation requires cognitive precision - current approach allows maintenance of professional activities with appropriate accommodations.\n\nNext appointment: February 2025\nImaging: Schedule MRI one week prior\n\n[Electronic Signature]\nBoard Certified Neurosurgeon\n[Hospital Name]"
      }
    },
    {
      "demographics": {
        "age": 45,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": true
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work when cataloging books",
          "Mild right-sided facial numbness",
          "Reports feeling off-balance when reaching for high library shelves"
        ],
        "medical_history": [
          "Radiation therapy to scalp for severe tinea capitis at age 8",
          "Migraine headaches since age 30, managed with sumatriptan",
          "Hypertension diagnosed 2 years ago, controlled with lisinopril",
          "No history of seizures",
          "No previous neurological conditions",
          "No family history of brain tumors",
          "Regular eye exams, last one 6 months ago was normal",
          "No history of trauma"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Additional consideration for radiation exposure history"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F45-O-MEN\nOccupation: Librarian\n\nINITIAL VISIT - March 15, 2014\nMRI FINDINGS:\n- 3.8cm left frontal parasagittal meningioma\n- Significant peritumoral edema\n- Mass effect on superior sagittal sinus\n- Enhancement pattern consistent with WHO Grade II\n- Evidence of dural tail sign\n\nASSESSMENT:\nHigh-risk features present:\n- Size >3cm\n- Significant edema\n- Critical location near motor strip\n- History of radiation exposure\n- Progressive neurological symptoms\nWHO Grade: II (preliminary radiological assessment)\n\nTREATMENT PLAN:\nRecommend immediate surgical intervention due to:\n1. Progressive symptoms affecting daily function\n2. Size and location\n3. Occupational impact\n4. Prior radiation exposure increasing malignant potential\n\n-------------------\n\nPRE-OP VISIT - April 2, 2014\nSurgical consent obtained\nPre-operative imaging completed\nSimpson Grade I resection planned\n\n-------------------\n\nSURGICAL NOTE - April 15, 2014\nProcedure: Left frontal craniotomy with image-guided navigation\nFindings: Simpson Grade II resection achieved\nPathology: Confirmed WHO Grade II meningioma\nNo immediate complications\n\n-------------------\n\nPOST-OP FOLLOW-UP - May 30, 2014\nPatient recovering well\nAdjuvant radiation therapy recommended\nStarted 60 Gy/30 fractions\n\n-------------------\n\n6-MONTH FOLLOW-UP - October 15, 2014\nMRI: No residual/recurrent tumor\nSymptoms significantly improved\nReturned to work with modifications\n\n-------------------\n\nANNUAL FOLLOW-UP - April 15, 2015\nMRI: Stable\nNeurological exam normal\nContinuing biannual monitoring\n\n-------------------\n\n2-YEAR FOLLOW-UP - April 2016\nSmall focus of enhancement noted\nClose monitoring recommended\nIncreased scan frequency to q4 months\n\n-------------------\n\n3-YEAR FOLLOW-UP - April 2017\nStable imaging\nNo new symptoms\nReturn to q6 month monitoring\n\n-------------------\n\n5-YEAR FOLLOW-UP - April 2019\nComplete neurological assessment\nMRI stable\nQuality of life assessment: Excellent\n\n-------------------\n\n7-YEAR FOLLOW-UP - April 2021\nContinued stability\nAnnual monitoring recommended\nNo evidence of recurrence\n\n-------------------\n\n10-YEAR FOLLOW-UP - March 2024\nLong-term survival achieved\nExcellent functional status\nContinue annual monitoring\n\nCURRENT STATUS:\nKPS Score: 90/100\nECOG Score: 1\n\nMONITORING PROTOCOL:\n- MRI with contrast every 12 months\n- Annual neuropsychological assessment\n- Regular ophthalmological evaluation\n- Quality of life assessments\n\nOCCUPATIONAL CONSIDERATIONS:\n- Full return to librarian duties\n- Ergonomic modifications implemented\n- No restrictions on reaching or computer work\n\nLong-term prognosis remains favorable with continued surveillance.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nFemale, 45 years old, Blood Type O\nOccupation: Librarian\n\nINITIAL VISIT - January 15, 2014\nChief Complaint: Progressive neurological symptoms including headaches and visual changes\n\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I characteristics\n- No signs of brain invasion\n\nASSESSMENT:\nGiven patient's history of prior radiation exposure and current symptoms, careful monitoring is warranted. While symptoms are concerning, tumor size and characteristics allow for initial conservative management.\n\nPLAN:\n1. Close monitoring with serial MRI scans\n2. Symptom management:\n   - Headache: Optimize migraine medication\n   - Vision: Monthly ophthalmology evaluations\n3. Occupational modifications recommended:\n   - Ergonomic workplace assessment\n   - Avoid prolonged overhead reaching\n4. Continue current hypertension management\n\nFOLLOW-UP VISIT - July 20, 2014 (6 months)\n- MRI shows stable tumor size\n- Headaches improved with medication adjustment\n- Vision stabilized\n- KPS: 90\n\nANNUAL FOLLOW-UP - January 2015\n- MRI: No significant change\n- Symptoms stable\n- Maintaining work schedule with accommodations\n- KPS: 90\n\nANNUAL FOLLOW-UP - January 2016\n- Minimal tumor growth (0.2cm)\n- Symptoms well-controlled\n- Added balance exercises to daily routine\n- KPS: 90\n\nANNUAL FOLLOW-UP - January 2017\n- Stable disease\n- Patient adapted well to modified work routine\n- Vision stable\n- KPS: 90\n\nANNUAL FOLLOW-UP - January 2018\n- No significant changes\n- Patient managing well with conservative approach\n- Added occupational therapy for balance\n- KPS: 85\n\nANNUAL FOLLOW-UP - January 2019\n- Slight increase in tumor size (0.3cm)\n- Increased frequency of monitoring\n- Discussing surgical options but maintaining conservative approach\n- KPS: 85\n\n6-MONTH FOLLOW-UP - July 2019\n- Stable findings\n- Symptoms well-managed\n- Continuing conservative approach\n- KPS: 85\n\nANNUAL FOLLOW-UP - January 2020\n- Stable disease\n- COVID-19 precautions discussed\n- Telemedicine follow-ups implemented\n- KPS: 85\n\nANNUAL FOLLOW-UP - January 2021\n- No significant changes\n- Patient satisfied with conservative management\n- Maintaining work capabilities\n- KPS: 85\n\nANNUAL FOLLOW-UP - January 2022\n- Stable disease\n- Quality of life well-maintained\n- Continuing current management plan\n- KPS: 85\n\nANNUAL FOLLOW-UP - January 2023\n- Minor progression (0.2cm)\n- Symptoms stable\n- Discussing radiation therapy as future option\n- KPS: 80\n\nRECENT FOLLOW-UP - January 2024\n- Stable disease\n- Patient continues to work with accommodations\n- Maintaining conservative approach\n- KPS: 80\n\nCURRENT STATUS:\n- WHO Grade I Meningioma\n- 10-year conservative management successful\n- Minimal progression\n- Good quality of life maintained\n\nFUNCTIONAL STATUS SCORES:\n- Karnofsky Performance Status (KPS): 80/100\n- ECOG Performance Status: 1\n\nONGOING RECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Regular ophthalmology follow-up\n3. Maintain current medication regimen\n4. Ergonomic workplace modifications\n5. Regular balance and physical therapy\n6. Consider radiation therapy if significant progression occurs\n\nNote: Conservative management has been successful in maintaining patient's quality of life and occupational function while monitoring disease progression carefully. Patient has adapted well to workplace modifications and maintains good functional status."
      }
    },
    {
      "demographics": {
        "age": 54,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work, especially when looking at computer screens",
          "Mild right-sided facial numbness that developed gradually over 2 months",
          "Reports of tinnitus in right ear"
        ],
        "medical_history": [
          "Migraine headaches since age 35, well-controlled with sumatriptan",
          "Hysterectomy at age 45 for uterine fibroids",
          "History of hormone replacement therapy for 5 years post-hysterectomy",
          "Mild hypertension diagnosed 2 years ago, managed with lifestyle modifications",
          "No history of cancer",
          "No significant family history of neurological conditions",
          "Annual eye exams normal until 3 months ago",
          "No previous head trauma or neurological disorders"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F54-O-SD\nPrimary Neurosurgeon: Dr. [Name]\n\nINITIAL VISIT - March 15, 2018\nPRESENTING SYMPTOMS: Progressive neurological symptoms including right-sided headaches, visual disturbances, and facial numbness. Occupational impact noted with computer screen intolerance.\n\nIMAGING:\nInitial MRI reveals a 3.8cm right sphenoid wing meningioma with significant mass effect and moderate peritumoral edema. Enhancement pattern consistent with WHO Grade II meningioma. Compression of right optic nerve noted.\n\nASSESSMENT:\nGiven size, location, and progressive symptoms affecting work performance, immediate surgical intervention recommended. High-risk features include:\n- Size >3cm\n- Peritumoral edema\n- Proximity to optic apparatus\n- Progressive neurological symptoms\n\nPLAN:\n1. Schedule surgical resection within 2 weeks\n2. Pre-operative optimization\n3. Detailed visual field testing\n4. Neuropsychological evaluation\n\nSURGICAL NOTE - April 2, 2018\nComplete microsurgical resection achieved (Simpson Grade II). Pathology confirms WHO Grade II atypical meningioma.\n\nFOLLOW-UP VISIT - July 15, 2018\nPost-operative MRI shows no residual tumor. Visual symptoms improved. Recommended adjuvant radiation therapy given Grade II histology.\n\nRADIATION ONCOLOGY - August-September 2018\nCompleted fractionated RT: 60 Gy in 30 fractions\n\nFOLLOW-UP VISITS:\nDecember 2018: Stable, returned to work part-time\nJune 2019: Full-time work resumed, no visual symptoms\nDecember 2019: Surveillance MRI stable\nJune 2020: Minor headaches, MRI stable\nDecember 2020: No new symptoms\nJune 2021: Surveillance MRI shows small enhancement at surgical site\nSeptember 2021: Gamma Knife radiosurgery to small recurrence\nJune 2022: Post-radiosurgery MRI stable\nDecember 2022: Continued stability\nJune 2023: No evidence of recurrence\nDecember 2023: Stable imaging and symptoms\nMarch 2024: Latest MRI shows continued stability\n\nCURRENT STATUS (2024):\n- Disease-free interval: 6 years\n- Regular ophthalmological monitoring\n- Maintaining full work schedule\n- Annual MRI surveillance recommended\n\nFUNCTIONAL SCORES:\nKPS Score: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nMONITORING PROTOCOL:\n- MRI every 6 months for next 5 years\n- Annual ophthalmological evaluation\n- Neuropsychological assessment annually\n- Regular cognitive function monitoring given occupation\n\nOCCUPATIONAL CONSIDERATIONS:\n- Ergonomic workplace modifications\n- Blue light filtering for computer screens\n- Regular work breaks implemented\n- Stress management strategies\n\nWHO Grade: II (Atypical Meningioma)\nSimpson Resection Grade: II\n\nThis case demonstrates successful aggressive management of a WHO Grade II meningioma with early intervention, leading to optimal outcomes and maintained professional functionality.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n54-year-old female software developer\nBlood Type: O\nWHO Grade I Meningioma\n\nINITIAL VISIT - March 15, 2014\nMRI FINDINGS:\n- 2.8 cm right sphenoid wing meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- Dural tail sign present\n- No hydrocephalus\n\nASSESSMENT:\nPatient presents with progressive symptoms but tumor size and location allow for initial conservative management. Occupation requires significant screen time, which may exacerbate visual symptoms.\n\nPLAN:\n1. Watchful waiting with close monitoring\n2. Ergonomic workplace assessment\n3. Regular ophthalmology follow-up\n4. Prophylactic anticonvulsants not indicated\n5. Continue current hypertension management\n\nFOLLOW-UP VISIT - September 20, 2014 (6 months)\nSymptoms stable. Minor improvement in headaches with workplace modifications.\nMRI: No significant change in tumor size or characteristics.\nPlan: Continue monitoring\n\nANNUAL FOLLOW-UP - March 18, 2015\nSymptoms stable. Vision unchanged.\nMRI: Tumor stable at 2.8 cm\nRecommended: Continue current management\n\nANNUAL FOLLOW-UP - March 22, 2016\nMinor increase in headache frequency\nMRI: Minimal growth to 2.9 cm\nAdded: Prophylactic amitriptyline for headache management\n\nANNUAL FOLLOW-UP - March 15, 2017\nSymptoms stable with medication\nMRI: No change from previous\nPatient adapting well to workplace modifications\n\nANNUAL FOLLOW-UP - March 20, 2018\nReports improved concentration with adjusted work schedule\nMRI: Stable at 2.9 cm\nContinue conservative management\n\nANNUAL FOLLOW-UP - March 19, 2019\nMinor visual symptoms progression\nMRI: Tumor stable\nOphthalmology consult: Minor right optic nerve compression\nDiscussion of potential future intervention if progression continues\n\nANNUAL FOLLOW-UP - March 17, 2020\nStable symptoms\nMRI: No significant change\nPatient satisfied with conservative approach\n\nANNUAL FOLLOW-UP - March 16, 2021\nSymptoms stable\nMRI: Minimal growth to 3.0 cm\nDiscussed surgical options but patient prefers continued observation\n\nANNUAL FOLLOW-UP - March 15, 2022\nSome increase in headache frequency\nMRI: Stable at 3.0 cm\nAdjusted medication regimen\n\nANNUAL FOLLOW-UP - March 14, 2023\nGenerally stable condition\nMRI: No significant change\nPatient continues to manage work responsibilities effectively\n\nMOST RECENT FOLLOW-UP - March 12, 2024\n10-year follow-up\nMRI: Stable disease\nPatient maintaining good quality of life with conservative management\n\nCURRENT MANAGEMENT:\n1. Annual MRI surveillance\n2. Regular ophthalmology follow-up\n3. Optimized workplace ergonomics\n4. Medication management for symptoms\n5. Regular neurological assessments\n\nFUNCTIONAL STATUS SCORES:\nKarnofsky Performance Status (KPS): 90\n- Able to carry on normal activity with minor symptoms\n\nECOG Performance Status: 1\n- Restricted in physically strenuous activity but ambulatory and able to carry out light work\n\nRECOMMENDATIONS:\nContinue current conservative management strategy with annual imaging unless significant symptom progression occurs. Patient has demonstrated excellent adaptation to workplace modifications and maintains high functional status."
      }
    },
    {
      "demographics": {
        "age": 51,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by spouse - increased irritability",
          "Mild right-sided facial numbness",
          "Balance difficulties when walking, particularly in dim lighting",
          "Difficulty concentrating at work for past 2-3 months"
        ],
        "medical_history": [
          "Hypertension diagnosed 3 years ago - controlled with lisinopril 10mg daily",
          "Mild traumatic brain injury from car accident 15 years ago - full recovery",
          "Seasonal allergies - takes OTC antihistamines as needed",
          "Appendectomy at age 23",
          "No history of cancer",
          "No family history of brain tumors",
          "Non-smoker",
          "Social alcohol use (2-3 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: A\nGender: Male\nAge at Presentation: 51\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms with 4-month history\n\nIMAGING:\nMRI reveals a 4.2 cm right frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe with 5mm midline shift. T2 sequence shows hyperintense signal. Contrast enhancement demonstrates homogeneous pattern typical of meningioma.\n\nASSESSMENT:\nWHO Grade II meningioma (atypical features on imaging)\nKPS Score: 80\nECOG: 1\n\nPLAN:\nGiven size, symptoms, and location, recommend immediate surgical intervention. Patient's professional status and progressive symptoms warrant aggressive approach.\n\nSURGICAL INTERVENTION - April 2, 2014\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology confirms WHO Grade II meningioma\nPost-op course uncomplicated\n\nFOLLOW-UP VISIT - July 15, 2014\nPatient reports improvement in headaches and vision\nAdjuvant radiation therapy completed (54 Gy in 30 fractions)\nMRI: No residual tumor\nKPS: 90\nECOG: 0\n\n6-MONTH FOLLOW-UP - October 2, 2014\nSurveillance MRI: No recurrence\nNeurological exam stable\nContinue q6month monitoring\n\n2015 VISITS (April & October):\nStable imaging\nMinor headaches managed with OTC medications\nKPS maintained at 90\nECOG: 0\n\n2016 VISITS (April & October):\nSmall area of enhancement noted in April\nOctober scan shows 1.2cm recurrence\nRecommend reoperation\n\nSECOND SURGERY - December 5, 2016\nSimpson Grade I resection achieved\nPathology confirms recurrent WHO Grade II\n\n2017-2019: Quarterly then biannual surveillance\nAll scans stable\nKPS: 90-95\nECOG: 0\n\n2020 VISITS (March & September):\nStable imaging\nPatient maintaining full work schedule\nNo new neurological symptoms\n\n2021-2023: Biannual monitoring\nNo evidence of recurrence\nRegular neuropsychological testing stable\nKPS: 95\nECOG: 0\n\nCURRENT STATUS (2024):\n10-year follow-up complete\nLatest MRI stable\nPatient asymptomatic\nMaintaining professional activities\nAnnual monitoring recommended going forward\n\nFINAL SCORES:\nCurrent KPS: 95/100\nCurrent ECOG: 0\n\nNOTES:\n- Aggressive initial approach with early surgical intervention likely contributed to good outcome\n- Regular imaging surveillance crucial for early detection of recurrence\n- Patient's compliance with follow-up and professional demands influenced treatment decisions\n- Blood type A noted for surgical planning purposes\n- Maintained high functional status throughout treatment course\n\nNext appointment scheduled for July 2024\nContinue annual MRI surveillance",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: A\nGender: Male\nAge at Presentation: 51\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive headaches, visual changes, balance issues\n\nIMAGING:\nMRI reveals a 2.8cm left frontal convexity meningioma with minimal surrounding edema. T2 sequence shows moderate signal intensity. No significant mass effect on adjacent structures.\n\nASSESSMENT:\nWHO Grade I meningioma (presumptive radiological diagnosis)\nKPS: 90\nECOG: 1\n\nPLAN:\nGiven patient's occupation (requires cognitive focus), symptoms, and tumor location/size, recommending close monitoring over immediate surgical intervention. Discussed risks/benefits with patient and spouse.\n\nMANAGEMENT PLAN:\n1. Serial MRI monitoring\n2. Dexamethasone 4mg daily for symptom management\n3. Neurology referral for headache management\n4. Occupational therapy evaluation\n5. Monthly clinical follow-up initially\n\n-------------------\n\nFOLLOW-UP - September 20, 2018\nSymptoms stable with steroid therapy. Headaches improved.\nMRI: No significant change in tumor size.\nPlan: Continue current management, begin steroid taper.\n\n-------------------\n\nANNUAL FOLLOW-UP - March 12, 2019\nMinimal symptom progression\nMRI: Tumor stable at 2.9cm\nMaintained work schedule with accommodations\nPlan: Continue monitoring, MRI every 6 months\n\n-------------------\n\nFOLLOW-UP - March 10, 2020\nReports improved balance with physical therapy\nMRI: Stable disease\nPlan: Extended MRI interval to annual given stability\n\n-------------------\n\nANNUAL FOLLOW-UP - March 15, 2021\nMinor visual symptoms persist but stable\nMRI: No growth (2.9cm)\nKPS: 90\nECOG: 1\nPlan: Continue annual monitoring\n\n-------------------\n\nANNUAL FOLLOW-UP - March 8, 2022\nWell-compensated with current management\nMRI: Stable disease\nMaintaining full-time work\nPlan: Continue annual imaging\n\n-------------------\n\nANNUAL FOLLOW-UP - March 14, 2023\nReports occasional headaches\nMRI: Minimal growth to 3.0cm\nDiscussed surgical options but patient prefers continued observation\nKPS: 85\nECOG: 1\nPlan: Return to 6-month imaging interval\n\n-------------------\n\nRECENT FOLLOW-UP - January 10, 2024\nSymptoms stable\nMRI: No further growth\nSuccessfully managing work duties with accommodations\nPlan: Continue current management approach\n\nCURRENT STATUS:\nKPS Score: 85/100\nECOG Performance Status: 1\n\nLONG-TERM MANAGEMENT SUMMARY:\n- Conservative approach successful over 6-year period\n- Minimal symptom progression\n- Maintained quality of life and occupational function\n- Patient satisfied with management strategy\n- Continued monitoring recommended\n\nNext appointment: July 2024 with repeat MRI\n\nNote: Conservative management has proven appropriate for this patient, with minimal tumor growth over 6 years and maintained functional status. Patient has adapted well to symptoms with supportive care measures."
      }
    },
    {
      "demographics": {
        "age": 66,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months becoming more severe in mornings, intermittent blurred vision in right eye, occasional balance issues when walking, subtle personality changes noted by spouse including increased irritability, one episode of confusion while organizing library books, mild right-sided facial numbness"
        ],
        "medical_history": [
          "Hypertension controlled with lisinopril 10mg daily, surgical removal of gallbladder in 2012, mild hearing loss in left ear diagnosed 5 years ago, history of migraine headaches in 30s-40s that had resolved, occasional tension headaches treated with OTC medications, family history of father with stroke at age 72, no history of seizures or neurological disorders, no prior head trauma or radiation exposure"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - 03/15/2014\nPatient: 66Y Male, Blood Type O\nOccupation: Librarian\nChief Complaint: Progressive headaches, visual disturbances, balance issues\n\nIMAGING:\nInitial MRI reveals 4.2cm left frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe with 5mm midline shift. T2 hyperintense with heterogeneous enhancement. No calcification noted.\n\nASSESSMENT:\nWHO Grade II meningioma (based on imaging characteristics)\nKPS: 80\nECOG: 1\n\nPLAN:\nGiven size, symptoms, and occupation requiring cognitive precision, recommend urgent surgical intervention. Schedule for craniotomy within 2 weeks.\n\nSURGICAL NOTE - 03/29/2014\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nMinimal residual tumor at superior sagittal sinus interface\nPathology confirms WHO Grade II atypical meningioma\nPost-op imaging shows expected post-surgical changes\n\nFOLLOW-UP - 06/15/2014\nCompleted 6-week course of adjuvant radiation (60 Gy/30fx)\nSymptoms improving\nKPS: 85\nECOG: 1\n\nFOLLOW-UP - 12/20/2014\n6-month MRI: No evidence of recurrence\nReturn to work part-time\nMild fatigue persisting\nKPS: 90\nECOG: 0-1\n\nANNUAL FOLLOW-UP - 03/15/2015\nMRI stable\nFull return to work\nHeadaches resolved\nKPS: 90\nECOG: 0\n\nFOLLOW-UP - 09/20/2016\nSurveillance MRI shows 8mm nodular enhancement near resection cavity\nRecommend SRS to residual tumor\nCompleted CyberKnife treatment (18 Gy single fraction)\n\nFOLLOW-UP - 03/15/2018\nStable disease\nAnnual cognitive assessment normal\nMaintaining work performance\nKPS: 90\nECOG: 0\n\nFOLLOW-UP - 03/20/2020\nMRI shows stable post-treatment changes\nNo new symptoms\nContinues library work with accommodations\nKPS: 90\nECOG: 0\n\nFOLLOW-UP - 04/15/2022\nMinimal progression (3mm growth) of residual tumor\nClose monitoring recommended\nMaintaining function\nKPS: 85\nECOG: 1\n\nCURRENT VISIT - 02/10/2024\n10-year follow-up\nMRI stable compared to 2022\nFunctionally independent\nWorking part-time by choice\nKPS: 85\nECOG: 1\n\nTREATMENT SUMMARY:\n- Initial Simpson II resection (2014)\n- Adjuvant radiation therapy\n- Salvage SRS for small recurrence (2016)\n- Maintained good functional status throughout\n- Regular cognitive assessments considering occupation\n- Successful disease control with multimodal approach\n\nFINAL SCORES:\nCurrent KPS: 85/100\nCurrent ECOG: 1\n\nMONITORING PLAN:\nContinue bi-annual MRI\nAnnual cognitive assessment\nMonitor for any new neurological symptoms",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n===================================================\n\nINITIAL VISIT - March 15, 2018\n----------------------------\nPATIENT: 66-year-old male librarian, Blood Type O\nPRESENTING SYMPTOMS: Progressive headaches (3 months), right eye blurred vision, balance issues, personality changes, episodic confusion, right facial numbness\nWHO GRADE: I (based on imaging characteristics)\n\nIMAGING:\nMRI reveals 2.4cm left frontal convexity meningioma, minimal peritumoral edema, no significant mass effect. T2 sequence shows moderate signal intensity. No critical structure compression.\n\nASSESSMENT & PLAN:\nGiven tumor size <3cm, minimal edema, and stable employment requiring cognitive function, recommending conservative management with close monitoring. Occupation as librarian requires attention to detail and cognitive clarity - will monitor for any work-related functional decline.\n\nRECOMMENDATIONS:\n1. MRI surveillance every 6 months initially\n2. Dexamethasone 4mg daily for symptom management, tapering schedule provided\n3. Continue current hypertension management\n4. Occupational modifications: frequent breaks, ergonomic considerations\n5. Monthly headache diary\n\nFOLLOW-UP VISITS\n---------------\n\nSeptember 20, 2018 (6-month):\n- Tumor stable at 2.4cm\n- Headaches improved with dexamethasone\n- Vision symptoms stable\n- Maintaining work schedule with modifications\n- Continue current management\n\nMarch 18, 2019 (1-year):\n- Minimal growth (2.5cm)\n- Symptoms well-controlled\n- Reduced dexamethasone to 2mg daily\n- Working full-time with accommodations\n- Continue surveillance\n\nMarch 15, 2020 (2-year):\n- Tumor stable at 2.5cm\n- Good symptom control\n- Successfully weaned off dexamethasone\n- Annual MRI schedule implemented\n- Maintaining quality of life\n\nMarch 22, 2021 (3-year):\n- No significant growth\n- Minor balance issues resolved\n- Retired from library work\n- Cognitive function stable\n- Continue annual monitoring\n\nMarch 14, 2022 (4-year):\n- Tumor stable at 2.5cm\n- No new symptoms\n- Excellent functional status\n- Managing well with conservative approach\n- Continue annual surveillance\n\nMarch 20, 2023 (5-year):\n- Minimal growth (2.6cm)\n- No new neurological symptoms\n- Quality of life maintained\n- Discussion of long-term monitoring plan\n- Transition to biennial MRI\n\nMarch 18, 2024 (6-year):\n- Stable disease\n- Well-maintained functional status\n- Patient satisfied with conservative approach\n- Continue biennial monitoring\n\nFUNCTIONAL STATUS SCORES:\n------------------------\nKarnofsky Performance Status (KPS): 90\n(Able to carry on normal activity with minor symptoms)\n\nECOG Performance Status: 1\n(Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nCONCLUSION:\nConservative management strategy successful with stable disease and maintained quality of life over 6-year period. Patient demonstrates excellent compliance with monitoring protocol and maintains good functional status."
      }
    },
    {
      "demographics": {
        "age": 44,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, worse in morning; Right-sided facial numbness and tingling; Occasional blurred vision in right eye; Balance difficulties when walking; Recent onset of nausea, particularly in mornings; Memory difficulties and trouble concentrating at work; One episode of seizure 2 weeks ago"
        ],
        "medical_history": [
          "BMI 34.2 (Obese Class I); Hypertension diagnosed 5 years ago, managed with lisinopril; Minor concussion from sports injury 15 years ago, fully recovered; Sleep apnea diagnosed 3 years ago, uses CPAP; Family history negative for brain tumors; No history of radiation exposure; Current medications: lisinopril 20mg daily; No known drug allergies; Social history: Former smoker (quit 8 years ago), occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M44-O-BMI34\nInitial Visit: March 15, 2014\n\nINITIAL CONSULTATION:\n44-year-old male presenting with progressive neurological symptoms and recent seizure. Initial MRI reveals a 4.2cm right frontal convexity meningioma with significant peritumoral edema and mass effect on adjacent structures. WHO Grade II features suspected on imaging.\n\nIMAGING FINDINGS:\n- MRI with/without contrast: Large right frontal convexity meningioma (4.2 x 3.8 x 3.6 cm)\n- Significant peritumoral edema\n- Mass effect with 6mm midline shift\n- Dural tail sign present\n- T2 hyperintense with heterogeneous enhancement\n\nTREATMENT PLAN:\nRecommend immediate surgical intervention due to:\n1. Tumor size >3cm\n2. Symptomatic presentation\n3. Evidence of mass effect\n4. Recent seizure activity\n5. Impact on daily functioning\n\n-------------------\n\nSURGICAL NOTE: April 2, 2014\nSimpson Grade II resection performed. Gross total resection achieved.\nPathology: WHO Grade II meningioma\nPost-op course uncomplicated.\n\nFOLLOW-UP VISITS:\n\nOctober 2014 (6 months post-op):\n- Improved neurological symptoms\n- MRI shows no residual tumor\n- Initiated adjuvant radiotherapy (60 Gy/30 fractions)\n- KPS: 90\n\nApril 2015 (1 year post-op):\n- Complete resolution of headaches\n- Minor residual facial numbness\n- MRI stable\n- KPS: 90\n\nOctober 2015:\n- Surveillance MRI stable\n- No new symptoms\n- Continuing biannual monitoring\n- KPS: 90\n\nApril 2016:\n- Small enhancement noted on MRI (7mm)\n- Asymptomatic\n- Close monitoring recommended\n- KPS: 90\n\nOctober 2016:\n- Enhancement stable\n- No new symptoms\n- KPS: 90\n\n2017-2019 (Biannual visits):\n- Serial MRIs show stable small enhancement\n- No new neurological symptoms\n- Weight management program initiated\n- KPS maintained at 90\n\nJanuary 2020:\n- MRI shows slight growth of enhancement (12mm)\n- Gamma Knife radiosurgery performed\n- KPS: 85\n\n2020-2024 (Quarterly then biannual monitoring):\n- Post-radiosurgery response favorable\n- Enhancement stable at 5mm\n- No new neurological symptoms\n- Regular monitoring continues\n- Latest KPS (2024): 90\n\nCURRENT STATUS (2024):\n- Disease stable\n- Maintained function\n- Continues regular monitoring\n- BMI improved to 31.4\n\nSCORES:\nKPS (Current): 90/100\nECOG: 1\n\nMONITORING PLAN:\n- Continue biannual MRI\n- Annual neuropsychological assessment\n- Regular weight management follow-up\n- Seizure prophylaxis maintenance\n\nNote: Aggressive initial approach with early surgical intervention and adjuvant therapy has resulted in good long-term control. Patient maintains high functional status and has returned to full work capacity.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n44-year-old male with meningioma\n\nINITIAL VISIT - March 15, 2014\nMRI FINDINGS:\n- 2.8cm right sphenoid wing meningioma\n- Moderate peritumoral edema\n- No significant mass effect on critical structures\n- WHO Grade I (presumptive radiological diagnosis)\n\nASSESSMENT:\nDespite presenting symptoms, tumor size and location favor initial conservative management. Patient's obesity and sleep apnea increase surgical risks.\n\nPLAN:\n1. Anti-epileptic medication: Levetiracetam 500mg BID\n2. Dexamethasone 4mg BID for edema control\n3. Monthly clinical monitoring initially\n4. Quarterly MRI for first year\n5. Sleep study referral for CPAP optimization\n6. Neurocognitive baseline testing\nKPS: 80 | ECOG: 1\n\nFOLLOW-UP - June 15, 2014\nSymptoms improved with medical management. Headaches reduced by 60%.\nMRI: Stable tumor size, decreased edema\nPLAN: Continue current management\n\nFOLLOW-UP - December 20, 2014\nGood symptom control. Patient adhering to CPAP therapy.\nMRI: No growth\nPLAN: Extend to 6-monthly MRI\n\nANNUAL REVIEW - December 15, 2015\nStable symptoms. Working full-time with accommodations.\nMRI: No significant change\nPLAN: Continue current management\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - December 10, 2016\nMinor headache exacerbation, resolved with medication adjustment\nMRI: Minimal growth (0.2cm in 2 years)\nPLAN: Maintain conservative approach\n\nANNUAL REVIEW - December 5, 2017\nWell-controlled symptoms. Weight loss program initiated.\nMRI: Stable\nPLAN: Annual MRI if remains stable\nKPS: 90 | ECOG: 0\n\nFOLLOW-UP - December 8, 2018\nBMI improved to 32.1. Sleep apnea better controlled.\nMRI: No progression\nPLAN: Continue annual monitoring\n\nANNUAL REVIEW - December 12, 2019\nMaintained clinical stability. Working successfully.\nMRI: Stable disease\nPLAN: Continue conservative management\nKPS: 90 | ECOG: 0\n\nFOLLOW-UP - December 15, 2020\nTelemedicine visit due to COVID-19\nMRI: No change\nPLAN: Maintain current approach\n\nANNUAL REVIEW - December 10, 2021\nComplete symptom control. BMI stable at 31.8.\nMRI: Stable disease\nPLAN: Continue annual monitoring\nKPS: 90 | ECOG: 0\n\nLATEST FOLLOW-UP - December 5, 2023\n10-year follow-up milestone\nMRI: No significant change from initial presentation\nExcellent quality of life maintained\nPLAN: Continue annual monitoring\nKPS: 90 | ECOG: 0\n\nSUMMARY OF MANAGEMENT APPROACH:\n- Successful conservative management over 10 years\n- No surgical intervention required\n- Excellent symptom control through medical management\n- Significant lifestyle improvements (weight, sleep apnea)\n- Maintained occupational function\n- High quality of life preserved\n\nCURRENT STATUS:\nKPS (Karnofsky Performance Status): 90\nECOG Performance Status: 0\n\nWHO Grade: I (presumptive, based on imaging characteristics and stability)\n\nRECOMMENDATIONS:\nContinue annual MRI surveillance\nMaintain current medical management\nRegular sleep apnea monitoring\nAnnual neurocognitive assessment"
      }
    },
    {
      "demographics": {
        "age": 56,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by spouse - increased irritability",
          "Mild right-sided facial numbness for past 2 months",
          "Balance difficulties when walking, particularly in dim lighting",
          "Recent memory issues affecting work performance"
        ],
        "medical_history": [
          "Hypertension - diagnosed 8 years ago, well-controlled on lisinopril 10mg daily",
          "Mild hearing loss in left ear - diagnosed 3 years ago",
          "Surgical history: Appendectomy (1985)",
          "No history of cancer",
          "No prior neurological conditions",
          "Family history: Father had stroke at age 72",
          "Current medications: Lisinopril 10mg daily, occasional ibuprofen for headaches",
          "No known drug allergies"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M56-A\nPrimary Diagnosis: Meningioma\n\nINITIAL VISIT - September 15, 2014\nChief Complaint: Progressive neurological symptoms with headaches\nMRI Findings: 4.2 cm right frontal convexity meningioma with significant peritumoral edema. Mass effect on right frontal lobe with 5mm midline shift. Enhancement pattern consistent with WHO Grade II meningioma.\nAssessment: Symptomatic right frontal meningioma requiring urgent intervention\nPlan: Scheduled for surgical resection within 2 weeks\nKPS: 80/100\nWHO Grade: II\n\nSURGICAL NOTE - September 30, 2014\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade: II resection achieved\nPathology: WHO Grade II atypical meningioma\nPost-op course: Uncomplicated\nPlan: Adjuvant radiation therapy recommended\n\nFOLLOW-UP - December 15, 2014\nStatus: Completed 6-week course of fractionated RT (60 Gy/30fx)\nSymptoms: Improving headaches, vision stabilized\nMRI: Post-surgical changes, no residual tumor\nPlan: Q3 month monitoring\n\n2015 QUARTERLY VISITS\n- March: Stable, minor radiation changes\n- June: Continued improvement\n- September: New baseline established\n- December: No evidence of recurrence\nKPS: 90/100\n\n2016-2017 BIANNUAL VISITS\n- June 2016: Stable imaging\n- December 2016: Small enhancement area noted (8mm)\n- June 2017: Enhancement stable\n- December 2017: No progression\nKPS: 90/100\n\n2018-2019 ANNUAL VISITS\nFebruary 2018: Surveillance MRI shows 1.2cm recurrence\nTreatment: Gamma Knife radiosurgery performed\nDecember 2019: Post-radiosurgery stability\nKPS: 85/100\n\n2020-2022 MONITORING\n- Annual MRIs show post-treatment changes\n- No new neurological symptoms\n- Maintained work performance\nKPS: 85/100\n\n2023-2024 CURRENT STATUS\n- Stable disease\n- Quarterly monitoring continued\n- Minor radiation-induced changes\n- Patient maintains executive position with accommodations\nCurrent KPS: 80/100\n\nFINAL SCORES (2024):\nKPS (Karnofsky Performance Status): 80/100\nECOG Performance Status: 1\n\nTREATMENT SUMMARY:\n1. Initial surgical resection (2014)\n2. Adjuvant radiation therapy\n3. Gamma Knife for recurrence (2018)\n4. Ongoing surveillance\n\nMONITORING PROTOCOL:\n- MRI with contrast every 3 months for first 2 years\n- Biannual MRI years 3-5\n- Annual MRI thereafter\n- Neuropsychological testing annually\n- Regular ophthalmological examinations\n\nNote: Patient's high-functioning professional status and early aggressive intervention strategy have contributed to favorable long-term outcome despite initial WHO Grade II designation.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: A\nGender: Male\nAge at Initial Presentation: 56\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive headaches, visual changes, balance issues\nMRI Findings: 2.4cm left frontal convexity meningioma, minimal surrounding edema\nWHO Grade: I (based on imaging characteristics)\nAssessment: Given size <3cm and minimal edema, candidate for conservative management\nPlan: Watchful waiting approach with serial imaging\nRecommendations: \n- MRI follow-up in 6 months\n- Neurology consult for headache management\n- Ophthalmology referral for vision assessment\nKPS: 90 | ECOG: 1\n\nFOLLOW-UP - September 20, 2018\nInterval MRI: No significant change in tumor size\nSymptoms: Mild improvement in headaches with prescribed medications\nPlan: Continue conservative management\nAdded: Propranolol 20mg BID for headache prophylaxis\nKPS: 90 | ECOG: 1\n\nANNUAL FOLLOW-UP - March 12, 2019\nMRI: Stable lesion size\nSymptoms: Better headache control, persistent mild visual symptoms\nOccupation Impact: Working full-time with workplace accommodations\nPlan: Annual MRI surveillance\nKPS: 90 | ECOG: 1\n\nANNUAL FOLLOW-UP - March 18, 2020\nMRI: Minimal growth (0.2mm), no new edema\nSymptoms: Stable\nNote: Telemedicine visit due to COVID-19 pandemic\nPlan: Continue current management\nKPS: 90 | ECOG: 1\n\nANNUAL FOLLOW-UP - April 5, 2021\nMRI: Stable disease\nSymptoms: Well-controlled with current regimen\nQuality of Life: Maintaining work and social activities\nPlan: Continue annual surveillance\nKPS: 90 | ECOG: 1\n\nANNUAL FOLLOW-UP - March 22, 2022\nMRI: No significant change\nSymptoms: Stable\nNote: Successfully adapted work schedule to manage fatigue\nPlan: Continue conservative approach\nKPS: 85 | ECOG: 1\n\nANNUAL FOLLOW-UP - March 14, 2023\nMRI: Stable disease\nSymptoms: Minor increase in headache frequency\nAdjustment: Propranolol increased to 30mg BID\nPlan: Continue annual monitoring\nKPS: 85 | ECOG: 1\n\nCURRENT VISIT - February 20, 2024\nMRI: No significant change from initial presentation\nLong-term Outcome: Successfully managed conservatively for 6 years\nQuality of Life: Maintained with minimal intervention\nOccupational Status: Working part-time by choice\nPlan: Continue annual MRI surveillance\nCurrent KPS: 85 | Current ECOG: 1\n\nMANAGEMENT SUMMARY:\n- Conservative approach successful over 6-year period\n- Stable disease with minimal symptom progression\n- Maintained good quality of life and occupational function\n- Regular monitoring has proven adequate\n- No surgical intervention required\n\nCURRENT MEDICATIONS:\n1. Lisinopril 10mg daily\n2. Propranolol 30mg BID\n3. PRN ibuprofen (limited use)\n\nMONITORING SCHEDULE:\n- Annual MRI\n- Semi-annual clinical evaluations\n- Annual ophthalmology assessment\n- Blood pressure monitoring\n\nFinal KPS Score: 85\nFinal ECOG Score: 1\n\nNotes authenticated by: [Assistant Name]\nBoard Certified Neurosurgeon\n[Date and Time Stamp]"
      }
    },
    {
      "demographics": {
        "age": 40,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": true
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 3 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of dizziness during stage performances",
          "Occasional nausea without vomiting",
          "Subtle personality changes noted by coworkers - increased irritability",
          "Difficulty maintaining balance during dance routines",
          "Recent problems with memorizing new performance scripts"
        ],
        "medical_history": [
          "Type 2 Diabetes diagnosed 5 years ago - managed with Metformin",
          "HbA1c consistently around 7.2%",
          "Mild hypertension - not currently on medication",
          "History of migraine headaches since age 30, but notes current headaches are different",
          "No prior neurological conditions",
          "No family history of brain tumors",
          "No history of radiation exposure",
          "Regular performer in theater productions for 15 years",
          "No significant head injuries"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly balance/coordination tests, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly balance/coordination tests, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M40-A-DM\nOccupation: Stage Artist\n\nINITIAL VISIT - March 15, 2014\nMRI FINDINGS:\n- 3.8cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- Compression of superior sagittal sinus\nWHO Grade: II (atypical features on imaging)\n\nASSESSMENT:\nPatient presents with concerning neurological symptoms significantly impacting professional performance abilities. Given tumor size, location, and symptom progression, immediate surgical intervention recommended.\n\nTREATMENT PLAN:\n1. Schedule surgical resection within 2 weeks\n2. Pre-operative optimization of diabetes management\n3. Neuropsychological evaluation baseline\n4. Functional MRI for surgical planning\n\nSURGICAL NOTE - April 1, 2014\n- Simpson Grade II resection achieved\n- Minor residual tumor at superior sagittal sinus\n- Pathology confirms WHO Grade II meningioma\n- No immediate post-operative complications\n\nFOLLOW-UP VISITS:\n\nJune 2014 (2 months post-op):\n- Improved headaches and vision\n- Starting physical therapy for balance\n- MRI shows post-surgical changes\n- Initiating fractionated RT (54 Gy/30fx)\n\nDecember 2014 (8 months post-op):\n- Completed radiation therapy\n- Returned to modified performance schedule\n- MRI stable\n- Memory improving with cognitive rehabilitation\n\nJune 2015:\n- Surveillance MRI stable\n- Full return to stage work\n- Minor balance issues resolved\n- Continue q4 month monitoring\n\n2016 (Annual Review):\n- Two stable MRIs\n- No new symptoms\n- Maintaining performance schedule\n- HbA1c improved to 6.8%\n\n2017:\n- Small area of enhancement noted on MRI\n- Increased monitoring frequency\n- Gamma Knife to residual (16 Gy)\n\n2018-2019:\n- Quarterly MRIs show stable disease\n- Maintaining full performance schedule\n- Annual neuropsychological testing stable\n\n2020-2021:\n- Continued stability on imaging\n- No new neurological symptoms\n- COVID-19 impact on performance schedule\n- Telemedicine follow-ups implemented\n\n2022-2023:\n- Biannual MRI surveillance\n- Stable disease\n- Full professional activity\n- Regular diabetes management\n\n2024 (Current Status):\n- 10-year follow-up\n- No evidence of progression\n- Maintains active performance career\n- Annual MRI surveillance plan\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90/100 (Able to perform normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nONGOING MONITORING:\n1. Biannual MRI surveillance\n2. Annual neuropsychological evaluation\n3. Regular diabetes management\n4. Quarterly neurosurgical follow-up\n5. Performance-specific functional assessments\n\nNote: Aggressive early intervention and comprehensive follow-up have enabled patient to maintain professional career with minimal interruption. Continue vigilant monitoring due to WHO Grade II status.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 40Y Male, Blood Type A\nOccupation: Stage Artist\n\nPRESENTING SYMPTOMS:\n- Progressive headaches (3-month duration, worse in morning)\n- Right eye blurred vision\n- Performance-related dizziness\n- Balance difficulties affecting dance routines\n- Memory issues with script learning\n- Personality changes (increased irritability)\n- Occasional nausea\n\nIMAGING:\nMRI reveals 2.8cm left frontal convexity meningioma\n- Minimal peritumoral edema\n- No significant mass effect\n- WHO Grade I characteristics\n- No calcification\n\nMANAGEMENT PLAN:\nGiven patient's active career and mild symptomatology, recommending conservative approach:\n1. Dexamethasone 4mg BID for symptom management\n2. Monthly neurological monitoring initially\n3. Quarterly MRI for first year\n4. Lifestyle modifications:\n   - Reduced performance schedule\n   - Balance rehabilitation exercises\n   - Memory enhancement techniques\n\nFOLLOW-UP VISIT - September 20, 2018\n- Headaches improved with steroids\n- Vision stabilized\n- Continuing performances with modifications\n- No tumor growth on follow-up MRI\n- Reduced steroid dosage to 2mg BID\n\nANNUAL REVIEW - March 12, 2019\n- Stable symptoms\n- MRI shows no progression\n- Maintaining modified performance schedule\n- Steroid dependency reduced\n- Continue quarterly monitoring\n\nFOLLOW-UP - March 10, 2020\n- Stable disease\n- Patient adapted well to modified routine\n- MRI unchanged\n- Reduced monitoring to biannual\n\nBIANNUAL REVIEW - September 15, 2021\n- Minor headache exacerbation\n- MRI stable\n- Adjusted work schedule\n- Added prophylactic migraine medication\n\nANNUAL REVIEW - March 8, 2022\n- Stable symptoms\n- No tumor progression\n- Successfully managing career\n- Continuing conservative approach\n\nFOLLOW-UP - March 14, 2023\n- Maintained stability\n- MRI unchanged\n- Well-adapted to management strategy\n- Regular diabetes monitoring maintained\n\nRECENT FOLLOW-UP - February 20, 2024\n- Continued stability\n- No significant progression\n- Successfully managing career with adaptations\n- Diabetes well-controlled\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nWHO Grade: I (Based on imaging characteristics)\n\nRECOMMENDATIONS:\n1. Continue biannual MRI monitoring\n2. Maintain modified performance schedule\n3. Regular diabetes management\n4. Annual neuropsychological assessment\n5. Consider surgical intervention only if:\n   - Significant tumor growth\n   - Worsening symptoms\n   - Impact on quality of life increases\n\nNote: Conservative management successful over 6-year period with stable disease and maintained quality of life. Patient has adapted well to lifestyle modifications while continuing career."
      }
    },
    {
      "demographics": {
        "age": 58,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of dizziness and mild balance issues",
          "Occasional nausea without vomiting",
          "Reports feeling increased pressure in head when bending over",
          "Subtle personality changes noted by family - increased irritability",
          "Right-sided facial numbness that developed gradually over 2 months"
        ],
        "medical_history": [
          "Hypertension - diagnosed 6 years ago, managed with lisinopril",
          "BMI 33.2 - Class I Obesity",
          "Migraines in 30s that resolved spontaneously",
          "Surgical history: Cholecystectomy (2012)",
          "No history of cancer",
          "No previous neurological conditions",
          "Family history: Mother had breast cancer",
          "Current medications: Lisinopril 10mg daily, multivitamin",
          "No known drug allergies"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: A\nGender: Female\nAge at Initial Presentation: 58\nBMI: 33.2\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms with headaches and visual changes\n\nIMAGING:\nMRI reveals a 4.2cm right sphenoid wing meningioma with significant mass effect and moderate peritumoral edema. Enhancement pattern consistent with WHO Grade II meningioma. Evidence of compression of right optic nerve.\n\nASSESSMENT:\nGiven size >3cm, location, and progressive symptoms, immediate surgical intervention recommended. High-risk features include:\n- Size >3cm\n- Peritumoral edema\n- Proximity to optic apparatus\n- Progressive neurological symptoms\nWHO Grade: II (preliminary based on imaging characteristics)\n\nPLAN:\n1. Schedule surgical resection within 2 weeks\n2. Pre-operative optimization of blood pressure\n3. Baseline neuro-ophthalmology evaluation\n4. Pre-surgical functional MRI and DTI tractography\n\nSURGICAL NOTE - April 1, 2014\nProcedure: Right frontotemporal craniotomy for tumor resection\nSimpson Grade II resection achieved\nEstimated blood loss: 300cc\nNo complications\nPathology confirms WHO Grade II meningioma\n\nFOLLOW-UP VISIT - July 1, 2014 (3 months post-op)\nSymptoms improved\nMRI shows small residual tumor (0.8cm)\nInitiated adjuvant radiotherapy: 54 Gy in 30 fractions\n\nFOLLOW-UP - January 15, 2015 (9 months post-op)\nPost-radiation MRI stable\nVisual symptoms resolved\nContinuing q6month monitoring\n\n2016 VISITS (q6months):\n- June: Stable imaging\n- December: No progression\n\n2017 VISITS:\n- June: Small increase in residual tumor (1.0cm)\n- December: Stable, continued monitoring\n\n2018 VISITS:\n- June: Further growth (1.3cm)\n- December: Decision for stereotactic radiosurgery to residual tumor\n\n2019:\n- March: Post-SRS follow-up\n- September: Stable disease\n\n2020-2022:\nAnnual MRI surveillance\nNo significant progression\nMaintained on antihypertensive therapy\n\n2023:\n- February: Small progression (1.5cm)\n- August: Stable\n\n2024 (Current):\nLatest MRI shows stable disease\nPatient maintains good functional status\nContinuing annual surveillance\n\nFUNCTIONAL STATUS SCORES:\nInitial Presentation:\n- KPS: 80\n- ECOG: 1\n\nCurrent (2024):\n- KPS: 90\n- ECOG: 0\n\nONGOING MONITORING:\n- Annual MRI with contrast\n- Biannual neurosurgical evaluation\n- Annual neuro-ophthalmology assessment\n- Regular BP monitoring\n- Weight management program\n\nLong-term prognosis remains guarded due to WHO Grade II status, but patient has maintained good functional status with aggressive initial intervention and close monitoring.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: A\nGender: Female\nAge at Initial Presentation: 58\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive headaches, visual changes, and neurological symptoms\n\nIMAGING:\nMRI reveals a 2.8cm right sphenoid wing meningioma with minimal surrounding edema.\nWHO Grade: I (based on imaging characteristics)\n\nASSESSMENT:\nGiven the patient's obesity, hypertension, and presenting symptoms, recommending close monitoring with consideration for intervention if symptoms worsen. Location and size warrant careful observation rather than immediate surgical intervention.\n\nPLAN:\n1. MRI surveillance every 6 months initially\n2. Neurology referral for headache management\n3. Ophthalmology consultation for visual symptoms\n4. BP optimization with PCP\n5. Weight management program referral\n\n-------------------\n\nFOLLOW-UP - September 20, 2014\nTumor stable in size. Visual symptoms improved with prescribed medications.\nHeadaches better controlled with topiramate 50mg daily.\nBP well-controlled: 128/82\n\n-------------------\n\nANNUAL VISIT - March 18, 2015\nMinimal tumor growth (0.2cm in 12 months).\nPatient reports improved quality of life with medical management.\nContinue current approach.\n\n-------------------\n\nFOLLOW-UP - March 22, 2016\nTumor stable. Patient maintaining full-time work.\nAdded: Vitamin D supplementation due to low levels.\nContinue surveillance.\n\n-------------------\n\nFOLLOW-UP - March 15, 2017\nNo significant changes. Patient lost 15 pounds.\nBMI improved to 30.8\nContinue annual monitoring.\n\n-------------------\n\nFOLLOW-UP - March 20, 2018\nSlight increase in tumor size (0.3cm growth).\nSymptoms stable. Discussing radiation therapy options but patient prefers continued observation.\n\n-------------------\n\nFOLLOW-UP - March 12, 2019\nTumor stable. Patient maintaining good functional status.\nBP well-controlled. Weight stable.\n\n-------------------\n\nFOLLOW-UP - March 17, 2020\nVirtual visit due to COVID-19 pandemic.\nNo new symptoms. Continue annual imaging.\n\n-------------------\n\nFOLLOW-UP - March 15, 2021\nMinimal growth (0.2cm). Total size now 3.5cm.\nDiscussing treatment options but maintaining conservative approach given stable symptoms.\n\n-------------------\n\nFOLLOW-UP - March 14, 2022\nNo significant changes. Patient comfortable with management plan.\nAdded: Balance therapy exercises.\n\n-------------------\n\nLATEST FOLLOW-UP - March 16, 2023\nTumor stable for past year.\nPatient maintaining good quality of life.\nContinue annual surveillance.\n\n-------------------\n\nMOST RECENT VISIT - February 20, 2024\n10-year follow-up milestone.\nTumor showed slow growth over decade (total 0.7cm) but patient maintained excellent functional status.\nConservative management approach successful.\n\nFUNCTIONAL STATUS SCORES:\nKarnofsky Performance Status (KPS): 90\n- Able to carry on normal activity with minor symptoms\n\nECOG Performance Status: 1\n- Restricted in physically strenuous activity but ambulatory and able to carry out light work\n\nRECOMMENDATIONS:\nContinue annual MRI surveillance\nMaintain current medical management\nRegular ophthalmology follow-up\nContinue weight management efforts\n\nNote: Conservative management strategy has proven successful over 10-year period with preservation of quality of life and minimal intervention required."
      }
    },
    {
      "demographics": {
        "age": 65,
        "gender": "Female",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty finding right words",
          "Mild right-sided facial numbness",
          "Balance difficulties when walking, especially in dim lighting",
          "Increased fatigue and difficulty concentrating at work",
          "One episode of focal seizure affecting right hand 2 weeks ago"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches in 30s-40s, resolved spontaneously",
          "Surgical removal of benign breast lump in 2010",
          "Osteoarthritis in both knees - managed with NSAIDs",
          "Family history of breast cancer (mother)",
          "No history of smoking",
          "Regular mammograms, last one normal 8 months ago",
          "Post-menopausal since age 52"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 65\nGender: Female\nBlood Type: B\nOccupation: Software Developer\n\nINITIAL VISIT - March 15, 2014\nPresenting Symptoms: Multiple concerning neurological symptoms including progressive headaches, right-sided visual disturbance, cognitive changes, facial numbness, and recent focal seizure. Symptoms significantly impacting work performance.\n\nMRI Findings:\n- 4.2 cm left frontal parasagittal meningioma\n- Significant peritumoral edema\n- Mass effect on superior sagittal sinus\n- Evidence of cortical compression\nWHO Grade: II (atypical features on imaging)\n\nAssessment:\nHigh-risk features present:\n- Size >3cm\n- Significant peritumoral edema\n- Critical location near motor strip\n- Progressive neurological symptoms\n- Impact on professional function\n\nPlan:\n1. Urgent surgical intervention recommended within 2 weeks\n2. Pre-operative optimization with dexamethasone 4mg QID\n3. Advanced surgical planning with functional MRI and DTI\n4. Discussed risks/benefits with patient\n\nSURGICAL NOTE - March 29, 2014\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade: II\nComplications: None\nPathology: WHO Grade II meningioma confirmed\n\nFOLLOW-UP VISIT - May 15, 2014\nPost-operative recovery proceeding well\nResidual tumor: Small residual along sinus (5mm)\nRecommended adjuvant radiation therapy\n\nRADIATION ONCOLOGY - June-July 2014\nCompleted fractionated RT: 60 Gy in 30 fractions\n\nFOLLOW-UP VISITS:\nDecember 2014: Stable, returned to work part-time\nJune 2015: MRI stable, working full-time\nDecember 2015: Minor enhancement at surgical site\nJune 2016: Stable imaging\nDecember 2016: New small enhancement noted\nMarch 2017: Gamma Knife to residual (16 Gy)\n\nANNUAL VISITS 2018-2020:\n- Quarterly MRIs showing stability\n- Maintained work schedule\n- Minor fatigue managed with lifestyle modifications\n- No recurrence of seizures\n\n2021-2024:\n- Biannual MRI surveillance\n- Last scan (January 2024): Stable disease\n- Continues full-time work with accommodations\n- Annual neuropsychological testing\n- Maintained on anticonvulsant prophylaxis\n\nCurrent Status (2024):\n- Disease stable\n- Independent in ADLs\n- Working full-time with minimal restrictions\n- Regular exercise program\n- Cognitive function preserved\n\nFunctional Status Scores:\nKPS: 90 (Able to carry on normal activity, minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nFollow-up Plan:\n1. Continue biannual MRI surveillance\n2. Annual neuropsychological assessment\n3. Maintain anticonvulsant therapy\n4. Regular monitoring of visual fields\n5. Occupational therapy as needed for computer work ergonomics\n\nNote: Proactive intervention strategy with early surgery and adjuvant radiation has resulted in excellent disease control and maintained professional functionality over 10-year period.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 65\nGender: Female\nBlood Type: B\nOccupation: Software Developer\n\nINITIAL VISIT - January 15, 2018\nPresenting Symptoms: Progressive neurological symptoms including headaches, visual disturbance, focal seizure, and cognitive changes raise significant concern. MRI reveals a 2.8cm left frontal convexity meningioma with moderate peritumoral edema.\n\nAssessment:\n- WHO Grade I meningioma (radiological features consistent)\n- Symptomatic presentation requiring intervention\n- KPS: 80/100\n- ECOG: 1\n\nPlan: Given patient's cognitive-demanding occupation and progressive symptoms, surgical intervention is indicated but patient prefers conservative approach initially.\n1. Start Dexamethasone 4mg BID for edema\n2. Levetiracetam 500mg BID for seizure prophylaxis\n3. Monthly clinical monitoring\n4. Occupational therapy referral for workplace adaptations\n\nFOLLOW-UP - March 30, 2018\nSymptoms improved with medical management:\n- Headaches reduced\n- Vision stable\n- No further seizures\nContinuing conservative management with close monitoring.\n\nFOLLOW-UP - September 15, 2018\nMRI shows stable tumor size\nSymptoms well-controlled\nReduced dexamethasone to 2mg BID\n\nANNUAL REVIEW - January 20, 2019\nStable disease\nPatient maintaining work with accommodations\nKPS: 85/100\nECOG: 1\n\nFOLLOW-UP - January 10, 2020\nMRI: Minor growth (3.0cm)\nSymptoms stable\nMaintaining conservative approach\nAdded memantine for cognitive support\n\nFOLLOW-UP - January 15, 2021\nStable disease\nPatient working part-time\nKPS: 80/100\nECOG: 1\n\nFOLLOW-UP - February 1, 2022\nMRI: Tumor growth to 3.3cm\nIncreasing symptoms\nDecision made for stereotactic radiosurgery (SRS)\nCompleted SRS in March 2022\n\nFOLLOW-UP - August 15, 2022\nPost-SRS course uncomplicated\nSymptoms improving\nWorking remotely full-time\n\nANNUAL REVIEW - January 10, 2023\nMRI: Tumor stable post-SRS\nSymptoms well-controlled\nKPS: 90/100\nECOG: 0\n\nLATEST FOLLOW-UP - January 5, 2024\nStable disease\nMaintaining good quality of life\nWorking successfully with accommodations\nRegular cognitive assessments stable\nKPS: 90/100\nECOG: 0\n\nMANAGEMENT SUMMARY:\nConservative approach with eventual SRS when indicated\nSuccessfully maintained cognitive function and work capability\nRegular monitoring continues\n\nCurrent Status:\nKPS (Karnofsky Performance Status): 90/100\nECOG Performance Status: 0\n\nNext Follow-up: Scheduled for July 2024 with MRI"
      }
    },
    {
      "demographics": {
        "age": 62,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of confusion and difficulty concentrating at work",
          "Occasional balance issues when walking",
          "Mild right-sided facial numbness that developed over last 2 months",
          "Reports increased irritability noticed by family members",
          "Two episodes of nausea and vomiting in past month, unrelated to food"
        ],
        "medical_history": [
          "Hypertension - diagnosed 8 years ago, managed with lisinopril",
          "BMI 33.2 - Class I Obesity",
          "Mild sleep apnea diagnosed 3 years ago, uses CPAP",
          "History of migraine headaches in 30s, resolved spontaneously",
          "Underwent surgery for herniated disc L4-L5 in 2015",
          "Family history of cardiovascular disease",
          "No history of cancer",
          "No significant head trauma",
          "Current medications: lisinopril 20mg daily, multivitamin"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 62\nGender: Male\nOccupation: Data Scientist\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms including headaches and visual disturbances\n\nIMAGING:\nInitial MRI reveals a 4.2 cm right frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe with 5mm midline shift. T2 hyperintense with heterogeneous enhancement. No calcification noted.\n\nASSESSMENT:\nWHO Grade II Meningioma (confirmed post-surgical pathology)\nHigh-risk features:\n- Size >3cm\n- Significant peritumoral edema\n- Proximity to critical structures\n- Impact on professional cognitive function\n\nTREATMENT PLAN:\nRecommend immediate surgical intervention due to:\n1. Symptomatic presentation\n2. Size and location\n3. Cognitive demands of patient's occupation\n4. Progressive neurological symptoms\n\nSURGICAL INTERVENTION - April 2, 2014\n- Simpson Grade II resection performed\n- Post-op MRI shows near-total resection\n- Minimal residual tumor along superior sagittal sinus\n\nFOLLOW-UP VISITS:\n\nOctober 2014 (6-month):\n- Improved headaches and vision\n- MRI shows post-surgical changes\n- Initiated adjuvant radiotherapy (60 Gy/30 fractions)\n- Return to work with modifications\n\nApril 2015 (1-year):\n- Stable neurological exam\n- MRI shows no progression\n- Managing hypertension well\n- Weight management program initiated\n\nOctober 2015:\n- Surveillance MRI stable\n- Cognitive function improved\n- Return to full-time work\n\nApril 2016:\n- Small area of enhancement noted\n- Close monitoring recommended\n- Increased scan frequency\n\nOctober 2016:\n- Growth in residual tumor\n- Decision for focused SRS to residual\n- 16 Gy single fraction delivered\n\n2017-2019 (Biannual visits):\n- Serial MRIs show stable disease\n- Regular cognitive assessments\n- Weight fluctuations addressed\n- Sleep apnea optimization\n\n2020-2022 (Annual visits):\n- Continued stability\n- Minor radiation changes on imaging\n- Maintained professional activities\n- Regular BP monitoring\n\n2023-2024:\n- 10-year follow-up\n- No evidence of progression\n- Annual MRI surveillance continued\n- Cognitive function preserved\n\nCURRENT STATUS (2024):\n- Disease stable\n- Maintaining professional work\n- Well-controlled hypertension\n- Improved BMI to 31.4\n\nPerformance Status Scores:\nKPS: 90 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nMONITORING PROTOCOL:\n- MRI every 6 months\n- Quarterly neurocognitive assessments\n- Regular ophthalmological exams\n- BP monitoring\n- Sleep study updates annually\n\nNote: Aggressive intervention strategy was warranted given:\n1. Professional cognitive demands\n2. Progressive symptoms\n3. Tumor characteristics\n4. Patient's overall good health status\n\nNext appointment: August 2024\nContinue current surveillance protocol\n\n/Signed by: Dr. [REDACTED]\nBoard Certified Neurosurgeon\nDate: February 15, 2024",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 62-year-old male, Data Scientist\nWHO Grade: II (based on imaging characteristics)\nBlood Type: O\nBMI: 33.2\n\nPRESENTING SYMPTOMS:\nProgressive constellation of symptoms including morning headaches, right-sided visual disturbance, cognitive changes, balance issues, and facial numbness, suggesting mass effect.\n\nIMAGING:\nMRI reveals a 3.2cm right frontal convexity meningioma with moderate peritumoral edema. Enhancement pattern and dural tail sign present. Mass effect on adjacent frontal lobe with minimal midline shift (3mm).\n\nASSESSMENT & PLAN:\nGiven patient's occupation requiring cognitive precision, symptoms warrant attention. However, considering comorbidities (hypertension, obesity, sleep apnea), recommending conservative initial approach with close monitoring.\n\nRECOMMENDATIONS:\n1. Dexamethasone 4mg BID for edema management\n2. Monthly clinical evaluations for first 3 months\n3. Ophthalmology referral for baseline visual assessment\n4. Continue CPAP compliance\n5. BP monitoring\n\nFOLLOW-UP VISIT - June 20, 2018\nSymptoms partially improved with steroid therapy. Visual symptoms stable.\nMRI: No significant change in tumor size.\nPlan: Taper dexamethasone, continue monitoring.\n\nANNUAL FOLLOW-UP - March 2019\nStable symptoms. Working full-time with accommodations.\nMRI: Minimal growth (0.2cm in maximum diameter)\nMaintained on reduced steroid dose.\n\nANNUAL FOLLOW-UP - March 2020\nMinor symptom progression.\nMRI: Tumor size 3.5cm\nDiscussed surgical options but patient prefers conservative management.\nIncreased steroid dose temporarily.\n\nANNUAL FOLLOW-UP - March 2021\nStable clinical picture.\nMRI: No significant change\nManaging work with flexible hours.\nImplemented cognitive rehabilitation strategies.\n\nANNUAL FOLLOW-UP - March 2022\nSome improvement in balance issues.\nMRI: Stable size\nMaintaining good quality of life with current management.\n\nANNUAL FOLLOW-UP - March 2023\nMild symptom progression but manageable.\nMRI: Minimal growth (3.6cm)\nContinuing conservative approach with close monitoring.\n\nLATEST FOLLOW-UP - January 2024\nStatus largely unchanged.\nMRI: Stable compared to previous\nMaintaining work-life balance with accommodations.\n\nCURRENT MANAGEMENT:\n- Low-dose dexamethasone (2mg daily)\n- Regular ophthalmology follow-up\n- Cognitive rehabilitation exercises\n- Ergonomic workplace modifications\n- Regular physical therapy for balance\n- Sleep hygiene optimization\n\nFUNCTIONAL STATUS:\nKPS Score: 80 (Able to perform normal activity with effort)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nMONITORING PLAN:\n- Bi-annual MRI\n- Quarterly clinical evaluations\n- Annual neuropsychological assessment\n- Regular ophthalmology follow-up\n- Monthly BP monitoring\n\nNote: Conservative management has provided stable disease control while maintaining patient's quality of life and ability to work. Will continue close monitoring with low threshold for intervention if significant progression occurs."
      }
    },
    {
      "demographics": {
        "age": 66,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty finding words",
          "Subtle personality changes noted by spouse - increased irritability",
          "Balance difficulties when walking, particularly in dim lighting",
          "Mild right-sided facial numbness",
          "Two episodes of nausea and vomiting in past month, unrelated to food"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Hypercholesterolemia - managed with atorvastatin 20mg daily",
          "Mild hearing loss in left ear - diagnosed 3 years ago",
          "Appendectomy (1985)",
          "No history of cancer",
          "No prior neurological conditions",
          "Family history: Father had stroke at age 72",
          "Non-smoker, occasional alcohol use (2-3 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n66-year-old male, Blood Type A\nOccupation: Financial Analyst\n\nINITIAL VISIT - March 15, 2014\nPresenting Symptoms: Progressive headaches, right eye vision changes, cognitive concerns, balance issues, facial numbness, and intermittent nausea/vomiting. Symptoms significantly impacting work performance as Financial Analyst.\n\nMRI Findings:\n- 4.2cm right frontal parasagittal meningioma\n- Significant peritumoral edema\n- Mass effect on superior sagittal sinus\n- WHO Grade II features suspected\n- Evidence of brain parenchyma compression\n\nTreatment Plan:\nRecommend immediate surgical intervention due to:\n1. Size >3cm\n2. Symptomatic presentation\n3. Critical location\n4. Impact on cognitive function essential for occupation\n\nSURGICAL NOTES - April 2, 2014\n- Simpson Grade II resection performed\n- Pathology confirms WHO Grade II meningioma\n- Minor residual tumor along sinus interface\n- Post-op imaging shows >95% resection\n\nFOLLOW-UP VISITS:\n\nJuly 2014 (3 months post-op):\n- Improved headaches and vision\n- Starting adjuvant radiation therapy\n- 54 Gy in 30 fractions planned\n\nJanuary 2015 (9 months post-op):\n- Complete radiation course finished\n- Minimal residual symptoms\n- MRI shows stable residual\n- Returned to work part-time\n\nJune 2015:\n- Full return to work\n- Surveillance MRI stable\n- Minor fatigue persists\n\nDecember 2015:\n- MRI stable\n- No new symptoms\n- Maintaining work schedule\n\n2016-2017 (q4 month monitoring):\n- Serial MRIs stable\n- Cognitive function normal\n- Working full capacity\n\n2018 (concerning finding):\n- Small growth in residual tumor\n- 5mm increase over 6 months\n- Recommend SRS to residual\n\nMarch 2019:\n- Post-SRS MRI stable\n- No new symptoms\n- Continuing q4 month monitoring\n\n2020-2022:\n- Annual MRIs stable\n- No recurrence\n- Maintaining normal work/life\n\n2023-2024:\n- Biannual monitoring\n- Disease stable\n- Regular cognitive assessments normal\n\nCurrent Status (2024):\n- Disease controlled\n- Full functional status\n- Continuing surveillance\n\nFunctional Status Scores:\nKPS: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nFollow-up Plan:\n- Continue biannual MRI\n- Annual neuropsychological testing\n- Monitor for any new symptoms\n- Regular quality of life assessments\n\nNote: Aggressive initial approach and careful monitoring have allowed patient to maintain professional activities with minimal interruption. Continue vigilant surveillance due to WHO Grade II status.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\n\nINITIAL VISIT - March 15, 2018\nPatient: 66-year-old male, Financial Analyst\nWHO Grade: I (based on imaging characteristics)\n\nIMAGING FINDINGS:\nMRI reveals a 2.8cm right frontal convexity meningioma with minimal surrounding edema. No significant mass effect on adjacent structures. T2 sequence shows moderate signal intensity.\n\nASSESSMENT:\nDespite presenting symptoms suggesting mass effect, patient's professional role and overall stable condition favor an initial conservative approach. Symptoms are currently manageable and not severely impacting daily function.\n\nPLAN:\n1. Close monitoring with serial imaging\n2. Medical management of symptoms:\n   - Dexamethasone 4mg BID for edema control\n   - Gradual taper over 2 weeks\n   - Levetiracetam 500mg BID prophylactically\n\nFOLLOW-UP: 3 months\n\n-------------------\n\nFOLLOW-UP VISIT - June 20, 2018\nSymptoms improved with medical management. Headaches reduced, vision stable.\nMRI: No significant change in tumor size.\nPlan: Continue conservative management\nNext follow-up: 6 months\n\n-------------------\n\nFOLLOW-UP VISIT - December 12, 2018\nStable symptoms. Maintaining work schedule with minor accommodations.\nMRI: Stable lesion size, minimal edema\nPlan: Annual MRI if remains stable\nNext follow-up: 12 months\n\n-------------------\n\nANNUAL FOLLOW-UP - December 15, 2019\nMinor progression of right-sided facial numbness.\nMRI: 2.9cm tumor, minimal growth\nPlan: Continue observation, added gabapentin 300mg TID for facial numbness\nNext follow-up: 6 months\n\n-------------------\n\nFOLLOW-UP VISIT - June 18, 2020\nStable symptoms with gabapentin\nMRI: No significant change\nPlan: Maintain current management\nNext follow-up: 12 months\n\n-------------------\n\nANNUAL FOLLOW-UP - June 22, 2021\nReports improved work-life balance with remote work option\nMRI: Stable at 2.9cm\nPlan: Continue conservative management\nNext follow-up: 12 months\n\n-------------------\n\nANNUAL FOLLOW-UP - July 5, 2022\nMinor increase in morning headaches\nMRI: 3.0cm, slight increase in peritumoral edema\nPlan: Increased dexamethasone temporarily, then tapered\nNext follow-up: 6 months\n\n-------------------\n\nFOLLOW-UP VISIT - January 12, 2023\nSymptoms stable with medication adjustment\nMRI: No further growth\nPlan: Continue current management\nNext follow-up: 12 months\n\n-------------------\n\nRECENT FOLLOW-UP - January 15, 2024\nMaintaining good quality of life, continues working\nMRI: Stable at 3.0cm\nPlan: Continue conservative management with annual imaging\n\nCURRENT FUNCTIONAL STATUS:\nKPS Score: 90 (Able to carry on normal activity with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nSUMMARY:\nConservative management has proven successful over 6-year period. Patient maintains professional activities with good quality of life. Minimal tumor growth (0.2cm over 6 years) justifies continued watchful waiting approach."
      }
    },
    {
      "demographics": {
        "age": 49,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of right-sided facial numbness",
          "Occasional balance difficulties when walking",
          "Mild personality changes noted by spouse - increased irritability",
          "Two episodes of nausea and vomiting in past month, unrelated to food"
        ],
        "medical_history": [
          "Hypertension - diagnosed 5 years ago, controlled with lisinopril",
          "Mild concussion from sports injury 15 years ago, fully recovered",
          "Appendectomy at age 23",
          "No history of cancer",
          "No seizures",
          "Family history: Mother had breast cancer at age 65",
          "Non-smoker",
          "Social alcohol use (2-3 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nGender: Male | Age: 49\n\nINITIAL VISIT - January 15, 2018\nChief Complaint: Progressive headaches, visual changes, facial numbness\n\nIMAGING:\nMRI reveals 4.2cm right sphenoid wing meningioma with significant peritumoral edema\n- Mass effect on right temporal lobe\n- Compression of right optic nerve\n- Enhancement pattern suggestive of WHO Grade II\n- Evidence of dural tail sign\n- Minimal calcification\n\nASSESSMENT:\nGiven size >3cm, critical location, and progressive neurological symptoms, immediate surgical intervention recommended. Patient's relatively young age and good health status favor aggressive treatment approach.\n\nPLAN:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative optimization of blood pressure\n3. Ophthalmology consult\n4. Neuropsychological evaluation\nWHO Grade: Suspected Grade II\n\n-------------------\n\nPOST-OPERATIVE NOTE - February 1, 2018\nProcedure: Right frontotemporal craniotomy for tumor resection\n- Simpson Grade II resection achieved\n- Minor residual tumor at cavernous sinus (<5%)\nPathology: WHO Grade II meningioma confirmed\n- Elevated MIB-1 index (8%)\n- Increased mitotic activity\n\n-------------------\n\nFOLLOW-UP - August 1, 2018 (6 months post-op)\nSymptoms: Significant improvement in headaches and vision\nMRI: Small residual enhancement at cavernous sinus\nPlan: Adjuvant radiotherapy recommended\n- Started fractionated RT (54 Gy/30 fractions)\n\n-------------------\n\nFOLLOW-UP - February 1, 2019 (1 year post-op)\nSymptoms: Stable\nMRI: No progression of residual tumor\nPlan: Continue q6month monitoring\n\n-------------------\n\nFOLLOW-UP - February 1, 2020 (2 years post-op)\nSymptoms: New onset occasional headaches\nMRI: Small increase in enhancement at surgical site\nPlan: Increased monitoring frequency to q4months\n\n-------------------\n\nFOLLOW-UP - March 15, 2021 (3 years post-op)\nSymptoms: Stable\nMRI: Stable disease\nPlan: Continue monitoring\n\n-------------------\n\nFOLLOW-UP - April 1, 2022 (4 years post-op)\nSymptoms: Mild right-sided facial numbness\nMRI: 1cm progression at cavernous sinus margin\nPlan: Gamma Knife radiosurgery to residual tumor (16 Gy)\n\n-------------------\n\nFOLLOW-UP - May 1, 2023 (5 years post-op)\nSymptoms: Improved facial sensation\nMRI: Decreased enhancement post-radiosurgery\nPlan: Continue q6month monitoring\n\n-------------------\n\nCURRENT VISIT - January 15, 2024 (6 years post-op)\nSymptoms: Stable\nMRI: No evidence of progression\nPlan: Continue surveillance imaging q6months\n\nFUNCTIONAL STATUS:\nKarnofsky Performance Status (KPS): 90%\n- Able to carry on normal activity with minor symptoms\n\nECOG Performance Status: 1\n- Restricted in physically strenuous activity but ambulatory\n\nOCCUPATIONAL IMPACT:\nPatient has maintained full-time employment as software engineer\nRecommended workplace accommodations:\n- Regular screen breaks\n- Proper lighting adjustments\n- Ergonomic workstation setup\n\nLONG-TERM MONITORING PLAN:\n1. Continue q6month MRI surveillance\n2. Annual ophthalmological evaluation\n3. Regular neuropsychological assessment\n4. BP monitoring every 3 months\n\nWHO Grade: II (Maintained throughout course)",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nGender: Male\nAge at Initial Presentation: 49\n\nINITIAL VISIT - January 15, 2014\nChief Complaint: Progressive headaches, visual changes, facial numbness\n\nIMAGING:\nMRI reveals a 2.8cm right sphenoid wing meningioma with minimal peritumoral edema.\nWHO Grade: I (presumptive radiological diagnosis)\nLocation: Right sphenoid wing with mild mass effect on temporal lobe\n\nASSESSMENT & PLAN:\nGiven the patient's stable employment, controlled hypertension, and relatively small tumor size, recommending conservative management with close monitoring. Patient agreeable to watchful waiting approach.\n\nInitial KPS: 90\nInitial ECOG: 1\n\nFOLLOW-UP VISITS:\n\nJuly 15, 2014 (6-month):\n- Headaches improved with prophylactic topiramate 50mg daily\n- Vision stable\n- MRI: No significant change in tumor size\n- Continue current management\n\nJanuary 20, 2015 (1-year):\n- Stable symptoms\n- MRI: Minimal growth (0.2mm)\n- Added memantine 10mg for cognitive protection\n- Continue monitoring\n\nJanuary 12, 2016 (2-year):\n- Well-controlled symptoms\n- MRI: No significant change\n- Maintaining work schedule with minor accommodations\n- Continue current medications\n\nJanuary 17, 2017 (3-year):\n- Reports improved balance\n- MRI: Stable lesion size\n- Reduced topiramate to 25mg daily due to good response\n\nJanuary 15, 2018 (4-year):\n- Stable neurological exam\n- MRI: No progression\n- Quality of life maintained\n- Continue conservative approach\n\nJanuary 22, 2019 (5-year):\n- Minor headache episodes, well-managed\n- MRI: Stable appearance\n- Transition to biennial imaging recommended\n\nJanuary 20, 2021 (7-year):\n- Stable symptoms\n- MRI: No significant change\n- Maintaining good functional status\n- Continue current management\n\nJanuary 18, 2023 (9-year):\n- Well-controlled symptoms\n- MRI: Stable lesion\n- Patient satisfied with conservative approach\n\nCurrent Visit - January 15, 2024 (10-year):\n- Maintains excellent functional status\n- MRI: No significant change over 10 years\n- Conservative management successful\n\nCURRENT MEDICATIONS:\n1. Topiramate 25mg daily\n2. Memantine 10mg daily\n3. Lisinopril 20mg daily\n\nMONITORING RECOMMENDATIONS:\n- Continue biennial MRI\n- Annual neurological examinations\n- Regular ophthalmology follow-up\n- Blood pressure monitoring\n\nCurrent KPS: 90\nCurrent ECOG: 1\n\nMANAGEMENT SUCCESS FACTORS:\n1. Patient compliance with monitoring\n2. Stable tumor characteristics\n3. Well-controlled symptoms\n4. Maintained quality of life\n5. Successful occupational adaptation\n\nThe conservative management approach has proven successful over 10 years with stable disease and good quality of life preservation. Continue current monitoring schedule unless new symptoms develop."
      }
    },
    {
      "demographics": {
        "age": 58,
        "gender": "Female",
        "blood_type": "AB",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of dizziness and mild balance issues",
          "Occasional nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Right-sided facial numbness that developed gradually over 2 months",
          "Difficulty concentrating at work, especially when reading"
        ],
        "medical_history": [
          "Hypertension - diagnosed 8 years ago, managed with lisinopril",
          "Migraine headaches since age 35, but pattern has changed recently",
          "BMI 33.2 - Class I Obesity",
          "Surgical history: Cholecystectomy (2012)",
          "Family history: Mother had breast cancer",
          "No history of head trauma or radiation exposure",
          "Current medications: Lisinopril 10mg daily, multivitamin",
          "No smoking history",
          "Regular mammograms, last one normal 8 months ago"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F58-AB\nOccupation: Librarian\nPrimary Diagnosis: Meningioma\n\nINITIAL VISIT - March 15, 2014\nMRI FINDINGS:\n- 4.2 cm right sphenoid wing meningioma\n- Significant mass effect on temporal lobe\n- Moderate peritumoral edema\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Evidence of compression of optic apparatus\n\nASSESSMENT:\nPatient presents with concerning neurological symptoms indicating progressive disease. Occupation requires significant cognitive function and visual acuity. Size and location of tumor warrant immediate intervention.\n\nPLAN:\n1. Scheduled for surgical resection within 2 weeks\n2. Pre-operative optimization with neurology for headache management\n3. Occupational impact assessment\nWHO Grade: II (preliminary based on imaging characteristics)\n\nSURGICAL NOTE - April 1, 2014\n- Simpson Grade II resection achieved\n- Minor residual tumor along cavernous sinus\n- Pathology confirms WHO Grade II meningioma\n- No immediate post-operative complications\n\nFOLLOW-UP VISIT - July 15, 2014\n- Improved vision and headaches\n- Started adjuvant radiation therapy\n- 54 Gy in 30 fractions completed\n- Return to work discussion initiated\n\nANNUAL FOLLOW-UP - April 2015\n- Stable MRI findings\n- Minor residual enhancement\n- Returned to work part-time\n- Continuing rehabilitation exercises\n\nFOLLOW-UP - October 2015\n- MRI shows no progression\n- Visual symptoms stable\n- Working full-time with accommodations\n\nBIANNUAL FOLLOW-UP - April 2016\n- Small area of enhancement noted\n- Close monitoring recommended\n- Maintaining work schedule\n\nFOLLOW-UP - October 2016\n- Slight progression of residual tumor\n- Gamma Knife radiosurgery scheduled\n- 16 Gy to residual tumor\n\nANNUAL FOLLOW-UP - April 2017\n- Post-radiosurgery changes as expected\n- Stable neurological exam\n- Continuing work with modifications\n\n2018-2020 (Biannual Visits):\n- Stable disease\n- Regular MRI monitoring\n- Minor headaches managed with medication\n- Maintaining work schedule\n\n2021-2023 (Annual Visits):\n- No tumor progression\n- Stable neurological status\n- Regular cognitive assessments\n- Continued work accommodation\n\nLATEST FOLLOW-UP - January 2024\n- 10-year follow-up milestone\n- MRI shows stable disease\n- Patient maintains good functional status\n- Continues working with accommodations\n\nCURRENT STATUS:\nKPS Score: 90 (Able to carry on normal activity with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nONGOING MANAGEMENT:\n1. Annual MRI surveillance\n2. Regular cognitive assessment\n3. Blood pressure monitoring\n4. Weight management program\n5. Occupational therapy as needed\n\nNote: Proactive intervention strategy with early surgical resection and adjuvant radiation therapy has resulted in good long-term control of disease while maintaining patient's professional functionality.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: AB\nOccupation: Librarian\nWHO Grade: I (confirmed via imaging characteristics)\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms with right-sided predominance\n\nImaging Findings:\n- MRI reveals 2.4cm right frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- T2 signal: moderately intense\n- Contrast enhancement: homogeneous\n\nAssessment:\nDespite symptomatic presentation, given the moderate size and patient factors, recommending close monitoring with option for intervention if progression occurs.\n\nManagement Plan:\n1. Conservative approach with vigilant monitoring\n2. Medical management of symptoms:\n   - Dexamethasone 4mg BID for 2 weeks, then taper\n   - Continue lisinopril 10mg daily\n   - Prophylactic anticonvulsant not indicated at this time\n\nFOLLOW-UP VISIT - September 20, 2014 (6 months)\n- Symptoms partially improved with steroid therapy\n- MRI: No significant change in tumor size\n- Visual symptoms stable\n- Headaches improved with medication adjustment\n\nANNUAL FOLLOW-UP - March 2015\n- MRI: Stable lesion size\n- Improved symptom control\n- Patient able to continue work with accommodations\n- Recommended ergonomic assessment at workplace\n\nFOLLOW-UP - March 2016\n- MRI: Minimal growth (0.2cm)\n- Symptoms stable\n- Maintaining conservative approach\n- Added prophylactic migraine medication\n\nFOLLOW-UP - March 2017\n- MRI: No additional growth\n- Patient well-adapted to condition\n- Maintaining work schedule with breaks\n- Added occupational therapy for balance exercises\n\nFOLLOW-UP - March 2018\n- MRI: Stable appearance\n- Quality of life maintained\n- Regular exercise program initiated\n- Weight management program discussed\n\nFOLLOW-UP - March 2020\n- Telemedicine visit due to COVID-19\n- Previous MRI comparison shows stability\n- Symptoms well-controlled\n- Added virtual support group participation\n\nFOLLOW-UP - March 2022\n- MRI: Minor progression (2.8cm)\n- Symptoms stable\n- Discussing potential future intervention options\n- Maintaining conservative approach for now\n\nCURRENT VISIT - January 2024\n- MRI: 3.0cm, showing slow progression\n- Symptoms managed but requiring closer monitoring\n- Discussing surgical options while maintaining conservative preference\n- Patient preference for continued observation\n\nFUNCTIONAL STATUS SCORES:\n- Karnofsky Performance Status (KPS): 80\n(Able to perform normal activity with effort, some symptoms)\n- ECOG Performance Status: 1\n(Restricted in physically strenuous activity but ambulatory)\n\nONGOING RECOMMENDATIONS:\n1. Continue MRI monitoring every 6 months\n2. Regular ophthalmological evaluations\n3. Maintain weight management program\n4. Workplace ergonomic modifications\n5. Regular blood pressure monitoring\n6. Quality of life assessments every visit\n7. Consider intervention if:\n   - Tumor growth >5mm/year\n   - Significant symptom progression\n   - New neurological deficits\n\nNote: Conservative management has been successful in maintaining patient's quality of life and occupational function over 10 years, though recent growth warrants closer monitoring."
      }
    },
    {
      "demographics": {
        "age": 57,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work, especially when looking at computer screens",
          "Mild right-sided facial numbness that developed gradually over 2 months",
          "Reports feeling unsteady when walking, particularly in dim lighting"
        ],
        "medical_history": [
          "Hypertension - diagnosed 5 years ago, controlled with lisinopril",
          "Migraine headaches since age 35, but notes current headaches are different",
          "BMI 33.2 - Class I Obesity",
          "Surgical history: Cholecystectomy (2012)",
          "No history of cancer",
          "No previous neurological conditions",
          "Family history significant for breast cancer in mother",
          "Current medications: Lisinopril 10mg daily, multivitamin",
          "No known drug allergies"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F57-O-DS\nPrimary Diagnosis: Meningioma\nWHO Grade: II (Atypical)\n\nINITIAL VISIT - March 15, 2014\nMRI FINDINGS:\n- 4.2 cm right sphenoid wing meningioma\n- Significant mass effect on temporal lobe\n- Moderate peritumoral edema\n- Enhancement pattern suggesting possible atypical features\n- Compression of optic apparatus\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms highly concerning for sphenoid wing meningioma. Occupation as data scientist requires extensive screen time, with symptoms significantly impacting work performance. Given size, location, and symptom progression, immediate surgical intervention recommended.\n\nTREATMENT PLAN:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative optimization of blood pressure\n3. Steroid therapy: Dexamethasone 4mg QID\n4. Prophylactic anticonvulsants\n\nSURGICAL NOTE - April 1, 2014\n- Simpson Grade II resection achieved\n- Subtotal removal due to cavernous sinus involvement\n- Pathology confirms WHO Grade II meningioma\n- No immediate post-operative complications\n\nFOLLOW-UP - July 15, 2014\n- Improved vision and headaches\n- Started adjuvant radiation therapy\n- 54 Gy in 30 fractions completed\n- Return to work with modifications\n\nANNUAL FOLLOW-UP - April 2015\n- Stable residual tumor\n- Minor radiation changes\n- Continuing every 6-month MRI surveillance\n- Return to full work duties\n\n2016-2017 (Bi-annual visits):\n- Stable imaging\n- Occasional headaches managed with medication\n- Regular ophthalmology follow-up\n- Weight management program initiated\n\n2018 SURVEILLANCE - March 15\n- Small increase in residual tumor (5mm)\n- Gamma Knife radiosurgery to residual tumor\n- 14 Gy to tumor margin\n\n2019-2020 (Quarterly visits):\n- Post-radiosurgery response favorable\n- Stable neurological exam\n- Weight reduction achieved (BMI 31.5)\n- Annual cognitive assessments stable\n\n2021 FOLLOW-UP - February 10\n- MRI shows stable disease\n- No new neurological symptoms\n- Maintaining work performance\n- BP well-controlled\n\n2022-2023 (Bi-annual visits):\n- Continued stability\n- Minor radiation-related changes stable\n- Regular cognitive assessments\n- Maintaining modified lifestyle\n\nCURRENT STATUS (2024):\n- 10-year follow-up shows no recurrence\n- Excellent functional status\n- Continues full-time work\n- Regular monitoring plan continues\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nMONITORING PLAN:\n- Continue bi-annual MRI\n- Annual neuropsychological testing\n- Regular ophthalmology follow-up\n- BP monitoring\n- Weight management support\n\nNote: Aggressive initial approach with early surgical intervention and adjuvant therapy has resulted in excellent long-term control. Patient's high-functioning occupation and successful outcome support the proactive treatment strategy employed.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nGender: Female | Age: 57 | Blood Type: O\nOccupation: Data Scientist\n\nINITIAL VISIT - January 15, 2018\nPresenting Symptoms: Progressive headaches, right eye visual disturbance, nausea, personality changes, concentration difficulties, right facial numbness, and gait instability.\n\nMRI Findings:\n- 2.8cm right sphenoid wing meningioma\n- Minimal perilesional edema\n- No significant mass effect\n- WHO Grade I (likely)\n\nAssessment:\nGiven the size (<3cm) and location, recommending close monitoring with consideration for conservative management. Patient's occupation requires significant screen time, which may exacerbate symptoms.\n\nInitial Management Plan:\n1. Watchful waiting with serial imaging\n2. Symptom management:\n   - Prescribed Dexamethasone 4mg daily for edema\n   - Continue Lisinopril 10mg daily\n3. Occupational modifications:\n   - Blue light filters for computer screens\n   - Regular breaks every 45 minutes\n   - Ergonomic workspace assessment\n\nFOLLOW-UP VISITS:\n\nJuly 2018 (6-month):\n- Minimal tumor growth (2.9cm)\n- Headaches improved with steroids\n- Gradually tapering dexamethasone\n- KPS: 90\n\nJanuary 2019 (1-year):\n- Stable tumor size\n- Vision symptoms stable\n- Added prophylactic anticonvulsant\n- MRI scheduled for 6 months\n- KPS: 90\n\nJanuary 2020 (2-year):\n- Tumor stable at 2.9cm\n- Improved headache control\n- Working full-time with accommodations\n- KPS: 90\n\nJanuary 2021 (3-year):\n- No tumor progression\n- Minor balance issues persist\n- Maintaining work schedule\n- Annual MRI recommended\n- KPS: 85\n\nJanuary 2022 (4-year):\n- Stable imaging findings\n- Well-controlled symptoms\n- Regular exercise program initiated\n- Weight management program discussed\n- KPS: 85\n\nJanuary 2023 (5-year):\n- Minimal growth (3.0cm)\n- Symptoms stable\n- Continue conservative management\n- Biennial MRI recommended\n- KPS: 85\n\nJanuary 2024 (6-year):\n- Tumor stable\n- Good quality of life maintained\n- Continuing work with accommodations\n- Next MRI scheduled for 2026\n- KPS: 85\n\nCurrent Status:\n- Conservative management successful\n- Stable disease\n- Well-maintained quality of life\n- Continuing professional activities\n\nPerformance Status Scores:\n- Karnofsky Performance Status (KPS): 85/100\n- ECOG Performance Status: 1\n\nRecommendations:\n1. Continue biennial MRI surveillance\n2. Maintain current medication regimen\n3. Regular neurology reviews\n4. Annual ophthalmology assessment\n5. Continue occupational accommodations\n6. Weight management program\n7. Regular exercise routine\n\nConservative management has proven effective with stable disease and good quality of life. Patient has maintained professional activities with appropriate accommodations. Will continue monitoring with adjusted imaging intervals unless clinical status changes.\n\nNext appointment: January 2026 (with interim neurology reviews)\n\n[Electronically signed]\nDr. [REDACTED]\nNeurosurgery Department"
      }
    },
    {
      "demographics": {
        "age": 56,
        "gender": "Female",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": true,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 3 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea, particularly in morning (initially attributed to pregnancy)",
          "Subtle personality changes noted by family - increased irritability",
          "Right-sided facial numbness developing over past 6 weeks",
          "Balance difficulties when walking, particularly in dimly lit areas",
          "Occasional tinnitus in right ear"
        ],
        "medical_history": [
          "BMI 33.2 (Class I Obesity)",
          "Currently 24 weeks pregnant with second child",
          "History of migraine headaches, but notes current headaches are different",
          "Surgical removal of ovarian cyst 5 years ago",
          "Family history of breast cancer (maternal aunt)",
          "Previous pregnancy without complications 4 years ago",
          "No history of radiation exposure",
          "Taking prenatal vitamins and occasional acetaminophen for headaches",
          "No prior neurological conditions"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Coordinated care with obstetrics",
            "Timing surgery for second trimester if possible"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nGender: Female | Age: 56 | Blood Type: B\nWHO Grade: II (Atypical Meningioma)\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive neurological symptoms during pregnancy (24 weeks gestation)\nMRI Findings:\n- 4.2cm right sphenoid wing meningioma\n- Significant mass effect with 8mm midline shift\n- Moderate peritumoral edema\n- Compression of right optic nerve\nAssessment: Given size, location, and progressive symptoms, immediate intervention warranted despite pregnancy.\nPlan: \n- Urgent neurosurgical intervention recommended post-fetal viability\n- Coordinated care with high-risk OB\n- Dexamethasone 4mg q6h initiated with close monitoring\n\nSURGICAL NOTE - April 2, 2018 (28 weeks gestation)\nProcedure: Right frontotemporal craniotomy for tumor resection\n- Simpson Grade II resection achieved\n- Fetal monitoring throughout procedure\n- No surgical complications\nPathology: WHO Grade II meningioma with increased mitotic activity\n\nPOST-OP FOLLOW-UP - April 30, 2018\n- Excellent wound healing\n- Visual symptoms improving\n- Headaches resolved\n- Continuing pregnancy monitoring\nPlan: Adjuvant radiation recommended post-delivery\n\nFOLLOW-UP - September 15, 2018\nStatus: Post successful C-section delivery\nPlan: Initiated fractionated RT (54 Gy/30 fx)\n\nANNUAL FOLLOW-UP - March 2019\nMRI: No evidence of recurrence\nSymptoms: Complete resolution of presenting symptoms\nPlan: Continue q4 month MRI surveillance\n\n2020 (Q1, Q2, Q3, Q4 visits):\n- Serial MRIs stable\n- Maintained neurological improvement\n- Minor radiation-related changes stable\n\n2021 (Biannual visits):\n- June: Small enhancement noted at surgical site\n- December: Enhancement stable, continued monitoring\n\n2022 (Biannual visits):\n- All MRIs stable\n- Neurologically intact\n- Weight management program initiated\n\n2023 (Biannual visits):\n- Continued stability\n- No new neurological symptoms\n- Regular exercise program maintained\n\n2024 (Most recent - January):\nMRI: Stable post-treatment changes\nNeurological exam: Normal\nWeight: BMI improved to 31.4\n\nCurrent Status:\nKPS Score: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nMONITORING PROTOCOL:\n- MRI every 6 months (Grade II protocol)\n- Neurological examination quarterly\n- Annual ophthalmological assessment\n- Regular cognitive function testing\n\nLong-term Prognosis: Favorable with continued surveillance\nNext appointment: July 2024 for routine follow-up and imaging\n\n/Signed by: [Attending Neurosurgeon]\nDate: January 15, 2024\nTime: 14:30",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nFemale, 56 years old, Blood Type: B\nWHO Grade I Meningioma\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive neurological symptoms during pregnancy (24 weeks gestation)\nMRI Findings: 2.8cm right petroclival meningioma with minimal perilesional edema\nAssessment: Given pregnancy status and moderate symptomatology, conservative management initially recommended\nPlan: \n- Close monitoring through remainder of pregnancy\n- Monthly clinical assessments\n- Dexamethasone 4mg BID with gradual taper based on symptoms\n- Neurology consult for headache management\n- High-risk OB consultation\n\nFOLLOW-UP - June 20, 2018 (32 weeks gestation)\nStatus: Symptoms stabilized with steroid therapy\n- Headaches improved\n- Vision symptoms stable\n- Continue current management\n- Schedule post-delivery imaging\n\nPOST-DELIVERY VISIT - September 30, 2018\nMRI: No significant change in tumor size\nSymptoms: Mild improvement post-delivery\nPlan: Continue conservative management with quarterly monitoring\n\nANNUAL FOLLOW-UP - March 15, 2019\nMRI: Stable lesion size\nSymptoms: Further improvement in headaches\nPlan: \n- Decrease monitoring to semi-annual\n- Continue conservative management\n- Physical therapy referral for balance exercises\n\n2020 VISITS (March 15 & September 20)\nMRI: No growth\nSymptoms: Well-controlled\nNotable: Patient adapted work schedule to reduce stress\nPlan: Continue semi-annual monitoring\n\n2021 VISITS (March 18 & September 22)\nMRI: Minimal growth (0.2cm over 3 years)\nSymptoms: Stable\nPlan: \n- Maintain current approach\n- Added vestibular rehabilitation therapy\n\n2022 VISITS (March 15 & September 20)\nMRI: Stable\nQuality of Life: Good\nPlan: Annual monitoring approved given stability\n\n2023 ANNUAL VISIT - March 16\nMRI: No change\nSymptoms: Well-managed\nPlan: Continue annual monitoring\n\n2024 ANNUAL VISIT - March 14\nMRI: Stable disease\nLong-term Outcome: Successful conservative management\nCurrent Status: Maintaining normal activities with minimal limitations\n\nFUNCTIONAL STATUS SCORES:\nKarnofsky Performance Status (KPS): 90\n(Able to carry on normal activity; minor signs/symptoms of disease)\n\nECOG Performance Status: 1\n(Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nMANAGEMENT RATIONALE:\nConservative approach chosen due to:\n1. Pregnancy status at presentation\n2. Stable tumor size\n3. Successful symptom management\n4. Patient preference\n5. Location near critical structures\n6. WHO Grade I status\n\nONGOING RECOMMENDATIONS:\n1. Annual MRI surveillance\n2. Symptom management as needed\n3. Regular exercise and weight management\n4. Stress reduction techniques\n5. Regular neurological assessments\n6. Continue balance/vestibular therapy as needed"
      }
    },
    {
      "demographics": {
        "age": 40,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": "Coffee Roaster",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increasing fatigue and difficulty concentrating at work",
          "Reports subtle changes in sense of smell over past 6 months",
          "Occasional episodes of right-sided facial numbness",
          "Mild balance issues when climbing library ladders"
        ],
        "medical_history": [
          "BMI 33.2 - Class I Obesity",
          "Migraine headaches since age 25, but notes pattern has changed recently",
          "Hypertension diagnosed 2 years ago, managed with lisinopril 10mg daily",
          "No history of head trauma or neurological conditions",
          "No family history of brain tumors",
          "Past surgical history: Cholecystectomy (2018)",
          "Regular exposure to coffee roasting fumes in current job",
          "No significant radiation exposure"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: A\nOccupation: Librarian/Coffee Roaster\nAge: 40F | BMI: 33.2\n\nINITIAL VISIT - March 15, 2015\nMRI FINDINGS:\n- 3.8cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Evidence of compression of superior sagittal sinus\n\nASSESSMENT:\nSymptomatic right frontal meningioma with concerning features warranting immediate intervention. High-risk factors include:\n- Size >3cm\n- Significant peritumoral edema\n- Progressive neurological symptoms\n- Occupation requiring balance and concentration\nWHO Grade: II (preliminary radiological assessment)\n\nTREATMENT PLAN:\nRecommend aggressive surgical resection given:\n1. Progressive symptoms\n2. Size and location\n3. Occupational hazards (ladder climbing, chemical exposure)\n4. Young age\nSchedule for Simpson Grade I resection within 2 weeks.\n\nFOLLOW-UP VISIT - April 30, 2015 (Post-operative)\n- Successful gross total resection achieved\n- Pathology confirms WHO Grade II meningioma\n- Minimal post-operative complications\n- Initiated adjuvant radiation therapy (60 Gy/30 fractions)\n\n6-MONTH FOLLOW-UP - October 2015\n- Completed radiation therapy\n- Improved headaches and vision\n- MRI shows no residual tumor\n- Cleared to return to work with restrictions on ladder climbing\n\nANNUAL FOLLOW-UP - March 2016\n- Stable imaging\n- Returned to full work duties\n- Minor fatigue persists\n- Continue q6month MRI surveillance\n\n2017 (Bi-annual visits):\nMarch: Stable imaging, improved stamina\nSeptember: New small enhancement at surgical margin (4mm)\n\n2018 (Bi-annual visits):\nMarch: Enhancement stable at 4mm\nSeptember: No progression, symptoms stable\n\n2019 (Bi-annual visits):\nMarch: Slight growth to 6mm\nSeptember: Initiated stereotactic radiosurgery for focal recurrence\n\n2020-2021:\nQuarterly MRIs - No progression\nMaintained work schedule with modifications\n\n2022-2023:\nSemi-annual MRIs - Stable disease\nRegular neuropsychological assessments\n\n2024 (Current Status):\n- No evidence of recurrence\n- Annual MRI surveillance\n- Maintained occupational duties with accommodations\n- Regular monitoring of cognitive function\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nONGOING RECOMMENDATIONS:\n1. Continue semi-annual MRI surveillance\n2. Annual neuropsychological assessment\n3. Occupational exposure monitoring\n4. Regular blood pressure monitoring\n5. Weight management program\n\nNote: Aggressive initial approach with early intervention and consistent monitoring has resulted in favorable long-term outcome despite WHO Grade II status.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: A\nOccupation: Librarian/Coffee Roaster\nWHO Grade: I (confirmed via imaging characteristics)\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive headaches, visual changes, and neurological symptoms\nMRI Findings: 2.8cm left frontal convexity meningioma, minimal surrounding edema\nAssessment: Given symptom progression and location, conservative management with close monitoring indicated.\nPlan: \n- MRI surveillance every 6 months initially\n- Neurology referral for headache management\n- Occupational health consultation regarding coffee roasting fumes exposure\n- BP monitoring; continue lisinopril\n\nFOLLOW-UP - September 20, 2014\nTumor stable at 2.8cm\nSymptoms partially improved with:\n- Workplace modifications (reduced roasting exposure)\n- Propranolol 40mg daily for headache prophylaxis\n- Ergonomic adjustments at library workstation\nPlan: Continue current management\n\nANNUAL VISIT - March 18, 2015\nMinimal tumor growth (2.9cm)\nSymptoms stable\nAdded: Vitamin D supplementation and weight management program\nPlan: Continue surveillance, extend to annual MRI\n\n2016-2018 ANNUAL VISITS\nTumor stable at 2.9cm\nImproved headache control\nBMI reduced to 31.5\nMaintaining modified work duties\nPlan: Annual MRI continued\n\n2019 VISIT - March 22\nSlight growth to 3.0cm\nNew intermittent right-sided facial paresthesia\nDiscussion of treatment options; patient prefers continued observation\nPlan: Return to 6-month surveillance\n\n2020-2022 BI-ANNUAL VISITS\nTumor stable at 3.0cm\nSymptoms managed with medication adjustments\nSuccessfully maintaining modified work schedule\nRegular exercise program implemented\n\n2023 VISIT - March 15\nTumor stable\nQuality of life maintained\nContinuing conservative management successfully\nPlan: Return to annual surveillance\n\n2024 VISIT - March 20\nTumor stable at 3.0cm\nWell-adapted to workplace modifications\nMaintaining stable neurological status\n\nCURRENT STATUS:\nKPS Score: 90 - Able to carry on normal activity with minor symptoms\nECOG Score: 1 - Restricted in physically strenuous activity but ambulatory\n\nMANAGEMENT SUMMARY:\nConservative approach successful over 10-year period\nRegular monitoring with stable disease\nQuality of life preserved through:\n- Workplace modifications\n- Lifestyle adjustments\n- Medication management\n- Weight reduction program\n\nNext Follow-up: March 2025\nContinue annual MRI unless new symptoms develop\n\n[Electronically signed]\nDr. [REDACTED]\nNeurosurgery Department"
      }
    },
    {
      "demographics": {
        "age": 66,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty finding right words",
          "Subtle weakness in left hand, noticed while typing at work",
          "Increased fatigue and difficulty concentrating during work hours",
          "Two episodes of loss of balance in past month",
          "Mild nausea without vomiting"
        ],
        "medical_history": [
          "Hypertension - diagnosed 8 years ago, controlled with lisinopril",
          "Migraine headaches in 30s-40s, resolved spontaneously",
          "BMI 33.2 - Class I Obesity",
          "Osteoarthritis in right knee",
          "Hormone replacement therapy for 5 years post-menopause (ages 52-57)",
          "No history of cancer",
          "No previous neurological conditions",
          "Family history: Mother had breast cancer at age 70"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 66\nGender: Female\nOccupation: Software Developer\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 4.2 cm parasagittal meningioma in right frontal region\n- Significant peritumoral edema\n- Mass effect on superior sagittal sinus\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Evidence of cortical invasion\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms significantly impacting daily function and occupation. Symptoms and imaging suggest aggressive tumor behavior. High-risk features include size >3cm, peritumoral edema, and location near critical structures.\n\nPLAN:\nRecommend immediate surgical intervention due to:\n1. Tumor size and location\n2. Progressive symptoms\n3. Occupation requiring fine motor skills and cognitive precision\n4. Risk of further neurological deterioration\n\n-------------------\n\nSURGICAL NOTE - April 2, 2018\nPROCEDURE: Right frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nWHO Grade II meningioma confirmed by pathology\nEstimated blood loss: 300cc\nNo immediate complications\n\n-------------------\n\nPOST-OP FOLLOW-UP - May 15, 2018\n- Improved vision and hand strength\n- Minimal residual weakness\n- Started adjuvant radiation therapy\n- Plan: 60 Gy in 30 fractions\n\n-------------------\n\n6-MONTH FOLLOW-UP - October 10, 2018\nMRI: Small residual enhancement at surgical site\nSymptoms: Significantly improved\nCompleted radiation therapy with good response\nReturn to work part-time\n\n-------------------\n\nANNUAL FOLLOW-UP - April 15, 2019\nMRI: Stable residual disease\nNeurologically intact\nFull return to work\nContinue q6month monitoring\n\n-------------------\n\n2-YEAR FOLLOW-UP - April 20, 2020\nMRI: Small area of enhancement showing slight progression\nNew protocol initiated:\n- Monthly cognitive assessments\n- Quarterly MRI surveillance\n- Consider repeat surgery if progression continues\n\n-------------------\n\n3-YEAR FOLLOW-UP - May 1, 2021\nMRI: Progressive disease\nSecond surgery recommended and performed\nPathology: Maintained WHO Grade II\nPost-op course uncomplicated\n\n-------------------\n\n4-YEAR FOLLOW-UP - April 15, 2022\nMRI: Post-treatment changes, no evidence of progression\nMaintained good functional status\nContinue surveillance protocol\n\n-------------------\n\n5-YEAR FOLLOW-UP - April 10, 2023\nMRI: Stable disease\nMinor cognitive complaints\nOccupational therapy initiated for cognitive optimization\n\n-------------------\n\nCURRENT STATUS (2024):\n- Disease stable\n- Maintaining professional work\n- Regular monitoring continues\n- Quality of life preserved\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90 (Able to carry on normal activity, minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nMONITORING PROTOCOL:\n- MRI every 6 months\n- Quarterly neurocognitive assessment\n- Monthly blood pressure monitoring\n- Regular occupational therapy evaluation",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 66, Female, Blood Type: A\nOccupation: Software Developer\n\nINITIAL VISIT - January 15, 2018\nPresenting Symptoms: Progressive neurological symptoms including headaches, visual disturbance, and left-hand weakness affecting work performance. Concerning for space-occupying lesion.\n\nMRI FINDINGS:\n- 2.8cm right frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I characteristics\n- No signs of aggressive features\n\nASSESSMENT:\nGiven patient's age, occupation, and symptom progression, recommending close monitoring with consideration for intervention if symptoms worsen. KPS 80/100.\n\nMANAGEMENT PLAN:\n1. Serial MRI monitoring\n2. Symptomatic management\n3. Occupational modifications\n4. Regular neurological assessments\n\n-------------------\n\nFOLLOW-UP - July 20, 2018 (6 months)\n- Stable symptoms\n- MRI shows no growth\n- Implemented ergonomic workspace modifications\n- Started on prophylactic topiramate for headache management\nKPS 85/100\n\n-------------------\n\nFOLLOW-UP - January 15, 2019 (1 year)\n- Improved headache control\n- Vision stable\n- MRI: No significant change\n- Continuing conservative management\nKPS 85/100\n\n-------------------\n\nFOLLOW-UP - January 20, 2020 (2 years)\n- Minor tumor growth (0.2cm)\n- Symptoms stable\n- Added physical therapy for balance training\n- Occupational therapy assessment for typing adaptations\nKPS 80/100\n\n-------------------\n\nFOLLOW-UP - February 10, 2021 (3 years)\n- Stable disease\n- Well-adapted to modified work routine\n- Maintaining regular exercise program\n- Blood pressure well-controlled\nKPS 85/100\n\n-------------------\n\nFOLLOW-UP - March 5, 2022 (4 years)\n- No significant progression\n- Cognitive function stable\n- Continuing conservative approach\n- Added memory exercises to daily routine\nKPS 80/100\n\n-------------------\n\nFOLLOW-UP - April 12, 2023 (5 years)\n- Minor symptom progression\n- MRI shows 0.3cm growth over 5 years\n- Discussed surgical options but patient prefers continued observation\n- Enhanced monitoring schedule implemented\nKPS 75/100\n\n-------------------\n\nCURRENT VISIT - January 30, 2024 (6 years)\n- Stable disease burden\n- Well-adapted to lifestyle modifications\n- Maintaining part-time work schedule\n- Continuing conservative management\n\nCURRENT STATUS:\nKPS Score: 75/100\nECOG Score: 1\n\nLONG-TERM MANAGEMENT RECOMMENDATIONS:\n1. Biannual MRI surveillance\n2. Regular neurocognitive assessments\n3. Continued lifestyle modifications\n4. Maintain work-life balance\n5. Regular physical therapy\n6. Blood pressure monitoring\n\nOCCUPATIONAL CONSIDERATIONS:\n- Reduced work hours to 6 hours/day\n- Enhanced lighting and screen modifications\n- Regular breaks every 45 minutes\n- Voice-to-text software implementation\n- Ergonomic workspace optimization\n\nThe conservative management approach has proven successful over 6 years with acceptable quality of life maintenance and continued occupational engagement. Patient has adapted well to lifestyle modifications and shows good compliance with monitoring protocols."
      }
    },
    {
      "demographics": {
        "age": 44,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": "Baker",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increasing fatigue and difficulty concentrating at work",
          "Reports occasional ringing in right ear",
          "Subtle personality changes noted by coworkers - more irritable than usual",
          "Two episodes of loss of balance while standing in the past month"
        ],
        "medical_history": [
          "BMI 33.2 - Class I Obesity",
          "Migraine headaches since age 35, but notes recent headaches are different in character",
          "Hypertension diagnosed 2 years ago - currently on lisinopril 10mg daily",
          "Surgical history: Cholecystectomy in 2018",
          "No history of cancer",
          "No previous neurological conditions",
          "Family history significant for mother with breast cancer",
          "No history of radiation exposure",
          "Regular medication: Lisinopril 10mg daily, multivitamin"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - March 15, 2014\nPatient: 44-year-old female, Blood Type A\nOccupation: Librarian/Baker\nChief Complaints: Progressive headaches, right-sided visual disturbance, balance issues\n\nIMAGING FINDINGS:\nMRI reveals a 4.2 cm right sphenoid wing meningioma with significant mass effect and perilesional edema. Enhancement pattern suggests WHO Grade II. Compression of right optic nerve noted.\n\nASSESSMENT:\nGiven size, location, and symptomatology, immediate surgical intervention recommended. Occupational demands require fine motor control and sustained concentration, currently compromised.\n\nPLAN:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative optimization of blood pressure\n3. Baseline neuro-ophthalmology evaluation\n4. WHO Grade II anticipated\n\nSURGICAL NOTE - April 2, 2014\n- Simpson Grade II resection achieved\n- Pathology confirms WHO Grade II meningioma\n- No immediate post-operative complications\n\nFOLLOW-UP VISIT - July 15, 2014\nPost-operative MRI shows small residual tumor (0.8 cm)\nRecommended adjuvant radiation therapy\nPatient completed 30 fractions of IMRT (54 Gy)\n\nFOLLOW-UP - January 10, 2015\nStable residual disease\nVisual symptoms improved\nReturn to work approved with modifications\n\nSURVEILLANCE VISITS:\n2015-2016 (q3 months):\n- Serial MRIs show stable disease\n- Gradual improvement in symptoms\n- Regular ophthalmology follow-up\n\n2017-2018 (q6 months):\n- Continued stability\n- Minor headaches managed with medication\n- Working full-time\n\n2019-2020 (q6 months):\n- Small growth noted in residual tumor (now 1.2 cm)\n- Gamma Knife radiosurgery performed February 2020\n- Good response to treatment\n\n2021-2022 (q6 months):\n- Stable disease post-radiosurgery\n- Weight management program initiated\n- BP well-controlled\n\n2023-2024 (q6 months):\n- Most recent MRI (January 2024) shows stable disease\n- Patient maintains good functional status\n- Continues regular work schedule with accommodations\n\nCURRENT STATUS (2024):\n- Disease stable\n- Regular monitoring continues\n- Weight management ongoing\n- BP controlled\n\nFunctional Status Scores:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nMONITORING PROTOCOL:\n- Continue q6 month MRI surveillance\n- Annual neuro-ophthalmology evaluation\n- Regular BP monitoring\n- Weight management follow-up\n\nWHO Grade: II (Atypical Meningioma)\nSimpson Resection Grade: II\n\nNote: Aggressive initial approach with early surgical intervention and adjuvant radiation therapy has resulted in good disease control. Occupational demands and obesity considered in treatment planning.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n44-year-old female, Blood Type A\nOccupation: Librarian/Baker\nWHO Grade I Meningioma\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm right frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- Typical \"dural tail\" sign present\n- No other intracranial abnormalities\n\nASSESSMENT:\nDespite presenting symptoms suggesting mass effect, tumor size and location allow for initial conservative management. Occupation requires attention to cognitive function and physical stamina. Obesity and hypertension noted as comorbidities.\n\nPLAN:\n1. Conservative monitoring with serial imaging\n2. Headache management optimization\n3. Blood pressure monitoring\n4. Lifestyle modifications\n\nFOLLOW-UP VISITS:\n\nSeptember 15, 2018 (6-month)\n- MRI shows stable tumor size\n- Headaches improved with prophylactic therapy (Topiramate 50mg daily)\n- BP well-controlled\n- Recommended ergonomic workplace modifications\n- Continue current management\n\nMarch 20, 2019 (1-year)\n- MRI: No significant change\n- Visual symptoms stable\n- Started balance therapy\n- Weight loss program initiated\n- Continue conservative approach\n\nMarch 18, 2020 (2-year)\n- MRI: Minimal growth (0.2cm)\n- Symptoms stable\n- BMI improved to 31.8\n- Maintaining work schedule with accommodations\n- Continue monitoring\n\nMarch 15, 2021 (3-year)\n- MRI: No interval growth\n- Headaches well-controlled\n- Vision stable\n- Added meditation program for stress management\n- Maintain current approach\n\nMarch 22, 2022 (4-year)\n- MRI: Stable\n- Patient adapted well to workplace modifications\n- Balance improved with therapy\n- Continue conservative management\n\nMarch 20, 2023 (5-year)\n- MRI: No significant change\n- Quality of life maintained\n- Working full-time with accommodations\n- Transitioned to biennial imaging\n\nMarch 15, 2024 (6-year)\n- MRI: Stable disease\n- Symptoms well-controlled\n- Patient satisfied with conservative approach\n- Maintaining work-life balance\n- Next MRI scheduled for 2026\n\nCURRENT MANAGEMENT:\n1. Biennial MRI surveillance\n2. Regular BP monitoring\n3. Lifestyle modification maintenance\n4. Symptom management as needed\n5. Regular balance assessments\n6. Occupational therapy consultation as needed\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory and able to carry out light work\n\nRECOMMENDATIONS:\n1. Continue current conservative management\n2. Maintain workplace ergonomic modifications\n3. Regular follow-up with primary care for obesity management\n4. Annual ophthalmological examination\n5. Consider surgical intervention only if significant progression or symptom worsening\n\nNote: Conservative approach successful with stable disease and maintained quality of life over 6-year period. Patient's occupational demands have been well-accommodated with current management strategy."
      }
    },
    {
      "demographics": {
        "age": 57,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Researcher",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months becoming more severe in mornings, intermittent blurred vision in right eye, occasional episodes of nausea, subtle personality changes noted by family members including increased irritability, recent difficulty with concentration at work, one episode of loss of balance when standing from seated position, mild right-sided facial numbness"
        ],
        "medical_history": [
          "Hypertension diagnosed 5 years ago - controlled with lisinopril 10mg daily, BMI 33.2, previous migraine history but pattern changed in recent months, underwent total hysterectomy at age 45 for fibroids, family history of breast cancer (maternal aunt), no history of radiation exposure, seasonal allergies treated with OTC antihistamines, mild osteoarthritis in right knee, completed menopause at age 51 with no hormone replacement therapy"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - March 15, 2014\nPatient ID: F57-A-2014\nWHO Grade: II (confirmed post-surgery)\n\nPRESENTING EVALUATION:\n57-year-old female researcher presents with progressive neurological symptoms. Initial MRI reveals a 4.2cm right frontal convexity meningioma with significant peritumoral edema and mass effect on adjacent frontal lobe. Tumor demonstrates heterogeneous enhancement and dural tail sign.\n\nIMAGING FINDINGS:\n- MRI with/without contrast: Large right frontal meningioma (4.2 x 3.8 x 3.6cm)\n- Significant vasogenic edema extending into corona radiata\n- Mild midline shift (5mm)\n- No signs of venous sinus invasion\n\nTREATMENT DECISION:\nGiven patient's occupation requiring high cognitive function, symptoms progression, and tumor characteristics, recommend urgent surgical intervention.\n\nSURGICAL INTERVENTION - April 2, 2014:\nSimpson Grade II resection performed. Post-operative course uncomplicated.\nPathology: WHO Grade II meningioma with increased mitotic activity (5/10 HPF)\n\nFOLLOW-UP VISITS:\n\nOctober 2014 (6-month):\n- Improved headaches and vision\n- MRI: No residual/recurrent tumor\n- Started adjuvant radiotherapy (60 Gy/30 fractions)\n- KPS: 90\n\nApril 2015 (1-year):\n- Maintaining work schedule\n- Minor fatigue from RT\n- MRI: Stable post-surgical changes\n- KPS: 90\n\nOctober 2015:\n- Complete resolution of presenting symptoms\n- MRI: No recurrence\n- Managing hypertension well\n- KPS: 100\n\nApril 2016:\n- Routine follow-up\n- MRI: Stable\n- Weight management program initiated\n- KPS: 100\n\n2017 (Biannual visits):\n- April: Small enhancement at surgical site (7mm)\n- October: Stable enhancement\n- Maintaining full work schedule\n- KPS: 90\n\n2018 (Biannual visits):\n- April: Enhancement stable\n- October: No progression\n- BMI improved to 31.5\n- KPS: 90\n\n2019 (Biannual visits):\n- April: Slight increase in enhancement (9mm)\n- October: SRS boost delivered to focal area\n- KPS: 90\n\n2020-2021 (Quarterly monitoring):\n- All visits show stable disease\n- Regular cognitive assessments: normal\n- Maintaining research career\n- KPS: 90\n\n2022-2023 (Biannual visits):\n- Stable imaging\n- No new symptoms\n- Regular exercise program\n- KPS: 90\n\n2024 (Latest visit - January):\n- 10-year follow-up\n- MRI: No recurrence\n- Fully functional at work\n- BMI: 30.1\n- KPS: 90\n\nCURRENT STATUS (2024):\n- Disease-free survival: 10 years\n- Maintaining professional activities\n- Well-controlled hypertension\n- Regular imaging surveillance continues\n\nPERFORMANCE SCORES:\n- Karnofsky Performance Status (KPS): 90/100\n- ECOG Performance Status: 1\n\nONGOING RECOMMENDATIONS:\n1. Biannual MRI surveillance\n2. Continue hypertension management\n3. Annual cognitive assessment\n4. Maintain healthy lifestyle modifications\n5. Regular neurosurgical follow-up\n\nNote: Proactive surgical intervention and early adjuvant RT likely contributed to favorable outcome despite WHO Grade II status. Patient's cognitive demands at work justified aggressive initial approach.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nGender: Female | Age: 57 | Blood Type: A\nOccupation: Researcher | BMI: 33.2\n\nINITIAL VISIT - March 15, 2018\nPresenting Symptoms: Progressive headaches (3 months), right eye blurred vision, nausea, personality changes, concentration issues, balance disturbance, right facial numbness.\nMRI Findings: 2.8cm left frontal convexity meningioma, minimal peritumoral edema, no significant mass effect.\nWHO Grade: I (presumptive based on imaging characteristics)\nAssessment: Given size <3cm and typical imaging features suggesting WHO Grade I meningioma.\nPlan: Conservative management with close monitoring due to:\n- Stable professional position requiring cognitive function preservation\n- Obesity increasing surgical risks\n- Controlled hypertension\nRecommendations:\n1. MRI follow-up every 6 months initially\n2. Dexamethasone 4mg daily for symptom management\n3. Lifestyle modifications: weight management program referral\n4. Continue current hypertension management\n\nFOLLOW-UP - September 20, 2018\nSymptoms: Headaches improved with dexamethasone\nMRI: Stable tumor size\nPlan: Continue conservative management\n\nFOLLOW-UP - March 12, 2019\nSymptoms: Stable\nMRI: No growth\nPlan: Extend MRI interval to annual\nDexamethasone tapered to 2mg daily\n\nANNUAL FOLLOW-UP - March 10, 2020\nSymptoms: Well-controlled\nMRI: Minimal growth (0.2cm)\nPlan: Continue annual monitoring\nOccupational adjustments recommended: regular breaks, stress management\n\nANNUAL FOLLOW-UP - March 15, 2021\nSymptoms: Stable\nMRI: No additional growth\nNote: Patient maintaining work schedule with accommodations\nPlan: Continue current management\n\nANNUAL FOLLOW-UP - March 8, 2022\nSymptoms: Occasional headaches\nMRI: Stable\nPlan: Added prophylactic migraine medication\nConsider cognitive rehabilitation for work optimization\n\nANNUAL FOLLOW-UP - March 14, 2023\nSymptoms: Well-managed\nMRI: No progression\nQuality of life assessment: Good\nPlan: Continue annual monitoring\n\nRECENT FOLLOW-UP - February 20, 2024\nSymptoms: Stable\nMRI: No significant changes over 6 years\nPatient maintaining research position with modifications\nPlan: Continue conservative management\nConsider biennial MRI if stability maintains\n\nCURRENT STATUS:\nKarnofsky Performance Status (KPS): 90\n- Able to carry on normal activity with minor symptoms\n\nECOG Performance Status: 1\n- Restricted in physically strenuous activity but ambulatory and able to carry out light work\n\nMANAGEMENT SUMMARY:\nSuccessfully maintained conservative approach for 6 years with:\n- Stable tumor size\n- Adequate symptom control\n- Preserved occupational function\n- Good quality of life\n- No surgical intervention required\n\nContinued monitoring recommended with focus on:\n1. Annual MRI surveillance\n2. Symptom management\n3. Weight management\n4. Cognitive function preservation\n5. Occupational adaptations as needed"
      }
    },
    {
      "demographics": {
        "age": 63,
        "gender": "Male",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": true
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of confusion and difficulty concentrating at work",
          "Subtle personality changes noted by family members",
          "Occasional balance issues when walking",
          "Mild right-sided facial numbness",
          "Increased fatigue and drowsiness during daytime"
        ],
        "medical_history": [
          "Radiation therapy to head/neck region for childhood lymphoma at age 12",
          "Hypertension - diagnosed 8 years ago, managed with lisinopril",
          "BMI 33.2 - Class I Obesity",
          "Sleep apnea diagnosed 3 years ago, uses CPAP",
          "Hyperlipidemia - managed with atorvastatin",
          "No history of seizures or neurological disorders",
          "No family history of brain tumors",
          "Former smoker - quit 15 years ago"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Additional consideration for radiation exposure history"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - March 15, 2014\nPatient: 63Y Male, Blood Type B\nOccupation: Data Scientist\nWHO Grade: II (confirmed post-surgery)\n\nPRESENTING SYMPTOMS:\n- Progressive headaches (4-month duration)\n- Right eye visual disturbance\n- Cognitive impairment affecting work performance\n- Personality changes\n- Balance disturbance\n- Right facial numbness\n- Fatigue/drowsiness\n\nIMAGING FINDINGS:\nMRI reveals 4.2cm left frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe. Enhancement pattern suggests possible WHO Grade II.\n\nASSESSMENT:\nHigh-risk features present:\n- Size >3cm\n- Significant peritumoral edema\n- Occupation requires high cognitive function\n- History of radiation exposure\n- Symptomatic presentation\n\nPLAN:\nRecommend immediate surgical intervention - craniotomy for gross total resection.\n\n-------------------\n\nPOST-OP FOLLOW-UP - May 2, 2014\nSimpson Grade II resection achieved\nPathology confirms WHO Grade II meningioma\nAdjuvant radiation therapy recommended\nStarted on dexamethasone for post-op edema\n\n-------------------\n\n6-MONTH FOLLOW-UP - November 15, 2014\nCompleted fractionated RT (60 Gy/30fx)\nImproved symptoms\nMRI: No evidence of residual/recurrence\nContinue q4 month monitoring\n\n-------------------\n\n2-YEAR FOLLOW-UP - March 20, 2016\nStable imaging\nMinor right facial numbness persists\nReturned to work full-time\nContinue q6 month monitoring\n\n-------------------\n\n4-YEAR FOLLOW-UP - April 5, 2018\nSmall focus of enhancement noted on MRI\nWatch and wait approach\nIncreased monitoring frequency to q3 months\n\n-------------------\n\n5-YEAR FOLLOW-UP - March 12, 2019\nEnhancement stable\nMaintaining good functional status\nContinue current monitoring schedule\n\n-------------------\n\n7-YEAR FOLLOW-UP - February 28, 2021\nSlight progression of enhancement\nDiscussion of repeat surgical intervention vs. radiosurgery\nOpted for CyberKnife treatment\n\n-------------------\n\n9-YEAR FOLLOW-UP - March 15, 2023\nPost-radiosurgery\nStable disease\nAnnual monitoring recommended\n\n-------------------\n\nCURRENT STATUS (January 2024):\n- Disease stable\n- Maintaining professional work\n- Regular CPAP use\n- BP well-controlled\n- Annual MRI surveillance planned\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90 (Able to carry on normal activity, minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nMONITORING PROTOCOL:\n- MRI with contrast q12 months\n- Neurological assessment q6 months\n- Cognitive function testing annually\n- Quality of life assessments\n\nNote: Aggressive initial approach with early intervention and consistent monitoring has resulted in good disease control despite WHO Grade II status. Patient maintains high functional status and continues professional work.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: B\nOccupation: Data Scientist\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms with morning headaches and visual changes\n\nIMAGING FINDINGS:\nMRI reveals a 2.8cm right sphenoid wing meningioma with moderate peritumoral edema. No significant mass effect on adjacent structures. WHO Grade I characteristics on imaging.\n\nASSESSMENT:\nGiven patient's history of prior radiation exposure and current symptomatology, careful consideration of management approach is warranted. Despite symptomatic presentation, conservative management initially preferred due to:\n- Location allows for careful monitoring\n- Size just under 3cm threshold\n- Patient's comorbidities (obesity, sleep apnea) increase surgical risks\n- Prior radiation exposure history complicates treatment options\n\nPLAN:\n1. Conservative management with close monitoring\n2. MRI surveillance every 4 months initially\n3. Dexamethasone 4mg BID for edema management\n4. Sleep study referral for CPAP optimization\n5. Occupational therapy evaluation for cognitive strategies\n6. BP monitoring and lifestyle modifications\n\nFOLLOW-UP - July 20, 2014\nSymptoms stable with steroid therapy. Minor improvement in headaches.\nMRI: No significant change in tumor size.\nPlan: Continue current management, begin steroid taper.\n\nFOLLOW-UP - February 12, 2015\nStable symptoms. Successfully tapered off steroids.\nMRI: Minimal growth (0.2cm), acceptable range.\nPlan: Extended MRI interval to 6 months.\n\nANNUAL REVIEW - March 5, 2016\nPatient maintaining work as data scientist with accommodations.\nMRI: Stable size and edema.\nPlan: Continue surveillance, annual MRI if stable.\n\nFOLLOW-UP - March 10, 2018\nMinor progression of visual symptoms.\nMRI: Growth to 3.1cm\nPlan: Increased monitoring frequency. Discussion of radiation therapy options if progression continues.\n\nANNUAL REVIEW - March 15, 2020\nStable disease. Managing work with adaptive technologies.\nMRI: No significant change.\nPlan: Continue annual surveillance.\n\nFOLLOW-UP - March 20, 2022\nWell-adapted to condition. Maintaining quality of life.\nMRI: Stable disease.\nPlan: Continue current management.\n\nLATEST FOLLOW-UP - January 10, 2024\n10-year follow-up shows successful conservative management.\nMRI: Stable disease, minimal growth over 10 years.\nPatient continues work with accommodations.\n\nFUNCTIONAL STATUS SCORES:\nKPS: 80 - Normal activity with effort, some signs/symptoms of disease\nECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nRECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain cognitive monitoring\n3. Regular ophthalmology follow-up\n4. Optimize cardiovascular health\n5. Consider radiation therapy only if significant progression\n\nWHO Grade: I (Based on imaging characteristics and growth pattern)\n\nNote: Conservative management has proven successful over 10-year period, with patient maintaining professional activities and quality of life. Occupation as data scientist has allowed for workplace accommodations and continued employment despite mild cognitive symptoms."
      }
    },
    {
      "demographics": {
        "age": 69,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": true,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Data generation failed"
        ],
        "medical_history": [
          "Data generation failed"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Coordinated care with obstetrics",
            "Timing surgery for second trimester if possible"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - March 15, 2014\nPatient ID: F69-A\nChief Concern: Incidental finding on MRI performed for unrelated headaches\n\nSIGNIFICANT CONSIDERATIONS:\n- 69-year-old female\n- Currently pregnant (high-risk pregnancy given advanced maternal age)\n- Occupation: Software Developer (cognitive demands noted)\n- Blood Type: A\n\nINITIAL IMAGING:\nMRI reveals a 2.8cm left frontal convexity meningioma\n- T1 with contrast: Homogeneous enhancement\n- T2: Moderate hyperintensity\n- FLAIR: Minimal perilesional edema\n- DWI/ADC: No restricted diffusion\n\nASSESSMENT:\nGiven patient's pregnancy status, occupation requiring cognitive precision, and tumor location, recommend close monitoring with consideration for post-pregnancy intervention.\n\nPLAN:\n1. Monthly MRI monitoring during pregnancy\n2. Neurosurgical evaluation post-delivery\n3. Detailed neuropsychological testing baseline\n\n-------------------\n\nFOLLOW-UP - September 20, 2014\nPost-delivery evaluation\nTumor size increased to 3.2cm\nWHO Grade I (presumptive)\nRecommending surgical intervention given growth rate\n\n-------------------\n\nSURGICAL NOTE - November 15, 2014\nSimpson Grade II resection performed\nPathology: WHO Grade I meningioma\nNo complications\n\n-------------------\n\nFOLLOW-UP VISITS:\n\n2015 (Quarterly):\n- Stable post-surgical cavity\n- No recurrence\n- Return to work achieved\n\n2016-2018 (Bi-annual):\n- Continued stability\n- Annual neuropsychological testing normal\n- MRI surveillance maintained\n\n2019-2021 (Annual):\n- Small area of enhancement noted in 2020\n- Watchful waiting with increased monitoring\n\n2022-2024 (Bi-annual):\n- Stable residual enhancement\n- No intervention required\n- Continuing surveillance\n\nCURRENT STATUS (2024):\nKPS Score: 90/100\nECOG Score: 1\n\nMONITORING PROTOCOL:\n- Annual MRI with contrast\n- Bi-annual neurosurgical evaluation\n- Annual neuropsychological assessment\n- Occupational therapy assessment as needed\n\nNote: Early intervention strategy proved successful with excellent functional outcomes. Patient maintains high-level cognitive function required for software development work.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [Redacted]\n69-year-old female, Blood Type A\nOccupation: Software Developer\nPregnancy Status: Currently pregnant\n\nINITIAL VISIT - January 15, 2015\nIncidental finding of meningioma during routine MRI.\nLocation: Right frontal convexity\nSize: 1.8 cm\nWHO Grade: I (presumptive based on imaging characteristics)\nNo mass effect or significant edema\nPatient asymptomatic\n\nASSESSMENT & PLAN:\nGiven patient's pregnancy status, age, and asymptomatic presentation, recommending conservative management with watchful waiting approach.\n- MRI monitoring every 6 months during pregnancy\n- Discussed potential occupational considerations (extended screen time, ergonomics)\n- Advised on pregnancy-safe stress management techniques\n\nFOLLOW-UP VISIT - July 20, 2015\nPost-partum follow-up\nTumor stable at 1.8 cm\nNo new symptoms\nContinuing conservative management\n\nANNUAL FOLLOW-UP - January 18, 2016\nTumor size: 1.9 cm (minimal growth)\nNo symptoms\nPatient maintaining full work schedule\nPlan: Continue annual monitoring\n\n2017 FOLLOW-UP - February 3, 2017\nTumor stable at 1.9 cm\nNo neurological symptoms\nPatient reports occasional headaches after prolonged computer use\nRecommendations:\n- Ergonomic workplace assessment\n- Blue light filtering glasses\n- Regular work breaks\n\n2018 FOLLOW-UP - January 22, 2018\nTumor size: 2.0 cm\nNo significant growth\nPatient well-adapted to workplace modifications\nContinue annual monitoring\n\n2020 FOLLOW-UP - February 15, 2020\nTumor stable at 2.0 cm\nNo new symptoms\nTelemedicine visit due to COVID-19 pandemic\nPatient working remotely - discussed ergonomic home office setup\n\n2022 FOLLOW-UP - March 10, 2022\nTumor size: 2.1 cm\nMinimal growth over 7 years\nNo neurological deficits\nContinue conservative management\n\n2024 FOLLOW-UP - January 8, 2024\nCurrent tumor size: 2.1 cm\nStable disease\nPatient maintaining excellent quality of life\nPlan: Continue biennial MRI monitoring\n\nFUNCTIONAL STATUS SCORES (as of 2024):\nKarnofsky Performance Status (KPS): 100\n- Fully active, able to carry on all pre-disease performance without restriction\n\nECOG Performance Status: 0\n- Fully active, able to carry on all pre-disease performance without restriction\n\nMANAGEMENT SUMMARY:\nSuccessfully managed with conservative approach for 9 years\nTotal growth: 0.3 cm over 9 years\nPatient maintains full professional and personal activities\nNo surgical intervention required\nExcellent quality of life preserved\n\nONGOING RECOMMENDATIONS:\n1. Biennial MRI surveillance\n2. Annual neurological examinations\n3. Maintain ergonomic workplace practices\n4. Continue regular exercise and stress management\n5. Report any new neurological symptoms promptly\n\nNext scheduled follow-up: January 2026\nImaging: MRI with and without contrast\n\nNotes authored by: [Assistant Name]\nBoard-certified Neurosurgeon\n[Hospital Name]"
      }
    },
    {
      "demographics": {
        "age": 45,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of right-sided facial numbness",
          "Occasional nausea without vomiting",
          "Increasing difficulty concentrating at work",
          "Reports mild balance issues when walking",
          "Two episodes of focal seizures affecting right arm in past month"
        ],
        "medical_history": [
          "Mild hypertension diagnosed 3 years ago, controlled with lisinopril 10mg daily",
          "Concussion from sports injury 15 years ago, fully recovered",
          "Appendectomy at age 12",
          "No history of cancer",
          "No family history of brain tumors",
          "Non-smoker",
          "Social alcohol use",
          "No regular medications except lisinopril"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M45-O\nPrimary Diagnosis: Intracranial Meningioma\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms with headaches and visual changes\n\nMRI FINDINGS:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Dural tail sign present\n- T2 hyperintense with heterogeneous enhancement\n\nASSESSMENT:\nWHO Grade II meningioma (suspected based on imaging characteristics)\nHigh-risk features:\n- Size >3cm\n- Significant peritumoral edema\n- Progressive neurological symptoms\n- Location affecting eloquent areas\n\nTREATMENT PLAN:\nRecommend immediate surgical intervention due to:\n1. Progressive symptoms\n2. Size and location\n3. Risk of further neurological deterioration\n4. Impact on patient's work performance\n\nSURGICAL INTERVENTION - April 2, 2014\n- Simpson Grade II resection performed\n- Pathology confirmed WHO Grade II meningioma\n- No immediate post-operative complications\n\nFOLLOW-UP VISITS:\n\nOctober 2014 (6 months post-op):\n- MRI shows no residual tumor\n- Improved neurological symptoms\n- Recommended adjuvant radiotherapy\n- Started 54 Gy/30 fractions\n\nApril 2015 (1 year post-op):\n- MRI stable\n- No recurrent symptoms\n- Continuing q6month monitoring\n- Return to work full-time\n\nOctober 2015:\n- Stable imaging\n- Minor headaches managed with OTC medications\n- Continue surveillance\n\n2016-2017 (q6month visits):\n- Serial MRIs show no recurrence\n- Maintained neurological improvement\n- Regular cognitive assessments normal\n\n2018-2019:\n- Small area of enhancement noted on right frontal region\n- Close monitoring with shortened interval MRIs\n- No intervention required yet\n\n2020-2021:\n- Stable imaging findings\n- COVID-19 protocols implemented\n- Telemedicine visits alternating with in-person\n- No new neurological symptoms\n\n2022-2023:\n- Continued stability\n- Annual MRI protocol initiated\n- Maintenance phase of follow-up\n\nLatest Visit (January 2024):\n- 10-year follow-up milestone\n- No evidence of recurrence\n- Excellent functional status\n- Continue annual surveillance\n\nCurrent Status:\nKPS Score: 90/100\nECOG Score: 1\n\nLONG-TERM MONITORING PLAN:\n1. Annual MRI with contrast\n2. Biannual neurological examinations\n3. Annual cognitive assessment\n4. Quality of life questionnaires\n5. Continue blood pressure monitoring\n\nNote: Patient has maintained excellent compliance with follow-up schedule and demonstrates successful long-term outcome following early aggressive intervention strategy.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n==================================================\n\nINITIAL VISIT - March 15, 2014\n-----------------------------\nPATIENT: 45-year-old male, Blood Type O\nDIAGNOSIS: Right frontal parasagittal meningioma (WHO Grade I)\n\nIMAGING FINDINGS:\n- MRI reveals 2.8cm right frontal parasagittal meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- Dural tail sign present\n- No hydrocephalus\n\nPRESENTING SYMPTOMS:\nNotable progression of neurological symptoms including:\n- Progressive headaches (4-month duration)\n- Right eye visual disturbance\n- Right-sided facial paresthesia\n- Focal seizures affecting right arm\n- Balance and concentration issues\n\nASSESSMENT & PLAN:\nGiven the size (<3cm) and WHO Grade I status, recommending close monitoring with potential for intervention if progression occurs. Starting anti-epileptic medication for seizure control.\n\nRECOMMENDATIONS:\n1. Levetiracetam 500mg BID for seizure management\n2. Continue lisinopril 10mg daily\n3. MRI surveillance every 4 months initially\n4. Neurological assessments quarterly\n5. Ophthalmology referral for baseline visual assessment\n\nFOLLOW-UP VISIT - July 20, 2014\n-------------------------------\nSymptoms stable. No new seizures. Vision unchanged.\nMRI: No significant change in tumor size.\nContinue current management plan.\n\nANNUAL FOLLOW-UP - March 10, 2015\n--------------------------------\nHeadaches improved with prophylactic treatment.\nMRI: Stable tumor size, minimal edema.\nMaintaining conservative approach.\n\nFOLLOW-UP - March 15, 2016\n--------------------------\nMinor increase in tumor size (3.0cm).\nSymptoms stable.\nAdded prophylactic migraine medication.\n\nFOLLOW-UP - March 12, 2017\n--------------------------\nTumor stable. Patient managing well with current regimen.\nReduced MRI frequency to biannual.\n\nFOLLOW-UP - March 20, 2018\n--------------------------\nNo significant changes. Patient adapted well to medication routine.\nMaintaining work schedule with accommodations.\n\nFOLLOW-UP - March 15, 2020\n--------------------------\nPost-COVID telemedicine visit.\nSymptoms stable. Continue current management.\n\nFOLLOW-UP - March 10, 2022\n--------------------------\nSlight increase in headache frequency.\nMRI: Tumor stable at 3.1cm.\nAdjusted headache medication.\n\nLATEST FOLLOW-UP - March 5, 2024\n-------------------------------\n10-year follow-up milestone.\nTumor remained relatively stable over monitoring period.\nPatient maintains good quality of life.\n\nCURRENT STATUS:\n- Tumor size: 3.1cm (stable)\n- Well-controlled symptoms\n- Maintaining full-time employment with accommodations\n- Good compliance with medication and follow-up\n\nFUNCTIONAL STATUS SCORES:\n- Karnofsky Performance Status (KPS): 90\n- ECOG Performance Status: 1\n\nONGOING MANAGEMENT PLAN:\n1. Continue biannual MRI surveillance\n2. Maintain current medication regimen\n3. Annual ophthalmology assessment\n4. Regular quality of life assessments\n5. Patient to continue logging any new symptoms\n\nNote: Conservative management approach has proven successful over 10-year period, with patient maintaining good functional status and quality of life. Will continue current strategy unless significant progression occurs."
      }
    },
    {
      "demographics": {
        "age": 65,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty finding correct words",
          "Mild right-sided facial numbness",
          "Balance difficulties when walking, particularly noticeable in past 6 weeks",
          "Increased fatigue and drowsiness during daytime",
          "One episode of nausea and vomiting last week"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily for past 8 years",
          "Osteoporosis - diagnosed 3 years ago, taking alendronate weekly",
          "Partial hysterectomy at age 45 for uterine fibroids",
          "History of migraines in 30s-40s, resolved spontaneously",
          "No prior neurological conditions",
          "No history of cancer",
          "No significant head trauma",
          "Family history notable for mother with breast cancer"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F65-A-LIB\nInitial Visit: March 15, 2014\n\nINITIAL CONSULTATION:\n65-year-old female librarian presenting with progressive neurological symptoms suggesting space-occupying lesion. Multiple high-risk symptoms warrant immediate intervention evaluation.\n\nMRI FINDINGS:\n- 4.2 cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect with 6mm midline shift\n- T2 hyperintense with heterogeneous enhancement\n- WHO Grade II features suspected\n- Compression of superior sagittal sinus\n\nASSESSMENT:\nGiven size, location, and symptom progression, immediate surgical intervention recommended. Occupation requires high cognitive function and visual acuity, making aggressive treatment crucial.\n\nTREATMENT PLAN:\n1. Schedule surgical resection within 2 weeks\n2. Pre-operative optimization with dexamethasone 4mg QID\n3. Comprehensive neuropsychological testing baseline\n4. Weekly monitoring until surgery\n\n-------------------\n\nSURGICAL NOTE: March 30, 2014\n- Simpson Grade II resection achieved\n- Pathology confirms WHO Grade II meningioma\n- MIB-1 index: 8%\n- Post-op MRI shows small residual along sinus\n\n-------------------\n\nFOLLOW-UP: June 15, 2014\n- Good recovery from surgery\n- Adjuvant radiotherapy completed (60 Gy/30 fractions)\n- Improved vision and balance\n- Return to work discussed\n\n-------------------\n\n6-MONTH FOLLOW-UP: September 30, 2014\n- MRI stable\n- Minimal residual symptoms\n- Returned to work part-time\n- Continue q3month monitoring\n\n-------------------\n\nANNUAL FOLLOW-UP: March 2015\n- MRI shows no progression\n- Fully returned to work\n- Maintained neurological improvement\n\n-------------------\n\n2016-2018: Bi-annual monitoring\n- Serial MRIs stable\n- No new symptoms\n- Continues regular work schedule\n- Annual neuropsychological testing normal\n\n-------------------\n\n2019: Small Progression Noted\n- 5mm growth in residual tumor\n- Gamma Knife radiosurgery performed\n- 16 Gy to residual tumor\n\n-------------------\n\n2020-2024: Annual Monitoring\n- Stable disease\n- Regular MRI surveillance\n- No new neurological symptoms\n- Continues work with accommodations\n\nCURRENT STATUS (2024):\n- Disease stable\n- Independent in daily activities\n- Working part-time as consultant librarian\n- Regular imaging surveillance continues\n\nFUNCTIONAL SCORES:\nInitial Presentation (2014):\n- KPS: 70\n- ECOG: 2\n\nCurrent (2024):\n- KPS: 90\n- ECOG: 1\n\nMONITORING PROTOCOL:\n- MRI every 6 months\n- Annual neuropsychological testing\n- Quarterly neurosurgical review\n- Regular ophthalmological assessment\n\nWHO Grade: II (Atypical Meningioma)\nSimpson Resection Grade: II\n\nThis case demonstrates successful aggressive management of WHO Grade II meningioma with long-term stability achieved through multimodal treatment approach.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 65\nGender: Female\nOccupation: Librarian\nBlood Type: A\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms over 4 months\n\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Moderate peritumoral edema\n- No significant mass effect\n- WHO Grade I (based on imaging characteristics)\n\nASSESSMENT:\nDespite symptomatic presentation, given the tumor size <3cm and patient's preference for conservative management, recommending close monitoring with option for intervention if progression occurs. Current symptoms may be partially managed with medical therapy.\n\nPLAN:\n1. Start Dexamethasone 4mg BID for edema management\n2. Follow-up MRI in 3 months\n3. Anti-seizure prophylaxis not indicated at this time\n4. Continue current medications\n5. Occupational modifications discussed - recommended reduced screen time and frequent breaks\n\nFOLLOW-UP VISIT - June 20, 2014\n- Improvement in headaches and vision\n- Dexamethasone tapered to 2mg daily\n- MRI shows stable tumor size\n- Continue conservative management\n\nANNUAL FOLLOW-UP - March 2015\n- Symptoms stable\n- MRI shows no growth\n- Discontinued dexamethasone\n- Annual monitoring plan implemented\n\nANNUAL FOLLOW-UP - March 2016\n- Minor headache complaints\n- No new neurological symptoms\n- MRI stable\n- Maintaining work schedule with modifications\n\nANNUAL FOLLOW-UP - March 2017\n- Stable symptoms\n- MRI unchanged\n- Patient satisfied with conservative approach\n\nBIENNIAL FOLLOW-UP - March 2019\n- Mild increase in headache frequency\n- MRI shows minimal growth (0.2cm)\n- Added prophylactic topiramate 50mg daily\n\nBIENNIAL FOLLOW-UP - March 2021\n- Well-controlled symptoms\n- MRI stable\n- Continuing conservative management\n\nBIENNIAL FOLLOW-UP - March 2023\n- Stable neurological status\n- MRI unchanged\n- Patient retired from library work\n- Quality of life well-maintained\n\nLATEST FOLLOW-UP - January 2024\n- Continued stability\n- No new symptoms\n- MRI unchanged from 2021\n- Patient satisfied with management approach\n\nFUNCTIONAL STATUS SCORES:\n- Karnofsky Performance Status (KPS): 90\n- ECOG Performance Status: 1\n\nCURRENT MANAGEMENT:\n- Biennial MRI surveillance\n- Regular blood pressure monitoring\n- Lifestyle modifications maintained\n- Topiramate 50mg daily\n- Regular balance assessments\n\nThe conservative management approach has proven successful over 10 years, with stable disease and well-maintained quality of life. Patient has adapted well to recommended lifestyle modifications and continues to function independently.\n\nWHO Grade: I (based on imaging characteristics and stability over time)"
      }
    },
    {
      "demographics": {
        "age": 50,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": "Wine Taster",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, particularly in the morning; Recent changes in sense of smell affecting wine-tasting ability; Intermittent blurred vision in right eye; Occasional episodes of nausea without vomiting; Subtle personality changes noted by coworkers (increased irritability); Difficulty concentrating during data analysis tasks that used to be routine; Two episodes of brief loss of balance in past month"
        ],
        "medical_history": [
          "Mild hypertension diagnosed 2 years ago, managed with lifestyle modifications; Concussion from skiing accident 15 years ago with full recovery; Family history of migraines (mother); History of occasional tension headaches responding well to OTC medications; No history of seizures; No prior neurological conditions; Annual eye exams normal until 6 months ago showing slight right optic disc edema; No history of cancer; Non-smoker; Moderate alcohol consumption due to profession"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M50-O-DS-WT\nPrimary Diagnosis: Meningioma (WHO Grade II)\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 4.2 cm right frontal meningioma with significant mass effect\n- Moderate peritumoral edema\n- Compression of olfactory tract and right optic nerve\n- Evidence of hyperostosis of adjacent frontal bone\n- Contrast enhancement pattern suggestive of higher-grade meningioma\n\nASSESSMENT:\nPatient's occupational requirements as data scientist and wine taster demand optimal cognitive and sensory function. Symptoms significantly impacting quality of life and work performance. Size and location of tumor warrant immediate intervention.\n\nTREATMENT PLAN:\nRecommended aggressive surgical resection (Simpson Grade I-II) followed by targeted radiation therapy.\n\nSURGICAL INTERVENTION - April 2, 2018\n- Right frontotemporal craniotomy\n- Simpson Grade II resection achieved\n- Pathology: WHO Grade II meningioma\n- No immediate post-operative complications\n\nFOLLOW-UP VISITS:\n\nJune 15, 2018 (2.5 months post-op)\n- Significant improvement in headaches and vision\n- Partial recovery of olfactory function\n- Started adjuvant radiation therapy (54 Gy/30 fractions)\n- MRI: No residual tumor\n\nDecember 2018 (8 months post-op)\n- Completed radiation therapy\n- Returned to work part-time\n- Some improvement in wine-tasting ability\n- MRI: No recurrence\n\nJune 2019 (14 months post-op)\n- Full-time work resumed\n- Mild radiation-related fatigue resolved\n- MRI: Stable\n\nJanuary 2020 (21 months post-op)\n- Small area of enhancement noted on MRI\n- Increased monitoring frequency\n- Watchful waiting approach adopted\n\nJuly 2020\n- Enhancement stable\n- Full professional function restored\n- Regular wine-tasting activities resumed\n\nJanuary 2021\n- MRI shows slight progression of enhancement\n- Gamma Knife radiosurgery performed on residual tissue\n\n2022 (Biannual visits)\n- Stable disease\n- No new neurological symptoms\n- Maintaining professional activities\n\n2023 (Quarterly monitoring)\n- Continued stability\n- Minor radiation changes on imaging\n- Excellent functional status\n\n2024 (Current status)\n- No evidence of progression\n- Full professional and social function\n- Annual MRI surveillance recommended\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nONGOING MONITORING:\n- MRI every 6 months\n- Quarterly neurological examinations\n- Annual ophthalmological assessment\n- Regular cognitive function testing\n- Quality of life assessments\n\nNote: WHO Grade II classification and patient's occupational requirements justified aggressive initial approach and careful monitoring schedule.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n50-year-old male, Blood Type O\nOccupation: Data Scientist/Professional Wine Taster\n\nINITIAL VISIT - March 15, 2014\nPresenting Symptoms: Progressive headaches, anosmia affecting occupation, right eye visual disturbance, balance issues, cognitive changes impacting work performance.\nMRI Findings: 2.8cm right frontal meningioma, minimal peritumoral edema, WHO Grade I\nKPS: 90/100\nECOG: 1\n\nTREATMENT DECISION:\nGiven tumor size <3cm, minimal edema, and patient's occupation requiring preserved olfactory function, recommending conservative management with close monitoring.\n\nFOLLOW-UP SCHEDULE:\n- MRI every 6 months for first 2 years\n- Neurological assessment quarterly\n- Ophthalmological evaluation every 6 months\n\nSeptember 15, 2014\nStable tumor size. Visual symptoms improved with prescribed dexamethasone during symptomatic periods.\nImplemented workplace accommodations: increased screen breaks, anti-glare monitors.\nKPS: 90/100\n\nMarch 20, 2015\nMRI shows no growth. Headaches better managed with prophylactic medications.\nRecommended: Stress reduction techniques, sleep hygiene optimization\nStarted on low-dose propranolol for headache prophylaxis.\n\nSeptember 18, 2015\nStable imaging. Patient reports improved work performance with accommodations.\nModified wine tasting schedule to morning sessions when symptoms are minimal.\nKPS: 95/100\n\nANNUAL VISITS 2016-2018\n- Annual MRI shows stable tumor size\n- Maintained professional activities with adaptations\n- Headaches well-controlled\n- Balance issues resolved\n- Regular ophthalmology follow-up confirms stable vision\n\nMarch 15, 2019 (5-YEAR FOLLOW-UP)\nComprehensive evaluation shows:\n- No tumor growth\n- Excellent symptom control\n- Successfully maintaining professional activities\n- Transitioned to biennial MRI\nKPS: 95/100\nECOG: 0\n\n2020-2022\nBiennial MRI continues to show stability\nMinor adjustments to headache management as needed\nMaintaining full professional activity\n\nLATEST VISIT - January 2024\n10-year follow-up demonstrates successful conservative management:\n- Tumor remains stable at 2.8cm\n- Patient maintains high functional status\n- Continues both professional roles with minimal adaptation\n- Quality of life preserved\n\nCURRENT STATUS:\nKPS: 95/100\nECOG: 0\n\nWHO Grade: I (unchanged)\nManagement Strategy: Continue conservative approach with biennial MRI and annual clinical assessment.\n\nLong-term Recommendations:\n1. Continue biennial MRI surveillance\n2. Annual neurological assessment\n3. Maintain current lifestyle modifications\n4. Regular ophthalmological follow-up\n5. Stress management and sleep hygiene maintenance\n\nNote: Conservative management strategy has proven successful over 10-year period, validating initial approach. Patient has maintained professional activities and quality of life with minimal intervention."
      }
    },
    {
      "demographics": {
        "age": 48,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Coffee Roaster",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months becoming more severe in morning, intermittent blurred vision in right eye, occasional episodes of nausea, subtle personality changes noted by family members including increased irritability, recent difficulty with concentration while coding, two episodes of stumbling while walking in past month, reports mild right-sided facial numbness"
        ],
        "medical_history": [
          "Migraine headaches (well-controlled until recent changes), mild hypertension diagnosed 2 years ago - managed with lisinopril 10mg daily, history of mild asthma as child (resolved), tonsillectomy at age 12, family history notable for father with brain tumor (type unknown), no history of seizures or neurological disorders, no prior surgeries except tonsillectomy, non-smoker, occasional alcohol use (2-3 drinks/week), exposure to coffee roasting fumes for past 5 years in secondary job"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M48-O-2014\nOccupation: Software Developer/Coffee Roaster\n\nINITIAL VISIT - March 15, 2014\nPresenting Symptoms: Progressive headaches (3 months), right eye blurred vision, nausea, personality changes, concentration difficulties, gait instability, right facial numbness.\nInitial MRI Findings: 4.2cm left frontal convexity meningioma with significant peritumoral edema, mass effect on frontal lobe. Enhancement pattern consistent with meningioma. Moderate midline shift of 7mm.\nWHO Grade: Suspected Grade II (pending pathology)\nAssessment: Given size, symptoms, and occupation requiring high cognitive function, immediate surgical intervention recommended.\nPlan: Schedule craniotomy within 2 weeks. Pre-operative optimization with dexamethasone 4mg QID.\n\nSURGICAL NOTE - March 28, 2014\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade: II\nPathology: WHO Grade II atypical meningioma\nPost-op course: Uncomplicated\nPlan: Adjuvant radiation therapy recommended\n\nFOLLOW-UP - June 15, 2014\nStatus: Completed 6-week course of fractionated RT (60 Gy/30fx)\nSymptoms: Improving headaches, vision normalized\nMRI: Post-surgical changes, no residual tumor\nPlan: Q3 month MRI surveillance\n\n2015 VISITS (Q3 months):\n- March: Stable, returned to software development part-time\n- June: Full work resumption, advised against coffee roasting due to fume exposure\n- September: Stable imaging\n- December: Continued stability\n\n2016 VISITS (Q4 months):\n- April: Small enhancement at surgical margin (7mm)\n- August: Enhancement stable\n- December: No progression\n\n2017 VISITS (Q4 months):\n- April: Enhancement increased to 1.2cm\n- May: Gamma Knife radiosurgery to recurrence\n- September: Good response\n- December: Stable\n\n2018-2019 (Q6 months):\nAll visits showed stability\n\n2020 VISIT - January:\nNew 8mm nodule adjacent to previous resection\nPlan: Close monitoring\n\n2021-2024 (Annual visits):\nStable disease, no progression\nLast visit (January 2024): Continues software development, discontinued coffee roasting\nRegular MRI surveillance continues\n\nCurrent Status (2024):\n- Disease stable\n- Maintained cognitive function\n- Regular neurological monitoring\n- Annual MRI surveillance\n\nFunctional Status Scores:\nKPS: 90 (Able to carry on normal activity, minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nTreatment Summary:\n1. Initial craniotomy (2014)\n2. Adjuvant RT (2014)\n3. Gamma Knife for recurrence (2017)\n4. Ongoing surveillance\n\nNote: Aggressive initial approach with early intervention and regular monitoring has resulted in good disease control and maintained professional functionality. Patient successfully transitioned away from potentially hazardous coffee roasting occupation.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nPrimary Occupation: Software Developer\nSecondary Occupation: Coffee Roaster\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive headaches, visual changes, balance issues\n\nMRI FINDINGS:\n- 2.8cm left frontal parasagittal meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (suspected based on imaging characteristics)\n- No calcification noted\n\nASSESSMENT:\nGiven tumor size (<3cm), minimal edema, and stable employment requiring cognitive function, recommending close monitoring over immediate surgical intervention. Occupational exposure to coffee roasting fumes noted - recommended workplace safety evaluation.\n\nPLAN:\n1. Serial MRI monitoring\n2. Headache management optimization\n3. Occupational therapy evaluation\n4. Neurology consult for headache management\n\nFOLLOW-UP VISIT - September 20, 2018\nStable symptoms. MRI shows no growth. Patient reports improved headache control with adjusted medication regimen.\nWHO Grade: I (unchanged)\n\nANNUAL FOLLOW-UP - March 12, 2019\nMRI stable. Visual symptoms unchanged. Maintaining full-time work schedule.\nRecommended: Continue current management plan\n\nANNUAL FOLLOW-UP - March 18, 2020\nMinor increase in headache frequency. MRI shows minimal growth (0.2cm).\nAdded: Prophylactic migraine medication\nWHO Grade: I (unchanged)\n\nANNUAL FOLLOW-UP - March 15, 2021\nPatient stable. Working remotely due to COVID-19. Reports decreased exposure to coffee roasting fumes.\nMRI: No significant changes\nModified workplace ergonomics recommendations for home office\n\nANNUAL FOLLOW-UP - March 22, 2022\nMRI stable. Patient reports good quality of life. Maintaining both occupations with modifications.\nWHO Grade: I (unchanged)\n\nANNUAL FOLLOW-UP - March 14, 2023\nMinor progression of visual symptoms. MRI shows 0.3cm growth over 5 years.\nDiscussed surgical options but maintaining conservative approach given slow progression.\n\nRECENT FOLLOW-UP - January 10, 2024\nMRI shows stable disease. Patient maintaining good functional status.\nContinuing conservative management with close monitoring.\n\nCURRENT MANAGEMENT PLAN:\n1. Continue bi-annual MRI surveillance\n2. Monthly headache diary\n3. Quarterly ophthalmology evaluations\n4. Occupational therapy as needed\n5. Regular workplace safety assessments for coffee roasting activities\n\nMEDICATIONS:\n- Lisinopril 10mg daily\n- Sumatriptan as needed for breakthrough headaches\n- Topiramate 50mg daily for migraine prophylaxis\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90 - Able to carry on normal activity; minor signs/symptoms of disease\nECOG: 1 - Restricted in physically strenuous activity but ambulatory and able to carry out light work\n\nRECOMMENDATIONS:\n1. Continue current monitoring schedule\n2. Consider surgical intervention if significant progression\n3. Maintain workplace safety protocols\n4. Regular cognitive function assessments\n5. Quality of life assessments every 6 months\n\nWHO Grade: I (consistent throughout monitoring period)\n\nNext scheduled follow-up: July 2024"
      }
    },
    {
      "demographics": {
        "age": 63,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work, especially when looking at computer screens",
          "Mild right-sided facial numbness that developed gradually",
          "Balance issues when walking, particularly noticeable in past 2 months"
        ],
        "medical_history": [
          "Hypertension - diagnosed 8 years ago, managed with lisinopril",
          "Migraine headaches since age 40, but pattern has changed recently",
          "BMI 33.2 - Class I Obesity",
          "Surgical history: Cholecystectomy (2010)",
          "Hormone replacement therapy for 5 years post-menopause (stopped 3 years ago)",
          "Family history of breast cancer (mother)",
          "No history of smoking or significant alcohol use",
          "Regular mammograms, last one normal 8 months ago"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nGender: Female | Age: 63 | Blood Type: O\nOccupation: Software Developer\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive headaches, visual changes, facial numbness\n\nMRI FINDINGS:\n- 4.2 cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Evidence of dural tail sign\n- Moderate midline shift (6mm)\n\nASSESSMENT:\nWHO Grade II Meningioma (confirmed post-surgery)\nHigh-risk features:\n- Size >3cm\n- Significant peritumoral edema\n- Proximity to motor strip\n- Occupational impact (visual/cognitive demands)\n\nTREATMENT PLAN:\nRecommend immediate surgical intervention due to:\n1. Symptomatic presentation\n2. Size and location\n3. Impact on patient's cognitive work requirements\n4. Progressive neurological symptoms\n\nSURGICAL INTERVENTION - April 2, 2018\n- Simpson Grade II resection\n- Subtotal removal due to adherence to superior sagittal sinus\n- Post-op MRI shows small residual (0.8cm)\n\nFOLLOW-UP VISITS:\n\nJuly 2018 (3 months post-op)\n- Improved headaches\n- Residual mild right facial numbness\n- Started adjuvant radiation therapy\n- KPS: 80\n\nJanuary 2019 (9 months post-op)\n- Completed radiation therapy\n- Stable residual tumor\n- Return to work part-time\n- MRI: No progression\n- KPS: 90\n\nJuly 2019 (15 months post-op)\n- Full-time work resumed\n- Minor visual complaints\n- MRI: Stable\n- KPS: 90\n\nJanuary 2020\n- Surveillance MRI: Stable\n- No new symptoms\n- Weight management program initiated\n- KPS: 90\n\nJuly 2020\n- Small increase in residual tumor (1.0cm)\n- Increased monitoring frequency\n- KPS: 85\n\nJanuary 2021\n- Further growth (1.3cm)\n- New treatment planning initiated\n- Gamma Knife radiosurgery scheduled\n- KPS: 85\n\nApril 2021\n- Gamma Knife completed\n- Well-tolerated\n- KPS: 85\n\nJanuary 2022\n- Post-radiosurgery MRI: tumor reduction to 0.9cm\n- Improved symptoms\n- KPS: 90\n\nJanuary 2023\n- Stable disease\n- Annual monitoring continued\n- Weight reduction achieved (BMI 31.5)\n- KPS: 90\n\nJanuary 2024\n- 6-year follow-up\n- Stable disease\n- Maintaining work performance\n- Regular cognitive assessments: stable\n- KPS: 90\n\nCURRENT STATUS (2024):\n- Disease stable\n- Maintained cognitive function\n- Regular monitoring continues\n- Working full-time with accommodations\n\nSCORES:\nKarnofsky Performance Status (KPS): 90/100\nECOG Performance Status: 1\n\nMONITORING PROTOCOL:\n- MRI every 6 months\n- Neurological examination every 3 months\n- Annual neuropsychological testing\n- Regular ophthalmological assessment\n\nOCCUPATIONAL CONSIDERATIONS:\n- Ergonomic workplace assessment\n- Regular screen breaks\n- Modified work schedule as needed\n- Blue light filtering for computer work\n\nLong-term prognosis remains guarded due to WHO Grade II status, requiring continued vigilant monitoring and proactive intervention for any signs of progression.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 63, Female, Blood Type: O\nOccupation: Software Developer\n\nINITIAL VISIT - January 15, 2018\nChief Complaint: Progressive headaches, visual changes, balance issues\nWHO Grade: I (based on imaging characteristics)\n\nImaging Findings:\n- MRI reveals 2.4cm left frontal convexity meningioma\n- Minimal perilesional edema\n- No mass effect on critical structures\n- T2 signal: moderately intense\n- Contrast enhancement: homogeneous\n\nAssessment:\nDespite symptomatic presentation, given tumor size <3cm and patient's preference, recommending conservative management with close monitoring. Occupational considerations (computer work) warrant careful attention to visual symptoms.\n\nPlan:\n1. MRI surveillance every 4 months initially\n2. Ophthalmology referral for baseline assessment\n3. Optimization of blood pressure management\n4. Ergonomic workplace assessment\n5. Consider prophylactic anti-seizure medication\n\nFOLLOW-UP VISIT - May 20, 2018\nStable symptoms. Minor improvement in headaches with workplace modifications.\nMRI: No significant change in tumor size\nPlan: Continue monitoring\n\nFOLLOW-UP - September 15, 2018\nVisual symptoms stable. Headaches better controlled.\nMRI: Stable\n\nANNUAL REVIEW - January 10, 2019\nTumor stable. Patient adapted well to workplace modifications.\nPlan: Extend MRI intervals to 6 months\n\n2020 VISITS (June 15 & December 10)\nMinimal growth (2.6cm). Symptoms stable.\nContinue conservative management.\n\n2021 VISITS (June 8 & December 5)\nSize stable at 2.6cm. Patient managing work well with accommodations.\nAdded: Balance exercises through physical therapy\n\n2022 VISITS (June 12 & December 8)\nMinor progression to 2.8cm. Symptoms stable.\nDiscussed surgical options but maintaining conservative approach given stability.\n\n2023 VISITS (June 15 & December 12)\nSize stable. Quality of life maintained.\nPatient approaching retirement, reducing computer work hours.\n\n2024 CURRENT STATUS (January 15)\nTumor size: 2.8cm (stable since 2022)\nSymptoms well-managed with conservative approach\nPatient retired, reporting improved work-life balance\n\nMANAGEMENT SUMMARY:\n- Successfully maintained conservative approach for 6 years\n- Regular MRI surveillance\n- Lifestyle modifications effective\n- No surgical intervention required\n- Quality of life preserved\n\nCurrent Performance Status:\nKPS Score: 90 (Able to carry on normal activity with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nRECOMMENDATIONS:\nContinue bi-annual MRI surveillance\nMaintain blood pressure control\nRegular ophthalmology follow-up\nContinue balance exercises\nAnnual neuropsychological assessment\n\nNote: Conservative management successful due to:\n- Slow growth rate\n- Patient compliance\n- Effective symptom management\n- Regular monitoring\n- Successful lifestyle adaptations"
      }
    },
    {
      "demographics": {
        "age": 42,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of dizziness and mild balance issues",
          "Occasional nausea without vomiting",
          "Right-sided facial numbness that developed gradually over 2 months",
          "Increased fatigue and difficulty concentrating at work"
        ],
        "medical_history": [
          "Migraine headaches since age 25, well-controlled with sumatriptan",
          "Surgical removal of ovarian cyst 5 years ago",
          "Family history of breast cancer (maternal aunt)",
          "No history of radiation exposure",
          "Regular mammograms, last one normal 8 months ago",
          "No prior neurological conditions",
          "Currently taking oral contraceptives for 10+ years",
          "No significant head trauma"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered"
          ],
          "monitoring_plan": "Standard MRI every 3 months",
          "surgical_approach": "",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Standard MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - 03/15/2014\nPatient: 42F, Blood Type A\nChief Complaint: Progressive neurological symptoms with right-sided predominance\n\nIMAGING:\nInitial MRI reveals a 4.2 cm right sphenoid wing meningioma with significant mass effect and moderate peritumoral edema. Enhancement pattern suggests WHO Grade II. Compression of optic apparatus noted.\n\nASSESSMENT:\nGiven size, location, and progressive symptoms, immediate surgical intervention recommended. High-risk features include:\n- Size >3cm\n- Proximity to critical structures (optic apparatus)\n- Progressive neurological symptoms\n- Impact on daily function/work performance\n\nPLAN:\n1. Schedule surgical resection within 2 weeks\n2. Pre-operative optimization\n3. Simpson Grade I resection targeted\n4. Discussed risks/benefits with patient\n\nSURGICAL NOTE - 04/01/2014\nProcedure: Right frontotemporal craniotomy for tumor resection\nFindings: WHO Grade II meningioma confirmed\nSimpson Grade II resection achieved\nNo immediate complications\n\nFOLLOW-UP VISITS:\n\n06/15/2014 (2.5 months post-op)\n- Improved headaches and vision\n- Residual facial numbness\n- MRI: Small residual tumor (1.1cm)\n- Plan: Adjuvant radiotherapy recommended\n\n12/15/2014 (8 months post-op)\n- Completed RT (54 Gy/30 fractions)\n- Improved symptoms\n- MRI: Stable residual disease\n\n06/15/2015\n- Surveillance MRI: No progression\n- Minor fatigue persists\n- Return to full-time work\n\n12/20/2015\n- Stable symptoms\n- MRI unchanged\n- Continue q6month monitoring\n\nAnnual visits 2016-2019:\n- Regular MRI surveillance\n- No tumor progression\n- Gradual improvement in quality of life\n- Maintained work status\n\n01/15/2020\n- Small increase in residual tumor (1.4cm)\n- New onset occasional headaches\n- Plan: Increased monitoring frequency\n\n06/20/2020\n- Further growth (1.8cm)\n- Plan: Stereotactic radiosurgery to residual tumor\n\n2021-2024:\n- Quarterly then semi-annual MRI\n- Post-SRS: Tumor stabilization\n- Well-controlled symptoms\n- Continues regular follow-up\n\nCurrent Status (2024):\n- Disease stable\n- Functionally independent\n- Working full-time\n- Annual MRI surveillance planned\n\nFunctional Status Scores:\nKPS: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nWHO Grade: II\nSimpson Grade: II\nCurrent Follow-up Protocol: Annual MRI with clinical assessment\n\nNote: Aggressive initial approach with early intervention and close monitoring has resulted in good disease control and maintained quality of life over 10-year period.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nGender: Female | Age: 42 | Blood Type: A\n\nINITIAL VISIT - January 15, 2018\nChief Complaint: Progressive headaches, visual changes, and neurological symptoms\nWHO Grade: I (based on imaging characteristics)\n\nMRI Findings:\n- 2.4cm right sphenoid wing meningioma\n- Minimal perilesional edema\n- No significant mass effect\n- T2 signal: Mildly hyperintense\n- Contrast enhancement: Homogeneous\n\nAssessment:\nDespite presenting symptoms, tumor size and location favor initial conservative management. Patient's occupation as an office worker allows for flexible follow-up scheduling. KPS 90/100.\n\nPlan:\n1. Hold oral contraceptives (may influence tumor growth)\n2. Monthly headache diary\n3. Quarterly ophthalmology evaluations\n4. MRI follow-up in 3 months\n\nFOLLOW-UP - April 20, 2018\n- Tumor stable at 2.4cm\n- Headaches improved after discontinuing OCPs\n- Vision stabilized\n- Continue conservative management\n\nFOLLOW-UP - October 15, 2018\n- No tumor growth\n- Symptoms stable\n- Transition to 6-month MRI intervals\n\nANNUAL FOLLOW-UP - October 10, 2019\n- Tumor size 2.5cm (minimal growth)\n- Symptoms well-controlled\n- Started prophylactic topiramate for headaches\n\nANNUAL FOLLOW-UP - October 15, 2020\n- Stable at 2.5cm\n- Excellent symptom control\n- Maintaining work schedule with accommodations\n\nANNUAL FOLLOW-UP - October 12, 2021\n- No significant growth\n- Patient adapted well to conservative management\n- Continue annual monitoring\n\nANNUAL FOLLOW-UP - October 18, 2022\n- Tumor stable\n- Quality of life maintained\n- Minor balance issues resolved with PT\n\nANNUAL FOLLOW-UP - October 16, 2023\n- Continued stability\n- Patient satisfied with conservative approach\n- Maintaining full-time work\n\nLATEST FOLLOW-UP - March 15, 2024\n- Tumor remains stable at 2.5cm\n- Excellent functional status\n- Continue annual monitoring\n\nMANAGEMENT SUMMARY:\nConservative approach successful over 6-year period\n- Regular MRI surveillance\n- Symptom management with medications\n- Lifestyle modifications\n- Occupational adjustments implemented\n\nCurrent Status:\nKPS (Karnofsky Performance Status): 90/100\nECOG Performance Status: 1\n\nRecommendations:\n1. Continue annual MRI\n2. Maintain headache diary\n3. Annual ophthalmology check\n4. Regular neurological assessments\n5. Consider surgical intervention only if:\n   - Significant tumor growth (>1cm)\n   - Progressive symptoms\n   - Visual deterioration\n\nNote: Conservative management successful due to:\n- Stable tumor size\n- Well-controlled symptoms\n- Patient compliance\n- Good quality of life maintenance\n- Successful occupational adaptation"
      }
    },
    {
      "demographics": {
        "age": 58,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work, especially when reviewing financial documents",
          "Mild right-sided facial numbness",
          "Balance issues when walking, particularly noticeable in last 2 months"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches in 30s, resolved spontaneously",
          "Surgical history: Cholecystectomy (2010)",
          "Hormone replacement therapy for 3 years post-menopause (discontinued 2019)",
          "Family history: Mother with breast cancer",
          "No history of smoking",
          "Occasional alcohol use (2-3 glasses of wine per week)",
          "Regular mammograms, last one normal (6 months ago)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F58-O-2014\nOccupation: Financial Analyst\n\nINITIAL VISIT - March 15, 2014\nPresenting Symptoms: Progressive headaches, right eye visual disturbance, nausea, personality changes, concentration difficulties, right facial numbness, and balance issues. Symptoms significantly impacting work performance as Financial Analyst.\n\nInitial MRI Findings:\n- 4.2 cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Evidence of dural tail sign\n\nAssessment:\nGiven size >3cm, peritumoral edema, and progressive neurological symptoms, immediate surgical intervention recommended. Location and symptoms suggest high-risk features requiring aggressive management.\n\nPlan:\n1. Scheduled for craniotomy and gross total resection within 2 weeks\n2. Pre-operative imaging protocol initiated\n3. Neurocognitive baseline testing ordered\nWHO Grade: II (confirmed post-surgery)\n\nFOLLOW-UP - April 10, 2014 (Post-operative)\n- Successful gross total resection achieved\n- Minimal residual enhancement on post-op MRI\n- Pathology confirms WHO Grade II meningioma\n- Initiated adjuvant radiation therapy (60 Gy/30 fractions)\n\nFOLLOW-UP - October 15, 2014 (6 months post-op)\n- Improved visual symptoms\n- Resolving headaches\n- MRI shows no recurrence\n- Returned to work part-time\n\nFOLLOW-UP - April 2015 (1 year post-op)\n- Complete resolution of initial symptoms\n- MRI stable\n- Full return to work\n- Continuing q6month monitoring\n\nANNUAL NOTES 2016-2019:\n- Bi-annual MRIs show no recurrence\n- Maintaining good functional status\n- Regular neurocognitive assessments stable\n- Continuing professional work without limitations\n\nFOLLOW-UP - March 2020\n- Small enhancement noted on routine MRI\n- 0.8 cm recurrence at original site\n- Proactive SRS recommended and completed (16 Gy single fraction)\n\nFOLLOW-UP 2021-2024:\n- Quarterly MRI surveillance\n- No further progression\n- Maintained professional activities\n- Annual neuropsychological testing stable\n\nCurrent Status (2024):\n- Disease stable\n- Fully functional at work\n- Maintaining regular surveillance\n\nPerformance Scores:\nKPS: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nTreatment Summary:\n1. Initial craniotomy with gross total resection (2014)\n2. Adjuvant radiation therapy completed\n3. SRS for small recurrence (2020)\n4. Ongoing surveillance\n\nPrognosis: Favorable with continued monitoring\nNext Follow-up: Scheduled for quarterly MRI and clinical assessment",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient: 58-year-old Female, Blood Type O\nOccupation: Financial Analyst\n\nINITIAL VISIT - September 15, 2014\nMRI FINDINGS:\n- 2.8cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (suspected based on imaging characteristics)\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms affecting work performance. Given tumor size and location, conservative management with close monitoring is recommended initially.\n\nMANAGEMENT PLAN:\n1. Serial MRI monitoring\n2. Symptomatic treatment:\n   - Dexamethasone 4mg BID for edema control\n   - Gradual taper over 4 weeks\n3. Occupational adjustments recommended:\n   - Regular breaks during detailed financial analysis\n   - Screen magnification for document review\n   - Ergonomic workspace assessment\n\nFOLLOW-UP VISIT - March 20, 2015\n- Symptoms partially improved with steroid therapy\n- MRI shows stable tumor size\n- KPS 90\n- Continue conservative management\n\nANNUAL FOLLOW-UP - February 12, 2016\n- Stable symptoms\n- MRI unchanged\n- Patient managing work duties with accommodations\n- Maintaining good quality of life\n- KPS 90\n\nANNUAL FOLLOW-UP - February 8, 2017\n- Slight increase in headache frequency\n- MRI shows minimal growth (0.2cm)\n- Added prophylactic topiramate 50mg daily\n- Continue watchful waiting\n- KPS 85\n\nANNUAL FOLLOW-UP - March 5, 2018\n- Improved headache control\n- Vision stable\n- MRI stable\n- Patient maintaining full-time work\n- KPS 85\n\nANNUAL FOLLOW-UP - April 10, 2019\n- New complaint of increased right facial numbness\n- MRI shows 0.3cm growth\n- Discussed surgical options but patient prefers continued observation\n- KPS 80\n\nANNUAL FOLLOW-UP - May 15, 2020\n- Stable symptoms\n- MRI unchanged\n- Maintaining work with accommodations\n- KPS 80\n\nANNUAL FOLLOW-UP - June 8, 2021\n- Increased balance issues\n- MRI shows minimal progression\n- Referred for physical therapy\n- Consider radiation therapy if symptoms worsen\n- KPS 75\n\nANNUAL FOLLOW-UP - July 12, 2022\n- Balance improved with PT\n- MRI stable\n- Continuing conservative management\n- KPS 75\n\nANNUAL FOLLOW-UP - August 9, 2023\n- Stable symptoms\n- MRI unchanged\n- Patient satisfied with conservative approach\n- KPS 75\n\nMOST RECENT FOLLOW-UP - February 15, 2024\n- All symptoms stable\n- MRI shows no significant change\n- Patient continues full-time work with accommodations\n- Conservative management successful\n- KPS 75\n\nCURRENT STATUS:\nKPS Score: 75/100\nECOG Score: 1\n\nLONG-TERM RECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain current medications\n3. Regular physical therapy sessions\n4. Occupational therapy as needed\n5. Regular ophthalmology check-ups\n6. Consider radiation therapy only if significant progression\n\nThe conservative management approach has been successful in maintaining patient's quality of life and allowing continued professional activity with appropriate accommodations. Will continue close monitoring with low threshold for intervention if significant progression occurs."
      }
    },
    {
      "demographics": {
        "age": 45,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": "Baker",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Difficulty concentrating at work, especially when looking at computer screens",
          "Occasional ringing in right ear",
          "Reports feeling more clumsy lately, dropping items while baking",
          "Mild right-sided facial numbness noticed in past 2 weeks"
        ],
        "medical_history": [
          "Migraine headaches since age 30, but notes current headaches feel different",
          "Myopia, corrected with glasses (-2.0 diopters both eyes)",
          "Tonsillectomy at age 12",
          "No history of cancer",
          "No previous head trauma or neurological conditions",
          "Regular mammograms, last one normal 8 months ago",
          "No family history of brain tumors",
          "Currently taking oral contraceptives (10+ years)",
          "No significant radiation exposure history"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F45-O-2014\nOccupation: Data Scientist/Baker\n\nINITIAL VISIT - March 15, 2014\nPresenting Symptoms: Progressive headaches, right visual disturbance, nausea, concentration difficulties, right-sided tinnitus, coordination issues, and facial numbness. Symptoms significantly impact both professional activities (computer work) and baking hobby.\n\nInitial MRI Findings:\n- 3.8cm right sphenoid wing meningioma\n- Significant mass effect on temporal lobe\n- Moderate peritumoral edema\n- Compression of optic nerve\nWHO Grade: II (atypical features on imaging)\n\nTreatment Plan:\nRecommend immediate surgical intervention due to:\n1. Size >3cm\n2. Critical location affecting vision\n3. Progressive neurological symptoms\n4. Impact on daily activities/occupation\n\nSURGICAL NOTE - April 2, 2014\nProcedure: Right frontotemporal craniotomy for tumor resection\nSimpson Grade II resection achieved\nMinimal residual tumor at cavernous sinus interface\nPost-op course uncomplicated\n\nFOLLOW-UP - July 15, 2014\nPatient reports improvement in headaches and vision\nResidual mild facial numbness\nMRI: Small residual enhancement at surgical site\nRecommended adjuvant radiotherapy\nStarted 54 Gy/30 fractions\n\nFOLLOW-UP - January 10, 2015\nPost-radiation follow-up\nSymptoms stable\nMRI: No progression of residual tumor\nCleared to return to full work duties\n\nFOLLOW-UP - July 2015, January 2016, July 2016\nBi-annual MRIs: Stable\nMinor headaches managed with standard analgesics\nReturned to both occupations successfully\n\nFOLLOW-UP - January 2017\nSlight enhancement noted in residual tumor\nIncreased monitoring frequency\n\nFOLLOW-UP - April 2017\nMRI shows small progression\nSecond surgery recommended and performed\nSimpson Grade I achieved\n\nANNUAL FOLLOW-UPS 2018-2020\nAll stable, no recurrence\nRegular MRI monitoring\nPatient maintaining full work schedule\n\nFOLLOW-UP - March 2021\nSmall recurrence noted\nGamma Knife radiosurgery performed\n18 Gy single fraction\n\nFOLLOW-UP 2022-2024\nQuarterly then bi-annual MRIs\nAll stable\nPatient continues both occupations with minimal limitations\n\nCurrent Status (2024):\n- Disease controlled\n- Maintaining professional activities\n- Annual MRI surveillance recommended\n- Minor residual facial numbness\n\nFunctional Status Scores:\nKPS: 90 (Able to carry on normal activity, minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nTreatment Summary:\n- Initial craniotomy (2014)\n- Adjuvant radiotherapy\n- Second surgery (2017)\n- Gamma Knife for recurrence (2021)\n- Ongoing surveillance\n\nNote: Aggressive initial approach and careful monitoring have allowed patient to maintain both professional roles while managing disease progression effectively.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F45-O-2014\nOccupation: Data Scientist/Baker\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms including headaches and visual changes\n\nMRI FINDINGS:\n- 2.8cm right sphenoid wing meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- WHO Grade I (likely)\n- No signs of aggressive features\n\nASSESSMENT & PLAN:\nGiven the size (<3cm) and location, recommending close monitoring with potential for conservative intervention. Patient's dual occupation requires careful attention to visual and cognitive function.\n\nMANAGEMENT STRATEGY:\n1. Watchful waiting with regular imaging\n2. Symptom management:\n   - Prophylactic anticonvulsants not indicated\n   - Dexamethasone 4mg daily for edema control\n   - Discontinuation of oral contraceptives recommended\n\nFOLLOW-UP SCHEDULE:\n- MRI every 4 months for first year\n- Ophthalmology evaluation quarterly\n- Monthly headache diary\n\n-------------------\n\nFOLLOW-UP VISIT - July 20, 2014\nSymptoms slightly improved with steroid therapy\nMRI: No significant change\nPlan: Continue current management\n\n-------------------\n\nANNUAL REVIEW - March 10, 2015\nTumor stable\nVisual symptoms stable\nReduced steroid dose to 2mg daily\nWork modifications implemented: ergonomic computer setup, regular breaks\n\n-------------------\n\nFOLLOW-UP - March 15, 2016\nMRI: Minimal growth (0.2cm in 2 years)\nSymptoms well-controlled\nPlan: Continue conservative management\nAdded: Occupational therapy for baking activities\n\n-------------------\n\nFOLLOW-UP - March 20, 2018\nTumor stability maintained\nPatient adapted well to work modifications\nMRI frequency reduced to annual\n\n-------------------\n\nFOLLOW-UP - March 15, 2020\nCOVID-19 Telehealth Visit\nSymptoms stable\nPrevious MRI (January 2020): No progression\nVirtual ergonomic assessment for home office\n\n-------------------\n\nFOLLOW-UP - March 10, 2022\nComplete neurological assessment\nMRI: Continued stability\nPatient successfully managing both careers\nMinor adjustments to work schedule recommended\n\n-------------------\n\nLATEST FOLLOW-UP - February 15, 2024\n10-year follow-up review\nMRI: Tumor remains stable at 3.0cm\nSymptoms well-controlled\nPatient maintains high functional status\n\nFUNCTIONAL STATUS SCORES:\n- Karnofsky Performance Status (KPS): 90\n- ECOG Performance Status: 1\n\nCURRENT MANAGEMENT:\n1. Annual MRI surveillance\n2. Bi-annual ophthalmology check\n3. PRN dexamethasone (rarely needed)\n4. Ergonomic workplace modifications\n5. Regular exercise program\n6. Stress management techniques\n\nQUALITY OF LIFE:\n- Maintains both careers successfully\n- Adapted baking techniques to accommodate occasional coordination issues\n- Manages computer work with regular breaks and proper positioning\n\nThe conservative management approach has proven successful over 10 years with minimal impact on patient's quality of life and career functions. Will continue current surveillance protocol.\n\nNext appointment: February 2025\nNext MRI: January 2025"
      }
    },
    {
      "demographics": {
        "age": 40,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increasing difficulty concentrating at work",
          "Reports subtle personality changes noted by coworkers - more irritable than usual",
          "Occasional episodes of right-sided facial numbness",
          "Mild balance issues when walking, especially when turning quickly"
        ],
        "medical_history": [
          "Migraine headaches since age 25, well-controlled with sumatriptan",
          "Myopia, corrected with glasses since childhood",
          "Tonsillectomy at age 12",
          "No history of cancer",
          "No previous neurological conditions",
          "No family history of brain tumors",
          "Regular annual check-ups with normal findings",
          "No significant trauma history",
          "Non-smoker",
          "Occasional alcohol use (1-2 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F40-O-MEN\nOccupation: Librarian\n==================================\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms including headaches, visual changes, and balance issues.\n\nMRI FINDINGS:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Compression of superior sagittal sinus\n\nASSESSMENT:\nGiven patient's young age, occupation requiring cognitive focus, and progressive symptomatology, immediate surgical intervention recommended. High-risk features include size >3cm, peritumoral edema, and proximity to critical venous structures.\n\nPLAN:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative optimization\n3. Detailed neuropsychological testing\n4. Visual field testing\nKPS: 80 ECOG: 1\n\n-----------------------------------\n\nSURGICAL NOTE - March 29, 2014\nPROCEDURE: Right frontal craniotomy for tumor resection\n- Simpson Grade II resection achieved\n- Tumor adherent to superior sagittal sinus\n- Estimated blood loss: 400cc\n- No complications\n\nPATHOLOGY: WHO Grade II (Atypical) Meningioma\n- Increased mitotic activity\n- Brain invasion present\n- Ki-67 index: 8%\n\n-----------------------------------\n\nPOST-OP FOLLOW-UP - April 15, 2014\n- Wound healing well\n- Improved headaches\n- Residual mild right facial numbness\nPLAN: \n- Initiate adjuvant radiation therapy\n- 54 Gy in 30 fractions\nKPS: 70 ECOG: 1\n\n-----------------------------------\n\n6-MONTH FOLLOW-UP - September 2014\n- Completed radiation therapy\n- Resolution of visual symptoms\n- Improved concentration at work\n- MRI: No evidence of residual/recurrent tumor\nPLAN: Continue q3 month monitoring\nKPS: 90 ECOG: 0\n\n-----------------------------------\n\nANNUAL FOLLOW-UP - March 2015\n- Functionally independent\n- Returned to full-time work\n- MRI: Stable post-surgical changes\nPLAN: Continue q6 month monitoring\nKPS: 100 ECOG: 0\n\n-----------------------------------\n\n3-YEAR FOLLOW-UP - March 2017\n- Asymptomatic\n- MRI: Small 8mm nodule at resection margin\nPLAN: \n- Increased monitoring frequency\n- Consider stereotactic radiosurgery if progression\nKPS: 100 ECOG: 0\n\n-----------------------------------\n\n5-YEAR FOLLOW-UP - March 2019\n- Nodule stable at 8mm\n- No new symptoms\n- Maintaining full work schedule\nPLAN: Continue q6 month monitoring\nKPS: 100 ECOG: 0\n\n-----------------------------------\n\n7-YEAR FOLLOW-UP - March 2021\n- Nodule increased to 12mm\n- No new symptoms\nINTERVENTION:\n- Gamma Knife radiosurgery to residual tumor\n- 16 Gy single fraction\nKPS: 90 ECOG: 0\n\n-----------------------------------\n\nCURRENT VISIT - January 2024\n- Post-radiosurgery MRI shows tumor regression\n- Asymptomatic\n- Continues full-time work\nPLAN: \n- Continue q6 month MRI surveillance\n- Annual neuropsychological testing\n- Consider molecular profiling if progression\n\nCurrent Status:\nKPS: 100\nECOG: 0\n\nLONG-TERM MONITORING PROTOCOL:\n1. Bi-annual MRI with volumetric analysis\n2. Annual neuropsychological assessment\n3. Regular ophthalmological evaluation\n4. Quality of life assessments\n5. Molecular testing if progression\n\nNote: Patient's occupation as librarian requires high cognitive function and visual acuity, justifying aggressive monitoring and early intervention approach.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient: 40F, Blood Type O\nOccupation: Librarian\nWHO Grade: I (confirmed via imaging characteristics)\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm right frontal convexity meningioma\n- Minimal peritumoral edema\n- No mass effect on critical structures\n- Dural tail sign present\n- T2 isointense\n\nASSESSMENT:\nDespite presenting symptoms, tumor characteristics favor initial conservative management. Size <3cm and minimal edema are favorable prognostic factors. Occupation requires cognitive function preservation.\n\nPLAN:\n1. Watchful waiting with serial imaging\n2. Symptomatic management:\n   - Prophylactic anticonvulsants not indicated\n   - Continue sumatriptan for migraines\n   - Added dexamethasone 4mg BID for 2 weeks with taper\n3. Occupational modifications recommended:\n   - Frequent breaks during reading tasks\n   - Ergonomic workplace assessment\n   - Reduced screen time\n\nFOLLOW-UP - September 20, 2018 (6 months)\n- Symptoms improved with steroid course\n- MRI: Stable tumor size\n- Vision symptoms resolved\n- Maintaining work schedule with modifications\nPLAN: Continue monitoring\n\nANNUAL FOLLOW-UP - March 12, 2019\n- MRI: No growth (2.8cm)\n- Headaches stable, managed with current regimen\n- Balance issues resolved\nPLAN: Annual MRI continuation\n\nANNUAL FOLLOW-UP - March 18, 2020\n- MRI: Minimal growth (2.9cm)\n- Symptoms stable\n- Adapted well to workplace modifications\nPLAN: Continue conservative management\n\nANNUAL FOLLOW-UP - March 15, 2021\n- MRI: Stable (2.9cm)\n- No new symptoms\n- Maintaining full-time work\nPLAN: Extend to 18-month imaging interval\n\n18-MONTH FOLLOW-UP - September 20, 2022\n- MRI: Stable\n- Excellent functional status\n- Well-adjusted to management strategy\nPLAN: Continue current approach\n\nBIENNIAL FOLLOW-UP - September 15, 2024\n- MRI: No progression (2.9cm)\n- Asymptomatic\n- Successfully maintaining work-life balance\nPLAN: Continue biennial monitoring\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90 (Able to carry on normal activity, minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nMANAGEMENT SUCCESS FACTORS:\n1. Patient's high compliance with monitoring\n2. Stable tumor characteristics\n3. Successful symptom management\n4. Effective workplace adaptations\n5. Preservation of quality of life\n6. No interference with occupation\n\nLONG-TERM RECOMMENDATIONS:\n1. Continue biennial MRI\n2. Annual ophthalmological examination\n3. Maintain workplace modifications\n4. Regular cognitive function assessment\n5. Continue current lifestyle modifications\n\nNote: Conservative approach successful with excellent outcome. Patient demonstrates ideal candidate profile for watchful waiting strategy."
      }
    },
    {
      "demographics": {
        "age": 52,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of right-sided facial numbness",
          "Increasing difficulty concentrating at work on financial reports",
          "Occasional nausea without vomiting",
          "Reports feeling more clumsy when typing",
          "Mild balance issues when walking, particularly noticeable when wearing heels"
        ],
        "medical_history": [
          "Migraine headaches since age 35, well-controlled with sumatriptan",
          "Hysterectomy at age 45 for uterine fibroids",
          "History of hormone replacement therapy for 3 years post-hysterectomy",
          "Mild hypertension diagnosed 2 years ago, managed with lifestyle modifications",
          "No history of cancer",
          "No significant family history of neurological conditions",
          "Regular mammograms, last one normal 8 months ago",
          "Non-smoker",
          "Occasional alcohol use (1-2 glasses of wine per week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nGender: Female | Age: 52 | Blood Type: A\nOccupation: Financial Analyst\n\nINITIAL VISIT - March 15, 2014\nChief Complaints: Progressive headaches, right-sided visual disturbance, facial numbness, cognitive changes\nMRI Findings: 4.2 cm left frontal convexity meningioma with significant peritumoral edema, mass effect on superior frontal gyrus. Evidence of dural tail sign. Contrast enhancement uniform.\nWHO Grade: Suspected Grade II (pending pathology)\nAssessment: Symptomatic meningioma requiring urgent intervention due to size, location, and progressive neurological symptoms impacting professional function.\nPlan: Scheduled for surgical resection within 2 weeks. Pre-operative optimization initiated.\n\nSURGICAL NOTE - March 30, 2014\nProcedure: Left frontal craniotomy for gross total resection\nFindings: Well-circumscribed, firm tumor with moderate vascularity\nPathology: WHO Grade II atypical meningioma\nPost-op course: Uncomplicated\n\nFOLLOW-UP - June 15, 2014\nStatus: Excellent recovery. Headaches resolved. Vision improving.\nMRI: No residual tumor. Expected post-surgical changes.\nPlan: Adjuvant radiotherapy recommended - 54 Gy in 30 fractions\n\nFOLLOW-UP - December 20, 2014\nStatus: Completed radiation therapy. Return to work full-time.\nImaging: Stable post-treatment changes\nPlan: Continue q6month monitoring\n\n2015-2016 (Bi-annual visits):\n- All visits show stable imaging\n- Gradual improvement in concentration\n- No new neurological symptoms\n- Regular MRI surveillance maintained\n\nSIGNIFICANT FOLLOW-UP - March 10, 2017\nMRI: Small 8mm nodule at original resection site\nPlan: Increased monitoring frequency to q3months\nSRS considered for early intervention\n\nFOLLOW-UP - September 2017\nSRS completed for recurrent nodule\nExcellent response noted\n\n2018-2020:\n- Quarterly then semi-annual monitoring\n- Stable imaging\n- Maintained professional activities\n- No cognitive decline\n\n2021-2023:\n- Annual surveillance\n- No evidence of recurrence\n- Patient maintains executive position at work\n- Excellent quality of life\n\nLATEST VISIT - January 2024\nStatus: Stable neurologically\nMRI: No evidence of recurrence\nPlan: Continue annual surveillance\n\nFunctional Status Scores:\nKPS: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nNote: Aggressive early intervention strategy with close monitoring proved highly successful in maintaining patient's professional and personal quality of life. Initial WHO Grade II classification warranted the comprehensive treatment approach taken.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n52-year-old female, Blood Type A\nOccupation: Financial Analyst\n\nINITIAL VISIT - March 15, 2018\nPresenting Symptoms: Progressive neurological symptoms including headaches, right-sided visual and sensory changes, balance issues, and cognitive concerns affecting work performance.\nMRI Findings: 2.8cm left frontal parasagittal meningioma with minimal surrounding edema\nWHO Grade: I (based on imaging characteristics)\nKPS: 90/100\nECOG: 1\n\nAssessment & Plan:\nGiven size <3cm and WHO Grade I features, recommending close monitoring with conservative management initially. Discussed treatment options with patient, emphasizing preservation of work function and quality of life.\n\nImmediate Interventions:\n1. Dexamethasone 4mg BID for symptom management\n2. Referral to neuro-ophthalmology\n3. Monthly headache diary\n4. Work modifications - suggested screen breaks and ergonomic assessment\n\nFOLLOW-UP VISIT - September 20, 2018\nSymptoms stable with steroid therapy\nMRI: No significant change\nPlan: Begin steroid taper, continue monitoring\n\nANNUAL FOLLOW-UP - March 12, 2019\nSymptoms well-controlled\nMRI: Stable lesion size\nMaintained work schedule with accommodations\nPlan: Continue annual monitoring\n\nANNUAL FOLLOW-UP - March 18, 2020\nMinor headache increase\nMRI: Minimal growth (0.2cm)\nPlan: Increase frequency of monitoring to 6-monthly\n\nFOLLOW-UP - September 15, 2020\nSymptoms stable\nMRI: No interval change\nPlan: Continue bi-annual monitoring\n\nANNUAL FOLLOW-UP - March 22, 2021\nWell-controlled symptoms\nMRI: Stable\nPatient maintaining full work schedule\nPlan: Return to annual monitoring\n\nANNUAL FOLLOW-UP - March 14, 2022\nMinimal symptoms\nMRI: No growth\nPlan: Continue annual monitoring\n\nANNUAL FOLLOW-UP - March 20, 2023\nStable condition\nMRI: No change\nPatient reports good work-life balance\nPlan: Maintain current management approach\n\nRECENT FOLLOW-UP - February 12, 2024\nSymptoms well-controlled\nMRI: Stable since initial presentation\nPatient successfully managing work responsibilities\nPlan: Continue annual monitoring\n\nCurrent Status:\nKPS: 95/100\nECOG: 0\n\nMANAGEMENT SUMMARY 2018-2024:\n- Successfully maintained conservative management approach\n- No surgical intervention required\n- Preserved occupational function\n- Excellent quality of life maintenance\n- Stable disease course over 6 years\n\nMonitoring Protocol:\n- Annual MRI with contrast\n- Regular neuro-ophthalmology follow-up\n- Blood pressure monitoring\n- Cognitive function assessment\n- Work performance evaluation\n\nQuality of Life Considerations:\n- Maintained full-time employment\n- Adapted work environment\n- Minimal medication requirements\n- Good social/professional functioning\n\nThe conservative management approach has proven successful for this patient, with stable disease and maintained quality of life over 6 years of follow-up."
      }
    },
    {
      "demographics": {
        "age": 50,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Increasing difficulty concentrating at work on computer screens",
          "Subtle personality changes noted by family - more irritable than usual",
          "Mild right-sided facial numbness that began 2 months ago",
          "Reports feeling more fatigued than usual despite adequate sleep"
        ],
        "medical_history": [
          "Migraine headaches since age 30, well-controlled with sumatriptan",
          "Hysterectomy at age 45 for uterine fibroids",
          "History of hormone replacement therapy for 3 years post-hysterectomy",
          "No prior neurological conditions",
          "No history of cancer",
          "No significant family history of brain tumors",
          "Regular vision checks with last exam 1 year ago showing normal results",
          "Non-smoker, occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F50-O-DS\nInitial Visit: March 15, 2014\n\nINITIAL CONSULTATION\nChief Complaint: Progressive neurological symptoms including headaches, visual changes, and facial numbness.\n\nIMAGING FINDINGS:\nMRI reveals a 3.8cm right sphenoid wing meningioma with significant peritumoral edema, mass effect on the optic nerve, and early signs of compression of adjacent brain tissue. T2 sequence shows hyperintensity, suggesting aggressive growth potential. No calcification noted.\n\nASSESSMENT:\nWHO Grade II meningioma (atypical features on imaging)\nGiven patient's occupation as a data scientist requiring high cognitive function and visual focus, symptoms significantly impact quality of life and work performance.\n\nTREATMENT PLAN:\nRecommend immediate surgical intervention - right pterional craniotomy for gross total resection.\nPre-surgical optimization with dexamethasone 4mg QID for edema management.\n\n-------------------\n\nPOST-OPERATIVE NOTE - April 2, 2014\nProcedure: Right pterional craniotomy with Simpson Grade II resection\nFindings: Firm, well-vascularized tumor with dural attachment\nPathology: Confirmed WHO Grade II meningioma\nPost-op course: Uncomplicated\n\n-------------------\n\nFOLLOW-UP VISITS:\n\nOctober 15, 2014 (6 months post-op)\n- MRI shows no residual tumor\n- Visual symptoms improved\n- Returned to work part-time\n- Started adjuvant radiotherapy (54 Gy in 30 fractions)\n\nApril 2, 2015 (1 year post-op)\n- MRI stable\n- Complete resolution of headaches\n- Full-time work resumed\n- Cognitive function normalized\n\nOctober 5, 2015\n- Surveillance MRI stable\n- No new symptoms\n\nApril 12, 2016\n- Small enhancement noted on MRI at surgical site\n- Recommend increased monitoring frequency\n\nOctober 3, 2016\n- Enhancement stable\n- Continue vigilant monitoring\n\n2017-2019 (Bi-annual visits)\n- Serial MRIs show stability\n- Maintained work performance\n- No recurrence of symptoms\n\nJanuary 15, 2020\n- New 1cm nodule at original surgical site\n- Recommend stereotactic radiosurgery (SRS)\n\nMarch 1, 2020\n- Completed SRS treatment (16 Gy single fraction)\n\n2021-2024 (Quarterly then bi-annual visits)\n- Post-SRS imaging shows tumor control\n- Maintained excellent functional status\n- Continue surveillance protocol\n\nCURRENT STATUS (2024):\n- Disease stable\n- Fully functional at work\n- No significant neurological deficits\n\nFUNCTIONAL SCORES:\nKPS: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nMONITORING PROTOCOL:\n- MRI every 6 months\n- Ophthalmology evaluation annually\n- Neuropsychological testing annually\n- Continue regular follow-up with neurosurgery\n\nNote: This proactive approach with early intervention and aggressive monitoring has resulted in excellent outcome with maintained quality of life and occupational function.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F50-O-DS\nPrimary Physician: Dr. [Name]\n=================================\n\nINITIAL VISIT - March 15, 2018\n------------------------------\nPRESENTING SYMPTOMS: 50F data scientist presents with progressive headaches, right-sided visual disturbance, facial numbness, and cognitive changes affecting work performance. Symptoms suggest possible mass effect.\n\nIMAGING: Initial MRI reveals 2.8cm left frontal convexity meningioma with minimal surrounding edema. No significant mass effect on critical structures. WHO Grade I characteristics on imaging.\n\nASSESSMENT: Given patient's occupation requiring detailed cognitive work and screen time, symptoms warrant attention but tumor characteristics favor conservative approach.\n\nPLAN:\n1. Watchful waiting with close monitoring\n2. Prophylactic anticonvulsants not indicated\n3. Optimize headache management with neurology consult\n4. Ergonomic workplace assessment\n5. Q6month MRI surveillance initially\n\nFOLLOW-UP VISIT - September 20, 2018\n-----------------------------------\nStable symptoms. Minor improvement in headaches with adjusted migraine management.\nMRI: No significant change in tumor size or characteristics.\nContinue conservative management.\n\nANNUAL VISIT - March 12, 2019\n----------------------------\nSymptoms stable. Successfully implemented workplace modifications (blue light filters, regular breaks).\nMRI: Stable lesion, no growth.\nWHO Grade I features maintained.\n\nANNUAL VISIT - March 18, 2020\n----------------------------\nMinor increase in headache frequency, managed with medication adjustment.\nMRI: Minimal growth (0.2mm), no new edema.\nContinue observation.\n\nANNUAL VISIT - March 15, 2021\n----------------------------\nPatient reports improved work adaptation. Vision stable.\nMRI: No interval change.\nMaintain current management approach.\n\nANNUAL VISIT - March 22, 2022\n----------------------------\nStable clinical course. Well-adapted to work modifications.\nMRI: No progression.\nExtended follow-up interval to 18 months given stability.\n\n18-MONTH FOLLOW-UP - September 15, 2023\n-------------------------------------\nMaintaining good quality of life. Minimal symptoms.\nMRI: Continued stability.\nPlan: Annual imaging appropriate given long-term stability.\n\nLATEST VISIT - March 10, 2024\n----------------------------\nSix-year follow-up shows successful conservative management.\nMRI: No significant change from initial presentation.\nPatient satisfied with management approach.\n\nFUNCTIONAL STATUS SCORES:\n------------------------\nKarnofsky Performance Status (KPS): 90/100\n(Able to carry on normal activity; minor symptoms of disease)\n\nECOG Performance Status: 1\n(Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nSUMMARY:\n--------\nConservative management has proven successful over 6-year period. Patient maintains high functional status and continues professional work with adaptations. Regular monitoring shows stable disease without need for surgical intervention.\n\nNext Follow-up: March 2025\nImaging: Annual MRI\nContinue current management strategy\n\n[Electronic Signature]\nBoard Certified Neurosurgeon\n[Date and Time Stamp]"
      }
    },
    {
      "demographics": {
        "age": 57,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 3 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion while coding at work",
          "Mild right-sided facial numbness",
          "Reports difficulty concentrating during long meetings",
          "Two episodes of stumbling while walking in past month",
          "Gradual personality changes noted by coworkers - more irritable than usual"
        ],
        "medical_history": [
          "Type 2 Diabetes diagnosed 8 years ago - managed with Metformin 1000mg BID",
          "Hypertension - on Lisinopril 10mg daily",
          "Migraine headaches since age 40 - previously well-controlled with sumatriptan",
          "Mild obesity (BMI 31)",
          "Laser eye surgery (LASIK) 12 years ago",
          "No history of cancer",
          "No significant head trauma",
          "Family history: Father had stroke at age 65"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M57-O-SD\nPrimary Diagnosis: Meningioma\nWHO Grade: II (Atypical)\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive neurological symptoms with occupational impact\nMRI Findings:\n- 4.2cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Evidence of dural tail sign\n- Moderate midline shift (6mm)\n\nAssessment:\nGiven patient's progressive symptoms, tumor size, and occupation requiring high cognitive function, immediate surgical intervention recommended. WHO Grade II suspected based on imaging characteristics.\n\nPlan:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative optimization of diabetes management\n3. Neurocognitive baseline testing\n4. Ophthalmology consultation for visual symptoms\n\nSURGICAL NOTE - March 29, 2018\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade: II\nFindings: Firm, well-circumscribed tumor with areas of brain invasion\nPathology: WHO Grade II meningioma confirmed\nPost-op course: Uncomplicated\n\nFOLLOW-UP - June 15, 2018 (2.5 months post-op)\n- Improved headaches and vision\n- Returned to work part-time\n- MRI shows small residual tumor (0.8cm)\nPlan: Adjuvant radiotherapy recommended\n\nRADIATION ONCOLOGY - July-August 2018\nTreatment: IMRT 60 Gy in 30 fractions\nCompletion date: August 30, 2018\n\nFOLLOW-UP - December 2018\n- Full return to work\n- Improved cognitive function\n- Stable MRI\nPlan: Continue q4 month monitoring\n\n2019 VISITS (March, July, November)\n- Stable neurological exam\n- No tumor progression on serial MRIs\n- Maintaining full work schedule\n- Diabetes well-controlled\n\n2020 VISITS (March, September)\n- Minor headaches managed with acetaminophen\n- MRI stable\n- Regular exercise program initiated\n- Cognitive function at baseline\n\n2021 VISITS (March, September)\n- New small enhancement (0.5cm) noted on September MRI\n- Watchful waiting approach adopted\n- Increased monitoring frequency\n\n2022 VISITS (January, April, July, October)\nJanuary: Growth to 0.7cm\nJuly: Stable\nOctober: Planning for second surgery due to growth to 1.2cm\n\nSECOND SURGERY - December 15, 2022\nProcedure: Reoperation for recurrence\nSimpson Grade: I\nPathology: Confirmed WHO Grade II\n\n2023 VISITS (March, June, September, December)\n- Post-op recovery excellent\n- No evidence of recurrence\n- Maintained work schedule\n- Diabetes remains controlled\n\n2024 CURRENT STATUS (March)\n- Disease-free on imaging\n- Full cognitive function\n- Maintaining executive-level work position\n- Regular exercise program\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nMONITORING PLAN:\n- Continue q4 month MRI surveillance\n- Annual neuropsychological testing\n- Regular diabetes management\n- Occupational therapy as needed\n\nNote: Aggressive initial approach with early intervention and close monitoring has allowed patient to maintain high-level cognitive function required for software development career. Regular screening for recurrence continues due to WHO Grade II status.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 57\nGender: Male\nOccupation: Software Developer\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive headaches, visual changes, cognitive symptoms\n\nIMAGING:\nMRI reveals 2.8cm left frontal convexity meningioma with moderate peritumoral edema. No significant mass effect on critical structures. WHO Grade I features radiologically.\n\nASSESSMENT:\nDespite symptomatic presentation, given tumor size <3cm and patient's preference for conservative management, recommending close monitoring with serial imaging. Symptoms may be partially attributable to concurrent conditions (diabetes, hypertension, prior migraine history).\n\nPLAN:\n1. MRI surveillance every 4 months initially\n2. Dexamethasone 4mg BID for edema management\n3. Optimize diabetes control with endocrinology\n4. Ergonomic workplace assessment\n5. Consider reduced screen time/frequent breaks\nKPS: 80 ECOG: 1\n\nFOLLOW-UP - July 20, 2014\nMild improvement in headaches with steroid therapy. Vision stable. Working remotely 3 days/week.\nMRI: No significant change in tumor size.\nPlan: Continue current management, taper dexamethasone.\n\nFOLLOW-UP - February 12, 2015\nReports better concentration with workplace modifications.\nMRI: Stable lesion size, slight decrease in edema.\nPlan: Extend MRI interval to 6 months.\n\nFOLLOW-UP - January 10, 2016\nMaintaining stable symptoms. Managing work effectively with accommodations.\nMRI: No growth. Calcification becoming more prominent.\nPlan: Continue surveillance, annual MRI if stable.\n\nFOLLOW-UP - January 15, 2017\nMinor headache exacerbation, managed with medication adjustment.\nMRI: Stable appearance, no progression.\nKPS: 85 ECOG: 1\n\nFOLLOW-UP - February 20, 2018\nGenerally stable. Successfully implemented standing desk setup.\nMRI: No significant change.\nPlan: Maintain annual imaging.\n\nFOLLOW-UP - March 5, 2019\nReports improved energy levels with lifestyle modifications.\nMRI: Stable lesion, no new concerns.\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - April 10, 2020\nTelemedicine visit due to COVID-19. Stable symptoms.\nMRI: No progression.\nPlan: Continue conservative management.\n\nFOLLOW-UP - May 15, 2021\nMaintaining good functional status. Working hybrid schedule.\nMRI: Stable appearance, slight increase in calcification.\nKPS: 90 ECOG: 0\n\nFOLLOW-UP - June 20, 2022\nWell-controlled symptoms. Managing work responsibilities effectively.\nMRI: No change from previous.\nPlan: Consider extending to biennial imaging.\n\nFOLLOW-UP - July 25, 2023\nContinues to do well with conservative management.\nMRI: Stable findings over 9-year period.\nPlan: Biennial imaging confirmed.\n\nMOST RECENT VISIT - January 15, 2024\nMaintains good quality of life. Minimal symptoms.\nMRI: No significant change.\nKPS: 90 ECOG: 0\n\nSUMMARY OF MANAGEMENT APPROACH:\nSuccessfully managed with conservative approach over 10-year period. Patient maintained high functional status and continued professional activities with appropriate accommodations. Regular monitoring showed stable disease without requiring surgical intervention.\n\nCURRENT STATUS:\nWHO Grade: I (radiological features)\nKPS Score: 90\nECOG Performance Status: 0\n\nFUTURE RECOMMENDATIONS:\n1. Continue biennial MRI surveillance\n2. Maintain workplace ergonomic modifications\n3. Regular monitoring of diabetes and hypertension\n4. Annual neurocognitive assessment\n5. Quality of life evaluation every 6 months"
      }
    },
    {
      "demographics": {
        "age": 67,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": true,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Increasing difficulty with balance when walking",
          "Episodes of confusion and difficulty finding correct words",
          "Right-sided facial numbness",
          "Occasional nausea without vomiting",
          "Fatigue and drowsiness"
        ],
        "medical_history": [
          "Type 2 Diabetes diagnosed 12 years ago - managed with metformin",
          "High-risk pregnancy at age 67 (extremely rare/unusual case)",
          "Hypertension - controlled with methyldopa due to pregnancy",
          "History of migraine headaches, but pattern changed recently",
          "Mild obesity (BMI 31)",
          "Cataract surgery left eye 3 years ago",
          "Family history of breast cancer (mother)",
          "No prior history of cancer",
          "No previous neurological conditions",
          "Currently in second trimester of pregnancy (high-risk)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Heightened concern for cognitive/functional preservation",
            "Coordinated care with obstetrics",
            "Timing surgery for second trimester if possible"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 67 | Sex: F | Blood Type: A\nOccupation: Librarian\nPrimary Diagnosis: Meningioma\n\nINITIAL VISIT - 03/15/2014\nChief Complaints:\n- Progressive headaches (4-month duration)\n- Right eye visual disturbance\n- Gait instability\n- Word-finding difficulty\n- Right facial numbness\n- Fatigue\n\nImaging:\nMRI reveals 4.2cm parasagittal meningioma with significant peritumoral edema, mass effect on superior sagittal sinus. Enhancement pattern suggestive of WHO Grade II.\n\nAssessment:\nHigh-risk case due to:\n- Pregnancy status (2nd trimester)\n- Size >3cm\n- Significant symptoms\n- Diabetes\n- Advanced maternal age\n\nPlan:\n1. Urgent neurosurgical intervention recommended post-pregnancy\n2. High-risk OB consult\n3. Weekly neurological monitoring\n4. Dexamethasone 4mg QID for edema\nWHO Grade: Suspected Grade II\n\nFOLLOW-UP - 06/20/2014\nPost-cesarean delivery at 32 weeks (medically indicated)\nProceeding with surgical intervention\nPre-surgical planning with neuronavigation\nWHO Grade: Pending surgical specimen\n\nSURGICAL NOTE - 07/05/2014\nProcedure: Simpson Grade II resection\nFindings: Adherent to superior sagittal sinus\nPathology: WHO Grade II meningioma\nPost-op course: Uncomplicated\n\nFOLLOW-UP - 01/15/2015\nAdjuvant radiotherapy completed (59.4 Gy/33 fractions)\nSymptoms improving\nMRI: No residual enhancement\n\nANNUAL FOLLOW-UP - 07/2015-2024\n2015: Stable imaging, improved symptoms\n2016: Small enhancement at surgical margin\n2017: Started stereotactic radiosurgery for recurrence\n2018: Complete response to SRS\n2019: Stable imaging\n2020: Continued stability\n2021: Minor enhancement, observation only\n2022: Stable disease\n2023: Continued stability\n2024: No evidence of progression\n\nCurrent Status (2024):\n- Disease stable\n- Annual MRI surveillance\n- Diabetes well-controlled\n- Retired from librarian position\n- Independent in ADLs\n\nFunctional Status:\nKPS Score: 90/100\nECOG Score: 1\n\nTreatment Summary:\n- Initial Simpson II resection\n- Adjuvant radiotherapy\n- Salvage SRS for early recurrence\n- Regular imaging surveillance\n\nRecommendations:\nContinue bi-annual MRI\nNeurocognitive monitoring\nDiabetes management optimization\n\nNote: Treatment approach was necessarily aggressive due to high-risk features and occupation requiring cognitive clarity. Early intervention strategy proved successful with good long-term control.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 67, Female, Blood Type: A\nOccupation: Librarian\n\nINITIAL VISIT - January 15, 2018\nChief Complaint: Progressive neurological symptoms with concurrent high-risk pregnancy\n\nMRI Findings:\n- 2.8cm left frontal convexity meningioma\n- Moderate peritumoral edema\n- No significant mass effect on critical structures\n- WHO Grade I (radiological features suggest typical meningioma)\n\nAssessment:\nGiven patient's complex presentation (advanced maternal age pregnancy, T2DM, hypertension), conservative management is warranted. Symptoms warrant close monitoring, but surgical intervention carries significant risks in current state.\n\nPlan:\n1. Monthly clinical monitoring during pregnancy\n2. Anti-epileptic prophylaxis (Levetiracetam 500mg BID)\n3. Dexamethasone 4mg BID for edema management\n4. Coordinate with high-risk OB team\n\nFOLLOW-UP - June 20, 2018\nPost-delivery status: Successful C-section at 36 weeks\nSymptoms: Mild improvement in headaches\nMRI: Stable tumor size\nPlan: Continue conservative management\n\nFOLLOW-UP - January 15, 2019\nSymptoms: Stable\nMRI: No growth\nPlan: Maintain 6-monthly monitoring\n\nFOLLOW-UP - January 10, 2020\nSymptoms: Minor worsening of right-sided facial numbness\nMRI: Minimal growth (0.2cm)\nPlan: \n- Increase steroid dose temporarily\n- Consider SRS if symptoms progress\n- Occupational modifications recommended (reduced screen time, ergonomic adjustments)\n\nFOLLOW-UP - February 15, 2021\nSymptoms: Stable with medication\nMRI: No further growth\nPlan: Continue current management\n\nFOLLOW-UP - March 20, 2022\nSymptoms: Well-controlled\nMRI: Stable\nPlan: Extend monitoring interval to annual\n\nFOLLOW-UP - April 5, 2023\nSymptoms: Occasional headaches\nMRI: No progression\nPlan: Maintain current approach\n\nLATEST FOLLOW-UP - February 1, 2024\nSymptoms: Well-managed with medications\nMRI: Stable disease\nQuality of life: Maintained, continues work with accommodations\n\nCurrent Management:\n- Annual MRI surveillance\n- Levetiracetam 500mg BID\n- PRN dexamethasone for symptom flares\n- Regular diabetes monitoring\n- Lifestyle modifications maintained\n\nFunctional Status Scores:\nKPS: 80 (Normal activity with effort)\nECOG: 1 (Restricted in physically strenuous activity)\n\nTreatment Rationale:\nConservative management chosen due to:\n1. Stable tumor size\n2. Acceptable symptom control\n3. Advanced age\n4. Comorbidities\n5. Patient preference\n6. Occupation allows for modifications\n\nLong-term Outlook:\nFavorable with current management strategy. Patient has adapted well to symptoms and maintains good quality of life with conservative approach."
      }
    },
    {
      "demographics": {
        "age": 62,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": "Wine Taster",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, particularly in the morning; Right-sided facial numbness; Gradual decline in sense of smell affecting wine tasting work; Recent episodes of difficulty finding correct words while speaking; Occasional balance issues when reaching for books on high shelves; Mild nausea without vomiting; Increasing fatigue over past 2 months"
        ],
        "medical_history": [
          "Hypertension controlled with lisinopril 10mg daily; Mild hearing loss in left ear diagnosed 5 years ago; History of concussion from bicycle accident 15 years ago with full recovery; Occasional migraines in 40s that resolved; Successful cataract surgery right eye 2 years ago; Family history of father with stroke at age 70; No history of seizures or other neurological conditions; No prior cancer history"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M62-O-MEN\nOccupation: Librarian/Professional Wine Taster\n\nINITIAL VISIT - March 15, 2014\nPresenting Symptoms: Progressive headaches, right facial numbness, anosmia affecting occupation, word-finding difficulties, balance issues, fatigue. Symptoms significantly impact professional wine tasting abilities.\n\nInitial MRI Findings:\n- 3.8cm right frontal meningioma\n- Significant peritumoral edema\n- Mass effect on frontal lobe\n- Compression of olfactory tract\nWHO Grade: II (atypical features on imaging)\n\nTreatment Plan:\nRecommend immediate surgical intervention due to:\n1. Size >3cm\n2. Symptomatic presentation\n3. Occupation-critical location affecting olfactory function\n4. Progressive neurological symptoms\n\nSURGICAL NOTES - April 2, 2014\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology confirms WHO Grade II meningioma\nPost-op course uncomplicated\n\nFOLLOW-UP VISITS:\n\nJuly 2014 (3 months post-op):\n- Improved headaches\n- Partial recovery of smell\n- Continuing speech therapy\n- MRI: No residual tumor\n- Recommended adjuvant radiotherapy\n\nJanuary 2015 (9 months post-op):\n- Completed fractionated RT (54 Gy/30 fx)\n- Improved word finding\n- Partial return to work\n- MRI: No recurrence\n\nJuly 2015:\n- Full return to work with accommodations\n- Smell function 60% recovered\n- MRI stable\n\n2016 (Biannual visits):\n- March: Stable symptoms, MRI clear\n- September: New small enhancement at surgical site\n\n2017:\n- March: Enhancement stable\n- September: Slight progression, 0.8cm nodule\n\n2018:\n- Decision for gamma knife radiosurgery for small recurrence\n- Post-SRS MRIs stable\n\n2019-2021 (Annual visits):\n- No tumor progression\n- Maintained wine tasting career with adapted techniques\n- Regular MRI surveillance\n\n2022-2024:\n- Quarterly monitoring\n- Last MRI (January 2024): Stable disease\n- Continues modified work schedule\n\nCurrent Status (2024):\n- Disease stable\n- Maintains professional activities with adaptations\n- Regular follow-up continues\n\nFunctional Status Scores:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nMonitoring Protocol:\n- MRI every 6 months\n- Neurological assessment quarterly\n- Olfactory function tests annually\n- Quality of life assessments\n\nLong-term Recommendations:\n1. Continue vigilant monitoring\n2. Maintain hypertension control\n3. Regular cognitive assessment\n4. Occupational therapy as needed\n5. Consider prophylactic anti-epileptic medication\n\nNote: Treatment approach prioritized preservation of olfactory function given patient's occupation while maintaining aggressive disease control due to WHO Grade II status.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nOccupation: Librarian/Wine Taster\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive headaches, right facial numbness, olfactory changes\n\nIMAGING:\nInitial MRI reveals a 2.3cm right frontal convexity meningioma, WHO Grade I characteristics. Minimal peritumoral edema. No significant mass effect on adjacent structures.\n\nASSESSMENT:\nGiven tumor size <3cm, minimal edema, and stable neurological status, recommending conservative management with close monitoring. Occupational considerations include impact on wine tasting abilities (olfactory symptoms) and library work (balance issues).\n\nPLAN:\n1. Serial MRI monitoring\n2. Prophylactic anticonvulsants not indicated\n3. Continue lisinopril 10mg daily\n4. Lifestyle modifications:\n   - Ergonomic assessment at workplace\n   - Use of library ladder with handrail\n   - Consider temporary reassignment from wine tasting duties\n\nFOLLOW-UP VISITS:\n\nSeptember 15, 2014 (6-month)\n- MRI: No significant change in tumor size\n- Symptoms stable\n- Initiated physical therapy for balance training\n- KPS: 90\n\nMarch 20, 2015 (1-year)\n- MRI: Minimal growth (0.1cm)\n- Headaches improved with prophylactic amitriptyline\n- Working part-time with accommodations\n- KPS: 90\n\nMarch 18, 2016 (2-year)\n- MRI: Stable at 2.4cm\n- Adapted to modified wine tasting technique\n- Balance improved with therapy\n- KPS: 90\n\nMarch 15, 2017 (3-year)\n- MRI: No growth\n- Maintaining work schedule with accommodations\n- Minor word-finding difficulties persist\n- Speech therapy consultation\n- KPS: 85\n\nMarch 20, 2018 (4-year)\n- MRI: Stable\n- Quality of life well-maintained\n- Continue conservative management\n- KPS: 85\n\nMarch 15, 2019 (5-year)\n- MRI: Minimal growth (2.5cm)\n- Symptoms stable\n- Discussed radiation options but patient prefers continued observation\n- KPS: 85\n\nMarch 18, 2021 (7-year)\n- MRI: Stable at 2.5cm\n- Semi-retired from wine tasting\n- Continues library work with modifications\n- KPS: 80\n\nMarch 15, 2023 (9-year)\n- MRI: No significant change\n- Well-adapted to limitations\n- Maintains independent lifestyle\n- KPS: 80\n\nCurrent Status (2024):\n- Stable disease\n- Conservative management successful\n- Maintains modified work schedule\n- Regular monitoring continues\n\nFUNCTIONAL STATUS SCORES:\n- Karnofsky Performance Status (KPS): 80/100\n- ECOG Performance Status: 1\n\nCURRENT MANAGEMENT:\n- Biennial MRI surveillance\n- Symptomatic management\n- Regular neurocognitive assessment\n- Quality of life focus\n- Occupational therapy as needed\n\nWHO Grade: I (based on imaging characteristics)\nTreatment Strategy: Continued observation with periodic imaging\n\nNote: Conservative management has provided stable disease control while maintaining patient's quality of life and partial work capability. Patient has adapted well to limitations with appropriate accommodations."
      }
    },
    {
      "demographics": {
        "age": 48,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Gradual onset of persistent headaches over 3 months, worse in morning; intermittent blurred vision in right eye; occasional episodes of nausea; recent difficulty concentrating at work; mild right-sided facial numbness; reports increased clumsiness when typing, particularly with right hand; mild personality changes noted by spouse (more irritable than usual)"
        ],
        "medical_history": [
          "Migraine headaches (diagnosed 10 years ago, well-controlled with sumatriptan until recent changes); mild hypertension (diagnosed 2 years ago, managed with lifestyle modifications); concussion from sports injury in college (fully recovered); family history of stroke (father); occasional neck pain from prolonged computer use; no history of seizures or neurological disorders; no prior surgeries; non-smoker; moderate alcohol consumption (2-3 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M48-SD-A\nPrimary: Dr. [Neurosurgeon Name]\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive neurological symptoms with 3-month history\n\nIMAGING:\nInitial MRI reveals a 3.8cm right frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe. T2 sequence shows hyperintense signal. No calcification noted.\n\nASSESSMENT:\nWHO Grade II meningioma (based on imaging characteristics)\nSignificant mass effect causing progressive neurological symptoms\nHigh-risk features: size >3cm, peritumoral edema, no calcification\nKPS: 80/100\nECOG: 1\n\nPLAN:\n1. Surgical resection recommended within 2 weeks\n2. Pre-operative functional MRI and DTI for surgical planning\n3. Discussed occupational impact - symptoms affecting work performance\n4. Pre-surgical clearance initiated\n\nSURGICAL NOTE - April 2, 2018\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology confirms WHO Grade II meningioma\nPost-op MRI shows near-total resection\n\nFOLLOW-UP - May 15, 2018\nPost-operative recovery proceeding well\nAdjuvant radiation therapy initiated\n54 Gy in 30 fractions\nKPS: 90/100\nECOG: 0\n\n6-MONTH FOLLOW-UP - October 2, 2018\nMRI shows no residual/recurrent tumor\nNeurological symptoms resolved\nReturned to work full-time\nContinue q6mo MRI surveillance\n\n2019 VISITS (April 15 & October 10)\nStable imaging\nNo new symptoms\nMaintaining work schedule\nKPS: 90/100\nECOG: 0\n\n2020 VISITS (April 8 & October 12)\nStable imaging\nMinor headaches - managed with standard analgesics\nMaintaining normal activities\nKPS: 90/100\nECOG: 0\n\n2021 VISITS (April 14 & October 11)\nSmall enhancement noted on right frontal region\n2mm growth from previous\nClose monitoring recommended\nKPS: 90/100\nECOG: 0\n\n2022 VISITS (January 15, April 12, July 15, October 10)\nProgressive growth to 5mm\nDecision for repeat surgical intervention\nSecond craniotomy performed December 1, 2022\nSimpson Grade I resection achieved\nKPS: 85/100 (post-surgery)\nECOG: 1\n\n2023 VISITS (March 15, June 14, September 13, December 12)\nPost-second surgery surveillance\nNo evidence of recurrence\nMaintained work schedule with accommodations\nKPS: 90/100\nECOG: 0\n\n2024 CURRENT STATUS (March 14)\nStable imaging\nNo neurological deficits\nRegular work schedule maintained\nContinuing q6mo MRI surveillance\nKPS: 90/100\nECOG: 0\n\nTREATMENT SUMMARY:\n- Initial presentation: WHO Grade II meningioma\n- Two surgical interventions (2018, 2022)\n- Complete adjuvant radiation therapy\n- Regular imaging surveillance\n- Excellent functional outcome\n- Maintained professional career\n\nCurrent KPS Score: 90/100\nCurrent ECOG Score: 0\n\nMONITORING PLAN:\n- Continue q6mo MRI through 2025\n- Annual MRI thereafter if stable\n- Regular neurocognitive assessments\n- Occupational therapy as needed\n- Monitor for any work-related limitations",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M48-SD-A\nPrimary: Dr. [Name]\nInitial Visit: March 15, 2014\n\nINITIAL CONSULTATION NOTE:\n48-year-old right-handed male software developer presenting with progressive neurological symptoms. MRI reveals a 2.3cm right frontal convexity meningioma, WHO Grade I characteristics, minimal peritumoral edema.\n\nOBJECTIVE FINDINGS:\n- MRI: Well-circumscribed, dural-based lesion with typical \"dural tail\" sign\n- Contrast enhancement: Homogeneous\n- No significant mass effect\n- Minimal peritumoral edema\n- Location: Right frontal convexity, non-eloquent area\n\nASSESSMENT & PLAN:\nGiven tumor size <3cm, minimal symptoms, and patient's preference, recommending conservative management with close monitoring.\n1. MRI surveillance every 6 months initially\n2. Occupational therapy referral for ergonomic workplace assessment\n3. Prophylactic anticonvulsants not indicated\n4. Continue current hypertension management\nWHO Grade: I (presumptive)\n\nFOLLOW-UP VISITS:\n\nSeptember 20, 2014:\nNo tumor growth. Symptoms stable. Implemented ergonomic modifications at work. Headaches improved with proper positioning and breaks.\nPlan: Continue monitoring.\n\nMarch 15, 2015:\nMinimal growth (0.1cm). Visual symptoms stable. Working reduced hours with more frequent breaks.\nPlan: Maintain current surveillance schedule.\n\nSeptember 18, 2015:\nNo interval growth. Patient reports improved concentration with workplace modifications.\nPlan: Consider extending MRI interval if stable at next visit.\n\nMarch 20, 2016:\nStable imaging. Symptoms well-managed with lifestyle modifications.\nPlan: Extend MRI interval to annual.\n\nMarch 15, 2017:\nNo growth. Patient maintaining full-time work with accommodations.\nAnnual MRI schedule maintained.\n\nMarch 18, 2018:\nStable imaging. Minor headache exacerbation managed with medication adjustment.\nPlan: Continue annual surveillance.\n\nMarch 16, 2019:\nMinimal growth (0.2cm over 5 years). Symptoms stable.\nPlan: Maintain conservative approach; discussed surgical options but patient prefers continued monitoring.\n\nMarch 20, 2020:\nTelemedicine visit due to COVID-19. No new symptoms.\nPlan: Continue annual imaging.\n\nMarch 15, 2021:\nStable imaging. Working remotely full-time, reports improved symptoms with home office setup.\nPlan: Maintain current management.\n\nMarch 18, 2022:\nNo growth. Quality of life well-maintained.\nPlan: Continue annual surveillance.\n\nMarch 16, 2023:\nStable disease. Patient satisfied with conservative approach.\nPlan: Annual MRI continued.\n\nMarch 15, 2024:\nTen-year follow-up. Total growth: 0.3cm over 10 years.\nSymptoms well-controlled. Patient continues full-time work.\nPlan: Consider biennial MRI given long-term stability.\n\nCURRENT STATUS (2024):\nKPS Score: 90 (Able to carry on normal activity with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nSUMMARY OF CONSERVATIVE MANAGEMENT SUCCESS:\n- Minimal tumor growth over 10 years\n- Maintained professional productivity\n- Excellent quality of life\n- Avoided surgical intervention\n- Well-managed symptoms through lifestyle modifications\n- Patient satisfaction with management approach"
      }
    },
    {
      "demographics": {
        "age": 66,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of confusion and difficulty finding correct words while speaking",
          "Mild right-sided facial numbness",
          "Occasional balance issues when walking",
          "Increased fatigue and difficulty concentrating at work",
          "One episode of focal seizure affecting right hand 2 weeks ago"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches (different from current headaches) - managed with sumatriptan PRN",
          "Menopause at age 52",
          "Osteoporosis diagnosed 2 years ago - taking calcium and vitamin D supplements",
          "Cholecystectomy in 2010",
          "No history of cancer",
          "No family history of brain tumors",
          "No prior radiation exposure to head/neck",
          "Regular mammograms and colonoscopy screenings up to date"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n66F, Blood Type A\nOccupation: Software Developer\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms with headaches\n\nMRI FINDINGS:\n- 4.2 cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on left frontal lobe\n- Dural tail sign present\n- Enhancement pattern consistent with WHO Grade II meningioma\n\nASSESSMENT:\nPatient presents with concerning neurological symptoms affecting work performance. Given tumor size, location, and symptom progression, immediate surgical intervention recommended. Occupation requires high cognitive function, making aggressive treatment crucial.\n\nPLAN:\n1. Scheduled for craniotomy and gross total resection within 2 weeks\n2. Pre-operative optimization with dexamethasone 4mg QID\n3. Neurocognitive baseline testing ordered\n4. WHO Grade to be determined post-resection\n\nFOLLOW-UP VISIT - April 30, 2014 (Post-operative)\nPROCEDURE: Left frontal craniotomy with gross total resection\nPATHOLOGY: WHO Grade II (Atypical) Meningioma\nPost-op course uncomplicated\nPLAN: \n- Adjuvant radiation therapy (60 Gy/30 fractions)\n- Follow-up MRI in 3 months\n\nFOLLOW-UP - August 15, 2014\nPost-radiation assessment\nMRI: No evidence of residual/recurrent tumor\nSymptoms significantly improved\nCleared to return to work with modifications\n\nSUBSEQUENT VISITS:\n\n2015 (Q3-monthly visits):\n- February: Stable MRI, improving symptoms\n- May: Continued stability\n- August: Minor radiation changes, no recurrence\n- November: Stable\n\n2016 (Q4-monthly visits):\n- March: Stable imaging\n- July: Small enhancement area - close monitoring\n- November: Enhancement stable, no intervention needed\n\n2017-2019 (Bi-annual visits):\n- All MRIs stable\n- Maintained work performance\n- Annual neuropsychological testing showing preserved function\n\n2020-2022 (Annual visits):\n- Continued stability\n- One episode of breakthrough seizure (2021) - Levetiracetam added\n- MRI remains stable\n\n2023-2024 (Most recent):\nJanuary 2024:\n- 10-year follow-up\n- No evidence of recurrence\n- Maintained professional activities\n- Continues annual monitoring\n\nCURRENT STATUS:\n- Disease-free at 10 years\n- Maintained cognitive function\n- Continues full-time work\n- Annual MRI surveillance recommended indefinitely\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nWHO Grade: II (Atypical Meningioma)\nTreatment Strategy: Aggressive surgical resection followed by adjuvant radiation\nOutcome: Excellent response with long-term disease control",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n66-year-old female, Blood Type A\nOccupation: Software Developer\n\nINITIAL VISIT - March 15, 2018\nPresenting Symptoms: Progressive neurological symptoms including headaches, visual disturbance, speech difficulties, and recent focal seizure. Symptoms affecting work performance as software developer.\n\nMRI Findings:\n- 2.8cm left frontal convexity meningioma\n- Moderate peritumoral edema\n- No significant mass effect\n- WHO Grade I (likely)\n\nAssessment:\nDespite symptomatic presentation, given tumor size <3cm and patient's preference for conservative management, recommending close monitoring with medical management of symptoms.\n\nInitial Management Plan:\n1. Dexamethasone 4mg BID for edema control\n2. Levetiracetam 500mg BID for seizure prophylaxis\n3. Occupational therapy referral for workplace adaptations\n4. Monthly clinical reviews initially\n\nFOLLOW-UP VISIT - June 20, 2018\nSymptoms improved with medical management. Patient able to continue work with accommodations (increased screen size, speech-to-text software).\nMRI: Stable tumor size\nPlan: Continue current management, decrease steroid dose gradually\n\nANNUAL REVIEW - March 12, 2019\nStable symptoms. Working full-time with adaptations.\nMRI: No growth\nWHO Grade I maintained\nPlan: Continue annual monitoring\n\nANNUAL REVIEW - March 15, 2020\nMinor headache progression\nMRI: 2.9cm, minimal growth\nPlan: Optimize headache management, continue monitoring\n\nANNUAL REVIEW - March 18, 2021\nStable symptoms\nMRI: No further growth\nPatient satisfied with conservative approach\nPlan: Continue annual imaging\n\nANNUAL REVIEW - March 16, 2022\nWell-controlled symptoms\nMRI: Stable at 2.9cm\nPatient maintaining good work-life balance\nPlan: Continue current management\n\nANNUAL REVIEW - March 14, 2023\nMinimal symptoms\nMRI: No growth\nPatient considering part-time work transition\nPlan: Continue annual monitoring\n\nCURRENT VISIT - February 20, 2024\nStable condition\nMRI: No growth since 2021\nPatient successfully transitioned to part-time work\nQuality of life well-maintained\n\nFunctional Status Scores:\n- Karnofsky Performance Status (KPS): 90 (Able to carry on normal activity with minor symptoms)\n- ECOG Performance Status: 1 (Restricted in physically strenuous activity but ambulatory)\n\nTreatment Success Metrics:\n- Tumor stability maintained\n- Symptoms well-controlled\n- Preserved occupational function\n- Minimal intervention needed\n- High patient satisfaction with conservative approach\n\nFuture Plan:\n- Continue annual MRI surveillance\n- Maintain current medication regimen\n- Regular quality of life assessments\n- Ongoing occupational therapy support as needed\n\nWHO Grade: I (maintained throughout monitoring period)\n\nNote: Conservative management strategy successful in maintaining patient's quality of life and occupational function while avoiding surgical intervention. Patient demonstrates excellent adaptation to symptoms with appropriate workplace modifications."
      }
    },
    {
      "demographics": {
        "age": 46,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Researcher",
          "olfactory_profession": "Chef",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, worse in morning; Intermittent blurred vision in right eye; Recent onset of clumsiness in left hand when cooking; Occasional nausea without vomiting; Reports difficulty concentrating at work; Mild personality changes noted by coworkers (more irritable than usual); Two episodes of focal seizures affecting left arm in past month"
        ],
        "medical_history": [
          "BMI 33.2; Hypertension diagnosed 2 years ago, managed with lisinopril 10mg daily; Migraine headaches since age 30 (previously well-controlled with sumatriptan); Surgical history: Cholecystectomy 2018; Family history: Mother with breast cancer; No prior neurological conditions; No history of head trauma; Current medications: Lisinopril 10mg daily, Sumatriptan as needed; No known drug allergies"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F46-O-2014\nPrimary Neurosurgeon: Dr. [Name]\n\nINITIAL VISIT - March 15, 2014\nPRESENTING SYMPTOMS & FINDINGS:\n- 46-year-old female chef/researcher with progressive neurological symptoms\n- Right parasagittal meningioma (4.2 cm) with significant peritumoral edema\n- WHO Grade II features on imaging\n- Symptoms significantly impacting occupational function\n- Focal seizures concerning for tumor progression\n\nMRI FINDINGS:\n- 4.2 x 3.8 x 3.6 cm right parasagittal meningioma\n- Moderate mass effect on superior sagittal sinus\n- Significant peritumoral edema\n- Non-calcified lesion with heterogeneous enhancement\n\nTREATMENT PLAN:\n- Urgent surgical intervention recommended\n- Preoperative optimization of blood pressure\n- Started on Dexamethasone 4mg QID\n- Levetiracetam 500mg BID for seizure prophylaxis\n\nSURGICAL INTERVENTION - April 2, 2014\n- Simpson Grade II resection achieved\n- Pathology: WHO Grade II atypical meningioma\n- Minor residual at superior sagittal sinus\n\nFOLLOW-UP VISITS:\n\nJuly 2014 (3-month post-op):\n- Improved neurological symptoms\n- No new seizures\n- Started adjuvant radiation therapy (60 Gy/30 fractions)\n\nJanuary 2015 (9-month post-op):\n- Complete radiation course completed\n- Minimal residual enhancement\n- Return to work approved with modifications\n\n2016 (Bi-annual visits):\n- March: Stable MRI, no recurrence\n- September: Continued stability, improved work performance\n\n2017 (Bi-annual visits):\n- March: Small area of enhancement noted\n- September: Enhancement stable, close monitoring advised\n\n2018 (Quarterly visits):\n- New 8mm nodule adjacent to resection cavity\n- Decision for stereotactic radiosurgery to nodule\n- Post-SRS: Good response\n\n2019-2020 (Bi-annual visits):\n- Stable disease\n- Regular occupational therapy for left hand dexterity\n- Maintained work activities with accommodations\n\n2021-2022 (Annual visits):\n- No evidence of progression\n- Maintained on anticonvulsants\n- Regular cognitive assessments: stable\n\n2023-2024 (Annual visits):\n- Long-term stability achieved\n- Continues regular monitoring\n- Maintained work capacity\n\nCURRENT STATUS (2024):\n- Disease stable\n- Maintained independence\n- Regular monitoring continues\n\nFUNCTIONAL SCORES:\nKPS Score: 90 (Able to carry on normal activity with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nMONITORING PROTOCOL:\n- MRI brain with contrast every 6 months\n- Neurological examination quarterly\n- Cognitive assessment annually\n- Occupational therapy evaluation as needed\n\nNote: Aggressive early intervention and close monitoring have contributed to favorable long-term outcomes. Patient's occupation as chef necessitated particular attention to left hand function and safety considerations.\n\nWHO Grade: II (Atypical Meningioma)\nSimpson Grade: II",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nGender: Female | Age: 46 | Blood Type: O\nOccupation: Researcher/Chef | BMI: 33.2\n\nINITIAL VISIT - March 15, 2014\nPresenting Symptoms: Progressive headaches, right eye visual disturbance, left hand coordination issues, focal seizures, cognitive changes.\nMRI Findings: 2.8cm right frontal convexity meningioma with moderate peritumoral edema\nWHO Grade: I (presumptive radiological diagnosis)\nAssessment: Symptomatic meningioma requiring intervention\nPlan: Given patient's occupational demands and symptom progression, recommending conservative surgical resection.\n\nPOST-SURGICAL FOLLOW-UP - June 2014\nProcedure: Simpson Grade II resection\nPathology: WHO Grade I meningioma\nPost-op course: Uncomplicated\nSymptoms: Improvement in headaches and visual symptoms\nPlan: Anti-epileptic medication (Levetiracetam 500mg BID)\nFollow-up MRI in 3 months\n\nFOLLOW-UP VISITS:\n\nDecember 2014\nStable post-surgical appearance\nMinor residual along dural attachment\nNo new symptoms\nContinue current medications\nAnnual MRI recommended\n\nMarch 2015\nReturn to work as researcher/chef\nMinimal residual symptoms\nGood hand coordination restored\nContinue Levetiracetam\nAnnual imaging\n\nMarch 2016\nStable imaging\nNo new symptoms\nSuccessfully managing work duties\nBegin weaning anti-epileptic medications\n\nMarch 2017\nNo tumor recurrence\nOff anti-epileptics\nFull work capacity\nContinue annual monitoring\n\nMarch 2018\nStable imaging\nBP well-controlled\nWeight management program initiated\nFocus on lifestyle modifications\n\nMarch 2020\nPandemic-related telemedicine visit\nStable symptoms\nWorking from home as researcher\nContinue monitoring\n\nMarch 2022\nMinimal residual visible on MRI\nNo new symptoms\nFull professional activity\nContinue biennial monitoring\n\nJanuary 2024\nLatest MRI shows stability\nNo neurological deficits\nExcellent quality of life\nNext follow-up 2026\n\nCurrent Status:\nKPS Score: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nManagement Summary:\n- Conservative surgical approach successful\n- Regular monitoring with gradually extended intervals\n- Excellent functional outcome\n- Maintained professional activities\n- Focus on lifestyle modifications and weight management\n- BP well-controlled\n- No tumor progression over 10-year period\n\nRecommendations:\n1. Continue biennial MRI\n2. Annual clinical assessment\n3. Maintain BP control\n4. Continue weight management efforts\n5. Regular ophthalmological check-ups\n6. Return if new symptoms develop\n\nNotes reflect conservative post-surgical management with emphasis on quality of life and occupational function preservation. Patient has maintained excellent outcome with minimal intervention needed after initial resection."
      }
    },
    {
      "demographics": {
        "age": 63,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": true
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty finding words",
          "Subtle personality changes noted by spouse - increased irritability",
          "Balance difficulties when walking, particularly in dim lighting",
          "Intermittent right-sided facial numbness",
          "Mild nausea without vomiting"
        ],
        "medical_history": [
          "Cranial radiation therapy 30 years ago for childhood retinoblastoma",
          "Hypertension - controlled with lisinopril 10mg daily",
          "Hypercholesterolemia - managed with atorvastatin 20mg daily",
          "Appendectomy (1985)",
          "No history of seizures",
          "No prior intracranial surgeries",
          "Family history negative for brain tumors",
          "20-pack year smoking history, quit 15 years ago"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Additional consideration for radiation exposure history"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - 03/15/2014\nPatient: 63Y Male, Blood Type O\nChief Complaint: Progressive neurological symptoms\n\nIMAGING:\nInitial MRI reveals a 4.2cm left frontal convexity meningioma with significant peritumoral edema. Mass effect on adjacent frontal lobe with 5mm midline shift. T2 hyperintense with heterogeneous enhancement. No calcification noted.\n\nASSESSMENT:\nWHO Grade II meningioma (atypical features on imaging)\nMultiple high-risk factors:\n- Size >3cm\n- Significant edema\n- History of cranial radiation\n- Progressive neurological symptoms\n- Critical location affecting executive function\n\nPLAN:\n1. Urgent surgical resection recommended\n2. Pre-operative optimization with dexamethasone 4mg QID\n3. Detailed neuropsychological testing\n4. Occupational impact assessment given cognitive demands of financial analysis work\n\nSURGICAL NOTE - 04/02/2014\n- Simpson Grade II resection achieved\n- Minor residual tumor at superior sagittal sinus interface\n- Pathology confirms WHO Grade II meningioma\n- No immediate post-operative complications\n\nFOLLOW-UP - 07/15/2014\n- Improved headaches and vision\n- Started adjuvant radiation therapy\n- 60 Gy in 30 fractions completed\n\nFOLLOW-UP - 01/20/2015\n- Stable imaging\n- Returned to work part-time\n- Continuing rehabilitation\n\nFOLLOW-UP - 07/15/2015\n- MRI shows no progression\n- Full-time work resumed\n- Minor word-finding difficulties persist\n\nANNUAL FOLLOW-UP - 2016-2019\n- Q6 month MRI surveillance\n- Stable disease\n- Maintained work performance\n- Annual neuropsychological testing\n\nFOLLOW-UP - 03/10/2020\n- Small area of enhancement noted at surgical site\n- Close monitoring recommended\n- Increased scan frequency to Q3 months\n\nFOLLOW-UP - 09/15/2020\n- Growth of residual tumor\n- Decision for stereotactic radiosurgery\n- 16 Gy single fraction delivered\n\nFOLLOW-UP - 2021-2024\n- Q6 month MRI surveillance\n- No further progression\n- Maintained independent function\n- Continues financial analyst work with accommodations\n\nCURRENT STATUS (2024):\n- Disease stable\n- Independent in ADLs\n- Working with minor cognitive adaptations\n\nFunctional Status Scores:\n- KPS: 90 (Able to carry on normal activity, minor symptoms)\n- ECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nTreatment Strategy Rationale:\nEarly aggressive intervention chosen due to:\n1. High-risk occupation requiring cognitive precision\n2. History of radiation exposure\n3. Tumor size and location\n4. Progressive neurological symptoms\n5. WHO Grade II classification\n\nMonitoring continues with emphasis on cognitive function and occupational performance.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nOccupation: Financial Analyst\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms including headaches and visual changes\n\nIMAGING:\nMRI reveals a 2.8cm left frontal convexity meningioma with moderate peritumoral edema. No significant mass effect on critical structures. WHO Grade I characteristics on imaging.\n\nASSESSMENT:\nGiven patient's history of prior radiation exposure and current symptomatology, careful consideration of management approach is warranted. While symptoms are present, patient's KPS score remains high (90) and occupation requires high cognitive function.\n\nPLAN:\n1. Conservative management with close monitoring\n2. Dexamethasone 4mg BID for edema management\n3. Monthly clinical evaluations for first 3 months\n4. Ophthalmology referral for baseline visual assessment\n5. Quarterly MRI for first year\n\nFOLLOW-UP VISIT - June 20, 2014\nSymptoms stable with steroid therapy. Visual symptoms improved.\nPlan: Gradual steroid taper. Continue monitoring.\n\nANNUAL REVIEW - March 2015\nMRI shows stable tumor size. Symptoms well-controlled.\nPlan: Continue conservative management. MRI frequency reduced to biannual.\n\nFOLLOW-UP - September 2016\nMinor headache progression noted.\nAdjusted medications: Added topiramate 50mg daily for headache prophylaxis.\nMRI: No significant change in tumor size.\n\nANNUAL REVIEW - March 2018\nPatient maintaining good functional status. Working full-time.\nMRI: Minimal growth (0.2cm over 4 years).\nPlan: Continue conservative approach. Annual MRI appropriate.\n\nFOLLOW-UP - March 2020\nStable symptoms. Managing work responsibilities well.\nMRI: No significant change.\nAdded: Virtual monitoring options due to COVID-19 pandemic.\n\nANNUAL REVIEW - March 2022\nMinor balance issues noted.\nPhysical therapy referral for balance training.\nMRI: Stable disease.\n\nLATEST FOLLOW-UP - January 2024\nMaintaining good quality of life. Working part-time by choice.\nMRI: No significant progression over 10-year period.\nSymptoms well-managed with current regimen.\n\nFUNCTIONAL STATUS SCORES:\n- Karnofsky Performance Status (KPS): 90/100\n- ECOG Performance Status: 1\n\nCURRENT MANAGEMENT:\n1. Annual MRI surveillance\n2. Topiramate 50mg daily\n3. PRN dexamethasone for symptom flares\n4. Regular balance therapy exercises\n5. Quarterly neurology reviews\n6. Annual ophthalmology assessment\n\nRECOMMENDATIONS:\n1. Continue current conservative management\n2. Consider work modifications if cognitive demands increase\n3. Maintain healthy lifestyle modifications\n4. Regular cognitive assessments\n5. Quality of life monitoring\n\nNote: Conservative approach has proven successful over 10-year period with stable disease and maintained functional status. Patient has adapted well to symptom management strategies while maintaining professional activities."
      }
    },
    {
      "demographics": {
        "age": 41,
        "gender": "Female",
        "blood_type": "AB",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Persistent headaches increasing in frequency over past 4 months, typically worse in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Difficulty concentrating at work, especially when looking at computer screens for long periods",
          "Occasional ringing in right ear starting 2 months ago",
          "Mild balance issues noted when walking, particularly when tired",
          "Reports increased fatigue and irritability"
        ],
        "medical_history": [
          "Migraine headaches since age 25, but notes current headaches feel different",
          "Lasik surgery 8 years ago with good results",
          "History of oral contraceptive use for 15 years",
          "No prior neurological conditions",
          "No family history of brain tumors",
          "Occasional tension headaches managed with OTC pain relievers",
          "Normal annual physical examinations",
          "No history of head trauma or radiation exposure"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F41-AB-DS\nPrimary Neurosurgeon: Dr. [Name]\n\nINITIAL VISIT - March 15, 2018\nPRESENTING SYMPTOMS: 41-year-old female data scientist presents with progressive neurological symptoms including morning headaches, right-sided visual disturbances, and balance issues. Symptoms significantly impacting work performance with computer screens.\n\nIMAGING FINDINGS:\nMRI reveals a 3.2cm right sphenoid wing meningioma with moderate peritumoral edema. Mass effect on adjacent temporal lobe. Enhancement pattern consistent with WHO Grade II meningioma.\n\nASSESSMENT & PLAN:\nGiven tumor size, location, and symptomatic presentation, recommend surgical intervention. Occupation requires high cognitive function and visual acuity - delayed intervention could impact professional capabilities.\nWHO Grade: II (preliminary based on imaging characteristics)\nRecommended aggressive surgical resection with potential need for adjuvant radiation.\n\nSURGICAL NOTE - April 3, 2018\nProcedure: Right frontotemporal craniotomy for tumor resection\nSimpson Grade II resection achieved\nMinimal residual tumor at cavernous sinus interface\nPathology confirms WHO Grade II meningioma\n\nFOLLOW-UP VISITS:\n\nJuly 2018 (3-month post-op):\n- Significant improvement in headaches and visual symptoms\n- MRI shows post-surgical changes, minimal enhancement at resection site\n- Initiated adjuvant radiation therapy (54 Gy/30 fractions)\n- Return to work approved with modifications\n\nJanuary 2019 (9-month post-op):\n- Completed radiation therapy\n- Minor fatigue persisting\n- MRI stable\n- Cleared for full work duties\n\nJuly 2019 (15-month post-op):\n- Maintaining good neurological status\n- MRI stable\n- Continue q6month monitoring\n\n2020 (Annual visits):\n- February: MRI stable, no new symptoms\n- August: Small area of enhancement noted at original site, close monitoring advised\n\n2021:\n- February: Enhancement stable\n- August: Slight increase in enhancement, discussed potential re-intervention\n\n2022:\n- February: Second surgery recommended due to progression\n- March: Second resection performed\n- August: Post-op recovery excellent, MRI clean\n\n2023:\n- February: Stable imaging\n- August: Continued stability, maintaining work schedule\n\n2024 (Current):\n- February: Six-year follow-up shows sustained tumor control\n- Patient maintains full professional activities\n- Continue bi-annual monitoring\n\nFUNCTIONAL STATUS SCORES:\nKPS Score: 90 (Able to carry on normal activity with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nONGOING MANAGEMENT:\n- Continue bi-annual MRI surveillance\n- Annual neuropsychological assessment\n- Regular ophthalmological monitoring\n- Maintain work modifications as needed (anti-glare screens, regular breaks)\n\nNote: This case demonstrates successful aggressive management of a WHO Grade II meningioma in a professional requiring high cognitive function. Early intervention and close monitoring have enabled maintained work performance and quality of life.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F41-AB-DS\nPrimary Diagnosis: Intracranial Meningioma\nWHO Grade: I (Benign)\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.4 cm right frontal convexity meningioma\n- Minimal peritumoral edema\n- No mass effect on critical structures\n- Characteristic dural tail sign present\n- T2 isointense with moderate enhancement\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms but tumor characteristics favor conservative management. Size and location permit watchful waiting approach. Occupation as Data Scientist requires significant screen time, which may exacerbate symptoms.\n\nINITIAL MANAGEMENT PLAN:\n1. Conservative monitoring with serial MRI\n2. Ergonomic workplace modifications\n3. Symptom management protocol\n4. Regular ophthalmological monitoring\n\nFOLLOW-UP VISITS:\n\nSeptember 18, 2018 (6-month)\n- Stable tumor size\n- Slight improvement in headaches with prescribed ergonomic interventions\n- Started on prophylactic migraine medication\n- Vision stable per ophthalmology report\nRecommendation: Continue monitoring\n\nMarch 12, 2019 (1-year)\n- No significant tumor growth (2.5 cm)\n- Patient reports better work tolerance with adjusted screen settings\n- Headache frequency decreased\nPlan: Maintain current management approach\n\nMarch 10, 2020 (2-year)\n- Tumor stable at 2.5 cm\n- Minor symptoms well-controlled\n- Patient adapted well to workplace modifications\n- Added blue light filtering glasses\nPlan: Continue annual MRI\n\nApril 15, 2021 (3-year)\n- Minimal growth to 2.6 cm\n- No new neurological symptoms\n- Patient maintaining full work schedule\n- Balance issues resolved\nPlan: Maintain conservative approach\n\nMay 20, 2022 (4-year)\n- Stable tumor size\n- Well-controlled symptoms\n- Added mindfulness practices for stress management\nPlan: Continue annual monitoring\n\nJune 8, 2023 (5-year)\n- No significant growth (2.6 cm)\n- Patient fully functional at work\n- Quality of life well-maintained\nPlan: Transition to biennial MRI\n\nJanuary 15, 2024 (5.5-year)\n- Stable disease\n- Excellent symptom control\n- Patient satisfied with conservative management\nPlan: Next MRI scheduled for June 2025\n\nCURRENT STATUS:\n- Tumor stable over 5.5-year period\n- Patient maintains full-time employment\n- Excellent quality of life\n- Well-adapted to management strategies\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90 - Able to carry on normal activity; minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory and able to carry out light work\n\nONGOING RECOMMENDATIONS:\n1. Biennial MRI surveillance\n2. Annual ophthalmological examination\n3. Continue workplace ergonomic measures\n4. Maintain headache diary\n5. Regular exercise and stress management\n6. Annual neurological assessment\n\nNote: Conservative management has proven successful with this patient, demonstrating that careful monitoring and lifestyle modifications can effectively manage benign meningiomas while maintaining quality of life and professional functionality."
      }
    },
    {
      "demographics": {
        "age": 41,
        "gender": "Male",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": false,
          "knowledge_worker_profession": null,
          "olfactory_profession": "Food Critic",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, worse in morning; Right-sided facial numbness and tingling; Occasional blurred vision in right eye; Recent changes in taste perception affecting work performance; Mild balance issues when walking; Increased irritability noted by family members"
        ],
        "medical_history": [
          "Type 2 diabetes diagnosed 6 years ago, managed with metformin; Hypertension diagnosed 4 years ago, controlled with lisinopril; History of migraine headaches but notes current headaches are different in character; Had sinus surgery 8 years ago for chronic sinusitis; Family history of stroke (father); BMI 31; Current medications: Metformin 1000mg BID, Lisinopril 10mg daily, Vitamin D supplement"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly olfactory function tests, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly olfactory function tests, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n\nINITIAL VISIT - March 15, 2018\nPatient: 41Y Male, Blood Type B\nChief Complaint: Progressive headaches, right-sided facial symptoms, visual changes\n\nIMAGING:\nMRI reveals 4.2cm right sphenoid wing meningioma with significant mass effect and peritumoral edema. Enhancement pattern consistent with WHO Grade II meningioma. Compression of right optic nerve and cavernous sinus noted.\n\nASSESSMENT:\nGiven patient's occupation as food critic, symptoms significantly impacting quality of life and work performance. Tumor size, location, and symptom progression warrant immediate intervention.\nWHO Grade: II (preliminary radiological assessment)\nKPS Score: 80\nECOG: 1\n\nPLAN:\n1. Scheduled for surgical resection within 2 weeks\n2. Pre-operative optimization of diabetes management\n3. Neurology and ophthalmology consults\n4. Discussed risks/benefits of surgery with patient\n\nSURGICAL NOTE - April 2, 2018\n- Simpson Grade II resection achieved\n- Pathology confirms WHO Grade II meningioma\n- No immediate post-operative complications\n\nFOLLOW-UP VISIT - July 15, 2018\nPost-operative MRI shows small residual tumor (0.8cm)\nRecommended adjuvant radiation therapy\nStarted 54 Gy/30 fractions\n\nFOLLOW-UP - January 10, 2019\nPost-radiation imaging stable\nImproved facial sensation\nVision normalized\nReturned to work with accommodations\n\nSURVEILLANCE VISITS:\nJuly 2019:\n- Stable imaging\n- Diabetes well-controlled\n- KPS: 90, ECOG: 0\n\nJanuary 2020:\n- No tumor progression\n- Regular taste testing ability restored\n- Maintaining work schedule\n\nJuly 2020:\n- MRI shows small area of enhancement (0.9cm)\n- Close monitoring recommended\n- Increased scan frequency to q4 months\n\nMarch 2021:\n- Slight progression (1.2cm)\n- Decision for stereotactic radiosurgery\n- 16 Gy single fraction delivered\n\nSeptember 2021:\n- Post-SRS response favorable\n- Lesion stable at 0.9cm\n- Continuing q4 month monitoring\n\n2022 (Quarterly visits):\n- Stable disease\n- Maintaining full work capacity\n- Regular diabetes management\n\n2023 (Quarterly visits):\n- No progression\n- Minor radiation changes stable\n- Maintaining quality of life\n\nJanuary 2024:\nLatest Status:\n- Disease stable\n- Full return to work activities\n- Well-controlled diabetes\n- Current KPS: 90\n- Current ECOG: 0\n\nMONITORING PROTOCOL:\n- MRI with contrast q4 months\n- Ophthalmology q6 months\n- Endocrinology for diabetes management q3 months\n- Annual neuropsychological evaluation\n\nCurrent WHO Grade: II (unchanged)\nFinal KPS Score: 90\nFinal ECOG Score: 0\n\nPROGNOSIS:\nFavorable with continued close monitoring. Patient maintains high functional status and professional activities with appropriate medical management.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n41-year-old male, Blood Type B\nOccupation: Food Critic\n\nINITIAL VISIT - March 15, 2018\nChief Complaint: Progressive headaches, right-sided facial symptoms, visual changes\n\nMRI FINDINGS:\n- 2.4 cm right sphenoid wing meningioma\n- Minimal surrounding edema\n- WHO Grade I (presumptive radiological diagnosis)\n- No significant mass effect on adjacent structures\n\nASSESSMENT:\nGiven patient's age, occupation, and symptom profile, recommending conservative management with close monitoring. Tumor size and location warrant careful observation, particularly given potential impact on taste perception affecting professional work.\n\nPLAN:\n1. MRI surveillance every 6 months initially\n2. Neurology referral for headache management\n3. Ophthalmology evaluation for visual symptoms\n4. Consider prophylactic anti-seizure medication\n5. Lifestyle modifications: weight management program referral\n6. Continue current medications\n\nFOLLOW-UP VISIT - September 20, 2018\n- Stable symptoms\n- MRI shows no significant change\n- Started topiramate 50mg daily for headache prophylaxis\n- Visual symptoms stable per ophthalmology\nKPS: 90 ECOG: 1\n\nANNUAL VISIT - March 12, 2019\n- Improved headache control\n- MRI stable\n- Weight loss of 10 lbs noted\n- Maintaining work schedule with minor accommodations\nKPS: 90 ECOG: 1\n\nFOLLOW-UP - March 18, 2020\n- Tumor stable on MRI\n- Reports better taste discrimination\n- Diabetes well-controlled (A1C 6.8)\n- Continuing conservative management\nKPS: 90 ECOG: 1\n\nANNUAL VISIT - April 5, 2021\n- MRI shows minimal growth (0.2cm over 3 years)\n- Symptoms stable\n- Added meditation practice for stress management\n- Maintaining professional activities\nKPS: 90 ECOG: 1\n\nFOLLOW-UP - April 12, 2022\n- Stable imaging\n- Reports occasional balance issues\n- Physical therapy referral made\n- Continuing conservative approach\nKPS: 85 ECOG: 1\n\nANNUAL VISIT - March 28, 2023\n- MRI stable\n- Improved balance with PT\n- Maintaining good quality of life\n- Professional activities unaffected\nKPS: 90 ECOG: 1\n\nRECENT VISIT - February 15, 2024\n- Six-year follow-up\n- Tumor stable at 2.6cm\n- Well-adapted to symptoms\n- Continues professional work successfully\n- Conservative management successful\n\nCURRENT STATUS:\nKPS: 90\nECOG: 1\n\nMANAGEMENT SUMMARY:\nConservative approach has proven successful over 6-year period. Patient has maintained high functional status and professional activity with minimal intervention. Regular monitoring has shown slow growth well within acceptable limits for continued observation.\n\nRECOMMENDATIONS:\n1. Continue annual MRI surveillance\n2. Maintain current medication regimen\n3. Regular ophthalmology follow-up\n4. Continue lifestyle modifications\n5. Consider quality of life assessments annually\n\nNote: Conservative management has been particularly appropriate given patient's stable symptoms, professional needs, and preference for minimal intervention. The slow growth rate and successful symptom management support continuing this approach."
      }
    },
    {
      "demographics": {
        "age": 68,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Researcher",
          "olfactory_profession": "Baker",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, particularly in the morning; Recent onset of right-sided weakness affecting arm and leg; Increasing difficulty with balance when walking; Occasional episodes of confusion and word-finding difficulties; Visual changes including intermittent double vision; Personality changes noted by family members including increased irritability"
        ],
        "medical_history": [
          "Hypertension controlled with lisinopril 10mg daily; Underwent surgery for benign prostate hyperplasia 5 years ago; History of mild hearing loss in left ear; Previous MRI for headaches 10 years ago was unremarkable; Family history of stroke (father); No history of seizures or neurological disorders; Former smoker - quit 15 years ago; Takes daily aspirin 81mg for cardiovascular prevention"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n68-year-old male, Blood Type O\nOccupation: Researcher/Baker\n\nINITIAL VISIT - January 15, 2018\nPresenting Symptoms: Progressive neurological symptoms including morning headaches, right-sided weakness, gait instability, cognitive changes, diplopia, and personality alterations. Symptoms significantly impacting work performance in both research and baking activities.\n\nImaging:\nMRI with/without contrast reveals:\n- 4.2 cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on motor cortex\n- WHO Grade II features suspected\n\nAssessment:\nGiven size, location, and symptomatology, immediate surgical intervention recommended. Occupational demands require fine motor control and cognitive clarity, currently compromised.\n\nPlan:\n1. Schedule surgical resection within 2 weeks\n2. Pre-operative optimization of blood pressure\n3. Discontinue aspirin 7 days before surgery\n\nSURGICAL NOTE - February 1, 2018\nProcedure: Left frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology: WHO Grade II meningioma\nNo immediate complications\n\nPOST-OP FOLLOW-UP - March 15, 2018\nSymptoms improving\nResidual mild right-sided weakness\nStarted physical therapy\nRecommended 6 weeks leave from work\nPlan: Adjuvant radiotherapy scheduled\n\nRADIATION ONCOLOGY - April-May 2018\nCompleted 60 Gy/30 fractions\nWell-tolerated\n\n6-MONTH FOLLOW-UP - August 2018\nMRI: No recurrence\nReturned to research work\nModified baking activities\nMild fatigue persisting\n\nANNUAL FOLLOW-UP - February 2019\nMRI: Stable\nResumed full work activities\nRight-sided strength 5/5\n\n18-MONTH FOLLOW-UP - August 2019\nMRI: Small enhancement at resection margin\nDecision: Increased monitoring frequency\n\n2-YEAR FOLLOW-UP - February 2020\nMRI: Stable enhancement\nMaintaining work activities\nSome COVID-19 related work modifications\n\n30-MONTH FOLLOW-UP - August 2020\nMRI: Slight progression of enhancement\nDiscussion of potential re-treatment options\n\n3-YEAR FOLLOW-UP - February 2021\nMRI: Further progression\nRecommended stereotactic radiosurgery\nCompleted CyberKnife treatment - 18 Gy single fraction\n\n4-YEAR FOLLOW-UP - February 2022\nMRI: Stable post-radiosurgery\nMaintaining modified work schedule\nNo new neurological symptoms\n\n5-YEAR FOLLOW-UP - February 2023\nMRI: Continued stability\nFull work engagement\nAnnual monitoring recommended\n\nCURRENT STATUS - January 2024\nMRI: Stable disease\nMaintaining regular activities\nNo significant neurological deficits\n\nFunctional Status Scores:\n- Current KPS: 90 (Able to carry on normal activity, minor symptoms)\n- ECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nTreatment Summary:\n- Initial Simpson II resection\n- Adjuvant radiotherapy\n- Salvage stereotactic radiosurgery\n- Regular imaging surveillance\n- Successful maintenance of occupational activities with modifications\n\nMonitoring Plan:\nContinue semi-annual MRI surveillance\nRegular neurocognitive assessments\nOccupational therapy as needed\nBP monitoring with lisinopril adjustment as needed",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n68-year-old male, Blood Type: O\nOccupation: Researcher/Baker\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms over 3 months\n\nMRI Findings:\n- 2.8cm left frontal convexity meningioma\n- Moderate peritumoral edema\n- Mass effect on adjacent frontal lobe\n- WHO Grade I (likely)\n\nAssessment:\nDespite conservative preference, presenting symptoms and imaging findings necessitate intervention due to:\n- Progressive neurological deficits\n- Location affecting motor function\n- Significant peritumoral edema\n- Impact on daily functioning/occupation\n\nPlan:\nGiven symptoms and size, recommending surgical resection with Simpson Grade II goal.\n\nSURGICAL INTERVENTION - April 2, 2014\n- Left frontal craniotomy\n- Simpson Grade II resection achieved\n- Pathology: WHO Grade I meningioma\n- No immediate complications\n\nPOST-OP FOLLOW-UP - May 15, 2014\n- Improved right-sided weakness\n- Headaches resolved\n- Balance improving with PT\n- Cleared to return to research work\n- Recommended modified duties as baker due to balance concerns\n\nFOLLOW-UP VISITS:\n\nOctober 15, 2014 (6-month):\n- No new symptoms\n- MRI: No residual/recurrence\n- Continuing PT for balance\n- Resumed part-time baking work\n\nApril 15, 2015 (1-year):\n- Stable neurological exam\n- MRI: No recurrence\n- Full return to work activities\n- Annual monitoring plan initiated\n\nApril 2016 (2-year):\n- Asymptomatic\n- MRI stable\n- Maintaining normal activities\n- BP well-controlled\n\nApril 2017 (3-year):\n- Minor intermittent headaches\n- MRI: No concerning changes\n- Continuing regular activities\n- Added prophylactic migraine medication\n\nApril 2018 (4-year):\n- Stable symptoms\n- MRI unchanged\n- Retired from baking, continues research\n- Focus on lifestyle modifications\n\nApril 2019 (5-year):\n- No new symptoms\n- MRI stable\n- Transitioned to biennial imaging\n\nApril 2021 (7-year):\n- Well-controlled symptoms\n- MRI: No recurrence\n- Fully retired, active lifestyle\n- Maintaining good quality of life\n\nApril 2023 (9-year):\n- Stable condition\n- MRI unchanged\n- Age-appropriate activity level\n- Continue biennial monitoring\n\nJanuary 2024 (Current):\n- Maintains good functional status\n- No concerning symptoms\n- Next MRI scheduled 2025\n\nCurrent Status:\nKPS Score: 90 (Able to carry on normal activity with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nManagement Summary:\nDespite initial conservative preference, surgical intervention was necessary due to progressive symptoms. Post-operative course demonstrated excellent outcome with successful return to activities. Long-term follow-up shows stable disease with good quality of life maintenance. Conservative approach resumed post-surgery with careful monitoring and minimal intervention.\n\nRecommendations:\n1. Continue biennial MRI surveillance\n2. Maintain BP control\n3. Regular exercise within limitations\n4. Annual neurological examinations\n5. Monitor cognitive function\n6. Quality of life assessments"
      }
    },
    {
      "demographics": {
        "age": 53,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Researcher",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work for past 2-3 months",
          "Mild right-sided facial numbness",
          "Reports feeling off-balance when walking"
        ],
        "medical_history": [
          "Migraine headaches since age 35, well-controlled with sumatriptan",
          "Hysterectomy at age 45 for uterine fibroids",
          "History of hormone replacement therapy for 5 years post-hysterectomy",
          "Mild hypertension managed with lifestyle modifications",
          "No history of cancer",
          "No significant family history of neurological conditions",
          "Regular mammograms and health screenings, all normal",
          "No prior head injuries or neurological disorders"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F53-O-2014\nOccupation: Researcher\n\nINITIAL VISIT - March 15, 2014\nPresenting Symptoms: Progressive headaches, right eye visual disturbance, nausea, personality changes, concentration difficulties, right facial numbness, and balance issues. Symptoms significantly impacting work performance as researcher.\n\nInitial MRI Findings:\n- 3.8cm right sphenoid wing meningioma\n- Significant mass effect on temporal lobe\n- Moderate peritumoral edema\n- Enhancement pattern consistent with WHO Grade II meningioma\n- Compression of optic nerve noted\n\nAssessment:\nGiven tumor size, location, and progressive symptomatology, immediate surgical intervention recommended. Patient's cognitive demands as researcher make preservation of function critical.\n\nPlan:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative optimization\n3. Baseline neuropsychological testing\n4. Ophthalmology consultation\n\nSURGICAL NOTE - April 1, 2014\nProcedure: Right frontotemporal craniotomy for tumor resection\n- Simpson Grade II resection achieved\n- Minor residual tumor at cavernous sinus (<5%)\nWHO Grade: II confirmed by pathology\nPost-op course: Uncomplicated\n\nFOLLOW-UP VISITS:\n\nJune 15, 2014 (2.5 months post-op)\n- Improved headaches and vision\n- Starting return-to-work protocol\n- MRI: Minimal residual enhancement\n- Plan: Adjuvant radiotherapy recommended\n\nSeptember 30, 2014\n- Completed 54 Gy/30 fractions radiation\n- Returned to work part-time\n- Minimal residual symptoms\n\nMarch 2015 (1 year post-op)\n- Full-time work resumed\n- MRI stable\n- Minor right facial numbness persists\n\nSeptember 2015\n- MRI: No progression\n- Maintaining work performance\n- 6-monthly monitoring continued\n\n2016-2017 (Bi-annual visits)\n- Serial MRIs stable\n- No new symptoms\n- Maintaining research career\n\nJanuary 2018\n- Small area of enhancement noted on MRI\n- Asymptomatic\n- Increased monitoring frequency\n\nJuly 2018\n- Enhancement stable\n- Continue vigilant monitoring\n\n2019-2020 (Quarterly visits)\n- Stable imaging\n- Annual neuropsychological testing normal\n- Maintaining full work capacity\n\n2021-2022\n- No progression\n- Semi-annual MRI protocol\n- Excellent functional status\n\n2023-2024\n- 10-year follow-up\n- No recurrence\n- Annual monitoring recommended\n\nCurrent Status (2024):\nKarnofsky Performance Score (KPS): 90%\n- Able to carry on normal activity with minor symptoms\n\nECOG Performance Status: 1\n- Restricted in physically strenuous activity but ambulatory and able to carry out light work\n\nTreatment Success Metrics:\n- Maintained professional career\n- Excellent quality of life\n- Long-term tumor control\n- Minimal residual symptoms\n\nOngoing Monitoring Plan:\n1. Annual MRI\n2. Yearly neuropsychological assessment\n3. Regular ophthalmology follow-up\n4. Continue monitoring for late recurrence\n\nNote: Early aggressive intervention and comprehensive follow-up have resulted in excellent outcome with maintenance of cognitive function critical for research career.",
        "conservative": "NEUROSURGICAL CLINICAL NOTES\nPatient ID: [Redacted]\nGender: Female | Age: 53 | Blood Type: O\nOccupation: Researcher\n\nINITIAL VISIT - March 15, 2018\nPresenting Symptoms: Progressive headaches, right eye visual disturbance, nausea, personality changes, concentration issues, right facial numbness, and balance problems. Symptoms suggest possible mass effect.\n\nInitial MRI Findings:\n- 2.8cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect on critical structures\n- WHO Grade I features (based on imaging characteristics)\n\nAssessment:\nDespite symptomatic presentation, tumor size and location favor initial conservative management. Patient's researcher occupation requires cognitive preservation, supporting careful monitoring approach.\n\nPlan:\n1. Close monitoring with serial MRI scans\n2. Headache management optimization\n3. Regular ophthalmological evaluations\n4. Balance therapy referral\n\nFOLLOW-UP VISIT - September 20, 2018 (6 months)\n- Headaches improved with medication adjustment\n- Vision stabilized\n- Balance improving with therapy\n- MRI: No significant change in tumor size\n- Continue conservative management\n\nANNUAL FOLLOW-UP - March 12, 2019\n- Symptoms stable\n- MRI: No growth\n- Patient maintaining work performance\n- Continue current management plan\n\nANNUAL FOLLOW-UP - March 18, 2020\n- Minor increase in headache frequency\n- MRI: 1mm growth (not clinically significant)\n- Adjusted headache medications\n- Added stress management counseling\n\nANNUAL FOLLOW-UP - March 15, 2021\n- Symptoms well-controlled\n- MRI: Stable\n- Patient adapted well to remote work during pandemic\n- Continue conservative approach\n\nANNUAL FOLLOW-UP - March 22, 2022\n- All symptoms stable\n- MRI: No changes\n- Patient maintaining good quality of life\n- Extended MRI interval to 18 months\n\n18-MONTH FOLLOW-UP - September 14, 2023\n- Minimal symptoms\n- MRI: Stable appearance\n- Patient considering partial retirement\n- Plan continued monitoring\n\nLATEST FOLLOW-UP - March 5, 2024\n- Excellent symptom control\n- MRI: No growth over 6 years\n- Patient successfully managing work-life balance\n- Plan: Continue biennial MRI monitoring\n\nCurrent Status:\n- Stable WHO Grade I meningioma\n- Well-controlled symptoms\n- Maintained cognitive function\n- Successful conservative management strategy\n\nFunctional Status Scores:\n- Karnofsky Performance Status (KPS): 90/100 \n(Able to carry on normal activity; minor symptoms)\n- ECOG Performance Status: 1 \n(Restricted in physically strenuous activity but ambulatory)\n\nTreatment Success Metrics:\n- No tumor growth over 6 years\n- Maintained professional activity\n- Preserved quality of life\n- Avoided surgical intervention\n- Well-managed symptoms\n\nRecommendations:\n1. Continue biennial MRI surveillance\n2. Annual neurological examinations\n3. Regular ophthalmology follow-up\n4. Maintain current medication regimen\n5. Continue stress management strategies\n\nLong-term Outlook:\nFavorable prognosis with current conservative management approach. Patient has demonstrated stability and successful symptom management without requiring surgical intervention."
      }
    },
    {
      "demographics": {
        "age": 68,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Baker",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty finding right words",
          "Subtle personality changes noted by family - increased irritability",
          "Mild right-sided weakness when typing at work",
          "Balance issues when standing for long periods while baking",
          "Two episodes of focal seizures affecting right arm in past month"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Mild hearing loss in left ear - diagnosed 5 years ago",
          "Cholesterol managed with atorvastatin 20mg daily",
          "History of migraine headaches in 30s-40s, resolved spontaneously",
          "Appendectomy at age 23",
          "No history of cancer",
          "No family history of brain tumors",
          "Former smoker - quit 15 years ago"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nPrimary Occupation: Software Developer/Baker\n\nINITIAL VISIT - March 15, 2014\nPresenting Symptoms: Progressive neurological symptoms including morning headaches, right-sided visual disturbance, cognitive changes, and focal seizures. Occupational impact noted with typing difficulties and balance issues affecting work performance.\n\nMRI Findings:\n- 4.2cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on left motor cortex\n- WHO Grade II features suspected\n- Evidence of dural tail sign\n\nAssessment:\nGiven size >3cm, significant edema, and progressive symptoms affecting daily function, immediate surgical intervention recommended. Location and symptoms suggest aggressive growth pattern.\n\nPlan:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative optimization with dexamethasone 4mg QID\n3. Anti-epileptic prophylaxis - Levetiracetam 500mg BID\n4. Discontinue work temporarily\n\nSURGICAL NOTE - April 1, 2014\n- Simpson Grade II resection achieved\n- Pathology confirms WHO Grade II meningioma\n- No immediate post-operative complications\n\nFOLLOW-UP VISIT - July 15, 2014\n- Improved neurological symptoms\n- Started adjuvant radiotherapy (60 Gy/30 fractions)\n- Cleared for part-time work return\n\nFOLLOW-UP - January 10, 2015\n- MRI shows no recurrence\n- Maintained on Levetiracetam\n- Full work resumption\n- WHO Grade II protocol monitoring initiated\n\nSUBSEQUENT VISITS:\n\n2015-2016 (Quarterly MRIs):\n- Stable imaging\n- Minor headaches managed\n- Working full-time\n- KPS 90\n\n2017-2018 (Biannual MRIs):\n- Small enhancement noted on left frontal region\n- Gamma Knife radiosurgery to residual tumor\n- Maintained work schedule\n- KPS 85\n\n2019-2020:\n- Stable disease\n- Annual MRIs\n- No new symptoms\n- KPS 85\n\n2021-2022:\n- Continued stability\n- Semi-annual monitoring\n- Retired from baking work\n- Continues software development\n- KPS 80\n\n2023-2024:\n- Recent MRI shows stable disease\n- Maintained on anti-epileptics\n- Regular cognitive assessments\n- KPS 80\n\nCurrent Status (2024):\n- Disease controlled\n- Independent in ADLs\n- Continues part-time software work\n- Regular monitoring maintained\n\nFunctional Status Scores:\n- KPS: 80/100 (Able to perform normal activity with effort)\n- ECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nTreatment Summary:\n- Initial craniotomy (2014)\n- Adjuvant radiotherapy\n- Gamma Knife for residual (2017)\n- Ongoing surveillance\n- Maintained on anti-epileptics\n\nMonitoring Protocol:\n- Semi-annual MRI with contrast\n- Quarterly neurology assessments\n- Annual neuropsychological testing\n- Regular occupational therapy evaluation",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nPrimary Occupation: Software Developer/Baker\n\nINITIAL VISIT - January 15, 2018\nChief Complaint: Progressive neurological symptoms with headaches and visual changes\n\nIMAGING:\nMRI reveals 2.8cm left frontal convexity meningioma with moderate peritumoral edema\nWHO Grade: I (based on imaging characteristics)\nLocation: Left frontal convexity, near motor strip\n\nASSESSMENT:\nGiven multiple symptomatic presentations and strategic location, surgical intervention was discussed. However, considering patient's age and preference for conservative management, we'll proceed with careful monitoring and medical management.\n\nPLAN:\n1. Dexamethasone 4mg BID for edema control\n2. Levetiracetam 500mg BID for seizure prophylaxis\n3. Monthly clinical monitoring initially\n4. Occupational therapy referral for workplace adaptations\n5. MRI follow-up in 3 months\n\n-------------------\n\nFOLLOW-UP - April 20, 2018\nSymptoms improved with medical management\nMRI: Stable tumor size, decreased edema\nReduced dexamethasone to 2mg BID\nAdded ergonomic workplace recommendations\n\n-------------------\n\nFOLLOW-UP - October 15, 2018\nStable symptoms\nMRI: No progression\nMaintained on reduced steroid dose\nPatient successfully implemented workplace modifications\n\n-------------------\n\nANNUAL FOLLOW-UP - January 10, 2019\nMinor headache complaints\nMRI: Stable disease\nContinued conservative management\nFurther reduced dexamethasone to 1mg daily\n\n-------------------\n\nANNUAL FOLLOW-UP - January 15, 2020\nWell-controlled symptoms\nMRI: Minimal growth (0.2cm)\nMaintained medical management\nPatient adapted well to modified work schedule\n\n-------------------\n\nANNUAL FOLLOW-UP - January 20, 2021\nStable neurological status\nMRI: No significant change\nSuccessfully weaned off dexamethasone\nContinuing anticonvulsant therapy\n\n-------------------\n\nANNUAL FOLLOW-UP - January 18, 2022\nMinor visual complaints\nMRI: Stable disease\nAdded ophthalmology follow-up\nMaintained conservative approach\n\n-------------------\n\nANNUAL FOLLOW-UP - January 16, 2023\nWell-compensated neurologically\nMRI: No progression\nPatient maintaining good quality of life\nContinues modified work schedule\n\n-------------------\n\nRECENT FOLLOW-UP - January 15, 2024\nStable symptoms\nMRI: No significant change over 6 years\nPatient satisfied with conservative management\n\nFUNCTIONAL STATUS SCORES:\nKarnofsky Performance Status (KPS): 80\n(Able to perform normal activity with effort, some symptoms)\n\nECOG Performance Status: 1\n(Restricted in physically strenuous activity but ambulatory)\n\nMANAGEMENT SUMMARY:\nConservative approach has proven successful with:\n- Stable disease control\n- Maintained functional independence\n- Successful workplace adaptation\n- Preserved quality of life\n- Minimal medical intervention needed\n\nOCCUPATIONAL CONSIDERATIONS:\n1. Software Development:\n- Implemented ergonomic workstation\n- Regular breaks for vision rest\n- Modified screen settings\n- Flexible work hours\n\n2. Baking:\n- Limited standing periods\n- Assistant for heavy lifting\n- Modified workspace for balance issues\n- Temperature-controlled environment\n\nCONTINUING RECOMMENDATIONS:\n1. Annual MRI surveillance\n2. Maintained anticonvulsant therapy\n3. Regular ophthalmology follow-up\n4. Continued occupational therapy as needed\n5. Annual neuropsychological assessment"
      }
    },
    {
      "demographics": {
        "age": 59,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressively worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of dizziness when changing positions",
          "Increased difficulty concentrating at work, especially when looking at computer screens",
          "Mild right-sided facial numbness that developed gradually over past 2 months",
          "Reports of recent personality changes noted by family - more irritable than usual",
          "Two episodes of nausea and vomiting in past month, unrelated to food or illness"
        ],
        "medical_history": [
          "Hypertension diagnosed 3 years ago, well-controlled with lisinopril 10mg daily",
          "Migraine headaches since age 35, but notes current headaches are different in nature",
          "Surgical removal of ovarian cyst in 2010",
          "Mother diagnosed with breast cancer at age 62",
          "No history of head trauma or neurological conditions",
          "Regular eye exams, last one 18 months ago was normal",
          "No significant radiation exposure history",
          "Non-smoker, occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F59-O-SD\nInitial Visit: March 15, 2014\n\nINITIAL CONSULTATION NOTE:\nChief Complaint: Progressive neurological symptoms including headaches, visual disturbance, and cognitive changes.\n\nIMAGING FINDINGS:\nMRI reveals a 4.2cm right sphenoid wing meningioma with significant mass effect and moderate peritumoral edema. Enhancement pattern consistent with WHO Grade II meningioma. Evidence of compression of the right optic nerve and temporal lobe.\n\nASSESSMENT & PLAN:\nGiven patient's occupation requiring high cognitive function and visual acuity, combined with progressive symptoms and tumor size >3cm, immediate surgical intervention is recommended. Pre-operative functional MRI and DTI tractography ordered to map eloquent areas.\n\nSURGICAL NOTE - April 2, 2014:\n- Simpson Grade II resection performed\n- Histopathology confirms WHO Grade II atypical meningioma\n- Post-op imaging shows near-total resection with small residual along sphenoid wing\n\nFOLLOW-UP VISITS:\n\nJune 15, 2014 (2-month post-op):\n- Improved vision and headaches\n- Started adjuvant radiation therapy (60 Gy/30 fractions)\n- KPS: 80\n\nDecember 2014 (6-month post-op):\n- Completed radiation therapy\n- Minor fatigue but returned to work\n- MRI: No evidence of progression\n- KPS: 90\n\nJune 2015:\n- Stable symptoms\n- MRI: No recurrence\n- Continuing q6month monitoring\n- KPS: 90\n\n2016-2017 (q6month visits):\n- Serial MRIs stable\n- Maintaining work performance\n- Annual neuropsychological testing implemented\n- KPS: 90-95\n\nJanuary 2018:\n- Small area of enhancement noted on MRI\n- Gamma Knife radiosurgery to residual tumor (16 Gy)\n- KPS: 90\n\n2019-2020 (q6month visits):\n- Post-radiosurgery response favorable\n- Maintained cognitive function\n- Regular ophthalmological monitoring\n- KPS: 90\n\n2021-2022:\n- Stable disease\n- Annual MRI protocol\n- Preventive cognitive rehabilitation implemented\n- KPS: 95\n\n2023-2024:\n- 10-year survival milestone\n- Minimal residual disease\n- Continues full-time work\n- Annual monitoring plan\n- KPS: 95\n\nCURRENT STATUS (2024):\nDisease Control: Excellent\nFunctional Status: Independent\nWork Status: Full-time employment\nQuality of Life: Excellent\n\nSCORES:\nKPS (Current): 95/100\nECOG: 0\n\nMONITORING PROTOCOL:\n- Annual MRI with volumetric analysis\n- Biannual neurocognitive assessment\n- Annual ophthalmological examination\n- Regular quality of life assessments\n\nNote: Proactive intervention strategy with early surgery and adjuvant radiation therapy has resulted in excellent long-term control and maintained professional functionality. Patient's high-functioning occupation and presenting symptoms justified aggressive initial approach.\n\nWHO Grade: II (Atypical Meningioma)",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nOccupation: Software Developer\nWHO Grade: I (confirmed via imaging characteristics)\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms including headaches and visual changes\n\nImaging Findings:\n- MRI reveals 2.8cm left frontal convexity meningioma\n- Minimal peritumoral edema\n- No mass effect on critical structures\n- T2 signal: moderately intense\n- Contrast enhancement: homogeneous\n\nAssessment:\nDespite symptomatic presentation, tumor characteristics favor initial conservative management given:\n- Size below 3cm threshold\n- Minimal edema\n- No critical structure compression\n- Patient's preference for non-surgical approach\n\nPlan:\n1. Conservative monitoring with serial MRI\n2. Occupational modifications:\n   - Blue light filtering glasses\n   - Ergonomic workstation assessment\n   - Regular screen breaks\n3. Medical management:\n   - Dexamethasone 4mg BID for 2 weeks, then taper\n   - Continue lisinopril 10mg daily\n4. Monthly neurology assessments initially\n\nFOLLOW-UP - September 20, 2014 (6 months)\n- Headaches improved with steroid therapy\n- Vision stabilized\n- MRI: No significant change in tumor size\n- Maintaining full work schedule with modifications\n\nANNUAL FOLLOW-UP - March 2015\n- Stable symptoms\n- MRI: No growth\n- Discontinued steroids\n- Managing work effectively with accommodations\n\nANNUAL FOLLOW-UP - March 2016\n- Minor headache episodes, well-controlled\n- MRI: Minimal growth (0.2cm in 2 years)\n- Maintaining good quality of life\n\nANNUAL FOLLOW-UP - March 2017\n- Stable symptoms\n- MRI: No additional growth\n- Successfully adapted work routine\n\nANNUAL FOLLOW-UP - March 2018\n- Reports occasional headaches\n- MRI: Stable\n- Continuing conservative management\n\nBIENNIAL FOLLOW-UP - March 2020\n- Well-compensated\n- MRI: No significant changes\n- Maintaining normal work activities\n\nBIENNIAL FOLLOW-UP - March 2022\n- Minor visual symptoms persist but stable\n- MRI: Minimal growth (0.3cm over 8 years)\n- Patient satisfied with conservative approach\n\nLATEST FOLLOW-UP - March 2024\n- Stable symptoms\n- MRI: No significant progression\n- Patient continues to work full-time\n- Quality of life well-maintained\n\nCurrent Status:\n- Tumor size: 3.3cm (total growth of 0.5cm over 10 years)\n- Minimal symptom progression\n- Well-adapted to condition\n\nFunctional Status Scores:\n- Karnofsky Performance Status (KPS): 90\n- ECOG Performance Status: 1\n\nLong-term Recommendations:\n1. Continue biennial MRI surveillance\n2. Maintain current work modifications\n3. Regular ophthalmology follow-up\n4. Consider intervention only if:\n   - Significant tumor growth (>5mm/year)\n   - Progressive neurological symptoms\n   - Patient preference changes\n\nNote: Conservative management has proven successful with this patient, demonstrating stable disease and maintained quality of life over 10 years. Continue monitoring with low threshold for intervention if status changes."
      }
    },
    {
      "demographics": {
        "age": 53,
        "gender": "Female",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work on computer screens",
          "Mild right-sided facial numbness",
          "Balance issues when walking, particularly in dimly lit areas"
        ],
        "medical_history": [
          "Migraine headaches since age 35, previously well-controlled with sumatriptan",
          "Hysterectomy at age 45 for uterine fibroids",
          "History of mild depression treated with sertraline 50mg daily",
          "No prior neurological conditions",
          "No history of cancer",
          "No radiation exposure",
          "Regular eye exams, last one 18 months ago was normal",
          "Non-smoker",
          "Occasional alcohol use (1-2 drinks/week)"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F53-B-DS\nPrimary Diagnosis: Meningioma\nWHO Grade: II (Atypical features noted)\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 4.2 cm left frontotemporal meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent structures\n- Enhancement pattern suggesting possible atypical features\n- Compression of optic structures noted\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms significantly impacting quality of life and cognitive function. Given occupation as Data Scientist requiring high cognitive performance and visual focus, symptoms are particularly concerning. Size and location of tumor warrant immediate intervention.\n\nTREATMENT PLAN:\nRecommended aggressive surgical resection (Simpson Grade I-II) followed by potential adjuvant radiation therapy.\n\nSURGICAL INTERVENTION - April 2, 2018\n- Left frontotemporal craniotomy\n- Simpson Grade II resection achieved\n- Minimal blood loss\n- No immediate complications\n- Pathology confirmed WHO Grade II meningioma\n\nPOST-OP FOLLOW-UP - May 15, 2018\n- Wound healing well\n- Improvement in visual symptoms\n- Headaches significantly reduced\n- Started physical therapy for balance issues\n- Recommended 6 weeks medical leave\n\nRADIATION ONCOLOGY CONSULT - June 20, 2018\n- Initiated fractionated RT (54 Gy/30 fractions)\n- Well-tolerated\n\nFOLLOW-UP VISITS:\n\nDecember 2018 (6 months post-op)\n- MRI shows no residual/recurrent tumor\n- Return to work approved\n- Minor residual facial numbness\n- Vision normalized\n\nJune 2019 (1 year post-op)\n- Stable MRI\n- No new symptoms\n- Continuing quarterly monitoring\n\nDecember 2019\n- MRI stable\n- Cognitive function optimal\n- Back to full work capacity\n\nJune 2020\n- Surveillance MRI shows small enhancement at surgical site\n- Close monitoring recommended\n- Increased scan frequency to every 3 months\n\nMarch 2021\n- Small growth noted\n- Decision for gamma knife radiosurgery\n- Treatment completed April 2021\n\n2022 (Quarterly visits)\n- Stable disease\n- No progression\n- Maintaining work performance\n- Annual ophthalmological exams normal\n\n2023 (Bi-annual visits)\n- Continued stability\n- No new symptoms\n- Maintaining regular cognitive assessments\n\nJanuary 2024 (Most recent)\n- MRI shows stable disease\n- Patient fully functional\n- Continuing bi-annual monitoring\n\nCURRENT STATUS:\n- Disease controlled\n- Patient maintains high functional status\n- Regular cognitive assessments show normal performance\n- Continuing professional work without limitations\n\nSCORES:\nKPS: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nONGOING MONITORING PLAN:\n- Bi-annual MRI with contrast\n- Annual neuropsychological assessment\n- Regular ophthalmological exams\n- Continue current follow-up schedule\n\nNote: Aggressive initial approach with early intervention and close monitoring has resulted in favorable outcome with maintained quality of life and professional functionality.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F53-B-DS\nPrimary: Dr. [Name]\nDiagnosis: Intracranial Meningioma\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 2.8cm right sphenoid wing meningioma\n- Minimal perilesional edema\n- No significant mass effect\n- WHO Grade I (suspected based on imaging characteristics)\n\nASSESSMENT:\nPatient presents with progressive neurological symptoms affecting work performance as data scientist. Given tumor size <3cm and minimal edema, conservative management initially preferred. Symptoms warrant close monitoring.\n\nPLAN:\n1. Watchful waiting with serial imaging\n2. Symptom management:\n   - Neurology referral for headache management\n   - Adjustment of current migraine medication\n   - Occupational therapy for computer work modifications\n3. Follow-up MRI in 3 months\n\nFOLLOW-UP - June 20, 2018\nStable tumor size. Minor improvement in headaches with medication adjustment.\nModified work station with anti-glare screen and regular breaks implemented.\nPlan: Continue monitoring, MRI in 6 months\n\nFOLLOW-UP - December 12, 2018\nNo tumor growth. Vision symptoms stable.\nImplemented workplace accommodations showing positive results.\nPlan: Annual MRI if stable\n\nANNUAL FOLLOW-UP - December 15, 2019\nMinimal growth (0.2cm). Symptoms stable.\nMaintaining work performance with accommodations.\nPlan: Continue conservative management, repeat MRI 6 months\n\nFOLLOW-UP - June 18, 2020\nNo additional growth. Patient adapting well to modified work routine.\nBalance issues improved with physical therapy.\nPlan: Resume annual monitoring\n\nANNUAL FOLLOW-UP - June 15, 2021\nStable disease. Quality of life maintained.\nWorking remotely due to COVID-19 has reduced screen-related symptoms.\nPlan: Continue annual monitoring\n\nANNUAL FOLLOW-UP - June 20, 2022\nMinor growth (0.3cm total since initial). \nSymptoms stable, managing work effectively.\nPlan: Increase monitoring frequency to 6 months\n\nFOLLOW-UP - December 12, 2022\nNo additional growth. Patient stable.\nConsider radiation therapy if progression continues.\nPlan: Continue 6-month monitoring\n\nFOLLOW-UP - June 15, 2023\nStable disease. Patient maintaining good functional status.\nSuccessfully managing work responsibilities.\nPlan: Continue current management approach\n\nLATEST FOLLOW-UP - January 10, 2024\nTumor stable at 3.1cm total.\nSymptoms well-controlled with conservative measures.\nPatient satisfied with management approach.\n\nCURRENT MANAGEMENT:\n1. Regular MRI monitoring (every 6 months)\n2. Optimized workplace ergonomics\n3. Regular physical therapy\n4. Modified migraine management\n5. Regular ophthalmology checks\n\nFUNCTIONAL STATUS SCORES:\n- Karnofsky Performance Status (KPS): 90\n(Able to carry on normal activity; minor signs/symptoms of disease)\n- ECOG Performance Status: 1\n(Restricted in physically strenuous activity but ambulatory and able to carry out light work)\n\nNOTES:\nConservative management has been successful in maintaining patient's quality of life and work capability. Patient has shown good adaptation to workplace modifications and maintains high functional status. Will continue close monitoring with low threshold for intervention if progression occurs."
      }
    },
    {
      "demographics": {
        "age": 65,
        "gender": "Female",
        "blood_type": "AB",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Financial Analyst",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of confusion and difficulty finding words during meetings",
          "Subtle right-sided facial numbness",
          "Occasional balance issues when walking",
          "Increased fatigue and difficulty concentrating at work",
          "One episode of focal seizure affecting right hand 2 weeks ago"
        ],
        "medical_history": [
          "Hypertension - diagnosed 8 years ago, controlled with lisinopril",
          "BMI 33.2 - Class I Obesity",
          "Migraines in 30s-40s, resolved spontaneously",
          "Osteoarthritis in both knees",
          "Cholecystectomy in 2010",
          "Family history of breast cancer (mother)",
          "No history of smoking",
          "Occasional alcohol use (1-2 drinks/week)",
          "Regular mammograms, last one normal 8 months ago",
          "No previous neurological conditions"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 65, Female, Blood Type: AB\nOccupation: Financial Analyst\nBMI: 33.2 (Obese Class I)\n\nINITIAL VISIT - March 15, 2014\nChief Complaints: Progressive headaches, right eye vision changes, cognitive symptoms, facial numbness, balance issues, work-affecting fatigue, recent focal seizure.\n\nIMAGING:\nMRI with/without contrast reveals:\n- 4.2cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on left frontal lobe\n- Dural tail sign present\n- No calcification noted\n\nASSESSMENT:\nWHO Grade II Meningioma (suspected based on imaging characteristics)\nGiven size, symptoms, and location, immediate surgical intervention recommended.\n\nTREATMENT PLAN:\n1. Schedule craniotomy within 2 weeks\n2. Preoperative optimization of blood pressure\n3. Dexamethasone 4mg QID for edema\n4. Anti-epileptic prophylaxis (Levetiracetam 500mg BID)\n\nSURGICAL NOTE - April 1, 2014\n- Simpson Grade II resection achieved\n- Minimal blood loss\n- No complications\nPathology confirms WHO Grade II Meningioma\n\nFOLLOW-UP VISITS:\n\nJune 2014 (2-month post-op):\n- Improved symptoms\n- No new neurological deficits\n- Started adjuvant radiotherapy (60 Gy/30 fractions)\n\nDecember 2014 (6-month post-op):\n- MRI: No residual/recurrent tumor\n- Returned to work part-time\n- Continuing rehabilitation\n\nJune 2015:\n- MRI stable\n- Full-time work resumed\n- Minor fatigue persists\n\nDecember 2015:\n- Surveillance MRI: Small enhancement at resection margin\n- Increased monitoring frequency\n\nJune 2016:\n- MRI shows 1.2cm recurrence\n- Recommended stereotactic radiosurgery (SRS)\n- Completed SRS August 2016\n\n2017-2019 (Biannual visits):\n- Stable disease\n- Regular MRI surveillance\n- Maintaining work performance\n- Regular cognitive assessments\n\n2020-2022 (Quarterly visits):\n- Minor progression noted in 2021\n- Second SRS course completed\n- Continued close monitoring\n\n2023-2024 (Current status):\n- Stable disease\n- Maintaining independent function\n- Continues working with accommodations\n- Regular imaging surveillance maintained\n\nCURRENT FUNCTIONAL STATUS (2024):\nKarnofsky Performance Status (KPS): 80%\n- Able to perform normal activities with effort\n- Some signs/symptoms of disease\n\nECOG Performance Status: 1\n- Restricted in physically strenuous activity\n- Ambulatory and able to carry out light work\n\nONGOING MONITORING:\n- MRI every 4 months\n- Quarterly neurocognitive assessments\n- Regular ophthalmological evaluations\n- Blood pressure monitoring\n- Quality of life assessments\n\nNote: Aggressive initial approach with early surgical intervention and adjuvant therapy has likely contributed to relatively stable long-term outcome despite WHO Grade II status. Continued vigilance warranted due to known recurrence risk.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nDemographics: 65F, AB+, Financial Analyst\nWHO Grade: I (Suspected based on imaging characteristics)\n\nINITIAL VISIT - March 15, 2018\nPresenting Symptoms: Progressive neurological symptoms including headaches, right-sided visual disturbance, cognitive changes, and focal seizure. Symptoms impacting work performance.\n\nImaging Findings:\n- MRI reveals 2.8cm left frontal convexity meningioma\n- Minimal perilesional edema\n- No significant mass effect\n- T2 isointense with moderate contrast enhancement\n\nAssessment & Plan:\nGiven patient's age, occupation requiring cognitive function, and symptom progression, recommending conservative management with close monitoring. Will defer surgical intervention unless symptoms worsen significantly.\n\nInitial Management Plan:\n1. Anti-epileptic medication: Levetiracetam 500mg BID\n2. Dexamethasone 4mg daily for edema management\n3. Monthly clinical assessment for first 3 months\n4. Occupational therapy referral for workplace adaptations\n5. Quarterly MRI surveillance\n\nFOLLOW-UP VISITS:\n\nJune 20, 2018 (3-month)\n- Symptoms stabilized with medical management\n- Maintaining work with accommodations\n- MRI: No significant change\n- Continue current management\n\nDecember 12, 2018 (6-month)\n- Improved headaches\n- Vision stable\n- Reduced steroid dose to 2mg daily\n- MRI: Stable lesion size\n\nJune 15, 2019 (1-year)\n- Maintained work status\n- Seizure-free on Levetiracetam\n- MRI: No growth\n- Steroid discontinued\n\nJune 2020 (2-year)\n- Stable symptoms\n- Adapted well to modified work schedule\n- MRI: Minimal growth (0.2cm)\n- Continue conservative management\n\nJune 2021 (3-year)\n- Minor balance issues resolved with PT\n- Cognitive function stable\n- MRI: No further growth\n- Transitioned to biannual imaging\n\nDecember 2022 (4.5-year)\n- Maintaining independent lifestyle\n- Regular exercise program initiated\n- MRI: Stable disease\n- Weight management program started\n\nMarch 2024 (6-year)\n- Successfully managing work responsibilities\n- No new neurological symptoms\n- MRI: No progression\n- Continue current management plan\n\nCURRENT STATUS (2024):\n- Stable disease\n- Well-controlled symptoms\n- Maintaining professional activities\n- Good quality of life\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nONGOING RECOMMENDATIONS:\n1. Biannual MRI surveillance\n2. Continue Levetiracetam\n3. Regular cognitive assessments\n4. Weight management program\n5. Occupational therapy as needed\n6. Annual neuropsychological evaluation\n\nNote: Conservative approach successful in maintaining quality of life while managing tumor-related symptoms. Patient demonstrates good compliance with monitoring protocol and maintains professional activities with appropriate accommodations."
      }
    },
    {
      "demographics": {
        "age": 65,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Researcher",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": true,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months, worse in morning; Right-sided facial numbness; Occasional balance issues when walking; Increasing difficulty concentrating at work; Mild personality changes noted by family; Two episodes of nausea/vomiting in past month; Recent vision changes - blurring in right peripheral field"
        ],
        "medical_history": [
          "Type 2 diabetes diagnosed 12 years ago, managed with metformin; Hypertension controlled with lisinopril; Total hysterectomy at age 48; History of migraine headaches but pattern changed recently; Osteoarthritis in left knee; Family history of breast cancer (mother); No prior neurological conditions; No history of cancer; Regular mammograms with last one clear 8 months ago; Current medications: metformin 1000mg BID, lisinopril 10mg daily, calcium/vitamin D supplement"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Special consideration for contrast due to diabetes",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: F65-O-2014\nPrimary Diagnosis: Meningioma\nWHO Grade: II (Atypical)\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms with headaches\nMRI Findings:\n- 4.2 cm right sphenoid wing meningioma\n- Significant peritumoral edema\n- Mass effect on temporal lobe\n- Enhancement pattern suggesting possible atypical features\nClinical Assessment:\n- Symptoms indicating increased ICP\n- Occupation as researcher requires high cognitive function\n- Diabetes may impact surgical planning\nTreatment Plan:\n- Recommend immediate surgical intervention\n- Simpson Grade I resection planned\n- Pre-op optimization of diabetes management\nKPS: 80/100\n\nSURGICAL NOTE - April 2, 2014\nProcedure: Right frontotemporal craniotomy for tumor resection\nFindings:\n- Simpson Grade II resection achieved\n- Tumor adherent to dural sinuses\n- Pathology confirms WHO Grade II meningioma\nPost-op Plan:\n- Adjuvant radiation recommended\n- Follow-up MRI in 3 months\n\nFOLLOW-UP - July 15, 2014\n- Post-radiation assessment\n- Minimal residual enhancement\n- Improved symptoms\n- Returned to work part-time\nKPS: 90/100\n\nANNUAL FOLLOW-UP - March 2015\n- Stable imaging\n- No new symptoms\n- Full-time work resumed\nKPS: 90/100\n\nSURVEILLANCE - September 2016\n- Small focus of enhancement noted\n- Recommend increased monitoring frequency\nKPS: 90/100\n\nINTERVENTION - January 2017\n- Gamma Knife radiosurgery for focal recurrence\n- 16 Gy to tumor margin\nKPS: 85/100\n\nFOLLOW-UP - 2018-2020 (Biannual visits)\n- Stable disease\n- Maintaining work schedule\n- Regular diabetes monitoring\nKPS: 85-90/100\n\nSURVEILLANCE - 2021-2024 (Annual visits)\n- No evidence of progression\n- Continued monitoring\n- Age-appropriate preventive care\nFinal Status (2024):\nKPS: 85/100\nECOG: 1\n\nTreatment Summary:\n- Initial surgical resection\n- Adjuvant radiation\n- Focal radiosurgery for limited recurrence\n- Successful maintenance of professional activities\n- Stable disease control over 10-year period\n\nRisk Factors Managed:\n- Diabetes\n- Age\n- WHO Grade II status\n- Occupation requiring high cognitive function\n\nLong-term Monitoring Plan:\n- Annual MRI\n- Diabetes management\n- Cognitive function assessment\n- Quality of life evaluation\n\nNote: Patient maintained relatively high functional status throughout treatment period, supporting aggressive initial intervention strategy. Occupation as researcher influenced treatment timing and modality choices to preserve cognitive function.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 65\nGender: Female\nBlood Type: O\nOccupation: Researcher\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive headaches, right facial numbness, balance issues\n\nMRI FINDINGS:\n- 2.8cm right sphenoid wing meningioma\n- Moderate peritumoral edema\n- Mass effect on temporal lobe\n- WHO Grade I (radiological features)\n\nASSESSMENT:\nDespite symptomatic presentation, considering patient's age, comorbidities (T2DM, HTN), and preference for conservative management. Tumor size borderline, location concerning but not immediately critical.\n\nPLAN:\n1. Conservative management with close monitoring\n2. Dexamethasone 4mg BID for edema management\n3. Monthly clinical follow-up initially\n4. Optimize diabetes management with endocrinology\nKPS: 80/100\nECOG: 1\n\nFOLLOW-UP - June 15, 2014\nSymptoms partially improved with steroids. Vision stable.\nMRI: No significant change\nPlan: Continue current management\nDexamethasone tapered to 2mg BID\n\nANNUAL FOLLOW-UP - March 2015\nStable symptoms\nMRI: Minimal growth (0.2cm)\nContinue monitoring\nKPS: 85/100\n\nFOLLOW-UP - March 2016\nMinor symptom progression\nMRI: Growth to 3.2cm\nDiscussed treatment options - patient prefers continued observation\nAdded prophylactic anticonvulsant\n\nFOLLOW-UP - March 2017\nStable clinical picture\nMRI: No significant change\nMaintaining work schedule with accommodations\nKPS: 80/100\n\nFOLLOW-UP - March 2018\nSome increase in headaches\nMRI: 3.4cm, increased edema\nReferred for radiation oncology consultation\nPatient opted for continued observation\nModified work schedule recommended\n\nFOLLOW-UP - March 2020\nPost-COVID telemedicine visit\nStable symptoms\nMRI: 3.5cm, stable edema\nContinue current management\n\nFOLLOW-UP - March 2022\nIncreasing balance issues\nMRI: 3.7cm\nDiscussed stereotactic radiosurgery\nPatient still preferring observation\nAdded physical therapy for balance\n\nCURRENT VISIT - January 2024\nSome progression of symptoms\nMRI: 3.9cm, moderate edema\nMaintaining independent function\nWorking part-time from home\nDiscussion of treatment options ongoing\n\nCURRENT STATUS:\nKPS Score: 70/100\nECOG Score: 2\n\nMANAGEMENT SUMMARY:\n- Successfully maintained conservative approach for 10 years\n- Regular MRI surveillance\n- Symptom management with medications\n- Work accommodations implemented\n- Quality of life preserved with minimal intervention\n- Patient able to continue modified research work\n\nRECOMMENDATIONS:\n1. Continue quarterly clinical monitoring\n2. MRI every 6 months\n3. Maintain current medications\n4. Consider SRS if further progression\n5. Continue PT/OT support\n6. Regular diabetes monitoring\n7. Cognitive assessment every 6 months\n\nWHO Grade: I (stable throughout monitoring period)\n\nNote: Conservative approach successful but reaching limits of observation-only management. Will need to strongly consider intervention if further progression occurs."
      }
    },
    {
      "demographics": {
        "age": 56,
        "gender": "Male",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": true
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Gradually worsening headaches over past 4 months, particularly in the morning",
          "Recent onset of blurred vision in right eye",
          "Episodes of nausea without vomiting",
          "Increasing difficulty concentrating at work on computer screens",
          "Subtle personality changes noted by spouse - more irritable than usual",
          "Occasional episodes of right-sided facial numbness",
          "Reports feeling off-balance when walking in past 2 weeks"
        ],
        "medical_history": [
          "Radiation therapy to head/neck region for childhood lymphoma at age 12",
          "Hypertension - diagnosed 3 years ago, managed with lisinopril",
          "BMI 33.2 - classified as Class I Obesity",
          "Sleep apnea diagnosed 2 years ago, uses CPAP",
          "Migraine headaches (infrequent) managed with sumatriptan PRN",
          "No history of seizures or neurological disorders",
          "No significant family history of brain tumors or cancer"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Additional consideration for radiation exposure history"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: M56-B-DS\nPrimary Diagnosis: Meningioma\nWHO Grade: II (Atypical Meningioma)\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms with concerning risk factors\nMRI Findings:\n- 4.2cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Evidence of brain-skull interface disruption\nAssessment: High-risk meningioma requiring immediate intervention due to:\n- Size >3cm\n- Significant symptomatology\n- History of radiation exposure\n- Critical location affecting cognitive function\nPlan: Recommend surgical resection within 2 weeks\n\nSURGICAL NOTE - April 1, 2014\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade: II\nFindings: Adherent to superior sagittal sinus\nPathology: WHO Grade II meningioma\nPost-op course: Uncomplicated\n\nFOLLOW-UP - July 1, 2014\nStatus: Improved symptoms\nMRI: Small residual tumor (0.8cm)\nPlan: Adjuvant radiation therapy recommended\n\nRADIATION ONCOLOGY - August-September 2014\nTreatment: IMRT 60 Gy in 30 fractions\nTolerance: Well-tolerated\n\nFOLLOW-UP - January 15, 2015\nStatus: Returned to work part-time\nMRI: Stable residual disease\nPlan: Continue q4 month monitoring\n\n2015-2016 VISITS (Q4 months):\n- Stable imaging\n- Gradual return to full work capacity\n- Minor right-sided facial numbness persisting\n\n2017-2018 VISITS (Q6 months):\n- No tumor progression\n- Maintained work performance\n- Regular CPAP compliance emphasized\n\n2019-2020 VISITS (Annual):\nFebruary 2019: Small area of enhancement noted\n- Increased monitoring frequency\n- Additional MR spectroscopy performed\n\n2021-2022:\n- Stable disease\n- Managing work-related screen time\n- Weight management program initiated\n\n2023-2024:\nJanuary 2024 (Most Recent Visit):\nStatus: Clinically stable\nMRI: No progression\nOccupational Impact: Successfully maintaining full-time work\nPlan: Continue annual monitoring\n\nCurrent Performance Status:\nKPS Score: 90 - Able to carry on normal activity with minor symptoms\nECOG Score: 1 - Restricted in physically strenuous activity but ambulatory\n\nTreatment Success Metrics:\n- Tumor control achieved\n- Maintained professional functionality\n- Quality of life preserved\n- Cognitive function stable\n\nLong-term Monitoring Plan:\n- Annual MRI with volumetric analysis\n- Biannual neurocognitive testing\n- Regular ophthalmological evaluation\n- Continued blood pressure monitoring\n\nNote: Early aggressive intervention strategy proved successful in maintaining patient's professional capacity and quality of life. Regular monitoring continues due to WHO Grade II status and radiation exposure history.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: B\nOccupation: Data Scientist\n\nINITIAL VISIT - March 15, 2014\nChief Complaint: Progressive neurological symptoms including headaches and visual changes\n\nIMAGING FINDINGS:\nMRI reveals a 2.8cm right frontal convexity meningioma with moderate peritumoral edema. No significant mass effect on adjacent structures. WHO Grade I characteristics on imaging.\n\nASSESSMENT:\nGiven patient's history of prior radiation exposure and current symptomatology, careful consideration of management approach is warranted. Despite symptomatic presentation, recommending initial conservative management with close monitoring due to:\n- Prior radiation exposure history complicating treatment options\n- Occupation requiring detailed cognitive function\n- Manageable current symptoms\n- Size just under 3cm threshold\n\nPLAN:\n1. Conservative management with vigilant monitoring\n2. MRI surveillance every 4 months initially\n3. Optimization of current medications:\n   - Increase lisinopril to better control BP\n   - Continue CPAP compliance\n4. Dexamethasone 4mg BID for edema management\n5. Occupational therapy referral for workplace adaptations\n\nFOLLOW-UP VISIT - July 20, 2014\nSymptoms slightly improved with steroid therapy. No tumor growth on follow-up MRI.\nMaintaining conservative approach. Patient reports better workplace function with adjusted computer setup.\n\nFOLLOW-UP - January 10, 2015\nStable imaging. Gradual steroid taper initiated. Patient managing work duties effectively.\n\nANNUAL REVIEW - March 2016\nTumor stable at 2.8cm. Symptoms well-controlled. Continuing surveillance.\n\nFOLLOW-UP - March 2017\nMinor growth to 2.9cm noted. Symptoms stable. Increasing MRI frequency to every 6 months.\n\nFOLLOW-UP - March 2018\nNo further growth. Patient maintaining good functional status at work. Continue current management.\n\nFOLLOW-UP - March 2020\nStable disease. Patient adapted well to remote work during pandemic. Visual symptoms stable.\n\nFOLLOW-UP - March 2022\nMinimal growth to 3.0cm. Discussing surgical options but maintaining conservative approach given stable symptoms.\n\nCURRENT VISIT - January 2024\nTumor stable at 3.0cm. Patient continues to work full-time with accommodations. Symptoms well-managed.\n\nCURRENT MANAGEMENT:\n- MRI surveillance every 6 months\n- Regular ophthalmology follow-up\n- Maintained weight loss program\n- Ergonomic workplace modifications\n- Sleep hygiene optimization\n\nFUNCTIONAL STATUS:\nKarnofsky Performance Score (KPS): 90\n- Able to carry on normal activity with minor symptoms\n\nECOG Performance Status: 1\n- Restricted in physically strenuous activity but ambulatory and able to carry out light work\n\nRECOMMENDATIONS:\nContinue conservative management with close monitoring. Surgical intervention to be considered only if significant progression or symptom worsening occurs.\n\n/Dr. [REDACTED]\nBoard Certified Neurosurgeon\nLicense #[REDACTED]"
      }
    },
    {
      "demographics": {
        "age": 60,
        "gender": "Female",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Librarian",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of nausea without vomiting",
          "Subtle personality changes noted by family - increased irritability",
          "Difficulty concentrating at work, especially when cataloging books",
          "Mild right-sided facial numbness that developed gradually",
          "Reports feeling unsteady when climbing library stairs",
          "Intermittent tinnitus in right ear"
        ],
        "medical_history": [
          "Hysterectomy at age 45 for uterine fibroids",
          "Migraine headaches since age 30, but pattern has changed recently",
          "Treated for hypertension for past 8 years - well controlled on lisinopril",
          "History of benign breast cysts - last mammogram normal 6 months ago",
          "Osteoarthritis in both knees",
          "No history of cancer",
          "No prior neurological conditions",
          "Family history significant for mother with breast cancer"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nSex: Female | Age: 60 | Blood Type: O\nOccupation: Librarian\n\nINITIAL VISIT - January 15, 2018\nChief Complaint: Progressive headaches, visual changes, and neurological symptoms\n\nIMAGING:\nMRI reveals 4.2cm right sphenoid wing meningioma with significant peritumoral edema\n- Mass effect on temporal lobe\n- Compression of optic nerve\n- Enhancement pattern suggestive of WHO Grade I/II\n- Evidence of dural tail sign\n\nASSESSMENT:\nGiven size >3cm, location, and progressive symptoms affecting daily function, immediate surgical intervention recommended. Occupation requires precise visual and cognitive function, making conservative management suboptimal.\n\nPLAN:\n1. Schedule craniotomy within 2 weeks\n2. Pre-operative optimization with dexamethasone 4mg QID\n3. Detailed visual field testing\n4. Neurocognitive assessment\n\nSURGICAL NOTE - January 30, 2018\n- Simpson Grade II resection achieved\n- Minimal residual tumor at cavernous sinus\n- Pathology: WHO Grade II meningioma\n- No immediate complications\n\nFOLLOW-UP - April 15, 2018\n- Improved vision and headaches\n- Post-op MRI shows small residual tumor\n- Recommended adjuvant radiotherapy\n- Started 54 Gy/30 fractions\n\nFOLLOW-UP - October 20, 2018\n- Post-radiation MRI stable\n- Return to work with accommodations\n- Mild fatigue persisting\n\nANNUAL FOLLOW-UP - January 2019\n- MRI stable\n- Returned to full work duties\n- No new neurological symptoms\n\nFOLLOW-UP - July 2020\n- Surveillance MRI shows small area of enhancement\n- Watchful waiting approach\n- Continue q6month monitoring\n\nFOLLOW-UP - January 2021\n- Slight progression of residual tumor\n- Gamma Knife radiosurgery to residual (14 Gy)\n- Maintaining work schedule with modifications\n\nFOLLOW-UP - July 2022\n- Post-SRS MRI shows tumor control\n- Minor radiation changes\n- Stable symptoms\n\nFOLLOW-UP - January 2023\n- Continued stability on imaging\n- Managing well at work\n- Annual monitoring recommended\n\nLATEST FOLLOW-UP - January 2024\n- MRI stable\n- No new symptoms\n- Continues library work with accommodations\n- Plan: Continue annual MRI surveillance\n\nFUNCTIONAL STATUS:\nKPS Score: 90 - Able to carry on normal activity with minor symptoms\nECOG Score: 1 - Restricted in physically strenuous activity but ambulatory\n\nONGOING MONITORING:\n- Biannual MRI through 2025\n- Annual neurocognitive assessment\n- Regular ophthalmology follow-up\n- Quality of life assessments\n\nNote: Aggressive initial approach with early surgical intervention and adjuvant therapy has resulted in good tumor control and maintained functional status, allowing patient to continue professional activities with minimal limitation.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: O\nOccupation: Librarian\nWHO Grade: I (confirmed via imaging characteristics)\n\nINITIAL VISIT - January 15, 2018\nChief Complaint: Progressive neurological symptoms with right-sided predominance\nMRI Findings: 2.4 cm right sphenoid wing meningioma, minimal peritumoral edema\nKPS Score: 90\nECOG Score: 1\n\nAssessment & Plan:\nGiven the size <3cm and minimal edema, recommending conservative management with close monitoring. Occupation requires cognitive clarity and physical stability - symptoms affecting work performance but not severely limiting.\n\nRecommendations:\n1. MRI surveillance every 6 months initially\n2. Medical management:\n   - Dexamethasone 4mg daily for 2 weeks, then taper\n   - Continue lisinopril for BP control\n   - Prophylactic anticonvulsant not indicated\n3. Occupational modifications:\n   - Temporary reassignment from tasks requiring prolonged concentration\n   - Avoid ladder/stair climbing when alone\n\nFOLLOW-UP VISIT - July 20, 2018\nTumor stable at 2.4 cm\nSymptoms: Moderate improvement in headaches post-steroid course\nPlan: Continue monitoring\n\nANNUAL VISIT - January 10, 2019\nMRI: Minimal growth (2.5 cm)\nSymptoms: Stable\nPlan: Extended monitoring interval to annual\n\nANNUAL VISIT - January 15, 2020\nMRI: Stable at 2.5 cm\nNotable improvement in work functionality\nPlan: Maintain annual surveillance\n\nANNUAL VISIT - January 12, 2021\nMRI: No growth\nSymptoms: Well-controlled\nAdded balance exercises to daily routine\nPlan: Continue annual monitoring\n\nANNUAL VISIT - January 18, 2022\nMRI: Stable disease\nPatient managing work duties effectively\nMinor visual symptoms persist but stable\nPlan: Maintain current approach\n\nANNUAL VISIT - January 20, 2023\nMRI: No progression\nQuality of life well-maintained\nRetired from library work\nPlan: Continue annual surveillance\n\nRECENT VISIT - January 15, 2024\nMRI: Stable at 2.5 cm\nSymptoms: Well-adapted to limitations\nCurrently volunteering part-time at local library\nPlan: Consider biennial MRI monitoring given long-term stability\n\nCurrent Status:\nKPS Score: 90\nECOG Score: 1\n\nSUMMARY OF CONSERVATIVE MANAGEMENT SUCCESS:\n- Tumor size remained stable over 6-year period\n- Successful symptom management with minimal intervention\n- Maintained professional functionality until planned retirement\n- Quality of life preserved through conservative approach\n- Patient adapted well to modified activity levels\n- No surgical intervention required\n\nLong-term Monitoring Plan:\n- Continue biennial MRI\n- Annual neurological examinations\n- Monitor vision and balance\n- Maintain BP control\n- Regular quality of life assessments\n\nThe conservative management approach has proven successful for this patient, with stable disease and well-maintained quality of life over a 6-year period. The patient's transition from full-time work to retirement and voluntary activities has been well-managed, with appropriate adaptations to activity levels."
      }
    },
    {
      "demographics": {
        "age": 65,
        "gender": "Female",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Data Scientist",
          "olfactory_profession": "Perfumer",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over past 4 months, worse in morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of confusion and difficulty concentrating at work",
          "Subtle personality changes noted by family members",
          "Mild right-sided facial numbness",
          "Balance difficulties when walking, particularly in dimly lit areas",
          "Increased fatigue and drowsiness during daytime"
        ],
        "medical_history": [
          "Hypertension - controlled with lisinopril 10mg daily",
          "Migraine headaches since age 40 - previously managed with sumatriptan PRN",
          "Menopause at age 52",
          "Osteoporosis diagnosed at age 60 - on calcium and vitamin D supplements",
          "Previous surgery for carpal tunnel syndrome (right wrist) in 2018",
          "Family history of breast cancer (mother)",
          "No history of smoking or significant alcohol use",
          "Regular mammograms and health screenings up to date"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: A\nOccupation: Data Scientist/Perfumer\n\nINITIAL VISIT - January 15, 2018\nChief Complaint: Progressive headaches, visual changes, cognitive symptoms\nWHO Grade: II (confirmed post-resection)\n\nIMAGING FINDINGS:\n- MRI reveals 4.2cm left frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- Enhancement pattern suggests possible WHO Grade II\n- Evidence of dural tail sign\n\nASSESSMENT:\nGiven patient's professional cognitive demands and progressive neurological symptoms, immediate surgical intervention recommended. Size >3cm and presence of edema indicate higher risk profile.\n\nTREATMENT PLAN:\n1. Schedule urgent surgical resection\n2. Simpson Grade I resection planned\n3. Pre-operative optimization of blood pressure\n4. Neuropsychological testing baseline\n\nFOLLOW-UP VISIT - March 30, 2018 (Post-operative)\n- Successful gross total resection achieved\n- Pathology confirms WHO Grade II meningioma\n- Minimal post-operative complications\n- Initial improvement in headaches and vision\n- Recommended adjuvant radiation therapy\n\nFOLLOW-UP - September 15, 2018\n- Post-radiation therapy assessment\n- Completed 54 Gy in 30 fractions\n- Improved cognitive function\n- Returned to work part-time\n- MRI shows no residual tumor\n\nFOLLOW-UP - March 2019\n- 6-month surveillance MRI stable\n- Improved work performance\n- Continue q6month imaging\n\n2020 VISITS (March and September)\n- Stable imaging\n- Minor headaches managed with acetaminophen\n- Full return to work activities\n- Maintaining perfumer work with appropriate PPE\n\n2021 VISITS (March and September)\n- Small area of enhancement noted on September MRI\n- Close monitoring recommended\n- Increased frequency of imaging to q4months\n\n2022 VISITS (January, May, September)\n- January: Enhancement stable\n- May: Slight progression\n- September: Decision for focused radiation (SRS)\n\n2023 VISITS (March, September)\n- Post-SRS response favorable\n- No new neurological symptoms\n- Continuing work with accommodations\n\n2024 CURRENT STATUS (January)\n- Stable disease\n- Maintaining professional activities\n- Regular monitoring continues\n\nFUNCTIONAL STATUS SCORES:\nKPS: 90 - Able to carry on normal activity with minor symptoms\nECOG: 1 - Restricted in physically strenuous activity but ambulatory\n\nMONITORING PROTOCOL:\n- MRI with contrast q4months\n- Neuropsychological testing annually\n- Occupational therapy assessment as needed\n- Special attention to olfactory function given perfumer occupation\n\nONGOING CONSIDERATIONS:\n1. Cognitive monitoring crucial for data science work\n2. Olfactory preservation essential for perfumer occupation\n3. Regular assessment of work-related chemical exposure\n4. Stress management strategies for high-cognitive demand profession",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nBlood Type: A\nOccupation: Data Scientist/Perfumer\n\nINITIAL VISIT - January 15, 2018\nChief Complaint: Progressive headaches, visual changes, cognitive symptoms\nMRI Findings: 2.8cm left frontal convexity meningioma, minimal surrounding edema\nWHO Grade: I (presumptive, based on imaging characteristics)\nAssessment: Given size <3cm and minimal edema, candidate for watchful waiting with close monitoring\nPlan: \n- MRI surveillance every 6 months initially\n- Continue lisinopril 10mg daily\n- Occupational considerations: Recommend workstation ergonomic assessment\n- Monitor cognitive function due to data analysis work requirements\nKPS: 90 | ECOG: 1\n\nFOLLOW-UP - July 20, 2018\nInterval MRI: No significant change in tumor size\nSymptoms: Headaches improved with position modification and sleep hygiene\nPlan: Continue conservative management\nNote: Discussed potential chemical sensitivity issues related to perfumer occupation\n\nFOLLOW-UP - January 10, 2019\nInterval MRI: Stable\nSymptoms: Visual symptoms stable, cognitive function adequate for work\nPlan: Extend MRI interval to annual if stable at next visit\nKPS: 90 | ECOG: 1\n\nFOLLOW-UP - January 15, 2020\nInterval MRI: Minimal growth (0.2mm), not clinically significant\nSymptoms: Well-controlled with current management\nPlan: Annual MRI continuation\nNote: Successfully managing work responsibilities\n\nFOLLOW-UP - January 20, 2021\nInterval MRI: Stable\nSymptoms: Occasional headaches, managed with lifestyle modifications\nPlan: Continue annual imaging\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - January 18, 2022\nInterval MRI: No significant change\nSymptoms: Stable\nNote: Adapted work schedule to manage fatigue\nPlan: Continue conservative approach\nKPS: 85 | ECOG: 1\n\nFOLLOW-UP - January 16, 2023\nInterval MRI: Stable disease\nSymptoms: Well-managed with current approach\nPlan: Continue annual surveillance\nNote: Maintaining good work-life balance\n\nCURRENT VISIT - January 15, 2024\nInterval MRI: No significant change over 6-year period\nSymptoms: Stable and manageable\nCurrent Management:\n- Annual MRI surveillance\n- Regular cognitive assessments\n- Lifestyle modifications including:\n  * Regulated work hours\n  * Ergonomic workspace\n  * Limited exposure to strong fragrances\n  * Regular exercise program\n  * Sleep hygiene protocol\n\nQuality of Life Measures:\n- Maintaining independent work status\n- Good social engagement\n- Adequate cognitive function for job requirements\n\nCurrent Status:\nKPS: 80 | ECOG: 1\n\nSUMMARY OF CONSERVATIVE MANAGEMENT SUCCESS:\n- Stable disease over 6-year period\n- Maintained professional activities\n- Well-managed symptoms\n- Avoided surgical intervention\n- Preserved quality of life\n\nLong-term Recommendations:\n1. Continue annual MRI surveillance\n2. Regular cognitive assessments\n3. Maintain current lifestyle modifications\n4. Monitor for any new neurological symptoms\n5. Regular blood pressure monitoring\n6. Annual ophthalmological examination\n\nThe conservative management approach has proven successful for this patient, allowing maintenance of professional activities and quality of life while avoiding surgical risks."
      }
    },
    {
      "demographics": {
        "age": 56,
        "gender": "Female",
        "blood_type": "B",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Perfumer",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": true,
        "medical_radiation_exposure": true
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 6 months, worse in the morning",
          "Recent onset of blurred vision in right eye",
          "Occasional episodes of dizziness and loss of balance",
          "Increased fatigue and difficulty concentrating at work",
          "Subtle personality changes noted by coworkers",
          "Mild right-sided facial numbness developing over past 3 months",
          "Reported decreased sense of smell affecting work as perfumer"
        ],
        "medical_history": [
          "Radiation therapy to head/neck region for childhood thyroid condition at age 12",
          "BMI 33.2 (Obesity Class I)",
          "Hypertension diagnosed 3 years ago, controlled with lisinopril",
          "Migraine headaches since age 30, but notes recent change in pattern",
          "No history of seizures or neurological disorders",
          "No family history of brain tumors",
          "Regular computer use with extended screen time in software development role",
          "Recent eye examination 2 months ago showing slight papilledema"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function",
            "Additional consideration for radiation exposure history"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - MENINGIOMA CASE\nPatient ID: F56-B\nOccupation: Software Developer/Perfumer\n\nINITIAL VISIT - March 15, 2018\nMRI FINDINGS:\n- 4.2cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on right frontal lobe\n- Compression of olfactory tract\nWHO Grade: II (atypical features noted)\n\nASSESSMENT:\nHigh-risk features present:\n- Size >3cm\n- Significant peritumoral edema\n- Critical location affecting olfactory function\n- Occupational impact (perfumer requiring olfactory acuity)\n- Prior radiation exposure history\n- Progressive neurological symptoms\n\nTREATMENT PLAN:\nRecommend immediate surgical intervention due to:\n1. Tumor size and location\n2. Progressive symptoms\n3. Occupational implications\n4. Prior radiation exposure increasing recurrence risk\n\n-------------------\n\nPOST-OPERATIVE NOTE - April 2, 2018\n- Simpson Grade II resection achieved\n- Minor residual tumor at skull base\n- Post-op MRI confirms >95% resection\n- Adjuvant radiotherapy recommended\n\n-------------------\n\nFOLLOW-UP - October 15, 2018\n- Improved vision and headaches\n- Partial recovery of olfactory function\n- Completed 54Gy/30fx radiation therapy\n- MRI shows no progression\n- Returned to work with accommodations\n\n-------------------\n\nFOLLOW-UP - April 20, 2019\n- Stable neurological exam\n- MRI stable\n- Continuing biannual monitoring\n- Partial olfactory function recovery\n\n-------------------\n\nFOLLOW-UP - March 10, 2020\n- MRI stable\n- No new symptoms\n- Working full-time\n- Olfactory function improved to 70%\n\n-------------------\n\nFOLLOW-UP - September 15, 2021\n- Small area of enhancement noted on MRI\n- Watchful waiting approach\n- Close monitoring implemented\n- Occupational function stable\n\n-------------------\n\nFOLLOW-UP - March 20, 2022\n- Enhancement stable\n- No new symptoms\n- Annual MRI recommended\n- Maintaining work performance\n\n-------------------\n\nFOLLOW-UP - April 5, 2023\n- MRI stable\n- No recurrence\n- Full occupational function\n- Regular monitoring continued\n\n-------------------\n\nLATEST FOLLOW-UP - February 10, 2024\n- MRI shows continued stability\n- No new symptoms\n- Excellent functional status\n- Maintaining regular follow-up schedule\n\nCURRENT STATUS:\nKPS Score: 90/100 (Able to carry on normal activity with minor symptoms)\nECOG Score: 1 (Restricted in physically strenuous activity but ambulatory)\n\nMONITORING PLAN:\n- Continue biannual MRI through 2025\n- Annual MRI thereafter if stable\n- Regular neurocognitive assessment\n- Occupational function monitoring\n- Quality of life assessments\n\nWHO Grade II classification maintained throughout follow-up period.",
        "conservative": "CLINICAL NOTES - MENINGIOMA CASE MANAGEMENT\nPatient ID: [REDACTED]\nSex: Female | Age: 56 | Blood Type: B\nOccupation: Software Developer/Perfumer\nWHO Grade: I (Confirmed via imaging characteristics)\n\nINITIAL VISIT - March 15, 2018\n----------------------------------------\nIMAGING FINDINGS:\n- MRI reveals 2.4cm left frontal convexity meningioma\n- Minimal surrounding edema\n- No significant mass effect\n- Dural tail sign present\n- T2 signal: moderately hypointense\n\nASSESSMENT:\nDespite symptomatic presentation, recommending conservative management given:\n- Moderate tumor size <3cm\n- Patient's preference for non-surgical approach\n- Stable neurological status\n- Occupational considerations\n\nMANAGEMENT PLAN:\n1. Watchful waiting with close monitoring\n2. Symptom management:\n   - Dexamethasone 4mg BID for 2 weeks, then taper\n   - Prophylactic anticonvulsant not indicated\n3. Occupational modifications:\n   - Ergonomic workplace assessment\n   - Regular screen breaks\n   - Blue light filtering glasses\n\nFOLLOW-UP: 3 months\n\n6-MONTH FOLLOW-UP - September 20, 2018\n----------------------------------------\n- Headaches improved with steroid course\n- Vision symptoms stable\n- No new neurological deficits\n- MRI: No significant change in tumor size\n- Continuing conservative management\n\nANNUAL FOLLOW-UP - March 18, 2019\n----------------------------------------\n- Stable symptoms\n- MRI: No growth\n- Patient adapting well to workplace modifications\n- Maintaining conservative approach\n\n2-YEAR FOLLOW-UP - March 15, 2020\n----------------------------------------\n- Minor progression of visual symptoms\n- MRI: 2.6cm (0.2cm growth over 2 years)\n- Discussed surgical options but patient prefers continued observation\n- Added: Vitamin D supplementation and lifestyle modifications\n\n3-YEAR FOLLOW-UP - March 22, 2021\n----------------------------------------\n- Stable symptoms\n- MRI: No additional growth\n- Patient successfully managing work with accommodations\n- Continuing conservative approach\n\n4-YEAR FOLLOW-UP - March 17, 2022\n----------------------------------------\n- Well-controlled symptoms\n- MRI: Stable at 2.6cm\n- Patient satisfied with management approach\n- Maintaining good quality of life\n\n5-YEAR FOLLOW-UP - March 20, 2023\n----------------------------------------\n- No new neurological symptoms\n- MRI: Stable disease\n- Transitioned to biennial imaging\n- Patient continues to work effectively\n\nCURRENT VISIT - March 15, 2024\n----------------------------------------\n- Stable clinical picture\n- MRI: No growth since 2021\n- Patient maintaining good functional status\n- Next imaging scheduled for March 2026\n\nFUNCTIONAL STATUS SCORES:\n- Karnofsky Performance Status (KPS): 90\n- ECOG Performance Status: 1\n\nONGOING RECOMMENDATIONS:\n1. Biennial MRI surveillance\n2. Regular ophthalmological evaluations\n3. Continued workplace accommodations\n4. Maintenance of healthy lifestyle\n5. Regular cognitive assessments\n6. Quality of life monitoring\n\nNote: Conservative management has proven successful with this patient, maintaining good quality of life and occupational function while avoiding surgical risks. Will continue current approach unless significant progression occurs."
      }
    },
    {
      "demographics": {
        "age": 44,
        "gender": "Male",
        "blood_type": "A",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Software Developer",
          "olfactory_profession": "Chef",
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months becoming more severe in mornings, intermittent blurred vision in right eye, occasional episodes of nausea, recent onset of clumsiness in left hand when typing, difficulty concentrating during work hours, one episode of focal seizure affecting left arm two weeks ago"
        ],
        "medical_history": [
          "Migraine headaches since age 35 (previously well-controlled with sumatriptan), mild hypertension diagnosed 2 years ago (managed with lifestyle modifications), concussion from sports injury at age 22 with full recovery, family history of brain tumor in maternal aunt, no history of cancer, non-smoker, occasional alcohol use"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation",
            "Critical to preserve olfactory function"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Extra careful approach near olfactory structures",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\nAge: 44\nGender: Male\nBlood Type: A\nOccupation: Software Developer/Chef\n\nINITIAL VISIT - March 15, 2018\nPresenting Symptoms:\n- Progressive headaches (3-month duration)\n- Morning headache severity\n- Right eye blurred vision\n- Left hand coordination issues\n- Work concentration difficulties\n- Recent focal seizure (left arm)\n- Nausea episodes\n\nInitial MRI Findings:\n- 4.2 cm right frontal convexity meningioma\n- Significant peritumoral edema\n- Mass effect on adjacent frontal lobe\n- No calcification noted\nWHO Grade: II (confirmed post-resection)\nTreatment Decision: Immediate surgical intervention recommended\n\nSURGICAL NOTE - April 2, 2018\nProcedure: Right frontal craniotomy with Simpson Grade II resection\nFindings: Adherent to superior sagittal sinus\nPathology: WHO Grade II meningioma\nPost-op Course: Uncomplicated\n\nFOLLOW-UP VISITS:\n\nJuly 15, 2018 (3 months post-op)\n- Improved headaches\n- Residual minor left hand weakness\n- Started adjuvant radiotherapy\n- MRI: No residual tumor\nPlan: Continue RT, quarterly monitoring\n\nJanuary 10, 2019 (9 months post-op)\n- Completed RT (60 Gy/30 fractions)\n- Return to work part-time\n- MRI: Stable\nPlan: Continue q3month monitoring\n\nApril 15, 2019\n- Full work resumption\n- Improved hand coordination\n- MRI: Stable\nPlan: Continue monitoring\n\n2020 (Quarterly Visits)\n- All MRIs stable\n- Minor fatigue\n- Full work capacity\nPlan: Extended monitoring interval to 6 months\n\n2021-2022 (Biannual Visits)\n- Stable imaging\n- No new symptoms\n- Regular work schedule maintained\nPlan: Continue current protocol\n\nJanuary 2023\n- Small enhancement on MRI\n- Asymptomatic\nPlan: Increased monitoring frequency\n\nJune 2023\n- Growth of enhancement (0.8cm)\nPlan: SRS to residual tumor\n\nDecember 2023\n- Post-SRS MRI stable\n- Asymptomatic\nPlan: Continue q3month monitoring\n\nMarch 2024 (Current)\n- Stable imaging\n- Maintaining full work schedule\n- No new neurological symptoms\n\nCurrent Status:\nKPS Score: 90/100\nECOG Score: 1\n\nLong-term Monitoring Plan:\n- Q3month MRI through 2024\n- Biannual neuropsychological testing\n- Annual ophthalmological evaluation\n- Regular seizure prophylaxis review\n\nOccupational Considerations:\n- Computer work requires continued monitoring of visual symptoms\n- Kitchen work assessed for safety with neurology input\n- Ergonomic workplace modifications implemented\n\nNote: Aggressive initial approach with early intervention and consistent monitoring has resulted in good disease control. Patient maintains high functional status with minimal impact on dual careers.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\n==================================================\n\nINITIAL VISIT - March 15, 2018\n-----------------------------\nPatient: 44-year-old male software developer/chef\nPresenting Symptoms: Progressive headaches (3 months), right eye blurred vision, left hand clumsiness, concentration issues, recent focal seizure\nMRI Findings: 2.8cm right frontal convexity meningioma, minimal perilesional edema, WHO Grade I characteristics\nKPS: 90/100 | ECOG: 1\n\nAssessment & Plan:\n- Given size <3cm and minimal edema, recommending close monitoring over immediate surgical intervention\n- Anticonvulsant therapy initiated: Levetiracetam 500mg BID\n- Dexamethasone 4mg daily for symptom management\n- Occupational considerations: Will impact both computer work and kitchen duties\n- Monthly follow-up initially\n\nFOLLOW-UP - June 20, 2018\n-------------------------\nSymptoms improved with medical management\nMRI: Stable lesion size\nPlan: Continue current medications\nReduced dexamethasone to 2mg daily\nReturn to work with modifications\n\nANNUAL FOLLOW-UP - March 2019\n----------------------------\nMRI: No growth\nSymptoms stable\nKPS: 90/100 | ECOG: 1\nMaintaining work schedule with accommodations\nContinue current management\n\nANNUAL FOLLOW-UP - March 2020\n----------------------------\nMRI: Minimal growth (0.2cm)\nHeadaches well-controlled\nContinuing conservative management\nAdded ergonomic workplace modifications\n\nANNUAL FOLLOW-UP - March 2021\n----------------------------\nMRI: Stable\nPatient adapted well to modified work routine\nKPS: 85/100 | ECOG: 1\nContinue monitoring\n\nANNUAL FOLLOW-UP - March 2022\n----------------------------\nMRI: No significant changes\nQuality of life maintained\nReduced levetiracetam to 250mg BID\nNo seizures in past 2 years\n\nANNUAL FOLLOW-UP - March 2023\n----------------------------\nMRI: Stable disease\nPatient managing well with current approach\nKPS: 85/100 | ECOG: 1\nTransitioned to biennial imaging\n\nLATEST FOLLOW-UP - March 2024\n----------------------------\nMRI: No significant changes over 6 years\nPatient satisfied with conservative management\nMaintaining modified work schedule\nQuality of life preserved\n\nCurrent Status:\nKPS Score: 85/100\nECOG Score: 1\n\nWHO Grade: I (based on imaging characteristics)\n\nLong-term Recommendations:\n1. Continue biennial MRI surveillance\n2. Maintain anticonvulsant therapy\n3. Regular occupational therapy assessments\n4. Ergonomic workplace modifications\n5. Stress management techniques\n6. Regular blood pressure monitoring\n\nThe conservative management approach has proven successful with this patient, maintaining good quality of life and work capability while avoiding surgical risks. Will continue monitoring with low threshold for intervention if significant changes occur."
      }
    },
    {
      "demographics": {
        "age": 60,
        "gender": "Male",
        "blood_type": "O",
        "occupation": {
          "knowledge_worker": true,
          "knowledge_worker_profession": "Researcher",
          "olfactory_profession": false,
          "stage_artist": false
        }
      },
      "medical_factors": {
        "diabetes": false,
        "pregnancy": false,
        "obesity": false,
        "medical_radiation_exposure": false
      },
      "clinical_data": {
        "presenting_symptoms": [
          "Progressive headaches over 3 months becoming more severe in mornings, intermittent blurred vision in right eye, occasional balance difficulties when walking, subtle personality changes noted by spouse including increased irritability, one episode of focal seizure affecting left hand 2 weeks ago, mild confusion with word-finding difficulties"
        ],
        "medical_history": [
          "Hypertension controlled with lisinopril 10mg daily, migraine headaches in 30s that resolved, surgical removal of appendix in 1985, family history of father with lung cancer, no prior neurological conditions, no history of head trauma, non-smoker, occasional alcohol use (2-3 drinks/week), occupational exposure to laboratory chemicals as researcher but uses appropriate PPE, annual physicals all normal until current symptoms began"
        ],
        "treatment_path": {
          "initial_action": "Immediate Imaging",
          "imaging_type": "MRI",
          "steps": [
            "Immediate comprehensive imaging ordered",
            "Heightened concern for cognitive/functional preservation"
          ],
          "monitoring_plan": "Monthly cognitive assessments, MRI every 3 months",
          "surgical_approach": "Microsurgical resection with intraoperative monitoring",
          "radiation_needed": false,
          "follow_up": "Regular monitoring with Monthly cognitive assessments, MRI every 3 months, immediate imaging for any new symptoms"
        }
      },
      "clinical_notes": {
        "aggressive": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n60-year-old male, Blood Type O\nOccupation: Research Scientist\n\nINITIAL VISIT - March 15, 2014\nPresenting Symptoms: Progressive headaches (3 months), right eye blurred vision, gait instability, personality changes, recent focal seizure (left hand), word-finding difficulties.\nImaging: MRI reveals 4.2cm right frontal convexity meningioma with significant peritumoral edema, mass effect on adjacent frontal lobe. T2 hyperintense with heterogeneous enhancement.\nWHO Grade: Suspected Grade II (based on imaging characteristics)\nPlan: Recommend immediate surgical intervention due to size, symptoms, and critical location.\n\nSURGICAL INTERVENTION - April 2, 2014\nProcedure: Right frontal craniotomy for tumor resection\nSimpson Grade II resection achieved\nPathology: WHO Grade II atypical meningioma\nPost-op course: Uncomplicated\n\nFOLLOW-UP VISIT - July 15, 2014\nStatus: Improved symptoms, minimal residual word-finding difficulties\nTreatment: Completed adjuvant radiation therapy (60 Gy/30 fractions)\nImaging: Post-radiation MRI shows no residual tumor\nPlan: q6month MRI surveillance\n\n2015 VISITS (January & July)\nStatus: Stable, returned to research work with accommodations\nImaging: No recurrence\nNeurological exam: Normal\n\n2016 VISITS (January & July)\nStatus: Maintaining function, occasional mild headaches\nImaging: Small enhancement at surgical site (July) - close monitoring advised\nPlan: Continue q6month surveillance\n\n2017 VISITS (January & July)\nStatus: Stable\nImaging: Enhancement stable, no progression\nNeurological exam: Intact\n\n2018 VISITS (January & July)\nStatus: Reports increased work-related stress\nImaging: Slight increase in enhancement\nPlan: More frequent MRI monitoring (q4months)\n\n2019 VISITS (Q4monthly)\nMarch: Small focus of recurrence noted\nJune: Decision for repeat surgery\nAugust: Second craniotomy performed\nPathology: Confirmed Grade II recurrence\nDecember: Post-op recovery satisfactory\n\n2020-2021 VISITS (Q6monthly)\nStatus: Stable post second surgery\nImaging: No evidence of recurrence\nPlan: Continued surveillance\n\n2022-2023 VISITS (Q6monthly)\nStatus: Maintained good functional status\nImaging: Stable post-treatment changes\nOccupational status: Modified research duties\n\nCURRENT STATUS (2024)\nPatient maintains good functional status with minimal deficits\nRegular MRI surveillance continues\nWorking part-time in research capacity\n\nPERFORMANCE SCORES:\nKPS: 90 (Able to carry on normal activity with minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nMONITORING PROTOCOL:\n- MRI with contrast q6months\n- Neurological examination q6months\n- Cognitive assessment annually\n- Quality of life assessments q6months\n- Occupational exposure monitoring\n- Seizure prophylaxis maintained\n\nLONG-TERM RECOMMENDATIONS:\n1. Continue surveillance imaging\n2. Maintain modified work schedule\n3. Regular cognitive assessments\n4. Monitor for radiation-induced changes\n5. Lifestyle modifications to reduce stress\n\nNote: This case demonstrates the importance of aggressive initial intervention and close monitoring in WHO Grade II meningiomas, particularly given the patient's cognitive-demanding occupation.",
        "conservative": "CLINICAL NOTES - NEUROSURGERY DEPARTMENT\nPatient ID: [REDACTED]\n60-year-old male, Blood Type O\nOccupation: Research Scientist\n\nINITIAL VISIT - January 15, 2018\nPresenting Symptoms: Progressive headaches (3 months), morning predominance, right eye visual disturbance, gait imbalance, personality changes, recent focal seizure (left hand), word-finding difficulties.\nImaging: MRI reveals 2.8cm right frontal convexity meningioma with moderate peritumoral edema\nWHO Grade: I (presumptive based on imaging characteristics)\nAssessment: Symptomatic meningioma requiring intervention due to progressive neurological symptoms\nPlan: Given patient's research career and need for cognitive preservation, recommending stereotactic radiosurgery (SRS) over surgical resection.\n\nFOLLOW-UP - April 20, 2018 (3 months post-SRS)\nSymptoms: Headaches improved, vision stable, no new seizures\nImaging: Stable lesion size, slight decrease in edema\nPlan: Continue anticonvulsant (Levetiracetam 500mg BID)\nOccupational status: Returned to research work with minor accommodations\n\nFOLLOW-UP - October 15, 2018\nSymptoms: Further improvement in headaches, no seizures\nImaging: Stable\nPlan: Continue current management, gradual tapering of dexamethasone\n\nANNUAL FOLLOW-UP - January 2019\nStatus: Clinically stable, maintaining work schedule\nImaging: Minor reduction in tumor volume\nPlan: Continue monitoring, maintain anticonvulsants\n\nANNUAL FOLLOW-UP - January 2020\nStatus: Well-controlled symptoms\nImaging: Stable disease\nPlan: Extended monitoring interval to 18 months\n\nFOLLOW-UP - July 2021\nStatus: Occasional mild headaches\nImaging: No progression\nPlan: Consider anticonvulsant discontinuation if seizure-free\n\nFOLLOW-UP - July 2022\nStatus: Successfully weaned off anticonvulsants\nImaging: Continued stability\nPlan: Annual monitoring\n\nFOLLOW-UP - July 2023\nStatus: Maintaining good functional status\nImaging: Stable disease with signs of radiation-induced changes\nPlan: Continue annual monitoring\n\nLATEST FOLLOW-UP - January 2024\nStatus: Stable neurological exam, continues research work\nImaging: No progression\nQuality of life: Excellent, fully independent\nPlan: Continue annual MRI surveillance\n\nCurrent Performance Status:\nKPS: 90 (Able to carry on normal activity, minor symptoms)\nECOG: 1 (Restricted in physically strenuous activity but ambulatory)\n\nTreatment Summary:\n- Initial SRS treatment (February 2018): 14 Gy single fraction\n- Conservative management strategy successful\n- Maintained cognitive function crucial for research work\n- No surgical intervention required\n- Excellent quality of life preservation\n\nLong-term Monitoring Plan:\n- Annual MRI surveillance\n- Neurological examination annually\n- Cognitive function assessment annually\n- Occupational therapy assessment as needed\n- Regular blood pressure monitoring with PCP\n\nNote: Patient has maintained excellent compliance with follow-up schedule and demonstrates successful outcome with conservative management approach."
      }
    }
  ],
  "metadata": {
    "total_cases": 100,
    "data_version": "1.0"
  }
}